data_2j5d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2j5d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -57.09 -56.96 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.483 2.122 . . . . 0.0 112.739 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.4 p -65.19 -35.6 81.59 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.92 -61.84 2.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.725 0.81 . . . . 0.0 111.922 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -45.43 73.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.837 0.855 . . . . 0.0 113.288 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.54 -53.82 53.8 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.662 0.601 . . . . 0.0 112.025 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 91.6 p -63.59 -42.13 98.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -64.69 -43.04 94.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.33 -41.66 97.39 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.0 mt -54.4 -50.52 67.37 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.579 0.752 . . . . 0.0 111.923 170.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.42 93.63 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.73 -50.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.483 0.713 . . . . 0.0 111.402 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.65 91.8 Favored Glycine 0 CA--C 1.545 1.943 0 O-C-N 123.687 0.617 . . . . 0.0 112.114 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 38.1 tp -57.86 -44.1 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.522 -0.839 . . . . 0.0 111.897 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.02 92.85 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.84 0.733 . . . . 0.0 113.868 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.32 -47.0 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.954 0.901 . . . . 0.0 110.494 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.67 -46.13 89.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 113.027 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.49 -42.25 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.42 1.088 . . . . 0.0 111.577 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.19 55.36 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 124.092 0.853 . . . . 0.0 111.821 170.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.403 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 20.4 t80 . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 26.6 tp -55.49 -44.03 99.44 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.117 -1.42 . . . . 0.0 114.822 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.79 -47.92 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.649 2.232 . . . . 0.0 113.488 172.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 68.4 m -57.12 -35.86 69.98 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.65 -56.26 23.63 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.021 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.39 -40.01 85.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 113.503 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.08 -43.85 82.55 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 57.7 p -68.76 -28.37 66.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -61.99 -45.03 95.42 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 67.2 mt -58.0 -45.27 87.12 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.405 0.682 . . . . 0.0 111.997 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.13 -50.98 63.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.079 1.352 . . . . 0.0 112.633 170.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.78 83.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.477 1.111 . . . . 0.0 113.753 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.59 -45.17 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 0.0 111.587 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.88 -49.05 73.83 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.611 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.89 -41.42 78.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 112.995 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.35 -47.01 78.0 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.99 1.281 . . . . 0.0 112.738 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.33 -42.34 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.394 0.677 . . . . 0.0 111.501 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -63.99 -50.3 69.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.485 1.288 0 CA-C-N 117.972 0.351 . . . . 0.0 111.894 173.538 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.553 1.085 0 CA-C-O 116.163 -1.875 . . . . 0.0 116.017 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -63.01 -37.57 52.28 Favored 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 122.559 2.173 . . . . 0.0 114.697 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 p -64.63 -46.33 83.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.11 -49.35 78.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 9.4 mt -49.78 -55.71 13.03 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.5 -37.6 81.6 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.6 p -55.36 -47.41 75.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -66.81 -45.35 78.64 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.404 0.681 . . . . 0.0 112.787 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.4 mt -49.39 -47.1 48.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.63 -37.12 85.05 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 173.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.39 -46.79 87.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.494 0.718 . . . . 0.0 112.523 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.2 mt -60.37 -46.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.466 0.706 . . . . 0.0 109.738 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.27 -62.78 2.62 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 125.569 1.557 . . . . 0.0 111.887 171.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.5 tp -50.57 -46.95 57.98 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.402 1.081 . . . . 0.0 111.882 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.76 -63.33 3.56 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.55 1.156 . . . . 0.0 113.996 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.47 -46.43 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.579 0.352 . . . . 0.0 110.595 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -49.5 -58.61 4.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.76 1.224 . . . . 0.0 113.193 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.2 tp -68.32 -33.82 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.484 1.114 . . . . 0.0 113.849 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.56 -39.56 91.07 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 125.408 1.48 . . . . 0.0 115.11 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -178.409 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 43.4 mt -43.49 -52.99 12.52 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.57 -54.93 2.05 Favored 'Trans proline' 0 C--N 1.356 0.941 0 CA-C-N 122.913 2.076 . . . . 0.0 113.411 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 4.2 p -63.85 -36.28 83.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.91 1.284 . . . . 0.0 112.668 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 35.6 mt -55.5 -59.18 5.19 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 50.5 mt -51.14 -46.81 62.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.578 0.751 . . . . 0.0 112.893 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.29 -57.52 10.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.533 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 84.8 p -56.39 -44.22 80.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -61.34 -51.34 69.23 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 3.8 mp -61.81 -39.79 92.99 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.1 -25.69 55.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.63 98.84 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.719 0.637 . . . . 0.0 111.284 165.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 30.5 mt -58.97 -54.93 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.145 0.903 . . . . 0.0 109.114 169.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.08 -61.18 3.19 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 125.188 1.375 . . . . 0.0 113.403 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 15.9 tp -55.73 -42.1 74.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.083 1.353 . . . . 0.0 112.185 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.43 -48.89 72.64 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.425 1.012 . . . . 0.0 112.994 171.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mt -57.9 -41.94 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.174 0.99 . . . . 0.0 110.778 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -55.87 -46.85 78.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.643 0.777 . . . . 0.0 109.886 172.673 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.293 2.2 mt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 119.749 3.24 . . . . 0.0 119.749 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -53.44 -65.57 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.297 2.665 . . . . 0.0 111.984 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.3 m -47.4 -45.04 24.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 47.3 mt -51.97 -64.44 0.82 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.215 -0.898 . . . . 0.0 112.057 173.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.5 mt -44.63 -59.22 2.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.356 1.462 . . . . 0.0 112.605 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.61 -48.42 81.86 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -60.28 -42.3 95.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -63.64 -48.69 76.22 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 31.7 mt -61.86 -34.27 75.68 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 -41.98 87.8 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.416 1.086 . . . . 0.0 113.153 166.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -67.52 -43.26 81.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 35.8 mt -59.25 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.017 0.527 . . . . 0.0 109.663 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.09 -55.16 16.27 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 124.8 1.19 . . . . 0.0 112.267 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.3 tp -45.33 -57.97 3.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.124 1.37 . . . . 0.0 111.879 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.76 -48.67 43.48 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.846 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.9 mt -59.86 -58.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.436 0.694 . . . . 0.0 109.387 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -47.65 -61.0 2.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.457 1.503 . . . . 0.0 112.621 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.2 pt -64.45 -44.76 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.47 95.78 Favored Glycine 0 N--CA 1.479 1.564 0 C-N-CA 124.886 1.231 . . . . 0.0 112.405 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 . . . . . 0 N--CA 1.47 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.36 172.578 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 55.1 t80 . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 117.699 -1.143 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.271 96.4 mt -62.64 -52.11 67.35 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 115.614 -2.136 . . . . 0.0 116.491 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -60.03 -43.28 37.42 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.41 2.073 . . . . 0.0 112.722 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 20.2 m -53.04 -55.22 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.155 0.909 . . . . 0.0 111.732 173.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 20.5 tp -52.79 -53.07 53.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.166 1.786 . . . . 0.0 112.488 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -50.92 -55.48 16.98 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.37 -36.9 81.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.9 p -59.73 -39.29 84.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.772 1.026 . . . . 0.0 113.772 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -68.01 -43.08 79.63 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.91 0.756 . . . . 0.0 112.802 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.07 -43.29 91.76 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.379 0.672 . . . . 0.0 111.045 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.71 -42.07 99.46 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.77 82.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 31.1 mt -59.09 -41.82 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.48 0.712 . . . . 0.0 110.298 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.95 -51.23 56.8 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 125.166 1.365 . . . . 0.0 114.212 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 13.1 tp -57.08 -45.69 83.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.573 0.749 . . . . 0.0 111.042 172.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -49.52 -59.41 7.22 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.335 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -51.11 -48.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.982 1.313 . . . . 0.0 112.98 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 36.6 t80 -40.99 -58.55 1.69 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.629 1.172 . . . . 0.0 112.876 168.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 36.1 mt . . . . . 0 N--CA 1.479 1.008 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.559 175.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.302 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.95 -43.73 34.95 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.093 1.862 . . . . 0.0 112.774 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.3 t -58.71 -51.69 68.9 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.347 1.059 . . . . 0.0 112.568 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.46 -57.21 12.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.591 1.957 . . . . 0.0 111.547 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 mp -46.28 -61.97 1.55 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.288 1.435 . . . . 0.0 113.69 175.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.42 -35.31 79.99 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.213 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.2 p -60.77 -45.4 94.49 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -59.75 -45.69 91.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.14 -45.62 79.54 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.735 0.647 . . . . 0.0 112.271 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.18 -38.03 89.21 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.23 93.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.266 0.626 . . . . 0.0 111.812 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.43 -47.71 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.176 170.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.17 -54.34 26.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.899 1.238 . . . . 0.0 114.084 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.6 tp -49.88 -49.84 48.04 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.09 -49.51 71.4 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.655 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.49 -47.06 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.382 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -54.03 -53.67 49.88 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.257 0.973 . . . . 0.0 112.096 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.7 mt -51.68 -56.56 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.506 1.122 . . . . 0.0 111.151 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.51 22.11 Favored Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.829 1.331 . . . . 0.0 113.459 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 125.554 1.542 . . . . 0.0 111.611 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.255 4.8 mt -49.73 -60.78 4.4 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.48 -53.26 3.0 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.351 2.701 . . . . 0.0 110.874 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 8.2 p -54.87 -44.3 73.93 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.84 -67.32 0.3 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.396 168.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.85 -50.22 57.23 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.62 -44.66 93.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.006 1.322 . . . . 0.0 114.322 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -61.13 -42.45 98.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.07 -45.47 94.61 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.3 tp -50.49 -54.5 21.79 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 0.0 112.652 170.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 12.1 tp -67.68 -29.6 68.91 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.4 -46.44 86.39 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.354 0.661 . . . . 0.0 112.758 170.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 33.9 mt -57.04 -48.23 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 170.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.59 -54.71 15.9 Favored Glycine 0 N--CA 1.482 1.714 0 C-N-CA 124.426 1.012 . . . . 0.0 113.024 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 12.9 tp -52.96 -49.21 66.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 111.233 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.49 -52.36 28.9 Favored Glycine 0 N--CA 1.482 1.723 0 O-C-N 124.253 0.97 . . . . 0.0 113.428 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.21 -51.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.896 0.878 . . . . 0.0 110.1 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -46.34 -56.29 6.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.783 1.233 . . . . 0.0 112.729 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 125.138 1.375 . . . . 0.0 111.543 175.563 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 116.666 -1.635 . . . . 0.0 115.37 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.71 -50.51 7.78 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.313 2.009 . . . . 0.0 112.294 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.2 m -50.56 -45.5 57.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.854 0.861 . . . . 0.0 112.408 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -66.68 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.683 1.593 . . . . 0.0 111.724 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pp -62.24 -43.8 97.99 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 mt -57.72 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.45 0.7 . . . . 0.0 112.344 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.5 p -63.55 -40.12 96.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -56.48 -51.13 69.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.6 mt -54.83 -51.43 65.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 112.633 172.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.0 mt -55.76 -43.28 76.54 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.711 1.204 . . . . 0.0 114.222 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.26 -47.35 75.58 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.33 1.452 . . . . 0.0 113.643 173.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.1 mt -61.21 -41.1 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.81 . . . . 0.0 111.131 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -57.71 14.82 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 124.154 0.909 . . . . 0.0 112.3 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 15.3 tp -48.67 -46.01 39.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.349 1.059 . . . . 0.0 111.827 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.85 -57.54 10.77 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.977 1.275 . . . . 0.0 113.548 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 33.7 mt -53.56 -43.93 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.654 1.182 . . . . 0.0 111.828 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -51.83 -54.11 32.62 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.044 0.84 . . . . 0.0 112.376 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.6 mt -56.54 -54.45 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.278 1.031 . . . . 0.0 109.863 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -44.34 -60.6 3.56 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 125.773 1.654 . . . . 0.0 112.577 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.8 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 . . . . . 0 N--CA 1.486 1.346 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 21.7 tp -44.47 -51.65 19.72 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 116.163 -1.875 . . . . 0.0 115.575 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -56.2 -52.45 7.18 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.451 2.101 . . . . 0.0 112.761 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 25.6 p -61.74 -35.22 77.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 52.5 mt -54.82 -64.15 0.93 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 117.726 -1.13 . . . . 0.0 112.291 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 19.1 mt -51.78 -50.04 61.49 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.198 0.999 . . . . 0.0 112.794 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 36.0 tp -53.31 -54.68 32.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.591 1.556 . . . . 0.0 112.737 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 76.8 p -63.66 -31.62 72.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -59.63 -49.4 77.89 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.532 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -43.61 79.52 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.99 -51.62 65.65 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.647 0.779 . . . . 0.0 112.828 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.45 -47.29 86.77 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.114 1.366 . . . . 0.0 114.118 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 26.0 mt -58.92 -49.11 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.162 0.585 . . . . 0.0 109.448 174.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.93 10.44 Favored Glycine 0 N--CA 1.483 1.823 0 O-C-N 124.665 1.228 . . . . 0.0 112.538 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.78 -45.94 70.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.885 1.274 . . . . 0.0 112.514 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -49.93 62.04 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 124.735 1.16 . . . . 0.0 113.123 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 17.7 mt -60.61 -48.62 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.076 0.95 . . . . 0.0 109.152 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -40.89 -59.65 1.38 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.101 1.36 . . . . 0.0 112.273 169.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.483 1.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.829 174.651 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -65.32 -58.45 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.904 1.736 . . . . 0.0 112.598 168.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 m -43.57 -44.77 6.35 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.6 tp -44.62 -67.59 0.27 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.237 2.215 . . . . 0.0 112.31 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 mp -71.26 -37.86 71.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.409 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.7 mt -49.1 -57.44 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.132 0.895 . . . . 0.0 111.334 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.5 t -54.05 -58.94 5.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.129 1.371 . . . . 0.0 111.697 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -50.35 -68.54 0.16 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.27 -55.23 35.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.26 -48.09 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.09 87.99 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 56.5 mt -55.86 -45.21 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.985 0.514 . . . . 0.0 110.689 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.11 -53.33 41.09 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 124.227 0.918 . . . . 0.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 16.7 tp -52.77 -47.22 67.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.563 0.745 . . . . 0.0 112.32 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.1 -51.79 47.94 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.868 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.7 mt -48.56 -46.0 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.159 0.983 . . . . 0.0 113.132 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -53.71 -56.28 18.74 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.658 0.599 . . . . 0.0 112.308 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 23.0 mt -50.59 -53.37 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.875 1.27 . . . . 0.0 110.326 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.81 -59.84 9.66 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 124.738 1.161 . . . . 0.0 112.278 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 125.552 1.541 . . . . 0.0 112.69 174.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.34 -41.62 61.2 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.145 -1.407 . . . . 0.0 114.345 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -51.49 -52.77 8.31 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.868 2.379 . . . . 0.0 114.32 165.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -59.66 -40.45 87.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.179 0.992 . . . . 0.0 113.432 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.16 -44.89 95.61 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.524 0.73 . . . . 0.0 112.414 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.19 -51.37 70.01 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.785 0.834 . . . . 0.0 112.087 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 25.6 tp -49.03 -53.48 19.94 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.592 1.557 . . . . 0.0 111.826 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 33.3 t -54.81 -57.29 12.17 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.909 1.284 . . . . 0.0 112.192 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -47.41 -52.39 17.01 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.358 1.063 . . . . 0.0 113.245 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.28 -50.37 73.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 47.5 mt -71.49 -32.31 68.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.47 -47.46 72.99 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.585 0.754 . . . . 0.0 111.615 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 23.2 mt -50.23 -53.59 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.179 1.392 . . . . 0.0 110.787 167.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.07 -60.21 4.64 Favored Glycine 0 N--CA 1.483 1.814 0 O-C-N 124.415 1.072 . . . . 0.0 113.286 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 15.4 tp -50.95 -46.34 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.606 1.162 . . . . 0.0 112.225 173.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.22 -53.33 43.56 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 124.773 1.178 . . . . 0.0 113.63 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 23.2 mt -53.31 -46.8 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.862 0.865 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -49.44 -59.63 3.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.835 1.654 . . . . 0.0 113.449 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.632 0.73 . . . . 0.0 111.651 177.539 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.27 36.0 mt . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.646 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -46.96 -52.09 8.26 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.12 2.547 . . . . 0.0 114.237 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.1 p -66.12 -47.2 74.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.14 -58.4 6.24 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.102 0.961 . . . . 0.0 110.999 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.6 mt -54.29 -52.74 60.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.631 1.172 . . . . 0.0 112.704 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.4 tp -55.15 -51.84 65.2 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.174 0.99 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.8 p -57.05 -39.7 75.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -63.27 -48.09 79.62 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.6 tp -58.76 -45.31 90.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.575 0.75 . . . . 0.0 112.394 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.46 -35.62 81.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.12 98.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.333 0.653 . . . . 0.0 112.422 172.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 27.2 mt -59.33 -49.57 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 169.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -47.75 -55.78 9.31 Favored Glycine 0 CA--C 1.546 2.008 0 C-N-CA 124.952 1.263 . . . . 0.0 113.091 174.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 55.9 tp -45.74 -56.76 4.9 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.296 1.439 . . . . 0.0 112.697 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.52 -48.24 55.66 Favored Glycine 0 CA--C 1.541 1.689 0 O-C-N 124.533 1.146 . . . . 0.0 113.756 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.0 mt -57.54 -50.78 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.96 0.504 . . . . 0.0 110.11 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -53.74 -54.79 33.16 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.704 1.253 . . . . 0.0 112.427 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.6 mt -53.85 -56.38 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.318 0.647 . . . . 0.0 111.356 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -46.76 -58.26 6.22 Favored Glycine 0 N--CA 1.487 2.036 0 O-C-N 124.481 1.113 . . . . 0.0 112.168 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 53.8 t80 . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -47.88 97.67 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.1 -52.86 6.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.75 2.3 . . . . 0.0 112.992 170.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 19.5 t -52.09 -48.99 64.44 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.182 0.993 . . . . 0.0 111.864 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.9 mp -55.34 -65.45 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.907 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mt -41.08 -61.5 0.99 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.363 1.465 . . . . 0.0 114.921 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 54.2 mt -62.79 -36.73 84.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -77.7 -34.37 52.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -67.3 -40.15 86.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 70.1 mt -53.81 -53.16 56.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 0.0 111.929 168.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 7.7 mt -48.48 -47.93 38.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.233 1.013 . . . . 0.0 113.237 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.73 -52.01 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 29.0 mt -61.28 -42.33 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.31 0.644 . . . . 0.0 110.636 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.99 -51.48 55.24 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.848 1.213 . . . . 0.0 112.831 173.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.35 -44.34 44.59 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.43 -57.36 19.0 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.456 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -47.76 -52.2 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.947 1.299 . . . . 0.0 110.971 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.61 -50.15 25.07 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.942 0.897 . . . . 0.0 113.227 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 122.913 0.485 . . . . 0.0 110.563 173.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.285 35.7 mt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -51.96 -71.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 121.518 1.479 . . . . 0.0 112.125 164.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 p -55.78 -42.31 75.36 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 47.1 mt -56.35 -61.36 2.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.49 -17.74 62.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.98 -41.04 82.94 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 165.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.9 p -61.68 -34.39 75.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -72.93 -38.47 66.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 118.28 -0.867 . . . . 0.0 113.211 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.6 tp -51.81 -47.01 64.49 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.649 0.593 . . . . 0.0 111.555 168.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.5 mt -49.62 -56.69 9.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.834 0.709 . . . . 0.0 112.436 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.52 -52.6 63.13 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 30.2 mt -56.04 -47.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.369 1.067 . . . . 0.0 110.357 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.15 -57.39 10.18 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.912 1.244 . . . . 0.0 112.724 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 30.0 tp -53.11 -45.96 68.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.221 1.009 . . . . 0.0 112.499 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.66 -56.07 6.72 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 125.233 1.397 . . . . 0.0 113.822 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.8 mt -59.32 -53.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.314 -0.943 . . . . 0.0 109.565 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -51.84 -58.24 7.02 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.559 -1.2 . . . . 0.0 113.101 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . 0.256 2.9 pp -60.79 -38.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.58 -47.61 90.05 Favored Glycine 0 N--CA 1.481 1.689 0 C-N-CA 123.83 0.728 . . . . 0.0 112.943 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 . . . . . 0 N--CA 1.478 0.974 0 CA-C-N 114.213 -0.994 . . . . 0.0 111.83 174.236 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 54.3 tp -54.91 -42.29 94.85 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.226 -1.369 . . . . 0.0 113.479 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -54.09 -51.84 9.72 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.132 1.888 . . . . 0.0 113.504 168.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 41.4 m -53.15 -48.67 67.76 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 80.4 mt -50.71 -59.89 3.61 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.665 170.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.0 mt -50.64 -57.91 7.1 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.99 -52.85 47.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.794 0.837 . . . . 0.0 113.164 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 60.5 p -66.77 -42.52 85.96 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -63.9 -43.38 96.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.74 -47.46 79.98 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 170.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 39.0 mt -56.68 -42.55 79.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 170.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.65 91.02 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 44.0 mt -55.37 -47.48 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 168.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.38 -53.57 23.75 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.52 1.057 . . . . 0.0 113.014 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.25 -41.75 69.14 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.79 -54.11 29.84 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.153 0.882 . . . . 0.0 112.42 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 13.2 mt -53.8 -54.32 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.614 1.166 . . . . 0.0 110.531 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -49.52 -50.95 39.65 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.193 1.797 . . . . 0.0 113.97 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.613 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.0 tp . . . . . 0 CA--C 1.553 1.059 0 CA-C-O 115.907 -1.997 . . . . 0.0 113.703 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.36 -52.32 4.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.35 2.033 . . . . 0.0 112.759 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -46.45 63.08 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.28 -66.55 0.51 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.866 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -47.15 -53.21 13.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.498 1.119 . . . . 0.0 113.978 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.01 -44.79 95.02 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.9 p -70.86 -41.89 70.81 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -57.81 -42.92 85.24 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.0 mt -56.19 -52.9 62.71 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 169.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.0 mt -49.17 -47.5 45.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 112.221 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.3 -48.57 76.41 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 16.4 mt -59.81 -49.26 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 123.55 0.74 . . . . 0.0 110.462 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.1 -51.27 36.09 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 124.25 0.928 . . . . 0.0 112.027 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.09 -46.13 79.14 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.214 1.005 . . . . 0.0 112.012 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -48.42 -53.65 15.52 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.253 0.93 . . . . 0.0 113.438 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.14 -50.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.252 0.621 . . . . 0.0 109.792 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.83 -55.63 18.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.041 0.936 . . . . 0.0 113.255 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -48.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.39 -55.59 12.69 Favored Glycine 0 N--CA 1.481 1.694 0 C-N-CA 124.196 0.903 . . . . 0.0 111.46 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 125.301 1.441 . . . . 0.0 114.402 174.845 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.49 -38.44 62.19 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 116.362 -1.78 . . . . 0.0 115.722 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -60.9 -64.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 CA-C-O 116.703 -1.457 . . . . 0.0 111.126 168.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -43.38 -42.78 4.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 41.6 mt -53.95 -71.08 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.089 0.956 . . . . 0.0 111.276 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 4.8 mt -46.43 -46.94 19.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.6 1.56 . . . . 0.0 114.73 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 67.1 mt -57.11 -53.54 56.91 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.138 1.375 . . . . 0.0 112.751 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 85.5 p -61.98 -39.69 93.04 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -58.49 -45.05 89.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 6.4 tp -66.8 -38.64 86.88 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 tp -55.19 -46.24 75.85 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.048 0.939 . . . . 0.0 110.429 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.66 80.03 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.7 mt -57.56 -48.08 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 117.748 0.249 . . . . 0.0 110.736 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.51 -49.67 38.61 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.322 0.963 . . . . 0.0 112.977 174.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 14.6 tp -53.12 -45.14 68.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.117 0.967 . . . . 0.0 112.557 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.71 -51.6 53.94 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.589 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 9.1 mt -59.03 -45.44 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.318 0.647 . . . . 0.0 109.587 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -47.82 -49.97 27.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.637 1.175 . . . . 0.0 113.504 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt . . . . . 0 N--CA 1.481 1.088 0 C-N-CA 123.349 0.66 . . . . 0.0 110.941 174.451 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.254 35.3 mt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.32 -59.11 0.47 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.8 p -59.42 -40.65 87.38 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.4 tp -50.7 -63.32 1.16 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.639 1.576 . . . . 0.0 110.756 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.42 -42.33 77.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.439 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.0 tp -53.6 -47.69 69.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.596 1.159 . . . . 0.0 111.654 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.7 p -66.62 -39.59 88.4 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -69.71 -35.45 75.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.4 mt -55.49 -49.05 73.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.956 0.785 . . . . 0.0 111.645 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.6 mt -51.55 -52.18 49.31 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.17 75.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.4 mt -59.1 -48.89 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.648 1.179 . . . . 0.0 111.695 169.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.1 -47.62 88.07 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.252 0.93 . . . . 0.0 113.25 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.86 -41.99 78.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.751 1.621 . . . . 0.0 111.575 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.18 -51.24 58.66 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.266 1.412 . . . . 0.0 112.321 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 29.8 mt -55.86 -47.67 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.378 1.071 . . . . 0.0 111.311 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -50.42 -63.16 1.21 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.47 1.106 . . . . 0.0 112.798 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.4 tp -69.59 -35.27 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -174.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.44 43.71 Favored Glycine 0 N--CA 1.479 1.515 0 C-N-CA 124.307 0.956 . . . . 0.0 111.832 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.528 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 C--O 1.219 -0.553 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.71 -34.96 7.16 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 -62.41 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 122.085 1.857 . . . . 0.0 112.406 160.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 36.4 p -55.42 -41.93 73.45 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.98 -62.16 2.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 116.513 -1.708 . . . . 0.0 113.079 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 22.6 tp -50.98 -53.92 28.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.526 0.73 . . . . 0.0 112.018 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt -60.01 -52.21 66.34 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 95.2 p -62.51 -39.35 93.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -58.72 -48.06 82.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 0.0 111.795 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 84.2 mt -53.74 -45.7 70.64 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.241 1.017 . . . . 0.0 112.64 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 27.4 tp -57.66 -46.49 84.16 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.129 0.572 . . . . 0.0 112.163 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.38 96.78 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 26.7 mt -57.26 -48.44 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.26 -55.09 20.78 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 124.396 0.998 . . . . 0.0 112.593 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 23.3 mt -51.66 -46.51 63.78 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.61 -52.83 45.54 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 124.787 1.185 . . . . 0.0 112.527 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.88 -48.26 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 113.758 -1.221 . . . . 0.0 110.281 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -30.38 41.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 44.4 pt . . . . . 0 N--CA 1.486 1.339 0 CA-C-N 119.677 1.126 . . . . 0.0 111.178 170.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.3 tp . . . . . 0 CA--C 1.549 0.931 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -54.66 -58.87 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.848 2.365 . . . . 0.0 114.182 171.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.2 p -58.67 -39.36 80.42 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.8 mp -54.21 -66.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 171.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 30.5 mt -50.86 -43.35 59.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.15 -49.89 70.34 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.1 p -69.62 -29.18 66.62 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -57.18 -44.96 84.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.074 0.549 . . . . 0.0 111.905 165.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.98 -35.22 76.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.03 -50.24 73.34 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.546 0.529 . . . . 0.0 111.994 167.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.49 -48.97 79.03 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.55 -47.23 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.67 1.188 . . . . 0.0 111.648 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.75 -57.75 11.78 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.411 1.481 . . . . 0.0 111.678 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.0 tp -49.7 -46.23 49.83 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.943 1.297 . . . . 0.0 112.171 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -46.81 -62.3 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.618 1.58 . . . . 0.0 113.847 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.91 -31.94 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -49.01 -67.41 0.27 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.313 1.045 . . . . 0.0 112.223 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . 0.294 2.3 pp -67.83 -30.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.27 -64.34 3.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 124.997 1.284 . . . . 0.0 112.723 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 176.335 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 4.4 p90 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.98 -46.01 30.8 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.732 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -55.4 -45.56 39.05 Favored 'Trans proline' 0 N--CA 1.48 0.681 0 C-N-CA 122.284 1.989 . . . . 0.0 111.923 164.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 55.0 m -47.55 -52.58 17.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.143 0.977 . . . . 0.0 112.003 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 58.7 mt -53.35 -61.62 2.18 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.882 0.873 . . . . 0.0 113.289 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 11.4 mt -54.97 -52.05 64.26 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.526 -1.215 . . . . 0.0 113.637 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.75 -58.79 7.06 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.245 1.418 . . . . 0.0 112.64 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 87.4 p -64.03 -37.27 86.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -66.79 -40.25 88.08 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.53 -51.07 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.569 0.7 . . . . 0.0 111.292 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.52 -38.91 72.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.393 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.28 86.15 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 6.9 mt -57.26 -48.46 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 171.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.53 -57.31 9.53 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.269 1.414 . . . . 0.0 112.618 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 62.4 tp -45.82 -53.12 10.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.19 -62.27 3.98 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 124.642 1.115 . . . . 0.0 112.963 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -54.25 -51.11 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.85 0.86 . . . . 0.0 110.828 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -61.18 -33.54 73.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.1 mt . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 123.237 0.615 . . . . 0.0 110.086 171.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -55.06 -44.62 47.83 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 121.885 1.723 . . . . 0.0 112.507 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.2 m -51.79 -53.29 41.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.869 0.868 . . . . 0.0 112.798 170.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.8 -44.84 78.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.4 mt -59.74 -50.91 71.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.008 0.923 . . . . 0.0 113.005 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.0 tp -57.12 -45.58 83.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.327 1.051 . . . . 0.0 110.998 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.8 t -51.2 -58.62 5.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.177 1.391 . . . . 0.0 113.487 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -48.01 -51.58 23.38 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.474 1.109 . . . . 0.0 113.494 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 44.2 tp -54.22 -57.07 12.56 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.767 1.227 . . . . 0.0 112.788 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.6 mt -54.35 -44.85 72.52 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.09 -54.48 7.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 25.5 mt -55.9 -40.94 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.123 0.569 . . . . 0.0 110.297 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -62.1 5.97 Favored Glycine 0 N--CA 1.48 1.597 0 O-C-N 124.801 1.313 . . . . 0.0 112.35 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.03 -49.75 30.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.807 0.843 . . . . 0.0 113.108 171.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.62 -64.22 3.85 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 125.268 1.413 . . . . 0.0 114.168 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.8 pp -56.62 -33.94 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.8 -58.05 6.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.906 1.282 . . . . 0.0 113.219 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 21.5 mt -56.9 -34.69 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.548 0.739 . . . . 0.0 111.166 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.24 31.35 0.96 Allowed Glycine 0 CA--C 1.54 1.622 0 N-CA-C 116.439 1.335 . . . . 0.0 116.439 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.614 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 26.7 t80 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.16 -53.23 67.53 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 115.842 -2.028 . . . . 0.0 114.737 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -56.39 -50.19 12.73 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 123.161 2.574 . . . . 0.0 113.159 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.7 m -57.02 -45.97 82.68 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.74 -46.19 89.24 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.023 1.329 . . . . 0.0 114.424 174.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.7 mt -53.23 -56.92 12.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.569 0.7 . . . . 0.0 111.113 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 9.9 tp -58.71 -45.15 90.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.393 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 42.8 t -47.78 -60.39 2.61 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.791 1.237 . . . . 0.0 113.062 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.55 -47.65 72.97 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.163 0.914 . . . . 0.0 113.21 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 4.7 mp -60.93 -53.78 53.05 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.9 mt -51.29 -54.56 24.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.33 1.052 . . . . 0.0 111.094 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.75 80.37 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.396 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 tt -64.19 -41.92 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.38 63.6 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 124.09 0.869 . . . . 0.0 112.008 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 9.5 tp -54.44 -50.47 67.59 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 113.611 -1.294 . . . . 0.0 111.588 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -49.47 -54.18 17.5 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 124.984 1.278 . . . . 0.0 113.941 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 10.2 mt -56.16 -48.56 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.632 0.773 . . . . 0.0 111.484 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -51.23 -52.35 45.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.901 0.881 . . . . 0.0 112.351 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 34.0 mt . . . . . 0 N--CA 1.483 1.218 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.879 177.637 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.276 17.9 mt . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 115.639 -2.124 . . . . 0.0 116.662 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -57.27 -57.5 1.25 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.203 1.935 . . . . 0.0 112.536 171.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.7 m -45.4 -46.01 13.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 37.2 mt -62.48 -54.25 42.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.492 1.517 . . . . 0.0 114.606 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.47 -43.74 68.39 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.572 0.749 . . . . 0.0 112.164 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.1 mt -53.08 -63.11 1.25 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.101 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.6 p -59.1 -43.34 91.85 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -66.03 -46.98 75.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.7 mt -56.29 -45.62 80.13 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.3 mt -60.8 -45.33 94.85 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.1 -46.54 79.06 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 11.0 mt -47.53 -54.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.789 0.835 . . . . 0.0 111.385 170.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.98 -56.81 14.76 Favored Glycine 0 CA--C 1.544 1.872 0 C-N-CA 124.548 1.07 . . . . 0.0 113.138 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.7 mt -51.83 -48.68 63.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.317 1.047 . . . . 0.0 111.702 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.68 -51.12 40.14 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.231 1.396 . . . . 0.0 112.488 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.5 mt -54.66 -54.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.023 1.329 . . . . 0.0 110.373 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -53.02 -51.71 60.8 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.969 1.418 . . . . 0.0 111.038 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.4 mt -56.67 -62.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 124.382 1.073 . . . . 0.0 109.796 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.76 4.48 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 124.734 1.159 . . . . 0.0 113.366 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.368 1.067 . . . . 0.0 112.741 -179.678 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.296 1.5 mm? -40.51 -61.56 1.17 Allowed Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.28 -56.51 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 122.966 2.444 . . . . 0.0 111.382 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 3.1 p -64.05 -27.82 69.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 38.0 tp -63.41 -52.63 60.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.997 1.319 . . . . 0.0 112.248 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -58.29 -36.34 73.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.38 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.68 -33.52 66.57 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 69.7 m -71.0 -35.04 71.93 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 172.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -56.29 -42.66 77.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.583 165.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.26 -34.69 65.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.82 -54.24 44.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.306 1.442 . . . . 0.0 110.895 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.09 -48.36 73.66 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.9 mt -61.3 -51.04 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.5 1.12 . . . . 0.0 111.823 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.94 -53.89 24.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.671 1.605 . . . . 0.0 112.845 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.54 -47.3 76.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.906 0.882 . . . . 0.0 112.731 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.18 -53.51 23.17 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.989 1.281 . . . . 0.0 113.131 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.66 -46.66 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.067 0.947 . . . . 0.0 112.517 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -51.4 -55.51 18.22 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.531 0.519 . . . . 0.0 112.392 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . 0.26 6.4 tp . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.334 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.15 -66.12 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.183 2.588 . . . . 0.0 111.17 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.0 m -48.73 -56.6 8.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.641 1.576 . . . . 0.0 112.47 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.8 mt -42.54 -51.26 5.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.804 1.642 . . . . 0.0 114.199 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.65 -26.69 20.61 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.95 -35.71 74.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 170.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -68.84 -38.0 79.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 168.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.1 mt -53.49 -50.38 65.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.579 0.752 . . . . 0.0 112.263 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.6 tp -51.02 -53.32 34.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.17 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.08 -51.82 39.56 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 19.4 mt -59.61 -56.58 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.412 0.685 . . . . 0.0 110.625 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.09 -50.52 45.17 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 124.281 0.943 . . . . 0.0 112.816 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.5 tp -56.11 -44.13 78.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.171 1.388 . . . . 0.0 112.139 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.11 -46.37 92.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.99 0.805 . . . . 0.0 113.2 177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.4 mp -53.08 -45.81 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 124.139 0.552 . . . . 0.0 111.425 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -56.57 -55.36 34.82 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.6 mt -53.32 -57.82 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.179 0.991 . . . . 0.0 111.243 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.82 -50.26 32.54 Favored Glycine 0 CA--C 1.548 2.124 0 C-N-CA 124.783 1.183 . . . . 0.0 112.403 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 177.065 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.256 23.8 mt -43.35 -43.62 11.39 Favored Pre-proline 0 N--CA 1.481 1.1 0 N-CA-C 118.714 2.857 . . . . 0.0 118.714 -177.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -51.7 -66.62 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.498 2.799 . . . . 0.0 113.199 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 19.5 p -54.26 -42.55 70.07 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 41.6 tp -55.96 -58.0 9.73 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.492 1.12 . . . . 0.0 112.218 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -47.2 85.96 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 173.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 51.9 tp -54.5 -45.58 73.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -62.1 -44.77 95.94 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.559 0.537 . . . . 0.0 112.173 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -67.72 -37.2 81.89 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.715 1.206 . . . . 0.0 112.488 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 20.3 mt -60.32 -51.14 70.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.697 1.199 . . . . 0.0 112.326 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.5 mt -58.77 -45.48 89.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.67 86.98 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 2.3 tt -70.9 -36.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.86 -50.4 54.66 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.244 0.926 . . . . 0.0 111.191 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.41 -42.74 82.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.721 -0.739 . . . . 0.0 112.651 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.64 -56.81 14.03 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.087 0.851 . . . . 0.0 112.674 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 6.2 mt -60.6 -41.01 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.727 0.811 . . . . 0.0 109.881 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -51.81 -61.75 2.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.286 1.034 . . . . 0.0 111.156 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 28.0 mt . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.865 177.434 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.113 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -67.11 -43.84 5.87 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 121.774 1.649 . . . . 0.0 114.705 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.3 p -68.11 -38.38 82.21 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.98 -39.91 87.31 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 173.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 17.0 mt -51.85 -47.2 64.54 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 167.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.37 -53.89 53.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 59.2 p -59.61 -39.7 85.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -68.75 -43.47 75.78 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 tp -57.43 -44.89 85.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.179 0.992 . . . . 0.0 111.918 170.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -48.78 79.52 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.378 1.071 . . . . 0.0 112.123 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.08 -46.54 85.29 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.521 1.129 . . . . 0.0 113.609 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.68 -53.32 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.307 0.643 . . . . 0.0 110.118 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -48.52 -51.2 22.77 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.155 1.359 . . . . 0.0 113.88 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -52.38 -48.66 65.48 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.01 -48.38 83.03 Favored Glycine 0 N--CA 1.488 2.103 0 O-C-N 124.181 0.926 . . . . 0.0 112.43 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.0 mt -56.89 -49.22 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 124.944 1.297 . . . . 0.0 110.471 175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.84 -49.14 59.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.563 1.145 . . . . 0.0 112.922 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.5 mm -52.91 -50.78 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.325 0.65 . . . . 0.0 111.231 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.14 -56.59 22.48 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 124.55 1.071 . . . . 0.0 113.075 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 22.8 mtt180 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.147 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.268 16.5 mt -46.88 -56.03 13.1 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 116.288 -1.815 . . . . 0.0 115.728 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.46 -45.32 11.93 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.453 2.102 . . . . 0.0 114.716 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 39.0 m -63.08 -38.62 91.91 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.26 -48.37 80.64 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.947 1.299 . . . . 0.0 111.698 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.56 -49.43 74.86 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.62 0.368 . . . . 0.0 111.306 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 39.3 p -61.64 -38.93 89.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -62.27 -45.67 92.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.33 -45.31 72.64 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 22.3 mt -62.29 -38.97 91.4 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.47 82.93 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 18.7 mt -60.08 -41.39 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.13 -52.18 23.25 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 124.919 1.247 . . . . 0.0 113.243 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.64 -44.51 85.68 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.919 0.888 . . . . 0.0 111.782 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.42 -55.35 30.57 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 115.313 -0.858 . . . . 0.0 114.269 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 4.8 tp -62.45 -28.73 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 112.824 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.75 -53.72 55.24 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.358 0.663 . . . . 0.0 110.66 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 34.0 mt . . . . . 0 N--CA 1.488 1.431 0 C-N-CA 124.149 0.98 . . . . 0.0 109.302 171.185 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.294 2.5 mt . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 118.318 2.71 . . . . 0.0 118.318 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.2 -52.19 9.29 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.142 1.895 . . . . 0.0 112.657 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.8 p -64.88 -38.64 91.63 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.86 -48.79 74.9 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.63 0.729 . . . . 0.0 111.509 171.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.98 -42.51 99.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.977 1.311 . . . . 0.0 113.614 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.6 tp -57.59 -46.32 84.16 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.521 0.728 . . . . 0.0 112.333 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.3 t -58.07 -45.08 87.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.566 0.746 . . . . 0.0 112.073 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -54.98 -43.41 73.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.1 tp -64.89 -44.09 90.75 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.005 0.522 . . . . 0.0 111.723 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.19 -35.83 76.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.96 83.38 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 168.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 10.5 mt -60.77 -45.29 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.66 -54.23 18.11 Favored Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.196 0.935 . . . . 0.0 113.266 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.4 tt -50.73 -47.47 59.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 111.626 174.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -56.16 26.51 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 124.3 1.0 . . . . 0.0 113.485 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.5 mt -53.58 -50.45 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.062 0.945 . . . . 0.0 110.178 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -50.13 -64.3 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.981 1.426 . . . . 0.0 112.268 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.2 pt -59.73 -43.77 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.32 -53.68 23.02 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 125.654 1.597 . . . . 0.0 113.622 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 54.5 ttt-85 . . . . . 0 N--CA 1.476 0.834 0 O-C-N 124.417 0.716 . . . . 0.0 112.695 178.431 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 79.3 t80 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 25.3 mt -47.09 -45.56 52.93 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -52.19 -63.65 0.24 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.468 2.779 . . . . 0.0 114.753 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 96.3 p -55.89 -43.98 77.74 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.19 0.596 . . . . 0.0 111.951 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.0 tp -52.2 -57.42 9.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.839 1.656 . . . . 0.0 111.852 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tp -53.01 -59.06 5.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.878 1.271 . . . . 0.0 111.125 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 39.1 mt -51.65 -52.62 46.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.85 1.26 . . . . 0.0 113.548 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 24.4 t -59.62 -52.98 63.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.946 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -60.84 -41.47 95.89 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -38.39 86.71 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.27 -29.24 68.79 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 167.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.73 -44.56 85.63 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.863 0.727 . . . . 0.0 112.748 167.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.39 -43.25 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.884 0.873 . . . . 0.0 109.796 166.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -48.93 -61.92 4.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.491 1.52 . . . . 0.0 113.622 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 7.0 tp -53.17 -40.93 64.72 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.438 1.095 . . . . 0.0 112.07 172.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.0 -60.62 7.36 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.644 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.5 -31.84 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.482 0.713 . . . . 0.0 111.605 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 83.2 t80 -50.96 -52.41 42.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.407 0.683 . . . . 0.0 111.917 168.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt . . . . . 0 N--CA 1.484 1.251 0 C-N-CA 124.275 1.03 . . . . 0.0 109.765 174.372 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 117.59 -1.195 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.65 128.42 36.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.845 0.858 . . . . 0.0 110.619 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.0 t -136.83 43.28 2.41 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.821 1.296 . . . . 0.0 113.263 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.6 t -114.84 101.24 8.86 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.027 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.94 91.8 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 113.346 -1.752 . . . . 0.0 106.898 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 67.0 mtt -64.08 96.23 0.14 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 113.281 -1.781 . . . . 0.0 115.254 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -81.87 117.44 22.13 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.333 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -104.17 -69.63 0.8 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -169.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -162.05 -96.85 0.11 Allowed Glycine 0 N--CA 1.478 1.463 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' B' ' 165' ' ' PHE . . . 59.25 -117.42 11.0 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 tp -106.24 108.7 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 113.814 -1.193 . . . . 0.0 110.069 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -63.67 -39.8 95.22 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 42.4 t -119.75 132.16 55.55 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.081 0.943 . . . . 0.0 113.159 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.39 -28.35 69.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 113.045 -1.889 . . . . 0.0 114.337 171.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -64.79 -46.2 83.09 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.957 0.503 . . . . 0.0 112.144 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -60.06 -40.02 88.02 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 25.7 tp -58.36 -41.56 84.98 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.933 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -55.69 -51.76 66.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.327 0.651 . . . . 0.0 112.169 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 92.9 t -52.6 -46.53 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 124.652 1.181 . . . . 0.0 111.798 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -77.12 -21.31 54.43 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.9 mt -49.05 -40.48 45.49 Favored Pre-proline 0 N--CA 1.475 0.781 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -57.09 -56.96 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.483 2.122 . . . . 0.0 112.739 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.4 p -65.19 -35.6 81.59 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.92 -61.84 2.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.725 0.81 . . . . 0.0 111.922 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -45.43 73.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.837 0.855 . . . . 0.0 113.288 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.54 -53.82 53.8 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.662 0.601 . . . . 0.0 112.025 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 91.6 p -63.59 -42.13 98.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -64.69 -43.04 94.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.33 -41.66 97.39 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.0 mt -54.4 -50.52 67.37 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.579 0.752 . . . . 0.0 111.923 170.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.42 93.63 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.73 -50.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.483 0.713 . . . . 0.0 111.402 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.65 91.8 Favored Glycine 0 CA--C 1.545 1.943 0 O-C-N 123.687 0.617 . . . . 0.0 112.114 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 38.1 tp -57.86 -44.1 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.522 -0.839 . . . . 0.0 111.897 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.02 92.85 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.84 0.733 . . . . 0.0 113.868 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.32 -47.0 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.954 0.901 . . . . 0.0 110.494 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.67 -46.13 89.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 113.027 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.49 -42.25 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.42 1.088 . . . . 0.0 111.577 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.19 55.36 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 124.092 0.853 . . . . 0.0 111.821 170.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -60.06 -45.52 92.6 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -64.53 -25.25 67.9 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.35 -23.86 63.82 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 170.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.4 t -111.59 -41.66 4.03 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.0 p -128.05 98.64 5.19 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.547 1.539 . . . . 0.0 110.07 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 C--O 1.247 0.922 0 CA-C-O 116.865 -1.541 . . . . 0.0 109.38 -175.418 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 116.846 -1.549 . . . . 0.0 107.704 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -94.59 -29.94 14.62 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 25.6 p -71.82 78.24 0.87 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 122.488 0.315 . . . . 0.0 110.195 164.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 47.7 t 177.08 149.18 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 110.315 -3.129 . . . . 0.0 106.9 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.57 103.09 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.838 0.828 . . . . 0.0 109.573 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 92.4 mtp -111.4 139.92 46.42 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.137 -1.392 . . . . 0.0 113.404 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -88.48 79.34 7.68 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -113.02 132.24 55.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.348 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -117.36 -94.45 1.76 Allowed Glycine 0 CA--C 1.535 1.328 0 O-C-N 125.939 2.024 . . . . 0.0 109.737 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.23 42.39 83.5 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 113.468 -1.366 . . . . 0.0 113.78 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 43.1 pt -71.21 159.09 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.031 1.332 . . . . 0.0 112.206 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -54.27 -61.51 2.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 24.6 t -113.98 101.34 9.16 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.366 1.079 . . . . 0.0 109.886 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.92 95.28 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 113.15 -1.841 . . . . 0.0 113.577 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 4.9 pm0 -66.53 -49.0 67.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.556 1.942 . . . . 0.0 114.265 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.94 -57.06 13.18 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.7 31.73 0.3 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -127.09 -72.58 0.64 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.269 163.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.9 m -60.94 -30.8 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.467 ' HB2' ' HA3' ' A' ' 155' ' ' GLY . 20.4 t80 -111.41 -4.31 14.92 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 26.6 tp -55.49 -44.03 99.44 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.117 -1.42 . . . . 0.0 114.822 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.79 -47.92 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.649 2.232 . . . . 0.0 113.488 172.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 68.4 m -57.12 -35.86 69.98 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.65 -56.26 23.63 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.021 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.39 -40.01 85.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 113.503 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.08 -43.85 82.55 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 57.7 p -68.76 -28.37 66.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -61.99 -45.03 95.42 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 67.2 mt -58.0 -45.27 87.12 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.405 0.682 . . . . 0.0 111.997 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.13 -50.98 63.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.079 1.352 . . . . 0.0 112.633 170.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.78 83.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.477 1.111 . . . . 0.0 113.753 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.59 -45.17 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 0.0 111.587 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.88 -49.05 73.83 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.611 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.89 -41.42 78.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 112.995 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.35 -47.01 78.0 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.99 1.281 . . . . 0.0 112.738 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.33 -42.34 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.394 0.677 . . . . 0.0 111.501 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -63.99 -50.3 69.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.86 -33.53 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 117.972 0.351 . . . . 0.0 111.894 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.87 -50.86 56.8 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 124.661 1.124 . . . . 0.0 112.884 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.435 ' NH2' ' HA ' ' B' ' 190' ' ' SER 0.288 14.8 ptm180 -67.98 -33.81 75.35 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -56.7 -34.66 67.65 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 173.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 mt -65.74 -24.79 67.04 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 171.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 47.9 p -117.05 -79.98 0.6 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.7 t -147.96 107.96 4.04 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.793 1.637 . . . . 0.0 110.066 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' SER . . . . . 0.435 ' HA ' ' NH2' ' B' ' 185' ' ' ARG . 32.1 t . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 116.405 -1.76 . . . . 0.0 113.858 -169.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -47.82 -46.37 30.76 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 167.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.6 p -98.63 109.84 22.54 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 123.427 1.584 . . . . 0.0 114.55 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 46.0 m -139.96 -176.36 4.56 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.242 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.65 92.83 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 170.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -85.54 50.86 2.04 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 122.322 1.058 . . . . 0.0 110.993 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -121.99 138.01 54.59 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -166.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -92.64 -39.97 11.01 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 112.464 -2.153 . . . . 0.0 110.78 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.78 -131.23 0.03 OUTLIER Glycine 0 CA--C 1.538 1.477 0 O-C-N 124.866 1.354 . . . . 0.0 112.605 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 171.86 83.87 0.06 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 tp -72.9 143.04 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 125.42 1.306 . . . . 0.0 114.166 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -60.6 -45.03 95.53 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.1 t -152.87 109.28 3.4 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.36 95.57 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.715 167.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -54.32 -49.21 70.23 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.195 0.598 . . . . 0.0 111.468 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.91 -52.02 66.82 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.62 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.88 -36.63 72.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -49.55 -56.89 8.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.617 1.167 . . . . 0.0 112.485 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.76 -42.46 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -56.01 -42.81 77.0 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.896 1.278 . . . . 0.0 114.403 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.74 -61.82 5.63 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 116.163 -1.875 . . . . 0.0 116.017 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -63.01 -37.57 52.28 Favored 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 122.559 2.173 . . . . 0.0 114.697 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 p -64.63 -46.33 83.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.11 -49.35 78.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 9.4 mt -49.78 -55.71 13.03 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.5 -37.6 81.6 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.6 p -55.36 -47.41 75.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -66.81 -45.35 78.64 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.404 0.681 . . . . 0.0 112.787 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.4 mt -49.39 -47.1 48.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.63 -37.12 85.05 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 173.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.39 -46.79 87.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.494 0.718 . . . . 0.0 112.523 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.2 mt -60.37 -46.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.466 0.706 . . . . 0.0 109.738 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.27 -62.78 2.62 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 125.569 1.557 . . . . 0.0 111.887 171.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.5 tp -50.57 -46.95 57.98 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.402 1.081 . . . . 0.0 111.882 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.76 -63.33 3.56 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.55 1.156 . . . . 0.0 113.996 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.47 -46.43 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.579 0.352 . . . . 0.0 110.595 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -49.5 -58.61 4.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.76 1.224 . . . . 0.0 113.193 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.2 tp -68.32 -33.82 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.484 1.114 . . . . 0.0 113.849 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.56 -39.56 91.07 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 125.408 1.48 . . . . 0.0 115.11 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -60.49 -23.13 64.26 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 68.7 mtm-85 -112.91 -13.02 13.19 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 161.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.09 -56.53 19.84 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 40.0 p -69.74 -66.03 0.64 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 122.845 0.458 . . . . 0.0 111.756 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 60.9 p -122.11 143.09 49.75 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.309 1.043 . . . . 0.0 109.477 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 C--O 1.258 1.528 0 CA-C-O 117.542 -1.218 . . . . 0.0 111.129 -173.086 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -57.6 -40.54 79.32 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.831 1.957 . . . . 0.0 111.672 167.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.5 m -99.72 89.65 4.19 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 169.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 39.5 m -56.83 109.7 0.68 Allowed 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 113.42 -1.718 . . . . 0.0 111.977 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.64 119.27 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.74 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -115.48 -26.94 7.33 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.949 170.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -119.26 116.18 25.72 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 168.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.54 -51.43 56.63 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.817 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.18 78.03 0.74 Allowed Glycine 0 CA--C 1.536 1.366 0 O-C-N 125.393 1.683 . . . . 0.0 113.014 170.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.97 -53.75 0.53 Allowed Glycine 0 N--CA 1.484 1.853 0 CA-C-N 113.686 -1.257 . . . . 0.0 115.5 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -36.84 139.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.52 -57.3 4.54 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.351 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 16.5 t -135.49 97.02 3.57 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.486 1.136 . . . . 0.0 113.195 -172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.15 -58.36 8.97 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -171.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -63.58 -36.27 83.24 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -55.66 -56.16 23.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.595 1.158 . . . . 0.0 111.573 170.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 31.5 mt -59.36 -38.79 81.34 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.508 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -59.35 -55.79 30.29 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.94 -30.52 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -66.3 -46.36 77.21 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 43.4 mt -43.49 -52.99 12.52 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.57 -54.93 2.05 Favored 'Trans proline' 0 C--N 1.356 0.941 0 CA-C-N 122.913 2.076 . . . . 0.0 113.411 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 4.2 p -63.85 -36.28 83.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.91 1.284 . . . . 0.0 112.668 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 35.6 mt -55.5 -59.18 5.19 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 50.5 mt -51.14 -46.81 62.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.578 0.751 . . . . 0.0 112.893 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.29 -57.52 10.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.533 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 84.8 p -56.39 -44.22 80.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -61.34 -51.34 69.23 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 3.8 mp -61.81 -39.79 92.99 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.1 -25.69 55.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.63 98.84 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.719 0.637 . . . . 0.0 111.284 165.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 30.5 mt -58.97 -54.93 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.145 0.903 . . . . 0.0 109.114 169.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.08 -61.18 3.19 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 125.188 1.375 . . . . 0.0 113.403 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 15.9 tp -55.73 -42.1 74.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.083 1.353 . . . . 0.0 112.185 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.43 -48.89 72.64 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.425 1.012 . . . . 0.0 112.994 171.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mt -57.9 -41.94 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.174 0.99 . . . . 0.0 110.778 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -55.87 -46.85 78.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 20.6 mt -58.18 -48.27 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.643 0.777 . . . . 0.0 109.886 172.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.52 -50.53 35.72 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 125.255 1.407 . . . . 0.0 112.984 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -54.55 -47.84 72.74 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.383 1.073 . . . . 0.0 111.695 173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -61.04 -33.02 72.64 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 4.6 mp -59.18 -55.91 28.91 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 167.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 41.3 p -81.08 -37.85 28.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 -170.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 19.6 p -122.88 5.39 9.38 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 118.798 2.888 . . . . 0.0 118.798 -175.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 117.574 -1.203 . . . . 0.0 109.702 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -139.08 136.46 35.24 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -160.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.6 m -63.54 115.56 4.79 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.313 1.054 . . . . 0.0 112.667 -171.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.4 p -135.29 113.39 11.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 112.501 -2.136 . . . . 0.0 111.554 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.93 112.48 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.926 -172.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.7 ttt -139.45 147.51 41.47 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.791 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -115.28 120.02 38.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.448 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -67.31 -22.65 65.61 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 117.737 2.495 . . . . 0.0 117.737 -170.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.76 172.36 33.17 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -161.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -136.25 -69.13 0.06 OUTLIER Glycine 0 N--CA 1.471 0.98 0 CA-C-O 121.63 0.572 . . . . 0.0 113.485 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.6 mt -70.95 126.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.459 1.123 . . . . 0.0 112.311 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -104.23 -42.27 5.56 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.267 -1.788 . . . . 0.0 114.063 171.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -122.0 94.87 4.44 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.911 0.862 . . . . 0.0 110.933 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -51.8 -46.59 64.28 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.793 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -47.18 -51.58 18.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.568 1.947 . . . . 0.0 113.32 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.9 -58.18 5.96 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.97 1.308 . . . . 0.0 112.268 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.02 -25.65 68.22 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -75.87 -52.61 9.96 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.749 0.819 . . . . 0.0 112.1 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.34 -47.55 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 O-C-N 124.151 0.907 . . . . 0.0 108.807 173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -34.4 51.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 117.643 2.461 . . . . 0.0 117.643 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.293 2.2 mt -36.6 -46.46 1.48 Allowed Pre-proline 0 N--CA 1.481 1.12 0 N-CA-C 119.749 3.24 . . . . 0.0 119.749 -173.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -53.44 -65.57 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.297 2.665 . . . . 0.0 111.984 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.3 m -47.4 -45.04 24.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 47.3 mt -51.97 -64.44 0.82 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.215 -0.898 . . . . 0.0 112.057 173.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.5 mt -44.63 -59.22 2.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.356 1.462 . . . . 0.0 112.605 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.61 -48.42 81.86 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -60.28 -42.3 95.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -63.64 -48.69 76.22 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 31.7 mt -61.86 -34.27 75.68 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 -41.98 87.8 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.416 1.086 . . . . 0.0 113.153 166.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -67.52 -43.26 81.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 35.8 mt -59.25 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.017 0.527 . . . . 0.0 109.663 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.09 -55.16 16.27 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 124.8 1.19 . . . . 0.0 112.267 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.3 tp -45.33 -57.97 3.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.124 1.37 . . . . 0.0 111.879 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.76 -48.67 43.48 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.846 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.9 mt -59.86 -58.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.436 0.694 . . . . 0.0 109.387 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 186' ' ' ARG . 72.8 t80 -47.65 -61.0 2.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.457 1.503 . . . . 0.0 112.621 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.2 pt -64.45 -44.76 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.47 95.78 Favored Glycine 0 N--CA 1.479 1.564 0 C-N-CA 124.886 1.231 . . . . 0.0 112.405 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -66.1 -54.16 29.1 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.36 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 13.7 mtp180 -48.56 -33.68 10.1 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 tp -44.22 -41.39 5.78 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.613 1.965 . . . . 0.0 115.023 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 19.3 m -113.37 -21.85 10.7 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -172.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.6 p -109.93 160.78 16.1 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.986 0.914 . . . . 0.0 112.459 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -174.838 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -98.32 101.72 13.25 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.297 1.046 . . . . 0.0 111.668 -170.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 9.9 t -152.85 146.7 25.25 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.038 -1.892 . . . . 0.0 111.9 -164.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 8.5 p -72.73 71.51 1.01 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.712 1.72 . . . . 0.0 113.754 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . 0.262 1.9 m -91.3 115.94 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 113.603 -1.635 . . . . 0.0 114.431 -174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 31.6 tpp 65.01 -64.65 0.16 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.591 2.356 . . . . 0.0 110.314 -167.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.79 117.77 4.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.061 1.744 . . . . 0.0 111.476 173.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 46.84 27.38 0.69 Allowed 'General case' 0 C--O 1.163 -3.474 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -144.73 60.05 0.5 Allowed Glycine 1 C--N 1.4 4.103 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.761 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 92.1 -170.15 32.79 Favored Glycine 0 CA--C 1.545 1.965 0 O-C-N 124.863 0.978 . . . . 0.0 111.997 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 6.3 pt -152.32 158.68 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.881 1.272 . . . . 0.0 112.664 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.74 -35.9 81.28 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -60.39 93.4 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 123.462 1.601 . . . . 0.0 114.119 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.76 82.19 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 111.687 -2.506 . . . . 0.0 109.282 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -53.08 -43.34 66.68 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 172.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -74.79 -48.35 25.85 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.046 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 69.4 mt -56.8 -43.26 80.78 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -62.35 -29.34 70.4 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.2 t -77.93 -53.62 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 121.432 0.634 . . . . 0.0 110.54 171.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -54.52 -49.06 71.13 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.812 1.245 . . . . 0.0 113.77 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.271 96.4 mt -62.64 -52.11 67.35 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 115.614 -2.136 . . . . 0.0 116.491 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -60.03 -43.28 37.42 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.41 2.073 . . . . 0.0 112.722 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 20.2 m -53.04 -55.22 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.155 0.909 . . . . 0.0 111.732 173.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 20.5 tp -52.79 -53.07 53.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.166 1.786 . . . . 0.0 112.488 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -50.92 -55.48 16.98 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.37 -36.9 81.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.9 p -59.73 -39.29 84.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.772 1.026 . . . . 0.0 113.772 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -68.01 -43.08 79.63 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.91 0.756 . . . . 0.0 112.802 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.07 -43.29 91.76 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.379 0.672 . . . . 0.0 111.045 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.71 -42.07 99.46 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.77 82.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 31.1 mt -59.09 -41.82 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.48 0.712 . . . . 0.0 110.298 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.95 -51.23 56.8 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 125.166 1.365 . . . . 0.0 114.212 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 13.1 tp -57.08 -45.69 83.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.573 0.749 . . . . 0.0 111.042 172.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -49.52 -59.41 7.22 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.335 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -51.11 -48.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.982 1.313 . . . . 0.0 112.98 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 36.6 t80 -40.99 -58.55 1.69 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.629 1.172 . . . . 0.0 112.876 168.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.78 -52.38 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.559 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.06 -57.64 8.63 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 125.298 1.428 . . . . 0.0 112.677 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -56.81 -49.46 75.3 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.151 1.38 . . . . 0.0 114.235 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -63.45 -37.55 87.71 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.37 -37.18 84.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.74 1.216 . . . . 0.0 113.588 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 33.6 p -84.35 -73.0 0.44 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 30.4 p -128.53 107.87 10.07 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.03 0.919 . . . . 0.0 109.877 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.477 0.924 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.639 -172.5 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -125.23 143.38 50.98 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.955 170.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.0 p -129.57 141.26 51.0 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.736 -167.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.5 t -93.75 128.84 40.17 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.65 113.15 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 166.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -65.48 -15.65 62.87 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 117.095 2.258 . . . . 0.0 117.095 -169.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -45.07 117.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -170.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttm 44.57 85.64 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 111.424 -2.625 . . . . 0.0 115.62 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.15 -108.59 0.02 OUTLIER Glycine 0 CA--C 1.534 1.254 0 CA-C-N 112.179 -2.282 . . . . 0.0 112.98 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.72 24.79 64.76 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 113.503 -1.349 . . . . 0.0 114.38 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.78 147.74 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -64.17 -71.44 0.18 Allowed 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.075 168.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.7 t -103.89 122.69 45.69 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.49 -34.89 31.05 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 113.554 -1.657 . . . . 0.0 112.236 168.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.606 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 14.9 mp0 -50.74 -53.33 32.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.587 1.555 . . . . 0.0 110.789 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -51.51 -57.79 8.09 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.387 1.075 . . . . 0.0 109.891 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 80.5 mt -52.85 -42.34 65.11 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -61.75 -50.17 73.45 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -70.73 -36.73 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 122.046 0.927 . . . . 0.0 110.724 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -54.74 -37.92 66.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.251 1.82 . . . . 0.0 113.565 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 13.0 tp -62.11 -49.83 83.09 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.302 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.95 -43.73 34.95 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.093 1.862 . . . . 0.0 112.774 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.3 t -58.71 -51.69 68.9 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.347 1.059 . . . . 0.0 112.568 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.46 -57.21 12.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.591 1.957 . . . . 0.0 111.547 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 mp -46.28 -61.97 1.55 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.288 1.435 . . . . 0.0 113.69 175.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.42 -35.31 79.99 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.213 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.2 p -60.77 -45.4 94.49 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -59.75 -45.69 91.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.14 -45.62 79.54 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.735 0.647 . . . . 0.0 112.271 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.18 -38.03 89.21 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.23 93.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.266 0.626 . . . . 0.0 111.812 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 42.4 mt -57.43 -47.71 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.176 170.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.17 -54.34 26.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.899 1.238 . . . . 0.0 114.084 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.6 tp -49.88 -49.84 48.04 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.09 -49.51 71.4 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.655 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.49 -47.06 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.382 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -54.03 -53.67 49.88 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.257 0.973 . . . . 0.0 112.096 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.7 mt -51.68 -56.56 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.506 1.122 . . . . 0.0 111.151 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.51 22.11 Favored Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.829 1.331 . . . . 0.0 113.459 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.7 -56.66 6.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.554 1.542 . . . . 0.0 111.611 171.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.1 tpt85 -62.69 -36.82 84.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.8 mt -49.85 -37.13 29.43 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 170.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.9 -45.99 5.26 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 26.0 p -128.62 132.74 48.16 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.022 0.915 . . . . 0.0 112.763 -173.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.259 1.6 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.006 178.636 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.005 -0.522 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -116.04 166.09 12.39 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 124.41 1.069 . . . . 0.0 111.545 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -126.94 171.69 11.09 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.506 2.323 . . . . 0.0 113.507 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 15.5 t 63.43 116.98 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 126.67 1.988 . . . . 0.0 113.268 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 21.4 t 70.93 135.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.936 2.094 . . . . 0.0 109.959 -172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.51 110.64 0.17 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -83.29 111.47 19.01 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.933 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -116.64 106.82 13.96 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.53 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.48 -62.59 5.87 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-N 112.855 -1.975 . . . . 0.0 113.937 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.94 -91.84 0.02 OUTLIER Glycine 0 N--CA 1.476 1.343 0 C-N-CA 124.84 1.21 . . . . 0.0 110.436 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.74 131.99 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 172.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.24 -55.26 34.05 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.66 168.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 9.2 t 172.28 141.53 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.247 1.819 . . . . 0.0 110.525 170.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.24 -43.26 52.92 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -60.99 -29.63 69.8 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -75.44 -42.1 54.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.025 0.93 . . . . 0.0 111.148 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 44.4 tp -67.56 -51.69 47.63 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.533 1.533 . . . . 0.0 114.8 173.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -89.88 -63.57 1.26 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.91 -59.99 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -56.53 -46.08 80.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.255 4.8 mt -49.73 -60.78 4.4 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.48 -53.26 3.0 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.351 2.701 . . . . 0.0 110.874 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 8.2 p -54.87 -44.3 73.93 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.84 -67.32 0.3 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.396 168.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.85 -50.22 57.23 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.62 -44.66 93.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.006 1.322 . . . . 0.0 114.322 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -61.13 -42.45 98.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.07 -45.47 94.61 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.3 tp -50.49 -54.5 21.79 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 0.0 112.652 170.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 12.1 tp -67.68 -29.6 68.91 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.4 -46.44 86.39 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.354 0.661 . . . . 0.0 112.758 170.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 33.9 mt -57.04 -48.23 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 170.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.59 -54.71 15.9 Favored Glycine 0 N--CA 1.482 1.714 0 C-N-CA 124.426 1.012 . . . . 0.0 113.024 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 12.9 tp -52.96 -49.21 66.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 111.233 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.49 -52.36 28.9 Favored Glycine 0 N--CA 1.482 1.723 0 O-C-N 124.253 0.97 . . . . 0.0 113.428 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.21 -51.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.896 0.878 . . . . 0.0 110.1 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -46.34 -56.29 6.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.783 1.233 . . . . 0.0 112.729 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.37 -61.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.138 1.375 . . . . 0.0 111.543 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.52 -52.18 29.69 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.514 1.531 . . . . 0.0 112.68 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -56.25 -59.84 4.37 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 117.562 -1.209 . . . . 0.0 110.71 173.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -45.78 -53.09 10.12 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 42.9 mt -56.67 -54.73 42.71 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 71.6 p -78.92 -25.33 43.7 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 5.0 t -99.95 145.35 27.94 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 117.26 -1.352 . . . . 0.0 111.578 177.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -108.35 123.98 49.66 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -165.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' B' ' 149' ' ' SER . 9.9 p -107.74 169.98 8.26 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.4 m -114.76 54.98 0.76 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.961 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.2 m -77.16 142.13 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.15 91.68 8.8 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.271 1.034 . . . . 0.0 113.562 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -142.87 128.67 19.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 111.417 -2.629 . . . . 0.0 112.058 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -100.32 -28.15 13.11 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 113.332 -1.758 . . . . 0.0 114.473 168.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.55 -107.26 0.53 Allowed Glycine 0 N--CA 1.48 1.622 0 C-N-CA 124.401 1.001 . . . . 0.0 114.852 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' B' ' 158' ' ' SER . . . -140.27 -123.95 2.05 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 124.286 0.946 . . . . 0.0 113.116 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.0 pp -49.81 147.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -79.22 -39.39 33.32 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.381 170.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.2 t -112.66 138.28 49.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.75 1.22 . . . . 0.0 111.418 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.48 9.47 3.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.612 -1.631 . . . . 0.0 113.832 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -55.63 -46.92 77.35 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.437 171.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -43.87 -56.59 3.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.878 1.271 . . . . 0.0 113.172 168.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 78.3 mt -64.21 -41.23 97.13 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.041 1.337 . . . . 0.0 113.838 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -73.41 -37.67 65.86 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.1 m -76.17 -27.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.32 -50.62 29.51 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.784 1.633 . . . . 0.0 111.692 171.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.0 mt -58.4 -49.16 95.07 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 116.666 -1.635 . . . . 0.0 115.37 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.71 -50.51 7.78 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.313 2.009 . . . . 0.0 112.294 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.2 m -50.56 -45.5 57.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.854 0.861 . . . . 0.0 112.408 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -66.68 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.683 1.593 . . . . 0.0 111.724 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pp -62.24 -43.8 97.99 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 mt -57.72 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.45 0.7 . . . . 0.0 112.344 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.5 p -63.55 -40.12 96.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -56.48 -51.13 69.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.6 mt -54.83 -51.43 65.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 112.633 172.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.0 mt -55.76 -43.28 76.54 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.711 1.204 . . . . 0.0 114.222 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.26 -47.35 75.58 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.33 1.452 . . . . 0.0 113.643 173.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.1 mt -61.21 -41.1 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.81 . . . . 0.0 111.131 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -57.71 14.82 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 124.154 0.909 . . . . 0.0 112.3 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 15.3 tp -48.67 -46.01 39.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.349 1.059 . . . . 0.0 111.827 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.85 -57.54 10.77 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.977 1.275 . . . . 0.0 113.548 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 33.7 mt -53.56 -43.93 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.654 1.182 . . . . 0.0 111.828 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -51.83 -54.11 32.62 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.044 0.84 . . . . 0.0 112.376 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.6 mt -56.54 -54.45 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.278 1.031 . . . . 0.0 109.863 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -44.34 -60.6 3.56 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 125.773 1.654 . . . . 0.0 112.577 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -65.8 -36.26 83.01 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.4 -42.12 98.23 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 29.9 mt -59.81 -44.21 94.1 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.702 0.801 . . . . 0.0 111.672 171.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.0 m -60.8 -48.92 79.6 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.828 0.705 . . . . 0.0 112.69 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 27.4 p -109.33 53.88 0.67 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.253 1.255 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.021 174.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -119.95 132.6 55.56 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 11.7 t -159.14 121.77 3.58 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 148' ' ' THR . 10.3 t 175.59 140.94 0.06 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.691 1.996 . . . . 0.0 110.948 161.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.89 134.23 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 59.83 -47.79 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.31 2.244 . . . . 0.0 115.31 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -120.98 162.47 19.86 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.311 1.444 . . . . 0.0 108.706 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -78.73 -2.65 40.37 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -126.66 81.14 0.36 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.601 162.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -160.18 127.2 1.75 Allowed Glycine 0 N--CA 1.48 1.588 0 C-N-CA 124.336 0.97 . . . . 0.0 111.868 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 pt -59.49 121.78 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -54.81 -54.39 42.8 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.869 -1.059 . . . . 0.0 112.817 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.44 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 72.8 m -79.55 62.77 3.95 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 123.1 1.429 . . . . 0.0 110.635 173.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -45.74 -52.68 10.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.911 2.084 . . . . 0.0 115.19 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.53 -25.17 16.95 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.693 172.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -95.77 48.7 1.14 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -170.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 75.7 mt -139.55 82.31 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.443 171.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -148.22 -39.97 0.17 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 162.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 t -113.42 -53.79 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -159.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -51.43 -70.18 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -170.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 21.7 tp -44.47 -51.65 19.72 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 116.163 -1.875 . . . . 0.0 115.575 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -56.2 -52.45 7.18 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.451 2.101 . . . . 0.0 112.761 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 25.6 p -61.74 -35.22 77.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 52.5 mt -54.82 -64.15 0.93 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 117.726 -1.13 . . . . 0.0 112.291 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 19.1 mt -51.78 -50.04 61.49 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.198 0.999 . . . . 0.0 112.794 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 36.0 tp -53.31 -54.68 32.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.591 1.556 . . . . 0.0 112.737 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 76.8 p -63.66 -31.62 72.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -59.63 -49.4 77.89 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.532 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -43.61 79.52 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.99 -51.62 65.65 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.647 0.779 . . . . 0.0 112.828 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.45 -47.29 86.77 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.114 1.366 . . . . 0.0 114.118 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 26.0 mt -58.92 -49.11 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.162 0.585 . . . . 0.0 109.448 174.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.93 10.44 Favored Glycine 0 N--CA 1.483 1.823 0 O-C-N 124.665 1.228 . . . . 0.0 112.538 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.78 -45.94 70.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.885 1.274 . . . . 0.0 112.514 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -49.93 62.04 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 124.735 1.16 . . . . 0.0 113.123 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 17.7 mt -60.61 -48.62 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.076 0.95 . . . . 0.0 109.152 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -40.89 -59.65 1.38 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.101 1.36 . . . . 0.0 112.273 169.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 70.4 mt -57.27 -54.73 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.829 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.07 -31.66 18.84 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 126.206 1.86 . . . . 0.0 116.191 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 14.6 tpt85 -99.22 -41.67 7.38 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -51.34 -38.99 56.08 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.23 -44.1 71.43 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 124.565 1.166 . . . . 0.0 112.985 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 22.5 m -82.29 -41.08 20.6 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.182 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 3.0 m -106.04 70.21 0.84 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.387 1.089 . . . . 0.0 112.775 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.245 0.838 0 CA-C-N 112.186 -2.279 . . . . 0.0 106.172 165.247 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -104.06 118.85 37.65 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.379 1.049 . . . . 0.0 110.153 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 p -45.9 -27.13 0.81 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.1 m -41.3 112.88 0.34 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.194 1.397 . . . . 0.0 114.424 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . 0.351 12.6 m 36.95 50.24 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.278 2.558 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -173.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.44 ' HG3' ' HB2' ' B' ' 149' ' ' SER . 11.1 mmt -76.3 83.19 3.07 Favored 'General case' 0 C--O 1.275 2.423 0 C-N-CA 125.098 1.359 . . . . 0.0 109.077 166.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 158' ' ' SER . 29.7 mttm -37.84 -62.81 0.52 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 127.824 2.45 . . . . 0.0 114.389 -169.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -112.22 80.81 1.38 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 124.137 0.898 . . . . 0.0 109.98 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 119.49 96.82 1.68 Allowed Glycine 0 CA--C 1.542 1.721 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.545 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.89 -62.04 0.58 Allowed Glycine 0 N--CA 1.48 1.605 0 CA-C-N 114.068 -1.066 . . . . 0.0 111.725 -171.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 pt -94.86 174.2 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.814 -0.693 . . . . 0.0 110.571 170.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -73.32 100.08 3.07 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 169.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 24.2 t -16.2 125.07 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 112.499 -2.137 . . . . 0.0 116.39 -172.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.36 53.89 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.559 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -56.64 -48.26 77.93 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 171.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -66.78 -34.3 77.53 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 80.0 mt -53.77 -47.13 71.02 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.875 0.87 . . . . 0.0 111.17 166.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -64.86 -42.69 94.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.225 1.01 . . . . 0.0 113.451 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.6 t -58.68 -39.8 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.571 0.748 . . . . 0.0 110.541 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -60.24 -23.69 64.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.068 1.347 . . . . 0.0 114.232 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 39.4 mt -43.57 -47.68 18.81 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -65.32 -58.45 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.904 1.736 . . . . 0.0 112.598 168.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 m -43.57 -44.77 6.35 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.6 tp -44.62 -67.59 0.27 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.237 2.215 . . . . 0.0 112.31 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 mp -71.26 -37.86 71.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.409 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.7 mt -49.1 -57.44 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.132 0.895 . . . . 0.0 111.334 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.5 t -54.05 -58.94 5.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.129 1.371 . . . . 0.0 111.697 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -50.35 -68.54 0.16 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.27 -55.23 35.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.26 -48.09 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.09 87.99 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 56.5 mt -55.86 -45.21 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.985 0.514 . . . . 0.0 110.689 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.11 -53.33 41.09 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 124.227 0.918 . . . . 0.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 16.7 tp -52.77 -47.22 67.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.563 0.745 . . . . 0.0 112.32 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.1 -51.79 47.94 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.868 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.7 mt -48.56 -46.0 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.159 0.983 . . . . 0.0 113.132 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -53.71 -56.28 18.74 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.658 0.599 . . . . 0.0 112.308 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 23.0 mt -50.59 -53.37 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.875 1.27 . . . . 0.0 110.326 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.81 -59.84 9.66 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 124.738 1.161 . . . . 0.0 112.278 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -49.06 -52.97 22.42 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.552 1.541 . . . . 0.0 112.69 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -53.94 -36.56 62.93 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.216 1.806 . . . . 0.0 114.266 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.3 mt -57.51 -39.71 77.11 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.57 -34.24 23.24 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 4.7 p -127.36 127.37 44.13 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 117.34 -1.314 . . . . 0.0 112.639 -173.404 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 119.425 -0.322 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 152' ' ' LYS . 12.7 t30 -130.52 -49.8 1.07 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 31.0 m -132.45 115.26 15.32 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' SER . . . . . 0.44 ' HB2' ' HG3' ' A' ' 151' ' ' MET . 5.1 t -109.76 -45.05 3.72 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 113.517 -1.674 . . . . 0.0 110.631 169.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.33 118.18 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.26 91.64 6.84 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.123 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -70.68 95.92 1.16 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -103.78 152.31 22.03 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 110.963 -2.835 . . . . 0.0 110.913 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 74.61 -88.18 0.73 Allowed Glycine 0 N--CA 1.479 1.508 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.18 74.0 0.39 Allowed Glycine 0 N--CA 1.479 1.501 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 160.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.8 156.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 113.387 -1.406 . . . . 0.0 113.602 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -43.61 -56.25 3.83 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -163.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 29.2 p -50.5 -54.28 23.55 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.57 1.148 . . . . 0.0 112.773 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.16 -54.77 35.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.512 1.525 . . . . 0.0 112.898 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -56.14 -41.75 75.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.277 1.031 . . . . 0.0 113.439 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -78.39 -34.72 47.94 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.86 -44.38 82.12 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.448 0.567 . . . . 0.0 111.394 161.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -83.08 13.39 4.11 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.8 t -106.58 -40.3 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 153.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -49.48 -62.55 1.49 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.359 1.464 . . . . 0.0 112.073 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.34 -41.62 61.2 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.145 -1.407 . . . . 0.0 114.345 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -51.49 -52.77 8.31 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.868 2.379 . . . . 0.0 114.32 165.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -59.66 -40.45 87.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.179 0.992 . . . . 0.0 113.432 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.16 -44.89 95.61 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.524 0.73 . . . . 0.0 112.414 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.19 -51.37 70.01 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.785 0.834 . . . . 0.0 112.087 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 25.6 tp -49.03 -53.48 19.94 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.592 1.557 . . . . 0.0 111.826 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 33.3 t -54.81 -57.29 12.17 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.909 1.284 . . . . 0.0 112.192 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -47.41 -52.39 17.01 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.358 1.063 . . . . 0.0 113.245 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.28 -50.37 73.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 47.5 mt -71.49 -32.31 68.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.47 -47.46 72.99 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.585 0.754 . . . . 0.0 111.615 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 23.2 mt -50.23 -53.59 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.179 1.392 . . . . 0.0 110.787 167.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.07 -60.21 4.64 Favored Glycine 0 N--CA 1.483 1.814 0 O-C-N 124.415 1.072 . . . . 0.0 113.286 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 15.4 tp -50.95 -46.34 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.606 1.162 . . . . 0.0 112.225 173.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.22 -53.33 43.56 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 124.773 1.178 . . . . 0.0 113.63 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 23.2 mt -53.31 -46.8 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.862 0.865 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -49.44 -59.63 3.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.835 1.654 . . . . 0.0 113.449 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.73 -49.9 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 121.632 0.73 . . . . 0.0 111.651 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.0 -48.27 46.31 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.719 1.628 . . . . 0.0 113.529 -178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -58.69 -33.31 70.01 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 114.249 1.204 . . . . 0.0 114.249 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.31 -50.5 10.09 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . 0.285 91.4 mt 6.47 -73.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 120.898 3.666 . . . . 0.0 120.898 -167.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.0 p -64.51 -44.41 91.0 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 39.5 p -90.52 58.4 3.95 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 123.17 1.462 . . . . 0.0 112.538 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 C--O 1.25 1.079 0 CA-C-N 112.726 -2.034 . . . . 0.0 107.987 -178.782 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 22.8 ttt-85 . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 21.4 78.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 127.245 2.218 . . . . 0.0 116.291 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.8 p -105.63 166.06 10.72 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -168.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.13 69.55 1.44 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.491 164.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 20.1 m -126.59 115.79 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.712 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 23.1 mmt -15.37 99.11 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 150' ' ' VAL . 71.9 mmtt -118.52 93.46 4.12 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 123.179 1.466 . . . . 0.0 112.871 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -115.82 100.5 8.05 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 113.209 -1.814 . . . . 0.0 107.382 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -80.21 -113.16 0.28 Allowed Glycine 0 N--CA 1.473 1.157 0 CA-C-N 113.299 -1.773 . . . . 0.0 108.989 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -177.37 -140.99 3.88 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-N 114.221 -0.989 . . . . 0.0 112.118 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 pt -134.88 -148.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 113.386 -1.407 . . . . 0.0 110.757 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -96.11 -59.79 1.77 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.837 0.289 . . . . 0.0 111.268 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.5 t -93.47 102.67 14.9 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.894 1.33 . . . . 0.0 112.634 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.73 -30.83 70.22 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 112.831 -1.986 . . . . 0.0 113.047 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -73.22 -32.01 64.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.316 1.046 . . . . 0.0 113.171 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -66.96 -45.54 77.43 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.647 166.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.0 tp -54.57 -37.05 65.02 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -56.75 -33.05 66.18 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.747 1.619 . . . . 0.0 114.668 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.3 -40.61 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -48.42 -60.51 2.62 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.27 36.0 mt -54.12 -55.03 40.84 Favored Pre-proline 0 N--CA 1.482 1.125 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.646 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -46.96 -52.09 8.26 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.12 2.547 . . . . 0.0 114.237 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.1 p -66.12 -47.2 74.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.14 -58.4 6.24 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.102 0.961 . . . . 0.0 110.999 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.6 mt -54.29 -52.74 60.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.631 1.172 . . . . 0.0 112.704 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.4 tp -55.15 -51.84 65.2 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.174 0.99 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.8 p -57.05 -39.7 75.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -63.27 -48.09 79.62 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.6 tp -58.76 -45.31 90.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.575 0.75 . . . . 0.0 112.394 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.46 -35.62 81.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.12 98.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.333 0.653 . . . . 0.0 112.422 172.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 27.2 mt -59.33 -49.57 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 169.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -47.75 -55.78 9.31 Favored Glycine 0 CA--C 1.546 2.008 0 C-N-CA 124.952 1.263 . . . . 0.0 113.091 174.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 55.9 tp -45.74 -56.76 4.9 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.296 1.439 . . . . 0.0 112.697 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.52 -48.24 55.66 Favored Glycine 0 CA--C 1.541 1.689 0 O-C-N 124.533 1.146 . . . . 0.0 113.756 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.0 mt -57.54 -50.78 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.96 0.504 . . . . 0.0 110.11 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -53.74 -54.79 33.16 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.704 1.253 . . . . 0.0 112.427 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.6 mt -53.85 -56.38 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.318 0.647 . . . . 0.0 111.356 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -46.76 -58.26 6.22 Favored Glycine 0 N--CA 1.487 2.036 0 O-C-N 124.481 1.113 . . . . 0.0 112.168 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.72 -52.02 54.62 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -55.15 -43.26 74.04 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.55 -47.48 85.38 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.932 0.77 . . . . 0.0 111.997 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 92.1 m -63.21 -39.38 94.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.947 0.499 . . . . 0.0 111.941 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.5 p -96.84 52.96 1.2 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.516 0.51 . . . . 0.0 112.237 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 126.81 2.044 . . . . 0.0 111.955 172.844 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 . . . . . 0 C--O 1.24 0.586 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -81.96 73.17 9.02 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.043 0.925 . . . . 0.0 109.383 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.3 m -88.51 131.64 34.83 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.808 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 58.8 m -50.71 -50.76 54.43 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.894 -1.503 . . . . 0.0 114.713 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.01 78.8 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 122.15 0.976 . . . . 0.0 110.663 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 30.8 mtt -137.37 134.67 36.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.821 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -54.24 -54.13 44.19 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -171.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -98.61 -43.1 6.97 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.384 0.428 . . . . 0.0 110.199 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -42.22 -67.9 0.8 Allowed Glycine 0 N--CA 1.476 1.365 0 C-N-CA 126.189 1.852 . . . . 0.0 115.226 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -111.42 -110.16 3.14 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.31 149.91 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.707 1.603 . . . . 0.0 113.985 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -74.33 -43.98 54.37 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.114 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 25.9 t -136.42 138.82 41.92 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.29 -43.86 85.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.943 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -48.03 -49.14 32.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.692 0.797 . . . . 0.0 112.812 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -63.34 -44.22 95.49 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.704 0.802 . . . . 0.0 112.416 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 40.8 tp -52.68 -45.83 66.97 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -64.25 -16.55 62.3 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 7.3 t -93.47 -48.65 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 124.477 1.11 . . . . 0.0 109.291 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -36.4 -71.79 0.07 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -47.88 97.67 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.1 -52.86 6.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.75 2.3 . . . . 0.0 112.992 170.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 19.5 t -52.09 -48.99 64.44 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.182 0.993 . . . . 0.0 111.864 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.9 mp -55.34 -65.45 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.907 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mt -41.08 -61.5 0.99 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.363 1.465 . . . . 0.0 114.921 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 54.2 mt -62.79 -36.73 84.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -77.7 -34.37 52.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -67.3 -40.15 86.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 70.1 mt -53.81 -53.16 56.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 0.0 111.929 168.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 7.7 mt -48.48 -47.93 38.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.233 1.013 . . . . 0.0 113.237 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.73 -52.01 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 29.0 mt -61.28 -42.33 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.31 0.644 . . . . 0.0 110.636 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.99 -51.48 55.24 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.848 1.213 . . . . 0.0 112.831 173.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.35 -44.34 44.59 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.43 -57.36 19.0 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.456 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -47.76 -52.2 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.947 1.299 . . . . 0.0 110.971 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.61 -50.15 25.07 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.942 0.897 . . . . 0.0 113.227 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 19.1 mt -61.63 -63.58 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.913 0.485 . . . . 0.0 110.563 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.09 -54.66 5.2 Favored Glycine 0 N--CA 1.474 1.219 0 C-N-CA 126.297 1.903 . . . . 0.0 114.162 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -96.55 -81.29 0.42 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.818 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -50.21 -56.69 10.02 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -166.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.48 -40.89 98.14 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.581 1.152 . . . . 0.0 111.719 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 31.6 p -63.7 -52.37 60.89 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 117.4 -1.286 . . . . 0.0 110.687 172.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 69.0 p -79.01 26.71 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.483 1.219 0 C-N-CA 123.258 0.623 . . . . 0.0 110.263 175.843 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 . . . . . 0 C--O 1.254 1.334 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.96 173.36 0.79 Allowed 'General case' 0 C--O 1.175 -2.854 0 CA-C-O 124.344 2.021 . . . . 0.0 110.369 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.7 p -46.05 127.7 8.66 Favored 'General case' 0 C--N 1.376 1.725 0 CA-C-N 110.686 -2.961 . . . . 0.0 118.663 -174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -55.68 140.47 41.36 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 129.082 2.953 . . . . 0.0 111.398 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.37 97.29 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.937 1.351 . . . . 0.0 109.785 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 43.8 mtt -115.31 48.01 1.23 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.307 -165.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -54.18 -53.08 58.31 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -86.93 -52.25 5.57 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.126 166.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -80.03 63.87 4.02 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-O 118.553 -1.137 . . . . 0.0 115.059 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.99 -75.66 1.04 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 124.778 1.18 . . . . 0.0 111.548 -173.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.53 87.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 123.444 1.592 . . . . 0.0 107.015 164.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -47.65 -36.94 11.78 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 127.258 2.223 . . . . 0.0 116.605 -164.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.2 p -160.56 145.06 14.19 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.932 1.395 . . . . 0.0 113.485 173.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.38 -29.0 70.08 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.358 -1.292 . . . . 0.0 113.365 163.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -45.67 -53.78 8.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.387 1.475 . . . . 0.0 110.83 170.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -44.44 -59.85 2.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.016 1.326 . . . . 0.0 113.269 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 mt -54.09 -55.04 31.39 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -57.7 -43.75 85.38 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 124.064 0.853 . . . . 0.0 112.863 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 p -76.72 -22.05 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -98.01 7.36 46.44 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.285 35.7 mt -49.79 -26.64 1.02 Allowed Pre-proline 0 N--CA 1.483 1.176 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -51.96 -71.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 121.518 1.479 . . . . 0.0 112.125 164.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 p -55.78 -42.31 75.36 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 47.1 mt -56.35 -61.36 2.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.49 -17.74 62.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.98 -41.04 82.94 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 165.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.9 p -61.68 -34.39 75.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -72.93 -38.47 66.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 118.28 -0.867 . . . . 0.0 113.211 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.6 tp -51.81 -47.01 64.49 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.649 0.593 . . . . 0.0 111.555 168.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.5 mt -49.62 -56.69 9.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.834 0.709 . . . . 0.0 112.436 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.52 -52.6 63.13 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 30.2 mt -56.04 -47.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.369 1.067 . . . . 0.0 110.357 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.15 -57.39 10.18 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.912 1.244 . . . . 0.0 112.724 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 30.0 tp -53.11 -45.96 68.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.221 1.009 . . . . 0.0 112.499 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.66 -56.07 6.72 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 125.233 1.397 . . . . 0.0 113.822 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.8 mt -59.32 -53.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.314 -0.943 . . . . 0.0 109.565 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -51.84 -58.24 7.02 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.559 -1.2 . . . . 0.0 113.101 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . 0.256 2.9 pp -60.79 -38.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.58 -47.61 90.05 Favored Glycine 0 N--CA 1.481 1.689 0 C-N-CA 123.83 0.728 . . . . 0.0 112.943 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -59.02 -50.84 72.56 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.213 -0.994 . . . . 0.0 111.83 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -54.24 -51.05 65.72 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.405 1.082 . . . . 0.0 113.336 175.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.39 -33.87 75.61 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 26.4 p -84.02 -58.09 2.92 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.301 1.0 . . . . 0.0 111.891 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 12.1 t -110.47 125.13 52.97 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.256 1.435 0 C-N-CA 131.519 3.928 . . . . 0.0 106.248 -178.919 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -82.6 142.02 32.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 82.3 p -67.65 -23.41 65.33 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 112.837 -1.983 . . . . 0.0 114.18 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 27.3 m -62.97 -43.73 98.0 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 58.0 t -82.9 -40.95 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.565 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 68.9 mtm -58.98 160.68 5.72 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.458 1.098 . . . . 0.0 111.544 169.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -101.1 68.17 1.23 Allowed 'General case' 0 C--O 1.201 -1.495 0 CA-C-O 124.301 2.0 . . . . 0.0 112.279 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -135.61 118.3 16.04 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 110.239 -3.164 . . . . 0.0 110.391 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.53 77.96 0.26 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 112.986 -1.915 . . . . 0.0 108.723 172.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.74 -57.14 5.05 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 124.332 0.968 . . . . 0.0 111.522 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 1.4 pp -116.0 156.09 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 112.342 -1.929 . . . . 0.0 109.926 171.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -67.76 -45.02 76.1 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 39.6 t -151.77 139.94 20.26 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.74 -55.07 38.91 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.707 170.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -47.47 -50.3 23.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.582 1.553 . . . . 0.0 112.53 172.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -52.49 -56.42 15.27 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.491 1.119 . . . . 0.0 112.628 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 25.4 mt -55.91 -48.97 74.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -54.19 -29.74 47.08 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.71 -38.62 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -82.34 -43.44 17.43 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -172.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 54.3 tp -54.91 -42.29 94.85 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.226 -1.369 . . . . 0.0 113.479 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -54.09 -51.84 9.72 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.132 1.888 . . . . 0.0 113.504 168.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 41.4 m -53.15 -48.67 67.76 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 80.4 mt -50.71 -59.89 3.61 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.665 170.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.0 mt -50.64 -57.91 7.1 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.99 -52.85 47.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.794 0.837 . . . . 0.0 113.164 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 60.5 p -66.77 -42.52 85.96 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -63.9 -43.38 96.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.74 -47.46 79.98 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 170.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 39.0 mt -56.68 -42.55 79.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 170.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.65 91.02 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 44.0 mt -55.37 -47.48 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 168.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.38 -53.57 23.75 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.52 1.057 . . . . 0.0 113.014 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.25 -41.75 69.14 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.79 -54.11 29.84 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.153 0.882 . . . . 0.0 112.42 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 13.2 mt -53.8 -54.32 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.614 1.166 . . . . 0.0 110.531 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -49.52 -50.95 39.65 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.193 1.797 . . . . 0.0 113.97 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.6 tp -68.13 -38.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.92 -43.43 87.6 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 170.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -61.54 -36.73 81.41 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -58.8 -60.84 3.19 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.845 0.716 . . . . 0.0 112.767 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.02 -61.22 2.28 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 13.1 p -126.97 -39.81 1.92 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -169.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 15.6 m -114.24 94.99 5.05 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -167.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.48 1.032 0 CA-C-N 112.225 -2.261 . . . . 0.0 110.392 169.146 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -91.38 141.68 28.5 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-O 121.642 0.734 . . . . 0.0 110.731 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.6 p -76.82 51.34 0.77 Allowed 'General case' 0 C--O 1.154 -3.942 0 CA-C-O 124.628 2.156 . . . . 0.0 115.748 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.9 m -51.35 115.72 1.72 Allowed 'General case' 0 C--N 1.403 2.927 0 CA-C-N 110.734 -2.939 . . . . 0.0 113.761 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.9 m -119.6 85.18 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.128 0.966 . . . . 0.0 110.921 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 16.3 mtm -58.85 116.84 4.02 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.966 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -57.87 -33.19 68.42 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 112.893 -1.958 . . . . 0.0 115.253 -171.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -78.67 -17.81 55.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 134.79 164.31 10.46 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 124.318 0.961 . . . . 0.0 112.007 -172.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.22 94.3 0.18 Allowed Glycine 0 N--CA 1.478 1.474 0 CA-C-N 113.467 -1.367 . . . . 0.0 112.003 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -97.8 152.72 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.631 1.205 . . . . 0.0 112.535 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -97.52 -40.2 8.77 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.399 -1.273 . . . . 0.0 114.024 164.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.0 t -63.38 101.34 0.31 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 122.202 1.001 . . . . 0.0 113.257 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.35 74.5 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.228 -1.806 . . . . 0.0 111.764 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.86 -34.6 63.1 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -65.17 -55.1 20.51 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.102 1.361 . . . . 0.0 112.667 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.9 tp -66.29 -32.39 73.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -53.15 -57.63 9.79 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.704 0.628 . . . . 0.0 112.08 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.2 m -66.55 -23.72 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -54.49 -49.11 70.9 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.0 tp -52.5 -55.88 27.96 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 115.907 -1.997 . . . . 0.0 113.703 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.36 -52.32 4.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.35 2.033 . . . . 0.0 112.759 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -46.45 63.08 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.28 -66.55 0.51 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.866 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -47.15 -53.21 13.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.498 1.119 . . . . 0.0 113.978 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.01 -44.79 95.02 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.9 p -70.86 -41.89 70.81 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -57.81 -42.92 85.24 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.0 mt -56.19 -52.9 62.71 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 169.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.0 mt -49.17 -47.5 45.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 112.221 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.3 -48.57 76.41 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 16.4 mt -59.81 -49.26 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 123.55 0.74 . . . . 0.0 110.462 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.1 -51.27 36.09 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 124.25 0.928 . . . . 0.0 112.027 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.09 -46.13 79.14 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.214 1.005 . . . . 0.0 112.012 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -48.42 -53.65 15.52 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.253 0.93 . . . . 0.0 113.438 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.14 -50.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.252 0.621 . . . . 0.0 109.792 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.83 -55.63 18.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.041 0.936 . . . . 0.0 113.255 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -48.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.39 -55.59 12.69 Favored Glycine 0 N--CA 1.481 1.694 0 C-N-CA 124.196 0.903 . . . . 0.0 111.46 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -55.73 -45.42 77.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.301 1.441 . . . . 0.0 114.402 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -65.04 -27.05 68.53 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.0 mt -78.06 -52.86 8.11 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.097 0.559 . . . . 0.0 111.982 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 23.0 p -95.98 -66.15 0.93 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 10.4 p -106.23 67.46 0.74 Allowed 'General case' 0 C--O 1.196 -1.753 0 CA-C-O 124.366 2.032 . . . . 0.0 115.564 -170.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 71.8 m . . . . . 0 N--CA 1.482 1.131 0 CA-C-N 111.384 -2.644 . . . . 0.0 107.654 173.632 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -135.37 -69.22 0.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.444 1.098 . . . . 0.0 111.952 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 57.7 p -62.51 -41.86 99.11 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.809 0.844 . . . . 0.0 112.817 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 6.9 m -111.97 104.67 12.95 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.516 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.36 120.49 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.986 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -118.37 -3.99 10.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -39.96 134.62 1.45 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.947 2.099 . . . . 0.0 115.711 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -69.53 111.72 5.56 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 125.443 1.714 . . . . 0.0 113.123 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 139.33 81.74 0.08 OUTLIER Glycine 0 N--CA 1.478 1.461 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.966 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.43 -153.84 18.83 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 114.049 -1.075 . . . . 0.0 112.246 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 37.4 pt -66.51 130.14 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -70.96 -32.69 69.63 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 44.1 t -139.14 127.79 23.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.443 0.639 . . . . 0.0 112.568 167.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.02 -56.19 5.48 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.071 -1.877 . . . . 0.0 114.054 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -51.77 -50.93 59.72 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -53.16 -56.19 18.32 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.334 1.021 . . . . 0.0 113.132 172.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mt -58.12 -39.8 79.62 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -57.26 -52.14 66.52 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.077 0.951 . . . . 0.0 112.729 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.05 -26.92 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -86.5 -5.02 59.26 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 15.3 tp -53.49 -38.44 62.19 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 116.362 -1.78 . . . . 0.0 115.722 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -60.9 -64.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 CA-C-O 116.703 -1.457 . . . . 0.0 111.126 168.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -43.38 -42.78 4.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 41.6 mt -53.95 -71.08 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.089 0.956 . . . . 0.0 111.276 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 4.8 mt -46.43 -46.94 19.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.6 1.56 . . . . 0.0 114.73 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 67.1 mt -57.11 -53.54 56.91 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.138 1.375 . . . . 0.0 112.751 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 85.5 p -61.98 -39.69 93.04 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -58.49 -45.05 89.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 6.4 tp -66.8 -38.64 86.88 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 tp -55.19 -46.24 75.85 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.048 0.939 . . . . 0.0 110.429 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.66 80.03 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.7 mt -57.56 -48.08 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 117.748 0.249 . . . . 0.0 110.736 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.51 -49.67 38.61 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.322 0.963 . . . . 0.0 112.977 174.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 14.6 tp -53.12 -45.14 68.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.117 0.967 . . . . 0.0 112.557 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.71 -51.6 53.94 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.589 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 9.1 mt -59.03 -45.44 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.318 0.647 . . . . 0.0 109.587 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -47.82 -49.97 27.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.637 1.175 . . . . 0.0 113.504 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -60.34 -52.14 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.349 0.66 . . . . 0.0 110.941 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.31 -44.88 52.78 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 124.872 1.225 . . . . 0.0 113.441 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -65.62 -47.71 74.69 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.251 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -49.27 -50.46 38.94 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 168.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 46.5 mt -51.42 -48.19 62.74 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.3 p -119.42 -65.22 1.19 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 34.0 p -80.09 14.16 1.98 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -170.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.252 1.207 0 O-C-N 124.055 0.847 . . . . 0.0 112.22 173.568 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -126.75 138.06 53.32 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.186 0.929 . . . . 0.0 110.388 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.0 p -127.35 -66.05 0.9 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.07 61.32 5.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.803 1.763 . . . . 0.0 111.826 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 1.4 m -104.92 -25.4 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 111.491 -2.595 . . . . 0.0 116.485 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -66.14 118.9 10.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.65 0.262 . . . . 0.0 111.597 -164.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 58.8 tttt 64.25 97.3 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 O-C-N 126.219 2.2 . . . . 0.0 109.869 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -98.24 118.46 34.92 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.216 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -149.91 -85.45 0.05 OUTLIER Glycine 0 N--CA 1.476 1.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 169.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 107.8 -158.75 14.76 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -170.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.21 134.84 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.881 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.15 -50.38 16.49 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -177.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -136.63 111.35 8.72 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.112 0.958 . . . . 0.0 112.707 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.29 68.67 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 112.859 -1.973 . . . . 0.0 111.937 167.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 2.1 mp0 -58.41 -56.93 15.77 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.608 1.563 . . . . 0.0 110.498 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -45.6 78.13 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.31 1.006 . . . . 0.0 112.032 174.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -55.21 37.4 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -52.07 -51.98 54.12 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.0 p -67.65 -40.85 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.47 -18.79 62.29 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.254 35.3 mt -40.34 -51.47 6.28 Favored Pre-proline 0 N--CA 1.483 1.188 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.32 -59.11 0.47 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.8 p -59.42 -40.65 87.38 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.4 tp -50.7 -63.32 1.16 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.639 1.576 . . . . 0.0 110.756 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.42 -42.33 77.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.439 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.0 tp -53.6 -47.69 69.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.596 1.159 . . . . 0.0 111.654 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.7 p -66.62 -39.59 88.4 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -69.71 -35.45 75.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.4 mt -55.49 -49.05 73.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.956 0.785 . . . . 0.0 111.645 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.6 mt -51.55 -52.18 49.31 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.17 75.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.4 mt -59.1 -48.89 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.648 1.179 . . . . 0.0 111.695 169.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.1 -47.62 88.07 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.252 0.93 . . . . 0.0 113.25 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.86 -41.99 78.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.751 1.621 . . . . 0.0 111.575 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.18 -51.24 58.66 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.266 1.412 . . . . 0.0 112.321 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 29.8 mt -55.86 -47.67 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.378 1.071 . . . . 0.0 111.311 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -50.42 -63.16 1.21 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.47 1.106 . . . . 0.0 112.798 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.4 tp -69.59 -35.27 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -174.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.44 43.71 Favored Glycine 0 N--CA 1.479 1.515 0 C-N-CA 124.307 0.956 . . . . 0.0 111.832 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -62.96 -37.13 85.87 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -60.68 -46.26 91.03 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.354 0.662 . . . . 0.0 112.512 171.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.65 -44.68 95.67 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . 0.259 16.9 m -71.8 -56.41 5.81 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 175.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 4.5 p -104.07 -74.58 0.64 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--O 1.25 1.09 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -173.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -63.51 146.99 52.57 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.034 -177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -138.18 111.19 7.79 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 81.2 p -72.05 9.44 0.95 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 19.3 m -105.96 84.16 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 124.255 1.979 . . . . 0.0 110.404 170.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.07 166.69 31.66 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 111.227 -2.715 . . . . 0.0 111.012 -167.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -73.71 132.92 43.19 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.543 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -130.08 71.18 1.44 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.24 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 62.18 29.36 72.71 Favored Glycine 0 N--CA 1.483 1.786 0 CA-C-N 112.657 -2.065 . . . . 0.0 114.57 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.64 -78.02 0.39 Allowed Glycine 0 N--CA 1.481 1.65 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 pp -53.51 131.01 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 122.243 1.02 . . . . 0.0 112.188 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -84.81 78.47 9.87 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.175 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t 64.66 129.64 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 112.263 -2.244 . . . . 0.0 114.741 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.84 -56.13 26.14 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.754 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -45.7 -45.11 14.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.749 1.22 . . . . 0.0 114.252 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -62.41 -58.22 8.43 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.037 0.935 . . . . 0.0 112.066 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.16 -38.93 84.65 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -51.0 -30.62 15.67 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.06 -37.1 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.65 -47.21 86.51 Favored 'General case' 0 C--O 1.219 -0.553 0 C-N-CA 126.166 1.786 . . . . 0.0 113.782 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.71 -34.96 7.16 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 -62.41 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 122.085 1.857 . . . . 0.0 112.406 160.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 36.4 p -55.42 -41.93 73.45 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.98 -62.16 2.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 116.513 -1.708 . . . . 0.0 113.079 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 22.6 tp -50.98 -53.92 28.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.526 0.73 . . . . 0.0 112.018 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt -60.01 -52.21 66.34 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 95.2 p -62.51 -39.35 93.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -58.72 -48.06 82.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 0.0 111.795 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 84.2 mt -53.74 -45.7 70.64 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.241 1.017 . . . . 0.0 112.64 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 27.4 tp -57.66 -46.49 84.16 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.129 0.572 . . . . 0.0 112.163 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.38 96.78 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 26.7 mt -57.26 -48.44 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.26 -55.09 20.78 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 124.396 0.998 . . . . 0.0 112.593 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 23.3 mt -51.66 -46.51 63.78 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.61 -52.83 45.54 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 124.787 1.185 . . . . 0.0 112.527 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.88 -48.26 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 113.758 -1.221 . . . . 0.0 110.281 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -30.38 41.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 44.4 pt -67.01 -40.46 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 119.677 1.126 . . . . 0.0 111.178 170.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.92 -47.46 79.4 Favored Glycine 0 N--CA 1.477 1.407 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.242 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.457 ' HG3' ' OG1' ' B' ' 189' ' ' THR . 3.7 ttt180 -61.42 -54.61 41.34 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.94 -39.25 3.88 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.978 0.911 . . . . 0.0 112.073 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.97 -57.22 8.3 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.17 0.919 . . . . 0.0 113.316 170.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . 0.282 2.6 t -101.47 -60.63 1.5 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 118.474 2.768 . . . . 0.0 118.474 -168.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' THR . . . . . 0.457 ' OG1' ' HG3' ' B' ' 185' ' ' ARG . 47.6 p -103.56 9.14 37.62 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 -168.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -96.51 -36.13 10.88 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.13 151.68 30.51 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.9 t -57.03 -51.01 70.98 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.44 117.29 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.825 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -124.34 125.54 44.51 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.445 1.091 . . . . 0.0 111.33 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -114.02 100.77 8.65 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.467 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -73.58 167.94 20.32 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.59 160.07 53.9 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.436 1.017 . . . . 0.0 114.487 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.15 129.97 0.04 OUTLIER Glycine 0 N--CA 1.487 2.051 0 CA-C-N 113.245 -1.478 . . . . 0.0 114.831 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.02 142.33 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.391 -0.904 . . . . 0.0 113.129 172.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -98.29 -72.07 0.66 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.306 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.2 t -49.94 -59.36 3.94 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -174.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 35.99 50.35 0.67 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.875 1.67 . . . . 0.0 114.21 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 66.75 -55.66 0.42 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.295 2.238 . . . . 0.0 114.475 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . 0.297 65.2 m-85 -75.87 -14.07 60.27 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 119.704 3.224 . . . . 0.0 119.704 -170.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.55 -32.72 28.46 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 165.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -65.18 -32.08 73.58 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.706 0.802 . . . . 0.0 111.426 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.5 m -97.13 43.1 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 168.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -151.47 -68.2 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.952 1.301 . . . . 0.0 110.905 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.3 tp -60.93 -35.74 27.7 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -54.66 -58.87 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.848 2.365 . . . . 0.0 114.182 171.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.2 p -58.67 -39.36 80.42 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.8 mp -54.21 -66.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 171.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 30.5 mt -50.86 -43.35 59.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.15 -49.89 70.34 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.1 p -69.62 -29.18 66.62 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -57.18 -44.96 84.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.074 0.549 . . . . 0.0 111.905 165.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.98 -35.22 76.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.03 -50.24 73.34 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.546 0.529 . . . . 0.0 111.994 167.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.49 -48.97 79.03 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.55 -47.23 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.67 1.188 . . . . 0.0 111.648 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.75 -57.75 11.78 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.411 1.481 . . . . 0.0 111.678 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.0 tp -49.7 -46.23 49.83 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.943 1.297 . . . . 0.0 112.171 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -46.81 -62.3 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.618 1.58 . . . . 0.0 113.847 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.91 -31.94 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -49.01 -67.41 0.27 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.313 1.045 . . . . 0.0 112.223 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . 0.294 2.3 pp -67.83 -30.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.27 -64.34 3.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 124.997 1.284 . . . . 0.0 112.723 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 -64.05 -22.11 66.79 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -56.42 -22.68 33.4 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 168.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.6 tp -49.86 -49.15 50.31 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.131 0.972 . . . . 0.0 111.833 167.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.2 p -93.39 -1.68 55.56 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 7.1 p -121.05 42.65 3.0 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 165.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 C--O 1.249 1.074 0 CA-C-N 113.023 -1.898 . . . . 0.0 108.785 167.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 74.76 -64.97 0.36 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 118.1 2.629 . . . . 0.0 118.1 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 16.6 p -121.23 147.27 45.85 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 19.6 m -70.4 171.36 10.15 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.563 1.145 . . . . 0.0 110.876 166.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . 0.456 ' HB ' ' HA3' ' B' ' 154' ' ' GLY 0.31 19.2 m -81.45 71.05 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 123.315 1.531 . . . . 0.0 113.933 179.041 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 77.5 mtm -82.8 108.54 16.22 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 112.256 -2.247 . . . . 0.0 111.563 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt 67.14 -64.56 0.25 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.624 1.97 . . . . 0.0 111.194 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -65.97 94.37 0.23 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.053 1.341 . . . . 0.0 109.557 166.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . 0.456 ' HA3' ' HB ' ' B' ' 150' ' ' VAL . . . -109.69 -171.79 20.46 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 112.859 -1.973 . . . . 0.0 112.34 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.9 -59.92 1.74 Allowed Glycine 0 N--CA 1.479 1.535 0 CA-C-N 113.726 -1.237 . . . . 0.0 115.628 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -43.68 144.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.383 1.473 . . . . 0.0 114.175 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -75.96 -21.89 56.52 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -167.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.407 ' HG ' ' CD ' ' B' ' 160' ' ' GLU . 0.3 OUTLIER -130.99 102.31 5.98 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.231 1.015 . . . . 0.0 111.295 175.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.81 -12.45 10.85 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.407 ' CD ' ' HG ' ' B' ' 158' ' ' SER . 2.5 mp0 -51.66 -29.06 16.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.976 1.311 . . . . 0.0 113.013 166.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -43.26 -46.05 6.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.608 1.963 . . . . 0.0 113.052 168.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 5.9 mp -52.16 -36.08 50.59 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.988 1.315 . . . . 0.0 113.96 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -89.42 -52.07 5.23 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -71.47 -20.96 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -51.34 -43.51 61.78 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.98 -46.01 30.8 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.732 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -55.4 -45.56 39.05 Favored 'Trans proline' 0 N--CA 1.48 0.681 0 C-N-CA 122.284 1.989 . . . . 0.0 111.923 164.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 55.0 m -47.55 -52.58 17.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.143 0.977 . . . . 0.0 112.003 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 58.7 mt -53.35 -61.62 2.18 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.882 0.873 . . . . 0.0 113.289 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 11.4 mt -54.97 -52.05 64.26 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.526 -1.215 . . . . 0.0 113.637 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.75 -58.79 7.06 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.245 1.418 . . . . 0.0 112.64 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 87.4 p -64.03 -37.27 86.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -66.79 -40.25 88.08 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.53 -51.07 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.569 0.7 . . . . 0.0 111.292 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.52 -38.91 72.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.393 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.28 86.15 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 6.9 mt -57.26 -48.46 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 171.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.53 -57.31 9.53 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.269 1.414 . . . . 0.0 112.618 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 62.4 tp -45.82 -53.12 10.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.19 -62.27 3.98 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 124.642 1.115 . . . . 0.0 112.963 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -54.25 -51.11 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.85 0.86 . . . . 0.0 110.828 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -61.18 -33.54 73.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.1 mt -51.46 -51.96 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.237 0.615 . . . . 0.0 110.086 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.47 -46.99 45.3 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 124.798 1.19 . . . . 0.0 112.62 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.07 -56.21 7.5 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -55.01 -37.05 66.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.086 0.954 . . . . 0.0 113.102 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 4.0 mp -64.72 -45.78 85.09 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 171.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 35.9 p -89.48 -15.2 33.6 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -171.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 11.9 p -61.59 154.12 25.84 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 115.005 1.484 . . . . 0.0 115.005 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 95.1 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.433 -1.27 . . . . 0.0 113.993 -173.362 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -107.37 102.85 12.11 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.834 0.826 . . . . 0.0 109.56 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.4 t -110.85 107.08 16.45 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.812 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 55.6 m -61.64 102.88 0.28 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.518 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.9 t -122.38 -46.46 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.547 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 84.7 mmm -129.34 152.45 48.88 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.322 1.049 . . . . 0.0 112.107 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -52.89 120.86 6.3 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.023 166.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -126.93 90.1 3.1 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.008 -176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -102.52 -65.14 0.73 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.383 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.08 90.64 0.7 Allowed Glycine 0 CA--C 1.538 1.498 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.93 -167.43 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -96.12 -47.43 6.07 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.8 t -126.08 125.72 43.04 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.628 0.727 . . . . 0.0 111.004 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.82 48.91 1.15 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 124.786 2.232 . . . . 0.0 113.026 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.525 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -66.13 -47.01 75.53 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 111.327 -2.67 . . . . 0.0 114.734 -174.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -74.13 -35.12 64.09 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.922 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.6 tp -52.38 -44.07 65.07 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.001 0.52 . . . . 0.0 111.284 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -52.51 -27.75 17.72 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.775 1.63 . . . . 0.0 114.952 171.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.0 t -88.97 -64.69 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.808 0.843 . . . . 0.0 108.79 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -45.13 -56.54 4.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.836 2.454 . . . . 0.0 115.615 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.251 0.2 OUTLIER -75.81 -41.42 3.45 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 -174.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -55.06 -44.62 47.83 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 121.885 1.723 . . . . 0.0 112.507 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.2 m -51.79 -53.29 41.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.869 0.868 . . . . 0.0 112.798 170.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.8 -44.84 78.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.4 mt -59.74 -50.91 71.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.008 0.923 . . . . 0.0 113.005 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.0 tp -57.12 -45.58 83.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.327 1.051 . . . . 0.0 110.998 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.8 t -51.2 -58.62 5.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.177 1.391 . . . . 0.0 113.487 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -48.01 -51.58 23.38 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.474 1.109 . . . . 0.0 113.494 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 44.2 tp -54.22 -57.07 12.56 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.767 1.227 . . . . 0.0 112.788 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.6 mt -54.35 -44.85 72.52 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.09 -54.48 7.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 25.5 mt -55.9 -40.94 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.123 0.569 . . . . 0.0 110.297 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -62.1 5.97 Favored Glycine 0 N--CA 1.48 1.597 0 O-C-N 124.801 1.313 . . . . 0.0 112.35 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.03 -49.75 30.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.807 0.843 . . . . 0.0 113.108 171.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.62 -64.22 3.85 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 125.268 1.413 . . . . 0.0 114.168 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.8 pp -56.62 -33.94 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.8 -58.05 6.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.906 1.282 . . . . 0.0 113.219 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 21.5 mt -56.9 -34.69 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.548 0.739 . . . . 0.0 111.166 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.24 31.35 0.96 Allowed Glycine 0 CA--C 1.54 1.622 0 N-CA-C 116.439 1.335 . . . . 0.0 116.439 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -122.47 -42.83 2.32 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -116.06 -39.21 3.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.316 0.647 . . . . 0.0 112.182 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 8.0 tp -83.93 55.43 3.28 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 123.573 1.654 . . . . 0.0 111.147 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.4 p -123.5 -27.14 4.1 Favored 'General case' 0 C--O 1.199 -1.586 0 CA-C-N 111.667 -2.515 . . . . 0.0 115.148 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 2.2 p -67.11 68.76 0.08 Allowed 'General case' 0 C--N 1.384 2.094 0 CA-C-O 124.999 2.333 . . . . 0.0 112.955 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--N 1.374 1.643 0 CA-C-N 109.789 -3.369 . . . . 0.0 111.151 -165.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 119.265 -0.398 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -54.48 -38.87 66.94 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 124.007 0.817 . . . . 0.0 113.191 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.7 p -112.76 119.22 37.31 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.71 1.204 . . . . 0.0 110.888 162.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 3.6 m -72.42 128.98 37.27 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.654 1.216 . . . . 0.0 112.742 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.4 -31.8 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -164.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 13.1 tpt -19.77 -64.43 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.451 2.7 . . . . 0.0 118.151 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -70.74 87.52 0.69 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.841 1.256 . . . . 0.0 108.597 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -76.71 114.16 15.15 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.107 -0.952 . . . . 0.0 113.557 -164.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 59.98 50.4 68.09 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.326 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -142.94 110.21 0.6 Allowed Glycine 0 N--CA 1.472 1.066 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 1.5 pp -48.3 131.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -54.75 -28.78 50.99 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 46.3 t -164.15 126.83 2.45 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.404 1.082 . . . . 0.0 110.665 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.01 -40.78 71.61 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.142 0.901 . . . . 0.0 110.499 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -50.27 -45.28 54.21 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.985 172.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -87.39 -25.58 23.75 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.02 -36.47 72.75 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.256 0.551 . . . . 0.0 111.534 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -49.55 -47.57 49.04 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 168.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.9 -40.55 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.976 0.91 . . . . 0.0 110.062 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -42.05 -58.22 2.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.816 1.646 . . . . 0.0 114.384 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.16 -53.23 67.53 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 115.842 -2.028 . . . . 0.0 114.737 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -56.39 -50.19 12.73 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 123.161 2.574 . . . . 0.0 113.159 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.7 m -57.02 -45.97 82.68 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.74 -46.19 89.24 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.023 1.329 . . . . 0.0 114.424 174.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.7 mt -53.23 -56.92 12.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.569 0.7 . . . . 0.0 111.113 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 9.9 tp -58.71 -45.15 90.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.393 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 42.8 t -47.78 -60.39 2.61 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.791 1.237 . . . . 0.0 113.062 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.55 -47.65 72.97 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.163 0.914 . . . . 0.0 113.21 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 4.7 mp -60.93 -53.78 53.05 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.9 mt -51.29 -54.56 24.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.33 1.052 . . . . 0.0 111.094 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.75 80.37 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.396 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 tt -64.19 -41.92 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.38 63.6 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 124.09 0.869 . . . . 0.0 112.008 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 9.5 tp -54.44 -50.47 67.59 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 113.611 -1.294 . . . . 0.0 111.588 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -49.47 -54.18 17.5 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 124.984 1.278 . . . . 0.0 113.941 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 10.2 mt -56.16 -48.56 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.632 0.773 . . . . 0.0 111.484 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -51.23 -52.35 45.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.901 0.881 . . . . 0.0 112.351 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 34.0 mt -54.77 -53.94 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.879 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.19 -50.74 44.95 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 125.096 1.331 . . . . 0.0 112.955 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -58.47 -51.26 70.62 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -64.56 -35.23 80.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 17.6 mt -78.97 -32.8 45.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.5 p -66.69 -47.47 72.32 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.285 0.991 . . . . 0.0 113.275 170.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 32.5 p -84.26 151.45 24.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.479 0.999 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.767 177.248 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 . . . . . 0 N--CA 1.465 0.304 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -114.78 103.55 11.08 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.108 0.956 . . . . 0.0 112.144 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 t -52.0 105.75 0.12 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.035 170.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.1 t -65.01 155.12 35.68 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 110.57 -3.013 . . . . 0.0 112.69 -170.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.88 -77.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 117.175 -1.393 . . . . 0.0 109.315 166.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.61 136.38 29.12 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -108.53 -59.18 1.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.053 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -80.6 118.33 22.08 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -166.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 130.1 69.09 0.11 Allowed Glycine 0 N--CA 1.478 1.448 0 CA-C-N 112.784 -2.007 . . . . 0.0 113.398 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -84.48 -111.4 0.63 Allowed Glycine 0 N--CA 1.476 1.309 0 C-N-CA 123.451 0.548 . . . . 0.0 112.703 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.85 153.66 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.447 1.118 . . . . 0.0 113.759 169.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.96 -77.33 0.07 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.087 -1.87 . . . . 0.0 113.335 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.2 t -99.76 100.6 11.57 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.513 1.149 . . . . 0.0 113.349 -170.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.69 -20.8 25.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -43.44 65.62 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 174.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -51.76 -55.21 21.09 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.895 1.678 . . . . 0.0 109.651 168.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.1 mt -55.3 -45.91 76.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -53.49 -55.36 26.05 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 15.3 m -69.77 -16.66 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -103.43 -23.65 13.52 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 118.275 2.695 . . . . 0.0 118.275 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.276 17.9 mt -47.9 -45.15 61.44 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-O 115.639 -2.124 . . . . 0.0 116.662 176.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -57.27 -57.5 1.25 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.203 1.935 . . . . 0.0 112.536 171.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.7 m -45.4 -46.01 13.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 37.2 mt -62.48 -54.25 42.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.492 1.517 . . . . 0.0 114.606 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.47 -43.74 68.39 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.572 0.749 . . . . 0.0 112.164 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.1 mt -53.08 -63.11 1.25 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.101 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.6 p -59.1 -43.34 91.85 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -66.03 -46.98 75.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.7 mt -56.29 -45.62 80.13 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.3 mt -60.8 -45.33 94.85 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.1 -46.54 79.06 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 11.0 mt -47.53 -54.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.789 0.835 . . . . 0.0 111.385 170.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.98 -56.81 14.76 Favored Glycine 0 CA--C 1.544 1.872 0 C-N-CA 124.548 1.07 . . . . 0.0 113.138 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.7 mt -51.83 -48.68 63.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.317 1.047 . . . . 0.0 111.702 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.68 -51.12 40.14 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.231 1.396 . . . . 0.0 112.488 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.5 mt -54.66 -54.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.023 1.329 . . . . 0.0 110.373 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -53.02 -51.71 60.8 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.969 1.418 . . . . 0.0 111.038 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.4 mt -56.67 -62.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 124.382 1.073 . . . . 0.0 109.796 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.76 4.48 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 124.734 1.159 . . . . 0.0 113.366 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -62.37 -55.97 22.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.368 1.067 . . . . 0.0 112.741 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -69.62 -17.15 63.5 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.74 -23.41 36.71 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 171.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 49.2 p -121.31 56.8 1.03 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.219 1.008 . . . . 0.0 111.426 -171.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 73.2 p -62.2 135.05 57.32 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 113.591 -1.64 . . . . 0.0 114.839 -160.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.979 0 C-N-CA 125.261 1.424 . . . . 0.0 108.929 176.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -63.74 133.0 52.73 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.028 0.442 . . . . 0.0 110.707 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 68.0 p -111.66 152.25 27.9 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -79.73 139.5 37.29 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.77 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.55 134.78 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 112.809 -1.996 . . . . 0.0 110.711 163.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -74.18 109.27 7.54 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.687 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -111.82 104.59 12.91 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.499 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -138.12 102.76 4.76 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.702 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 165.65 65.43 0.03 OUTLIER Glycine 0 N--CA 1.487 2.081 0 O-C-N 125.33 1.644 . . . . 0.0 111.087 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.11 110.09 3.52 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.07 0.843 . . . . 0.0 112.826 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 pt -21.24 98.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 127.149 2.179 . . . . 0.0 116.375 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 71.94 -46.28 0.64 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.848 2.059 . . . . 0.0 113.964 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 27.0 t -161.74 113.23 1.71 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.876 2.47 . . . . 0.0 110.329 171.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.75 -33.87 67.0 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.444 -1.707 . . . . 0.0 113.66 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.65 -42.98 85.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.055 1.342 . . . . 0.0 112.513 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.56 -45.45 83.28 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 46.4 tp -54.34 -44.04 71.76 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 123.729 0.643 . . . . 0.0 112.599 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -56.12 -47.66 77.68 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 6.1 m -74.12 -31.65 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.96 -51.1 71.49 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.485 1.116 . . . . 0.0 111.399 169.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.296 1.5 mm? -40.51 -61.56 1.17 Allowed Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.28 -56.51 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 122.966 2.444 . . . . 0.0 111.382 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 3.1 p -64.05 -27.82 69.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 38.0 tp -63.41 -52.63 60.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.997 1.319 . . . . 0.0 112.248 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -58.29 -36.34 73.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.38 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.68 -33.52 66.57 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 69.7 m -71.0 -35.04 71.93 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 172.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -56.29 -42.66 77.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.583 165.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.26 -34.69 65.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.82 -54.24 44.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.306 1.442 . . . . 0.0 110.895 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.09 -48.36 73.66 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.9 mt -61.3 -51.04 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.5 1.12 . . . . 0.0 111.823 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.94 -53.89 24.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.671 1.605 . . . . 0.0 112.845 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.54 -47.3 76.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.906 0.882 . . . . 0.0 112.731 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.18 -53.51 23.17 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.989 1.281 . . . . 0.0 113.131 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.66 -46.66 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.067 0.947 . . . . 0.0 112.517 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -51.4 -55.51 18.22 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.531 0.519 . . . . 0.0 112.392 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . 0.26 6.4 tp -61.76 -42.47 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.334 175.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.58 -52.95 31.09 Favored Glycine 0 N--CA 1.483 1.785 0 C-N-CA 124.417 1.008 . . . . 0.0 113.424 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -56.15 -50.89 69.87 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.811 1.244 . . . . 0.0 111.212 175.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -65.02 -24.16 67.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.7 mt -65.2 -52.34 55.41 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.032 0.933 . . . . 0.0 112.806 166.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 3.3 p -70.72 -19.96 62.7 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 174.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 49.5 m -71.53 136.59 47.58 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.276 0.631 . . . . 0.0 109.454 165.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.246 0.887 0 CA-C-O 117.717 -1.135 . . . . 0.0 111.955 179.529 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -51.4 121.75 6.8 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 84.1 m -117.63 134.49 54.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.648 167.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.6 t -93.42 -70.28 0.71 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.649 1.218 . . . . 0.0 111.144 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . 0.291 35.5 m 36.58 103.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 22.8 ttt -72.92 82.97 1.21 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.984 170.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -147.77 136.15 21.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.48 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -156.29 128.86 7.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 112.643 -2.071 . . . . 0.0 108.921 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.53 -97.35 1.18 Allowed Glycine 0 N--CA 1.476 1.337 0 N-CA-C 107.002 -2.439 . . . . 0.0 107.002 171.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -50.48 126.16 23.6 Favored Glycine 0 N--CA 1.477 1.379 0 O-C-N 126.27 1.806 . . . . 0.0 113.861 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -81.33 143.74 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 113.682 -1.259 . . . . 0.0 111.148 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -40.9 97.09 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.795 172.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.0 t -174.85 119.34 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.269 1.428 . . . . 0.0 110.916 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.89 -77.99 0.6 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.032 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -60.81 -40.59 93.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.512 1.125 . . . . 0.0 110.229 173.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -55.27 -46.5 76.14 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.674 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.31 -56.14 25.89 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.809 0.844 . . . . 0.0 111.659 168.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -49.94 -49.75 48.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 73.6 t -49.1 -45.07 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.576 1.15 . . . . 0.0 112.29 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -94.97 14.61 21.16 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt -48.05 -42.08 46.66 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.15 -66.12 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.183 2.588 . . . . 0.0 111.17 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.0 m -48.73 -56.6 8.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.641 1.576 . . . . 0.0 112.47 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.8 mt -42.54 -51.26 5.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.804 1.642 . . . . 0.0 114.199 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.65 -26.69 20.61 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.95 -35.71 74.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 170.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -68.84 -38.0 79.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 168.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.1 mt -53.49 -50.38 65.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.579 0.752 . . . . 0.0 112.263 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.6 tp -51.02 -53.32 34.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.17 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.08 -51.82 39.56 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 19.4 mt -59.61 -56.58 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.412 0.685 . . . . 0.0 110.625 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.09 -50.52 45.17 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 124.281 0.943 . . . . 0.0 112.816 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.5 tp -56.11 -44.13 78.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.171 1.388 . . . . 0.0 112.139 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.11 -46.37 92.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.99 0.805 . . . . 0.0 113.2 177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.4 mp -53.08 -45.81 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 124.139 0.552 . . . . 0.0 111.425 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -56.57 -55.36 34.82 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.6 mt -53.32 -57.82 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.179 0.991 . . . . 0.0 111.243 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.82 -50.26 32.54 Favored Glycine 0 CA--C 1.548 2.124 0 C-N-CA 124.783 1.183 . . . . 0.0 112.403 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -62.32 -47.13 85.6 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -68.45 -24.97 64.78 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.4 mt -73.09 -51.33 18.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.635 165.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.4 p -64.13 -37.11 86.26 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . 0.315 9.5 t 20.4 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 128.24 2.616 . . . . 0.0 117.84 174.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 C--O 1.251 1.165 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.594 177.332 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 8.6 p30 7.91 75.73 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.269 2.228 . . . . 0.0 116.807 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 36.9 p -119.98 98.73 6.22 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.121 0.962 . . . . 0.0 110.498 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 70.9 m -79.72 163.27 24.64 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -168.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.49 127.44 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.777 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 12.2 tpt -61.37 -66.49 0.53 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.184 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 85.6 mttt 34.6 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -115.06 147.54 40.04 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.891 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 134.3 104.75 0.84 Allowed Glycine 0 N--CA 1.485 1.901 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.636 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.55 -101.06 0.25 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.014 1.293 . . . . 0.0 111.366 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -47.09 125.74 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -52.35 -43.12 64.46 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 113.892 -1.504 . . . . 0.0 114.284 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -138.64 115.13 10.5 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.283 1.033 . . . . 0.0 113.023 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.15 -45.13 71.93 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.043 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -54.17 -51.08 65.49 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.583 1.153 . . . . 0.0 112.698 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -47.58 85.01 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 20.8 tp -52.42 -52.47 53.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.296 1.038 . . . . 0.0 111.555 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -49.25 -60.38 2.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.676 1.19 . . . . 0.0 111.6 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 18.5 m -66.0 -25.64 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -176.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.21 -42.73 30.48 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.256 23.8 mt -43.35 -43.62 11.39 Favored Pre-proline 0 N--CA 1.481 1.1 0 N-CA-C 118.714 2.857 . . . . 0.0 118.714 -177.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -51.7 -66.62 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.498 2.799 . . . . 0.0 113.199 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 19.5 p -54.26 -42.55 70.07 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 41.6 tp -55.96 -58.0 9.73 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.492 1.12 . . . . 0.0 112.218 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -47.2 85.96 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 173.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 51.9 tp -54.5 -45.58 73.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -62.1 -44.77 95.94 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.559 0.537 . . . . 0.0 112.173 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -67.72 -37.2 81.89 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.715 1.206 . . . . 0.0 112.488 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 20.3 mt -60.32 -51.14 70.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.697 1.199 . . . . 0.0 112.326 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.5 mt -58.77 -45.48 89.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.67 86.98 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 2.3 tt -70.9 -36.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.86 -50.4 54.66 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.244 0.926 . . . . 0.0 111.191 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.41 -42.74 82.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.721 -0.739 . . . . 0.0 112.651 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.64 -56.81 14.03 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.087 0.851 . . . . 0.0 112.674 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 6.2 mt -60.6 -41.01 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.727 0.811 . . . . 0.0 109.881 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -51.81 -61.75 2.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.286 1.034 . . . . 0.0 111.156 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 28.0 mt -60.25 -41.34 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.865 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.35 -47.39 89.96 Favored Glycine 0 N--CA 1.48 1.626 0 C-N-CA 125.134 1.35 . . . . 0.0 115.922 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -74.11 -37.03 64.26 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -59.28 -32.54 70.12 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 1.4 mp -44.67 -34.75 2.33 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.942 1.297 . . . . 0.0 113.41 169.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.1 p -97.22 -75.17 0.55 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.751 0.82 . . . . 0.0 111.012 167.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.9 t -75.83 89.35 2.88 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.918 1.342 . . . . 0.0 114.023 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.48 1.03 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.112 177.551 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -140.5 116.59 10.5 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.108 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.9 p -70.16 144.17 52.07 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 76.7 p -68.37 174.9 3.66 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.084 -1.416 . . . . 0.0 114.648 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 87.8 t -93.64 130.81 42.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 155.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -107.07 137.22 45.55 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.19 0.995 . . . . 0.0 112.449 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.5 90.85 5.69 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.549 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -166.36 122.21 1.24 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 112.381 -2.191 . . . . 0.0 107.102 174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.02 -100.73 0.01 OUTLIER Glycine 0 N--CA 1.484 1.837 0 O-C-N 124.144 0.903 . . . . 0.0 112.044 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -110.51 -81.9 1.26 Allowed Glycine 0 N--CA 1.475 1.286 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -175.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 tt -106.73 134.13 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -51.63 -47.79 63.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.8 t -149.8 106.96 3.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.398 1.094 . . . . 0.0 112.885 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.65 -31.35 72.49 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.495 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 16.8 mp0 -59.08 -60.03 4.51 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.295 1.438 . . . . 0.0 110.527 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -45.32 -57.88 3.7 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.443 1.897 . . . . 0.0 111.413 172.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.0 tp -39.25 -64.49 0.46 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.899 2.08 . . . . 0.0 113.19 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -55.95 -51.24 68.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.2 1.4 . . . . 0.0 112.556 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.9 t -59.62 -37.13 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 123.965 0.791 . . . . 0.0 111.836 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -80.09 -33.93 38.42 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 117.535 2.42 . . . . 0.0 117.535 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -33.37 -57.33 0.57 Allowed Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -67.11 -43.84 5.87 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 121.774 1.649 . . . . 0.0 114.705 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.3 p -68.11 -38.38 82.21 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.98 -39.91 87.31 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 173.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 17.0 mt -51.85 -47.2 64.54 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 167.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.37 -53.89 53.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 59.2 p -59.61 -39.7 85.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -68.75 -43.47 75.78 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 tp -57.43 -44.89 85.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.179 0.992 . . . . 0.0 111.918 170.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -48.78 79.52 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.378 1.071 . . . . 0.0 112.123 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.08 -46.54 85.29 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.521 1.129 . . . . 0.0 113.609 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.68 -53.32 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.307 0.643 . . . . 0.0 110.118 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -48.52 -51.2 22.77 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.155 1.359 . . . . 0.0 113.88 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -52.38 -48.66 65.48 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.01 -48.38 83.03 Favored Glycine 0 N--CA 1.488 2.103 0 O-C-N 124.181 0.926 . . . . 0.0 112.43 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.0 mt -56.89 -49.22 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 124.944 1.297 . . . . 0.0 110.471 175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.84 -49.14 59.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.563 1.145 . . . . 0.0 112.922 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.5 mm -52.91 -50.78 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.325 0.65 . . . . 0.0 111.231 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.14 -56.59 22.48 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 124.55 1.071 . . . . 0.0 113.075 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 22.8 mtt180 -54.2 -48.01 71.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -60.44 -38.1 83.04 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.62 -57.92 10.65 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 124.457 1.098 . . . . 0.0 110.439 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 28.6 p -87.77 40.45 0.94 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.7 t -47.18 128.22 11.42 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.774 1.629 . . . . 0.0 114.846 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.245 0.858 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.27 179.122 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 41.83 87.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 O-C-N 125.421 1.7 . . . . 0.0 113.775 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 23.2 p -89.04 -50.98 5.84 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.974 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 19.7 m -105.11 -52.28 2.87 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.115 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.82 119.36 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 122.335 1.064 . . . . 0.0 109.143 -171.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.46 84.91 3.27 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 113.272 -1.786 . . . . 0.0 111.776 -169.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.64 76.78 7.51 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 112.266 -2.243 . . . . 0.0 113.669 -172.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -163.14 134.92 5.08 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.143 -1.844 . . . . 0.0 111.626 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.37 66.43 1.9 Allowed Glycine 0 N--CA 1.476 1.312 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -176.25 -66.0 0.06 OUTLIER Glycine 0 N--CA 1.475 1.278 0 CA-C-N 113.387 -1.406 . . . . 0.0 111.705 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.78 77.35 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.984 0 CA-C-O 124.16 1.934 . . . . 0.0 108.738 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -81.97 19.23 1.16 Allowed 'General case' 0 C--O 1.191 -1.987 0 CA-C-N 111.557 -2.565 . . . . 0.0 116.162 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 47.9 t -173.53 119.95 0.31 Allowed 'General case' 0 C--N 1.369 1.439 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.959 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.55 -36.94 65.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.177 -1.829 . . . . 0.0 109.668 174.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -58.69 -45.57 89.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.313 1.045 . . . . 0.0 112.624 172.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.6 -46.09 84.15 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.669 172.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 16.3 tp -52.91 -37.14 60.36 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 175.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -50.17 -59.9 3.48 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.684 0.794 . . . . 0.0 112.677 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.49 -34.71 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.177 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -53.69 -62.64 1.52 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.106 1.363 . . . . 0.0 113.554 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.268 16.5 mt -46.88 -56.03 13.1 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 116.288 -1.815 . . . . 0.0 115.728 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.46 -45.32 11.93 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.453 2.102 . . . . 0.0 114.716 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 39.0 m -63.08 -38.62 91.91 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.26 -48.37 80.64 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.947 1.299 . . . . 0.0 111.698 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.56 -49.43 74.86 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.62 0.368 . . . . 0.0 111.306 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 39.3 p -61.64 -38.93 89.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -62.27 -45.67 92.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.33 -45.31 72.64 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 22.3 mt -62.29 -38.97 91.4 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.47 82.93 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 18.7 mt -60.08 -41.39 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.13 -52.18 23.25 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 124.919 1.247 . . . . 0.0 113.243 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.64 -44.51 85.68 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.919 0.888 . . . . 0.0 111.782 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.42 -55.35 30.57 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 115.313 -0.858 . . . . 0.0 114.269 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 4.8 tp -62.45 -28.73 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 112.824 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.75 -53.72 55.24 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.358 0.663 . . . . 0.0 110.66 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 34.0 mt -54.71 -46.66 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 124.149 0.98 . . . . 0.0 109.302 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.39 -48.07 42.23 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.797 1.665 . . . . 0.0 114.338 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -61.42 -28.84 69.55 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 174.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -81.48 -32.97 32.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.23 -21.44 66.23 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 71.5 p -88.91 -33.66 17.21 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 171.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 71.9 p -71.38 166.83 20.84 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.953 176.782 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -126.19 120.49 30.21 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.377 0.608 . . . . 0.0 111.392 176.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.7 t -103.83 128.65 51.25 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.546 168.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.9 m -142.64 124.07 14.79 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.18 125.38 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 164.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -89.85 77.9 6.92 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.511 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -88.97 130.04 35.53 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -83.92 -44.4 14.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 112.018 -2.356 . . . . 0.0 113.188 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.97 129.66 15.86 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.725 1.155 . . . . 0.0 114.892 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.25 93.79 0.13 Allowed Glycine 0 CA--C 1.541 1.674 0 CA-C-N 112.719 -1.74 . . . . 0.0 109.754 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 6.0 tp -125.83 133.51 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 124.087 0.522 . . . . 0.0 111.405 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -113.92 128.92 56.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.869 169.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.4 t 18.77 109.59 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.98 -27.51 68.34 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.661 168.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -63.02 -51.27 67.43 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.048 0.939 . . . . 0.0 112.188 169.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -54.32 -49.16 70.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.355 1.462 . . . . 0.0 110.884 171.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.55 -43.9 80.37 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -59.58 -47.2 86.47 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.0 t -56.94 -45.69 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -64.5 -29.77 70.81 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 172.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.294 2.5 mt -44.98 -47.64 30.44 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 118.318 2.71 . . . . 0.0 118.318 -173.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.2 -52.19 9.29 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.142 1.895 . . . . 0.0 112.657 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.8 p -64.88 -38.64 91.63 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.86 -48.79 74.9 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.63 0.729 . . . . 0.0 111.509 171.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.98 -42.51 99.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.977 1.311 . . . . 0.0 113.614 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.6 tp -57.59 -46.32 84.16 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.521 0.728 . . . . 0.0 112.333 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.3 t -58.07 -45.08 87.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.566 0.746 . . . . 0.0 112.073 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -54.98 -43.41 73.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.1 tp -64.89 -44.09 90.75 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.005 0.522 . . . . 0.0 111.723 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.19 -35.83 76.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.96 83.38 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 168.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 10.5 mt -60.77 -45.29 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.66 -54.23 18.11 Favored Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.196 0.935 . . . . 0.0 113.266 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.4 tt -50.73 -47.47 59.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 111.626 174.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -56.16 26.51 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 124.3 1.0 . . . . 0.0 113.485 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.5 mt -53.58 -50.45 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.062 0.945 . . . . 0.0 110.178 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -50.13 -64.3 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.981 1.426 . . . . 0.0 112.268 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.2 pt -59.73 -43.77 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.32 -53.68 23.02 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 125.654 1.597 . . . . 0.0 113.622 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 54.5 ttt-85 -83.87 -53.3 5.69 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.417 0.716 . . . . 0.0 112.695 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -70.86 -29.98 66.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 -161.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.8 tt -55.02 -34.11 63.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.546 1.138 . . . . 0.0 112.595 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.9 t -105.26 -44.65 4.69 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 16.3 m -125.65 104.67 8.5 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 116.745 -1.598 . . . . 0.0 113.299 167.099 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -76.26 133.14 40.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.702 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.1 m -96.91 88.75 4.64 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.942 0.877 . . . . 0.0 110.481 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 12.2 t 65.25 117.38 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 112.27 -2.241 . . . . 0.0 114.367 171.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.41 129.76 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.502 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 12.6 ttt -144.81 72.55 1.34 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.744 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -90.81 120.62 32.0 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.462 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -126.92 121.11 30.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.119 -1.855 . . . . 0.0 112.771 -169.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.6 -82.46 0.17 Allowed Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.774 -1.103 . . . . 0.0 114.015 -171.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.52 -48.3 3.94 Favored Glycine 0 N--CA 1.474 1.221 0 O-C-N 125.01 1.065 . . . . 0.0 112.524 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mt -55.49 115.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.365 1.866 . . . . 0.0 107.622 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.22 -41.81 94.08 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.037 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 33.8 t -116.79 103.28 10.17 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.9 -36.64 79.78 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.087 167.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' B' ' 160' ' ' GLU . 7.8 mp0 -56.15 -46.5 79.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.285 1.834 . . . . 0.0 112.318 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -57.28 -58.53 7.83 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.44 1.087 . . . . 0.0 112.411 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 33.7 tp -52.93 -41.19 64.23 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -49.66 -56.29 10.64 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 16.0 m -76.31 -26.63 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.0 -49.89 75.88 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.919 1.288 . . . . 0.0 112.603 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 25.3 mt -47.09 -45.56 52.93 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -52.19 -63.65 0.24 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.468 2.779 . . . . 0.0 114.753 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 96.3 p -55.89 -43.98 77.74 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.19 0.596 . . . . 0.0 111.951 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.0 tp -52.2 -57.42 9.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.839 1.656 . . . . 0.0 111.852 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tp -53.01 -59.06 5.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.878 1.271 . . . . 0.0 111.125 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 39.1 mt -51.65 -52.62 46.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.85 1.26 . . . . 0.0 113.548 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 24.4 t -59.62 -52.98 63.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.946 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -60.84 -41.47 95.89 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -38.39 86.71 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.27 -29.24 68.79 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 167.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.73 -44.56 85.63 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.863 0.727 . . . . 0.0 112.748 167.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.39 -43.25 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.884 0.873 . . . . 0.0 109.796 166.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -48.93 -61.92 4.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.491 1.52 . . . . 0.0 113.622 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 7.0 tp -53.17 -40.93 64.72 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.438 1.095 . . . . 0.0 112.07 172.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.0 -60.62 7.36 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.644 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.5 -31.84 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.482 0.713 . . . . 0.0 111.605 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 83.2 t80 -50.96 -52.41 42.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.407 0.683 . . . . 0.0 111.917 168.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt -66.96 -52.52 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.275 1.03 . . . . 0.0 109.765 174.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -45.53 -50.35 10.73 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 125.877 1.703 . . . . 0.0 113.628 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -67.53 -45.77 74.76 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.8 1.24 . . . . 0.0 113.777 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -61.92 -18.96 62.08 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 68.9 mt -68.74 -44.09 74.52 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.299 1.04 . . . . 0.0 112.275 166.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 22.8 p -96.54 -75.22 0.54 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.673 1.189 . . . . 0.0 114.117 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 38.7 p -97.04 162.7 13.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.299 1.44 . . . . 0.0 114.557 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 C--O 1.254 1.308 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.97 178.574 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -57.09 -56.96 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.483 2.122 . . . . 0.0 112.739 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.4 p -65.19 -35.6 81.59 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.92 -61.84 2.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.725 0.81 . . . . 0.0 111.922 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -45.43 73.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.837 0.855 . . . . 0.0 113.288 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.54 -53.82 53.8 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.662 0.601 . . . . 0.0 112.025 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.535 ' HA ' HD12 ' A' ' 175' ' ' LEU . 91.6 p -63.59 -42.13 98.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -64.69 -43.04 94.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.33 -41.66 97.39 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 172' ' ' SER . 85.0 mt -54.4 -50.52 67.37 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.579 0.752 . . . . 0.0 111.923 170.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.42 93.63 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.73 -50.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.483 0.713 . . . . 0.0 111.402 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.65 91.8 Favored Glycine 0 CA--C 1.545 1.943 0 O-C-N 123.687 0.617 . . . . 0.0 112.114 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 183' ' ' ILE . 38.1 tp -57.86 -44.1 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.522 -0.839 . . . . 0.0 111.897 173.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.02 92.85 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.84 0.733 . . . . 0.0 113.868 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.32 -47.0 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.954 0.901 . . . . 0.0 110.494 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.67 -46.13 89.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 113.027 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 179' ' ' LEU . 41.5 mm -59.49 -42.25 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.42 1.088 . . . . 0.0 111.577 173.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.19 55.36 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 124.092 0.853 . . . . 0.0 111.821 170.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.403 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 20.4 t80 . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 26.6 tp -55.49 -44.03 99.44 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.117 -1.42 . . . . 0.0 114.822 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.79 -47.92 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.649 2.232 . . . . 0.0 113.488 172.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' SER . . . . . 0.456 ' HA ' HD12 ' B' ' 171' ' ' LEU . 68.4 m -57.12 -35.86 69.98 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.65 -56.26 23.63 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.021 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.39 -40.01 85.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 113.503 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' B' ' 168' ' ' SER . 85.6 mt -57.08 -43.85 82.55 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' B' ' 175' ' ' LEU . 57.7 p -68.76 -28.37 66.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -61.99 -45.03 95.42 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 67.2 mt -58.0 -45.27 87.12 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.405 0.682 . . . . 0.0 111.997 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' B' ' 172' ' ' SER . 1.0 OUTLIER -53.13 -50.98 63.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.079 1.352 . . . . 0.0 112.633 170.157 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.78 83.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.477 1.111 . . . . 0.0 113.753 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.59 -45.17 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 0.0 111.587 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.88 -49.05 73.83 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.611 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.89 -41.42 78.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 112.995 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.35 -47.01 78.0 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.99 1.281 . . . . 0.0 112.738 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.33 -42.34 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.394 0.677 . . . . 0.0 111.501 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -63.99 -50.3 69.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.485 1.288 0 CA-C-N 117.972 0.351 . . . . 0.0 111.894 173.538 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.553 1.085 0 CA-C-O 116.163 -1.875 . . . . 0.0 116.017 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -63.01 -37.57 52.28 Favored 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 122.559 2.173 . . . . 0.0 114.697 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 p -64.63 -46.33 83.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.11 -49.35 78.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 9.4 mt -49.78 -55.71 13.03 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.5 -37.6 81.6 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.6 p -55.36 -47.41 75.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -66.81 -45.35 78.64 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.404 0.681 . . . . 0.0 112.787 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.616 ' HA ' HD12 ' A' ' 177' ' ' ILE . 25.4 mt -49.39 -47.1 48.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 174.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.63 -37.12 85.05 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 173.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.39 -46.79 87.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.494 0.718 . . . . 0.0 112.523 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 174' ' ' LEU . 6.2 mt -60.37 -46.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.466 0.706 . . . . 0.0 109.738 172.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.27 -62.78 2.62 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 125.569 1.557 . . . . 0.0 111.887 171.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.5 tp -50.57 -46.95 57.98 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.402 1.081 . . . . 0.0 111.882 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.76 -63.33 3.56 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.55 1.156 . . . . 0.0 113.996 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.47 -46.43 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.579 0.352 . . . . 0.0 110.595 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -49.5 -58.61 4.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.76 1.224 . . . . 0.0 113.193 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.2 tp -68.32 -33.82 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.484 1.114 . . . . 0.0 113.849 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.56 -39.56 91.07 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 125.408 1.48 . . . . 0.0 115.11 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -178.409 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 43.4 mt -43.49 -52.99 12.52 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.57 -54.93 2.05 Favored 'Trans proline' 0 C--N 1.356 0.941 0 CA-C-N 122.913 2.076 . . . . 0.0 113.411 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 4.2 p -63.85 -36.28 83.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.91 1.284 . . . . 0.0 112.668 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 35.6 mt -55.5 -59.18 5.19 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 50.5 mt -51.14 -46.81 62.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.578 0.751 . . . . 0.0 112.893 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.29 -57.52 10.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.533 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 84.8 p -56.39 -44.22 80.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -61.34 -51.34 69.23 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 177' ' ' ILE . 3.8 mp -61.81 -39.79 92.99 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.1 -25.69 55.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.63 98.84 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.719 0.637 . . . . 0.0 111.284 165.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' B' ' 174' ' ' LEU . 30.5 mt -58.97 -54.93 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.145 0.903 . . . . 0.0 109.114 169.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.08 -61.18 3.19 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 125.188 1.375 . . . . 0.0 113.403 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 15.9 tp -55.73 -42.1 74.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.083 1.353 . . . . 0.0 112.185 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.633 ' HA2' HD12 ' B' ' 183' ' ' ILE . . . -56.43 -48.89 72.64 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.425 1.012 . . . . 0.0 112.994 171.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mt -57.9 -41.94 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.174 0.99 . . . . 0.0 110.778 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -55.87 -46.85 78.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.633 HD12 ' HA2' ' B' ' 180' ' ' GLY . 20.6 mt . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.643 0.777 . . . . 0.0 109.886 172.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.293 2.2 mt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 119.749 3.24 . . . . 0.0 119.749 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -53.44 -65.57 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.297 2.665 . . . . 0.0 111.984 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.3 m -47.4 -45.04 24.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 47.3 mt -51.97 -64.44 0.82 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.215 -0.898 . . . . 0.0 112.057 173.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.5 mt -44.63 -59.22 2.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.356 1.462 . . . . 0.0 112.605 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.61 -48.42 81.86 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -60.28 -42.3 95.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -63.64 -48.69 76.22 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.444 HD23 HD12 ' A' ' 177' ' ' ILE . 31.7 mt -61.86 -34.27 75.68 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 -41.98 87.8 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.416 1.086 . . . . 0.0 113.153 166.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -67.52 -43.26 81.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.444 HD12 HD23 ' A' ' 174' ' ' LEU . 35.8 mt -59.25 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.017 0.527 . . . . 0.0 109.663 172.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.09 -55.16 16.27 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 124.8 1.19 . . . . 0.0 112.267 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.487 ' O ' HG12 ' A' ' 183' ' ' ILE . 46.3 tp -45.33 -57.97 3.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.124 1.37 . . . . 0.0 111.879 169.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -50.76 -48.67 43.48 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.846 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.9 mt -59.86 -58.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.436 0.694 . . . . 0.0 109.387 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -47.65 -61.0 2.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.457 1.503 . . . . 0.0 112.621 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 179' ' ' LEU . 38.2 pt -64.45 -44.76 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.47 95.78 Favored Glycine 0 N--CA 1.479 1.564 0 C-N-CA 124.886 1.231 . . . . 0.0 112.405 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 . . . . . 0 N--CA 1.47 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.36 172.578 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 55.1 t80 . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 117.699 -1.143 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.271 96.4 mt -62.64 -52.11 67.35 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 115.614 -2.136 . . . . 0.0 116.491 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -60.03 -43.28 37.42 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.41 2.073 . . . . 0.0 112.722 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 20.2 m -53.04 -55.22 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.155 0.909 . . . . 0.0 111.732 173.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 20.5 tp -52.79 -53.07 53.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.166 1.786 . . . . 0.0 112.488 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -50.92 -55.48 16.98 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' B' ' 174' ' ' LEU . 5.7 mp -61.37 -36.9 81.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.9 p -59.73 -39.29 84.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.772 1.026 . . . . 0.0 113.772 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -68.01 -43.08 79.63 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.91 0.756 . . . . 0.0 112.802 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 174' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' B' ' 171' ' ' LEU . 34.2 mt -59.07 -43.29 91.76 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.379 0.672 . . . . 0.0 111.045 172.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.71 -42.07 99.46 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.77 82.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 31.1 mt -59.09 -41.82 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.48 0.712 . . . . 0.0 110.298 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.95 -51.23 56.8 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 125.166 1.365 . . . . 0.0 114.212 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 13.1 tp -57.08 -45.69 83.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.573 0.749 . . . . 0.0 111.042 172.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -49.52 -59.41 7.22 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.335 169.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -51.11 -48.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.982 1.313 . . . . 0.0 112.98 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.546 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 36.6 t80 -40.99 -58.55 1.69 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.629 1.172 . . . . 0.0 112.876 168.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 36.1 mt . . . . . 0 N--CA 1.479 1.008 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.559 175.6 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.302 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.95 -43.73 34.95 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.093 1.862 . . . . 0.0 112.774 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.3 t -58.71 -51.69 68.9 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.347 1.059 . . . . 0.0 112.568 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.46 -57.21 12.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.591 1.957 . . . . 0.0 111.547 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 mp -46.28 -61.97 1.55 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.288 1.435 . . . . 0.0 113.69 175.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.42 -35.31 79.99 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.213 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.2 p -60.77 -45.4 94.49 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -59.75 -45.69 91.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.14 -45.62 79.54 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.735 0.647 . . . . 0.0 112.271 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.18 -38.03 89.21 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.23 93.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.266 0.626 . . . . 0.0 111.812 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.414 HG13 ' HB1' ' B' ' 176' ' ' ALA . 42.4 mt -57.43 -47.71 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.176 170.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.17 -54.34 26.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.899 1.238 . . . . 0.0 114.084 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.6 tp -49.88 -49.84 48.04 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.09 -49.51 71.4 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.655 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.49 -47.06 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.382 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -54.03 -53.67 49.88 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.257 0.973 . . . . 0.0 112.096 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.7 mt -51.68 -56.56 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.506 1.122 . . . . 0.0 111.151 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.51 22.11 Favored Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.829 1.331 . . . . 0.0 113.459 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 125.554 1.542 . . . . 0.0 111.611 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.255 4.8 mt -49.73 -60.78 4.4 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.48 -53.26 3.0 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.351 2.701 . . . . 0.0 110.874 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 8.2 p -54.87 -44.3 73.93 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.84 -67.32 0.3 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.396 168.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.85 -50.22 57.23 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.62 -44.66 93.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.006 1.322 . . . . 0.0 114.322 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -61.13 -42.45 98.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.07 -45.47 94.61 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.3 tp -50.49 -54.5 21.79 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 0.0 112.652 170.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' B' ' 175' ' ' LEU . 12.1 tp -67.68 -29.6 68.91 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -63.4 -46.44 86.39 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.354 0.661 . . . . 0.0 112.758 170.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 33.9 mt -57.04 -48.23 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 170.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.59 -54.71 15.9 Favored Glycine 0 N--CA 1.482 1.714 0 C-N-CA 124.426 1.012 . . . . 0.0 113.024 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 12.9 tp -52.96 -49.21 66.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 111.233 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.49 -52.36 28.9 Favored Glycine 0 N--CA 1.482 1.723 0 O-C-N 124.253 0.97 . . . . 0.0 113.428 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.21 -51.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.896 0.878 . . . . 0.0 110.1 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 76.8 t80 -46.34 -56.29 6.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.783 1.233 . . . . 0.0 112.729 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 125.138 1.375 . . . . 0.0 111.543 175.563 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 116.666 -1.635 . . . . 0.0 115.37 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.71 -50.51 7.78 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.313 2.009 . . . . 0.0 112.294 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.2 m -50.56 -45.5 57.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.854 0.861 . . . . 0.0 112.408 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -66.68 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.683 1.593 . . . . 0.0 111.724 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pp -62.24 -43.8 97.99 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 mt -57.72 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.45 0.7 . . . . 0.0 112.344 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.5 p -63.55 -40.12 96.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -56.48 -51.13 69.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.6 mt -54.83 -51.43 65.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 112.633 172.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.0 mt -55.76 -43.28 76.54 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.711 1.204 . . . . 0.0 114.222 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.415 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -55.26 -47.35 75.58 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.33 1.452 . . . . 0.0 113.643 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.1 mt -61.21 -41.1 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.81 . . . . 0.0 111.131 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -57.71 14.82 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 124.154 0.909 . . . . 0.0 112.3 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 182' ' ' TYR . 15.3 tp -48.67 -46.01 39.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.349 1.059 . . . . 0.0 111.827 172.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.85 -57.54 10.77 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.977 1.275 . . . . 0.0 113.548 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 33.7 mt -53.56 -43.93 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.654 1.182 . . . . 0.0 111.828 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 179' ' ' LEU . 88.6 t80 -51.83 -54.11 32.62 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.044 0.84 . . . . 0.0 112.376 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.6 mt -56.54 -54.45 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.278 1.031 . . . . 0.0 109.863 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -44.34 -60.6 3.56 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 125.773 1.654 . . . . 0.0 112.577 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.8 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 . . . . . 0 N--CA 1.486 1.346 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 21.7 tp -44.47 -51.65 19.72 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 116.163 -1.875 . . . . 0.0 115.575 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -56.2 -52.45 7.18 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.451 2.101 . . . . 0.0 112.761 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 25.6 p -61.74 -35.22 77.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 52.5 mt -54.82 -64.15 0.93 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 117.726 -1.13 . . . . 0.0 112.291 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.514 ' O ' HD12 ' B' ' 174' ' ' LEU . 19.1 mt -51.78 -50.04 61.49 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.198 0.999 . . . . 0.0 112.794 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 36.0 tp -53.31 -54.68 32.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.591 1.556 . . . . 0.0 112.737 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' SER . . . . . 0.544 ' HA ' HD12 ' B' ' 175' ' ' LEU . 76.8 p -63.66 -31.62 72.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -59.63 -49.4 77.89 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.532 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' LEU . . . . . 0.514 HD12 ' O ' ' B' ' 170' ' ' LEU . 0.5 OUTLIER -56.41 -43.61 79.52 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 172.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' B' ' 172' ' ' SER . 79.4 mt -54.99 -51.62 65.65 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.647 0.779 . . . . 0.0 112.828 170.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.45 -47.29 86.77 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.114 1.366 . . . . 0.0 114.118 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.415 HG13 ' HB1' ' A' ' 176' ' ' ALA . 26.0 mt -58.92 -49.11 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.162 0.585 . . . . 0.0 109.448 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.93 10.44 Favored Glycine 0 N--CA 1.483 1.823 0 O-C-N 124.665 1.228 . . . . 0.0 112.538 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.78 -45.94 70.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.885 1.274 . . . . 0.0 112.514 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -49.93 62.04 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 124.735 1.16 . . . . 0.0 113.123 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 177' ' ' ILE . 17.7 mt -60.61 -48.62 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.076 0.95 . . . . 0.0 109.152 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -40.89 -59.65 1.38 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.101 1.36 . . . . 0.0 112.273 169.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.483 1.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.829 174.651 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -65.32 -58.45 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.904 1.736 . . . . 0.0 112.598 168.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 m -43.57 -44.77 6.35 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.6 tp -44.62 -67.59 0.27 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.237 2.215 . . . . 0.0 112.31 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 mp -71.26 -37.86 71.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.409 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.7 mt -49.1 -57.44 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.132 0.895 . . . . 0.0 111.334 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.5 t -54.05 -58.94 5.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.129 1.371 . . . . 0.0 111.697 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -50.35 -68.54 0.16 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.27 -55.23 35.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.26 -48.09 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.457 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -66.68 -39.09 87.99 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.509 HG13 ' HB1' ' B' ' 176' ' ' ALA . 56.5 mt -55.86 -45.21 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.985 0.514 . . . . 0.0 110.689 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.11 -53.33 41.09 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 124.227 0.918 . . . . 0.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 16.7 tp -52.77 -47.22 67.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.563 0.745 . . . . 0.0 112.32 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.622 ' HA2' HD12 ' A' ' 183' ' ' ILE . . . -54.1 -51.79 47.94 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.868 173.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.7 mt -48.56 -46.0 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.159 0.983 . . . . 0.0 113.132 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -53.71 -56.28 18.74 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.658 0.599 . . . . 0.0 112.308 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.622 HD12 ' HA2' ' A' ' 180' ' ' GLY . 23.0 mt -50.59 -53.37 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.875 1.27 . . . . 0.0 110.326 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.81 -59.84 9.66 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 124.738 1.161 . . . . 0.0 112.278 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 125.552 1.541 . . . . 0.0 112.69 174.934 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.34 -41.62 61.2 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.145 -1.407 . . . . 0.0 114.345 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -51.49 -52.77 8.31 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.868 2.379 . . . . 0.0 114.32 165.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -59.66 -40.45 87.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.179 0.992 . . . . 0.0 113.432 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.16 -44.89 95.61 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.524 0.73 . . . . 0.0 112.414 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.19 -51.37 70.01 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.785 0.834 . . . . 0.0 112.087 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 25.6 tp -49.03 -53.48 19.94 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.592 1.557 . . . . 0.0 111.826 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 33.3 t -54.81 -57.29 12.17 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.909 1.284 . . . . 0.0 112.192 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -47.41 -52.39 17.01 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.358 1.063 . . . . 0.0 113.245 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.28 -50.37 73.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 47.5 mt -71.49 -32.31 68.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.509 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -66.47 -47.46 72.99 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.585 0.754 . . . . 0.0 111.615 169.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.457 HG13 ' HB1' ' A' ' 176' ' ' ALA . 23.2 mt -50.23 -53.59 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.179 1.392 . . . . 0.0 110.787 167.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.07 -60.21 4.64 Favored Glycine 0 N--CA 1.483 1.814 0 O-C-N 124.415 1.072 . . . . 0.0 113.286 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 15.4 tp -50.95 -46.34 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.606 1.162 . . . . 0.0 112.225 173.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.22 -53.33 43.56 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 124.773 1.178 . . . . 0.0 113.63 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 23.2 mt -53.31 -46.8 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.862 0.865 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 22.0 t80 -49.44 -59.63 3.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.835 1.654 . . . . 0.0 113.449 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.632 0.73 . . . . 0.0 111.651 177.539 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 166' ' ' LEU 0.27 36.0 mt . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.646 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -46.96 -52.09 8.26 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.12 2.547 . . . . 0.0 114.237 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.1 p -66.12 -47.2 74.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.14 -58.4 6.24 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.102 0.961 . . . . 0.0 110.999 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.6 mt -54.29 -52.74 60.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.631 1.172 . . . . 0.0 112.704 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.4 tp -55.15 -51.84 65.2 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.174 0.99 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.8 p -57.05 -39.7 75.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -63.27 -48.09 79.62 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 177' ' ' ILE . 14.6 tp -58.76 -45.31 90.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.575 0.75 . . . . 0.0 112.394 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.46 -35.62 81.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -61.97 -42.12 98.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.333 0.653 . . . . 0.0 112.422 172.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 174' ' ' LEU . 27.2 mt -59.33 -49.57 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 169.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -47.75 -55.78 9.31 Favored Glycine 0 CA--C 1.546 2.008 0 C-N-CA 124.952 1.263 . . . . 0.0 113.091 174.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 55.9 tp -45.74 -56.76 4.9 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.296 1.439 . . . . 0.0 112.697 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.52 -48.24 55.66 Favored Glycine 0 CA--C 1.541 1.689 0 O-C-N 124.533 1.146 . . . . 0.0 113.756 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.407 HD12 ' HA2' ' A' ' 178' ' ' GLY . 27.0 mt -57.54 -50.78 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.96 0.504 . . . . 0.0 110.11 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -53.74 -54.79 33.16 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.704 1.253 . . . . 0.0 112.427 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.6 mt -53.85 -56.38 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.318 0.647 . . . . 0.0 111.356 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -46.76 -58.26 6.22 Favored Glycine 0 N--CA 1.487 2.036 0 O-C-N 124.481 1.113 . . . . 0.0 112.168 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 53.8 t80 . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -47.88 97.67 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.1 -52.86 6.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.75 2.3 . . . . 0.0 112.992 170.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 19.5 t -52.09 -48.99 64.44 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.182 0.993 . . . . 0.0 111.864 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.9 mp -55.34 -65.45 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.907 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mt -41.08 -61.5 0.99 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.363 1.465 . . . . 0.0 114.921 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' B' ' 174' ' ' LEU . 54.2 mt -62.79 -36.73 84.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -77.7 -34.37 52.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -67.3 -40.15 86.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' B' ' 171' ' ' LEU . 70.1 mt -53.81 -53.16 56.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 0.0 111.929 168.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 7.7 mt -48.48 -47.93 38.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.233 1.013 . . . . 0.0 113.237 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.416 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -57.73 -52.01 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.497 HG13 ' HB1' ' A' ' 176' ' ' ALA . 29.0 mt -61.28 -42.33 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.31 0.644 . . . . 0.0 110.636 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.99 -51.48 55.24 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.848 1.213 . . . . 0.0 112.831 173.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.35 -44.34 44.59 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.43 -57.36 19.0 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.456 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -47.76 -52.2 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.947 1.299 . . . . 0.0 110.971 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.61 -50.15 25.07 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.942 0.897 . . . . 0.0 113.227 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 122.913 0.485 . . . . 0.0 110.563 173.842 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 169' ' ' LEU 0.285 35.7 mt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -51.96 -71.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 121.518 1.479 . . . . 0.0 112.125 164.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 p -55.78 -42.31 75.36 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 47.1 mt -56.35 -61.36 2.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.49 -17.74 62.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.98 -41.04 82.94 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 165.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 175' ' ' LEU . 6.9 p -61.68 -34.39 75.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 169.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -72.93 -38.47 66.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 118.28 -0.867 . . . . 0.0 113.211 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.6 tp -51.81 -47.01 64.49 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.649 0.593 . . . . 0.0 111.555 168.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 172' ' ' SER . 94.5 mt -49.62 -56.69 9.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.834 0.709 . . . . 0.0 112.436 168.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.52 -52.6 63.13 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.42 HG13 ' HB1' ' B' ' 176' ' ' ALA . 30.2 mt -56.04 -47.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.369 1.067 . . . . 0.0 110.357 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.15 -57.39 10.18 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.912 1.244 . . . . 0.0 112.724 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 30.0 tp -53.11 -45.96 68.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.221 1.009 . . . . 0.0 112.499 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.66 -56.07 6.72 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 125.233 1.397 . . . . 0.0 113.822 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.8 mt -59.32 -53.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.314 -0.943 . . . . 0.0 109.565 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -51.84 -58.24 7.02 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.559 -1.2 . . . . 0.0 113.101 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 184' ' ' GLY 0.256 2.9 pp -60.79 -38.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.05 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 183' ' ' ILE . . . -59.58 -47.61 90.05 Favored Glycine 0 N--CA 1.481 1.689 0 C-N-CA 123.83 0.728 . . . . 0.0 112.943 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 . . . . . 0 N--CA 1.478 0.974 0 CA-C-N 114.213 -0.994 . . . . 0.0 111.83 174.236 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' B' ' 169' ' ' LEU . 54.3 tp -54.91 -42.29 94.85 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.226 -1.369 . . . . 0.0 113.479 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -54.09 -51.84 9.72 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.132 1.888 . . . . 0.0 113.504 168.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 41.4 m -53.15 -48.67 67.76 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' B' ' 166' ' ' LEU . 80.4 mt -50.71 -59.89 3.61 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.665 170.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.0 mt -50.64 -57.91 7.1 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.99 -52.85 47.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.794 0.837 . . . . 0.0 113.164 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 60.5 p -66.77 -42.52 85.96 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -63.9 -43.38 96.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.74 -47.46 79.98 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 170.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 39.0 mt -56.68 -42.55 79.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 170.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.42 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -65.17 -43.65 91.02 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 175.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 44.0 mt -55.37 -47.48 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 168.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.38 -53.57 23.75 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.52 1.057 . . . . 0.0 113.014 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.25 -41.75 69.14 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.79 -54.11 29.84 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.153 0.882 . . . . 0.0 112.42 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 13.2 mt -53.8 -54.32 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.614 1.166 . . . . 0.0 110.531 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -49.52 -50.95 39.65 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.193 1.797 . . . . 0.0 113.97 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.613 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.0 tp . . . . . 0 CA--C 1.553 1.059 0 CA-C-O 115.907 -1.997 . . . . 0.0 113.703 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.36 -52.32 4.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.35 2.033 . . . . 0.0 112.759 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -46.45 63.08 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.28 -66.55 0.51 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.866 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -47.15 -53.21 13.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.498 1.119 . . . . 0.0 113.978 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.01 -44.79 95.02 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.9 p -70.86 -41.89 70.81 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -57.81 -42.92 85.24 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' A' ' 177' ' ' ILE . 28.0 mt -56.19 -52.9 62.71 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 169.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.0 mt -49.17 -47.5 45.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 112.221 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.3 -48.57 76.41 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 174' ' ' LEU . 16.4 mt -59.81 -49.26 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 123.55 0.74 . . . . 0.0 110.462 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.1 -51.27 36.09 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 124.25 0.928 . . . . 0.0 112.027 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.09 -46.13 79.14 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.214 1.005 . . . . 0.0 112.012 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -48.42 -53.65 15.52 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.253 0.93 . . . . 0.0 113.438 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.14 -50.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.252 0.621 . . . . 0.0 109.792 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.83 -55.63 18.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.041 0.936 . . . . 0.0 113.255 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -48.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.39 -55.59 12.69 Favored Glycine 0 N--CA 1.481 1.694 0 C-N-CA 124.196 0.903 . . . . 0.0 111.46 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 125.301 1.441 . . . . 0.0 114.402 174.845 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' B' ' 169' ' ' LEU . 15.3 tp -53.49 -38.44 62.19 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 116.362 -1.78 . . . . 0.0 115.722 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -60.9 -64.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 CA-C-O 116.703 -1.457 . . . . 0.0 111.126 168.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -43.38 -42.78 4.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' B' ' 166' ' ' LEU . 41.6 mt -53.95 -71.08 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.089 0.956 . . . . 0.0 111.276 170.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 4.8 mt -46.43 -46.94 19.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.6 1.56 . . . . 0.0 114.73 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 67.1 mt -57.11 -53.54 56.91 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.138 1.375 . . . . 0.0 112.751 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 85.5 p -61.98 -39.69 93.04 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -58.49 -45.05 89.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' LEU . . . . . 0.52 HD12 HD12 ' B' ' 177' ' ' ILE . 6.4 tp -66.8 -38.64 86.88 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 tp -55.19 -46.24 75.85 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.048 0.939 . . . . 0.0 110.429 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.66 80.03 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.52 HD12 HD12 ' B' ' 174' ' ' LEU . 36.7 mt -57.56 -48.08 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 117.748 0.249 . . . . 0.0 110.736 173.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.51 -49.67 38.61 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.322 0.963 . . . . 0.0 112.977 174.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 14.6 tp -53.12 -45.14 68.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.117 0.967 . . . . 0.0 112.557 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -55.71 -51.6 53.94 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.589 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 9.1 mt -59.03 -45.44 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.318 0.647 . . . . 0.0 109.587 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 48.3 t80 -47.82 -49.97 27.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.637 1.175 . . . . 0.0 113.504 171.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt . . . . . 0 N--CA 1.481 1.088 0 C-N-CA 123.349 0.66 . . . . 0.0 110.941 174.451 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.254 35.3 mt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.32 -59.11 0.47 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.8 p -59.42 -40.65 87.38 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.4 tp -50.7 -63.32 1.16 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.639 1.576 . . . . 0.0 110.756 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.42 -42.33 77.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.439 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.0 tp -53.6 -47.69 69.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.596 1.159 . . . . 0.0 111.654 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 175' ' ' LEU . 24.7 p -66.62 -39.59 88.4 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -69.71 -35.45 75.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.4 mt -55.49 -49.05 73.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.956 0.785 . . . . 0.0 111.645 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 172' ' ' SER . 86.6 mt -51.55 -52.18 49.31 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 170.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.17 75.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.4 mt -59.1 -48.89 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.648 1.179 . . . . 0.0 111.695 169.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.1 -47.62 88.07 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.252 0.93 . . . . 0.0 113.25 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.86 -41.99 78.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.751 1.621 . . . . 0.0 111.575 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.18 -51.24 58.66 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.266 1.412 . . . . 0.0 112.321 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 29.8 mt -55.86 -47.67 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.378 1.071 . . . . 0.0 111.311 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -50.42 -63.16 1.21 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.47 1.106 . . . . 0.0 112.798 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 183' ' ' ILE . 7.4 tp -69.59 -35.27 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.44 43.71 Favored Glycine 0 N--CA 1.479 1.515 0 C-N-CA 124.307 0.956 . . . . 0.0 111.832 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.528 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 C--O 1.219 -0.553 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.71 -34.96 7.16 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 -62.41 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 122.085 1.857 . . . . 0.0 112.406 160.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 36.4 p -55.42 -41.93 73.45 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.98 -62.16 2.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 116.513 -1.708 . . . . 0.0 113.079 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' B' ' 174' ' ' LEU . 22.6 tp -50.98 -53.92 28.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.526 0.73 . . . . 0.0 112.018 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt -60.01 -52.21 66.34 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 95.2 p -62.51 -39.35 93.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -58.72 -48.06 82.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 0.0 111.795 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' B' ' 177' ' ' ILE . 84.2 mt -53.74 -45.7 70.64 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.241 1.017 . . . . 0.0 112.64 172.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 27.4 tp -57.66 -46.49 84.16 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.129 0.572 . . . . 0.0 112.163 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.38 96.78 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 174' ' ' LEU . 26.7 mt -57.26 -48.44 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.26 -55.09 20.78 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 124.396 0.998 . . . . 0.0 112.593 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.408 ' O ' HG12 ' B' ' 183' ' ' ILE . 23.3 mt -51.66 -46.51 63.78 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.61 -52.83 45.54 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 124.787 1.185 . . . . 0.0 112.527 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.88 -48.26 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 113.758 -1.221 . . . . 0.0 110.281 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -30.38 41.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 179' ' ' LEU . 44.4 pt . . . . . 0 N--CA 1.486 1.339 0 CA-C-N 119.677 1.126 . . . . 0.0 111.178 170.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 169' ' ' LEU . 7.3 tp . . . . . 0 CA--C 1.549 0.931 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -54.66 -58.87 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.848 2.365 . . . . 0.0 114.182 171.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.2 p -58.67 -39.36 80.42 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 2.8 mp -54.21 -66.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 171.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 30.5 mt -50.86 -43.35 59.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.15 -49.89 70.34 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.1 p -69.62 -29.18 66.62 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.438 ' HE1' HD23 ' A' ' 169' ' ' LEU . 24.3 m170 -57.18 -44.96 84.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.074 0.549 . . . . 0.0 111.905 165.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.98 -35.22 76.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.03 -50.24 73.34 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.546 0.529 . . . . 0.0 111.994 167.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.426 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -58.49 -48.97 79.03 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.55 -47.23 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.67 1.188 . . . . 0.0 111.648 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.75 -57.75 11.78 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.411 1.481 . . . . 0.0 111.678 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.0 tp -49.7 -46.23 49.83 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.943 1.297 . . . . 0.0 112.171 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -46.81 -62.3 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.618 1.58 . . . . 0.0 113.847 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.91 -31.94 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -49.01 -67.41 0.27 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.313 1.045 . . . . 0.0 112.223 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . 0.294 2.3 pp -67.83 -30.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.27 -64.34 3.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 124.997 1.284 . . . . 0.0 112.723 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 176.335 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 165' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' B' ' 168' ' ' SER . 4.4 p90 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.98 -46.01 30.8 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.732 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -55.4 -45.56 39.05 Favored 'Trans proline' 0 N--CA 1.48 0.681 0 C-N-CA 122.284 1.989 . . . . 0.0 111.923 164.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 168' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' B' ' 165' ' ' PHE . 55.0 m -47.55 -52.58 17.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.143 0.977 . . . . 0.0 112.003 174.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.412 HD21 HD11 ' A' ' 169' ' ' LEU . 58.7 mt -53.35 -61.62 2.18 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.882 0.873 . . . . 0.0 113.289 176.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 11.4 mt -54.97 -52.05 64.26 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.526 -1.215 . . . . 0.0 113.637 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.75 -58.79 7.06 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.245 1.418 . . . . 0.0 112.64 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 87.4 p -64.03 -37.27 86.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -66.79 -40.25 88.08 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.53 -51.07 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.569 0.7 . . . . 0.0 111.292 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.52 -38.91 72.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.393 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.28 86.15 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.426 HG13 ' HB1' ' A' ' 176' ' ' ALA . 6.9 mt -57.26 -48.46 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 171.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.53 -57.31 9.53 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.269 1.414 . . . . 0.0 112.618 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 62.4 tp -45.82 -53.12 10.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.19 -62.27 3.98 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 124.642 1.115 . . . . 0.0 112.963 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -54.25 -51.11 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.85 0.86 . . . . 0.0 110.828 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -61.18 -33.54 73.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.1 mt . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 123.237 0.615 . . . . 0.0 110.086 171.988 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 169' ' ' LEU 0.251 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 . . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -55.06 -44.62 47.83 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 121.885 1.723 . . . . 0.0 112.507 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.2 m -51.79 -53.29 41.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.869 0.868 . . . . 0.0 112.798 170.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 166' ' ' LEU . 22.4 mt -55.8 -44.84 78.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 173.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.4 mt -59.74 -50.91 71.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.008 0.923 . . . . 0.0 113.005 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.0 tp -57.12 -45.58 83.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.327 1.051 . . . . 0.0 110.998 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.8 t -51.2 -58.62 5.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.177 1.391 . . . . 0.0 113.487 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -48.01 -51.58 23.38 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.474 1.109 . . . . 0.0 113.494 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 44.2 tp -54.22 -57.07 12.56 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.767 1.227 . . . . 0.0 112.788 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.6 mt -54.35 -44.85 72.52 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.09 -54.48 7.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.617 HG13 ' HB1' ' B' ' 176' ' ' ALA . 25.5 mt -55.9 -40.94 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.123 0.569 . . . . 0.0 110.297 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -62.1 5.97 Favored Glycine 0 N--CA 1.48 1.597 0 O-C-N 124.801 1.313 . . . . 0.0 112.35 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.03 -49.75 30.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.807 0.843 . . . . 0.0 113.108 171.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.62 -64.22 3.85 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 125.268 1.413 . . . . 0.0 114.168 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.8 pp -56.62 -33.94 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.8 -58.05 6.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.906 1.282 . . . . 0.0 113.219 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 21.5 mt -56.9 -34.69 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.548 0.739 . . . . 0.0 111.166 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.24 31.35 0.96 Allowed Glycine 0 CA--C 1.54 1.622 0 N-CA-C 116.439 1.335 . . . . 0.0 116.439 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.614 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 26.7 t80 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.16 -53.23 67.53 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 115.842 -2.028 . . . . 0.0 114.737 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -56.39 -50.19 12.73 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 123.161 2.574 . . . . 0.0 113.159 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.7 m -57.02 -45.97 82.68 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.74 -46.19 89.24 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.023 1.329 . . . . 0.0 114.424 174.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.7 mt -53.23 -56.92 12.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.569 0.7 . . . . 0.0 111.113 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' B' ' 171' ' ' LEU . 9.9 tp -58.71 -45.15 90.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.393 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 42.8 t -47.78 -60.39 2.61 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.791 1.237 . . . . 0.0 113.062 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.55 -47.65 72.97 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.163 0.914 . . . . 0.0 113.21 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 4.7 mp -60.93 -53.78 53.05 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.9 mt -51.29 -54.56 24.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.33 1.052 . . . . 0.0 111.094 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.617 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -60.7 -48.75 80.37 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.396 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 tt -64.19 -41.92 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.38 63.6 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 124.09 0.869 . . . . 0.0 112.008 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 9.5 tp -54.44 -50.47 67.59 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 113.611 -1.294 . . . . 0.0 111.588 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' B' ' 183' ' ' ILE . . . -49.47 -54.18 17.5 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 124.984 1.278 . . . . 0.0 113.941 176.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 10.2 mt -56.16 -48.56 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.632 0.773 . . . . 0.0 111.484 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -51.23 -52.35 45.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.901 0.881 . . . . 0.0 112.351 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.411 HD12 ' HA2' ' B' ' 180' ' ' GLY . 34.0 mt . . . . . 0 N--CA 1.483 1.218 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.879 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.276 17.9 mt . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 115.639 -2.124 . . . . 0.0 116.662 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -57.27 -57.5 1.25 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.203 1.935 . . . . 0.0 112.536 171.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.7 m -45.4 -46.01 13.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 37.2 mt -62.48 -54.25 42.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.492 1.517 . . . . 0.0 114.606 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.47 -43.74 68.39 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.572 0.749 . . . . 0.0 112.164 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.1 mt -53.08 -63.11 1.25 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.101 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.6 p -59.1 -43.34 91.85 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -66.03 -46.98 75.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 174' ' ' LEU . 8.7 mt -56.29 -45.62 80.13 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.3 mt -60.8 -45.33 94.85 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.463 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.1 -46.54 79.06 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.439 HG13 ' HB1' ' B' ' 176' ' ' ALA . 11.0 mt -47.53 -54.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.789 0.835 . . . . 0.0 111.385 170.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.549 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -51.98 -56.81 14.76 Favored Glycine 0 CA--C 1.544 1.872 0 C-N-CA 124.548 1.07 . . . . 0.0 113.138 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.7 mt -51.83 -48.68 63.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.317 1.047 . . . . 0.0 111.702 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.68 -51.12 40.14 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.231 1.396 . . . . 0.0 112.488 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.549 HD12 ' HA2' ' A' ' 178' ' ' GLY . 21.5 mt -54.66 -54.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.023 1.329 . . . . 0.0 110.373 174.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -53.02 -51.71 60.8 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.969 1.418 . . . . 0.0 111.038 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.4 mt -56.67 -62.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 124.382 1.073 . . . . 0.0 109.796 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.76 4.48 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 124.734 1.159 . . . . 0.0 113.366 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.368 1.067 . . . . 0.0 112.741 -179.678 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.296 1.5 mm? -40.51 -61.56 1.17 Allowed Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.28 -56.51 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 122.966 2.444 . . . . 0.0 111.382 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 3.1 p -64.05 -27.82 69.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 38.0 tp -63.41 -52.63 60.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.997 1.319 . . . . 0.0 112.248 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -58.29 -36.34 73.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.38 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.68 -33.52 66.57 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 69.7 m -71.0 -35.04 71.93 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 172.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -56.29 -42.66 77.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.583 165.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.26 -34.69 65.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.82 -54.24 44.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.306 1.442 . . . . 0.0 110.895 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.439 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -55.09 -48.36 73.66 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.463 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.9 mt -61.3 -51.04 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.5 1.12 . . . . 0.0 111.823 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.94 -53.89 24.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.671 1.605 . . . . 0.0 112.845 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.54 -47.3 76.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.906 0.882 . . . . 0.0 112.731 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.18 -53.51 23.17 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.989 1.281 . . . . 0.0 113.131 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.66 -46.66 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.067 0.947 . . . . 0.0 112.517 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -51.4 -55.51 18.22 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.531 0.519 . . . . 0.0 112.392 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 181' ' ' ILE 0.26 6.4 tp . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.334 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.15 -66.12 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.183 2.588 . . . . 0.0 111.17 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.0 m -48.73 -56.6 8.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.641 1.576 . . . . 0.0 112.47 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.8 mt -42.54 -51.26 5.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.804 1.642 . . . . 0.0 114.199 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.65 -26.69 20.61 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.95 -35.71 74.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 170.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -68.84 -38.0 79.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 168.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.1 mt -53.49 -50.38 65.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.579 0.752 . . . . 0.0 112.263 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.6 tp -51.02 -53.32 34.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.17 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.08 -51.82 39.56 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 181' ' ' ILE . 19.4 mt -59.61 -56.58 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.412 0.685 . . . . 0.0 110.625 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.09 -50.52 45.17 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 124.281 0.943 . . . . 0.0 112.816 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.453 HD23 HD11 ' B' ' 177' ' ' ILE . 5.5 tp -56.11 -44.13 78.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.171 1.388 . . . . 0.0 112.139 176.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -58.11 -46.37 92.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.99 0.805 . . . . 0.0 113.2 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 177' ' ' ILE . 2.4 mp -53.08 -45.81 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 124.139 0.552 . . . . 0.0 111.425 172.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -56.57 -55.36 34.82 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.6 mt -53.32 -57.82 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.179 0.991 . . . . 0.0 111.243 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.82 -50.26 32.54 Favored Glycine 0 CA--C 1.548 2.124 0 C-N-CA 124.783 1.183 . . . . 0.0 112.403 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 177.065 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.507 HD23 HD23 ' B' ' 169' ' ' LEU 0.256 23.8 mt -43.35 -43.62 11.39 Favored Pre-proline 0 N--CA 1.481 1.1 0 N-CA-C 118.714 2.857 . . . . 0.0 118.714 -177.004 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -51.7 -66.62 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.498 2.799 . . . . 0.0 113.199 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 19.5 p -54.26 -42.55 70.07 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.507 HD23 HD23 ' B' ' 166' ' ' LEU . 41.6 tp -55.96 -58.0 9.73 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.492 1.12 . . . . 0.0 112.218 175.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -47.2 85.96 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 173.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 51.9 tp -54.5 -45.58 73.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -62.1 -44.77 95.94 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.559 0.537 . . . . 0.0 112.173 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -67.72 -37.2 81.89 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.715 1.206 . . . . 0.0 112.488 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 20.3 mt -60.32 -51.14 70.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.697 1.199 . . . . 0.0 112.326 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.5 mt -58.77 -45.48 89.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.67 86.98 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.453 HD11 HD23 ' A' ' 179' ' ' LEU . 2.3 tt -70.9 -36.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.86 -50.4 54.66 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.244 0.926 . . . . 0.0 111.191 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.41 -42.74 82.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.721 -0.739 . . . . 0.0 112.651 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -51.64 -56.81 14.03 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.087 0.851 . . . . 0.0 112.674 170.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 6.2 mt -60.6 -41.01 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.727 0.811 . . . . 0.0 109.881 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -51.81 -61.75 2.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.286 1.034 . . . . 0.0 111.156 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 28.0 mt . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.865 177.434 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.113 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -67.11 -43.84 5.87 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 121.774 1.649 . . . . 0.0 114.705 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.3 p -68.11 -38.38 82.21 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 169' ' ' LEU . 46.6 mt -66.98 -39.91 87.31 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 17.0 mt -51.85 -47.2 64.54 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 167.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.37 -53.89 53.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 59.2 p -59.61 -39.7 85.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -68.75 -43.47 75.78 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 tp -57.43 -44.89 85.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.179 0.992 . . . . 0.0 111.918 170.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -48.78 79.52 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.378 1.071 . . . . 0.0 112.123 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.43 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -58.08 -46.54 85.29 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.521 1.129 . . . . 0.0 113.609 176.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.507 HG22 HD11 ' A' ' 181' ' ' ILE . 58.9 mt -53.68 -53.32 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.307 0.643 . . . . 0.0 110.118 170.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.495 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -48.52 -51.2 22.77 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.155 1.359 . . . . 0.0 113.88 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -52.38 -48.66 65.48 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.01 -48.38 83.03 Favored Glycine 0 N--CA 1.488 2.103 0 O-C-N 124.181 0.926 . . . . 0.0 112.43 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 177' ' ' ILE . 27.0 mt -56.89 -49.22 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 124.944 1.297 . . . . 0.0 110.471 175.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.84 -49.14 59.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.563 1.145 . . . . 0.0 112.922 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.5 mm -52.91 -50.78 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.325 0.65 . . . . 0.0 111.231 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.14 -56.59 22.48 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 124.55 1.071 . . . . 0.0 113.075 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 22.8 mtt180 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.147 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.268 16.5 mt -46.88 -56.03 13.1 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 116.288 -1.815 . . . . 0.0 115.728 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.46 -45.32 11.93 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.453 2.102 . . . . 0.0 114.716 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 39.0 m -63.08 -38.62 91.91 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.26 -48.37 80.64 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.947 1.299 . . . . 0.0 111.698 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.56 -49.43 74.86 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.62 0.368 . . . . 0.0 111.306 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 39.3 p -61.64 -38.93 89.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -62.27 -45.67 92.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.33 -45.31 72.64 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 22.3 mt -62.29 -38.97 91.4 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.47 82.93 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.43 HG13 ' HB1' ' A' ' 176' ' ' ALA . 18.7 mt -60.08 -41.39 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.13 -52.18 23.25 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 124.919 1.247 . . . . 0.0 113.243 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.64 -44.51 85.68 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.919 0.888 . . . . 0.0 111.782 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.42 -55.35 30.57 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 115.313 -0.858 . . . . 0.0 114.269 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 4.8 tp -62.45 -28.73 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 112.824 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.75 -53.72 55.24 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.358 0.663 . . . . 0.0 110.66 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 34.0 mt . . . . . 0 N--CA 1.488 1.431 0 C-N-CA 124.149 0.98 . . . . 0.0 109.302 171.185 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.294 2.5 mt . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 118.318 2.71 . . . . 0.0 118.318 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.2 -52.19 9.29 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.142 1.895 . . . . 0.0 112.657 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.8 p -64.88 -38.64 91.63 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.86 -48.79 74.9 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.63 0.729 . . . . 0.0 111.509 171.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.98 -42.51 99.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.977 1.311 . . . . 0.0 113.614 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.6 tp -57.59 -46.32 84.16 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.521 0.728 . . . . 0.0 112.333 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.3 t -58.07 -45.08 87.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.566 0.746 . . . . 0.0 112.073 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.437 ' O ' HG13 ' A' ' 177' ' ' ILE . 29.3 m80 -54.98 -43.41 73.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 169.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.1 tp -64.89 -44.09 90.75 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.005 0.522 . . . . 0.0 111.723 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.19 -35.83 76.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.96 83.38 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 168.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 173' ' ' HIS . 10.5 mt -60.77 -45.29 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 173.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.66 -54.23 18.11 Favored Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.196 0.935 . . . . 0.0 113.266 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 183' ' ' ILE . 7.4 tt -50.73 -47.47 59.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 111.626 174.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -57.06 -56.16 26.51 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 124.3 1.0 . . . . 0.0 113.485 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.5 mt -53.58 -50.45 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.062 0.945 . . . . 0.0 110.178 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -50.13 -64.3 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.981 1.426 . . . . 0.0 112.268 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 179' ' ' LEU . 27.2 pt -59.73 -43.77 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.32 -53.68 23.02 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 125.654 1.597 . . . . 0.0 113.622 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 54.5 ttt-85 . . . . . 0 N--CA 1.476 0.834 0 O-C-N 124.417 0.716 . . . . 0.0 112.695 178.431 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 79.3 t80 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 25.3 mt -47.09 -45.56 52.93 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -52.19 -63.65 0.24 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.468 2.779 . . . . 0.0 114.753 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 96.3 p -55.89 -43.98 77.74 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.19 0.596 . . . . 0.0 111.951 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.0 tp -52.2 -57.42 9.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.839 1.656 . . . . 0.0 111.852 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tp -53.01 -59.06 5.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.878 1.271 . . . . 0.0 111.125 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 39.1 mt -51.65 -52.62 46.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.85 1.26 . . . . 0.0 113.548 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 24.4 t -59.62 -52.98 63.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.946 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -60.84 -41.47 95.89 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -38.39 86.71 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.27 -29.24 68.79 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 167.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.73 -44.56 85.63 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.863 0.727 . . . . 0.0 112.748 167.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.39 -43.25 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.884 0.873 . . . . 0.0 109.796 166.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -48.93 -61.92 4.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.491 1.52 . . . . 0.0 113.622 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.519 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 7.0 tp -53.17 -40.93 64.72 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.438 1.095 . . . . 0.0 112.07 172.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -52.0 -60.62 7.36 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.644 171.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.5 -31.84 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.482 0.713 . . . . 0.0 111.605 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.519 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 83.2 t80 -50.96 -52.41 42.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.407 0.683 . . . . 0.0 111.917 168.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt . . . . . 0 N--CA 1.484 1.251 0 C-N-CA 124.275 1.03 . . . . 0.0 109.765 174.372 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 117.59 -1.195 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.65 128.42 36.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.845 0.858 . . . . 0.0 110.619 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.0 t -136.83 43.28 2.41 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.821 1.296 . . . . 0.0 113.263 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.6 t -114.84 101.24 8.86 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.027 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.94 91.8 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 113.346 -1.752 . . . . 0.0 106.898 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 67.0 mtt -64.08 96.23 0.14 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 113.281 -1.781 . . . . 0.0 115.254 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -81.87 117.44 22.13 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.333 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -104.17 -69.63 0.8 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -169.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -162.05 -96.85 0.11 Allowed Glycine 0 N--CA 1.478 1.463 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' B' ' 165' ' ' PHE . . . 59.25 -117.42 11.0 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 162' ' ' LEU . 9.6 tp -106.24 108.7 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 113.814 -1.193 . . . . 0.0 110.069 175.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -63.67 -39.8 95.22 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 42.4 t -119.75 132.16 55.55 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.081 0.943 . . . . 0.0 113.159 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.39 -28.35 69.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 113.045 -1.889 . . . . 0.0 114.337 171.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 163' ' ' LYS . 23.2 mm-40 -64.79 -46.2 83.09 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.957 0.503 . . . . 0.0 112.144 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -60.06 -40.02 88.02 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.536 HD13 HG21 ' A' ' 156' ' ' ILE . 25.7 tp -58.36 -41.56 84.98 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.933 172.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 166' ' ' LEU . 64.4 mttp -55.69 -51.76 66.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.327 0.651 . . . . 0.0 112.169 171.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 92.9 t -52.6 -46.53 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 124.652 1.181 . . . . 0.0 111.798 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -77.12 -21.31 54.43 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 163' ' ' LYS . 24.9 mt -49.05 -40.48 45.49 Favored Pre-proline 0 N--CA 1.475 0.781 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -57.09 -56.96 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.483 2.122 . . . . 0.0 112.739 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.4 p -65.19 -35.6 81.59 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.92 -61.84 2.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.725 0.81 . . . . 0.0 111.922 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -45.43 73.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.837 0.855 . . . . 0.0 113.288 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.54 -53.82 53.8 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.662 0.601 . . . . 0.0 112.025 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.535 ' HA ' HD12 ' A' ' 175' ' ' LEU . 91.6 p -63.59 -42.13 98.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -64.69 -43.04 94.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.33 -41.66 97.39 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 172' ' ' SER . 85.0 mt -54.4 -50.52 67.37 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.579 0.752 . . . . 0.0 111.923 170.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.42 93.63 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.73 -50.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.483 0.713 . . . . 0.0 111.402 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.65 91.8 Favored Glycine 0 CA--C 1.545 1.943 0 O-C-N 123.687 0.617 . . . . 0.0 112.114 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 183' ' ' ILE . 38.1 tp -57.86 -44.1 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.522 -0.839 . . . . 0.0 111.897 173.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.02 92.85 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.84 0.733 . . . . 0.0 113.868 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.32 -47.0 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.954 0.901 . . . . 0.0 110.494 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.67 -46.13 89.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 113.027 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 179' ' ' LEU . 41.5 mm -59.49 -42.25 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.42 1.088 . . . . 0.0 111.577 173.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.19 55.36 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 124.092 0.853 . . . . 0.0 111.821 170.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -60.06 -45.52 92.6 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.437 ' HD3' ' HA ' ' A' ' 186' ' ' ARG . 29.5 mmt180 -64.53 -25.25 67.9 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.35 -23.86 63.82 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 170.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.4 t -111.59 -41.66 4.03 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.0 p -128.05 98.64 5.19 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.547 1.539 . . . . 0.0 110.07 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.432 ' HA ' HH11 ' A' ' 186' ' ' ARG . 26.0 t . . . . . 0 C--O 1.247 0.922 0 CA-C-O 116.865 -1.541 . . . . 0.0 109.38 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 116.846 -1.549 . . . . 0.0 107.704 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -94.59 -29.94 14.62 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 25.6 p -71.82 78.24 0.87 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 122.488 0.315 . . . . 0.0 110.195 164.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 47.7 t 177.08 149.18 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 110.315 -3.129 . . . . 0.0 106.9 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.57 103.09 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.838 0.828 . . . . 0.0 109.573 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 92.4 mtp -111.4 139.92 46.42 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.137 -1.392 . . . . 0.0 113.404 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -88.48 79.34 7.68 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -113.02 132.24 55.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.348 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -117.36 -94.45 1.76 Allowed Glycine 0 CA--C 1.535 1.328 0 O-C-N 125.939 2.024 . . . . 0.0 109.737 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.23 42.39 83.5 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 113.468 -1.366 . . . . 0.0 113.78 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 43.1 pt -71.21 159.09 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.031 1.332 . . . . 0.0 112.206 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -54.27 -61.51 2.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 24.6 t -113.98 101.34 9.16 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.366 1.079 . . . . 0.0 109.886 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.92 95.28 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 113.15 -1.841 . . . . 0.0 113.577 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.525 ' O ' HG22 ' B' ' 164' ' ' VAL . 4.9 pm0 -66.53 -49.0 67.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.556 1.942 . . . . 0.0 114.265 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.94 -57.06 13.18 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.7 31.73 0.3 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -127.09 -72.58 0.64 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.269 163.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.525 HG22 ' O ' ' B' ' 160' ' ' GLU . 34.9 m -60.94 -30.8 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -173.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.619 ' HB2' ' HA2' ' A' ' 155' ' ' GLY . 20.4 t80 -111.41 -4.31 14.92 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 26.6 tp -55.49 -44.03 99.44 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.117 -1.42 . . . . 0.0 114.822 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.79 -47.92 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.649 2.232 . . . . 0.0 113.488 172.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.456 ' HA ' HD12 ' B' ' 171' ' ' LEU . 68.4 m -57.12 -35.86 69.98 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.65 -56.26 23.63 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.021 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.39 -40.01 85.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 113.503 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' B' ' 168' ' ' SER . 85.6 mt -57.08 -43.85 82.55 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' B' ' 175' ' ' LEU . 57.7 p -68.76 -28.37 66.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -61.99 -45.03 95.42 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 67.2 mt -58.0 -45.27 87.12 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.405 0.682 . . . . 0.0 111.997 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' B' ' 172' ' ' SER . 1.0 OUTLIER -53.13 -50.98 63.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.079 1.352 . . . . 0.0 112.633 170.157 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.78 83.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.477 1.111 . . . . 0.0 113.753 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.59 -45.17 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 0.0 111.587 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.88 -49.05 73.83 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.611 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.89 -41.42 78.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 112.995 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.35 -47.01 78.0 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.99 1.281 . . . . 0.0 112.738 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.33 -42.34 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.394 0.677 . . . . 0.0 111.501 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.405 ' CZ ' ' HD3' ' B' ' 186' ' ' ARG . 40.1 t80 -63.99 -50.3 69.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.86 -33.53 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 117.972 0.351 . . . . 0.0 111.894 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' GLY . . . . . 0.409 ' HA2' HD12 ' B' ' 187' ' ' LEU . . . -54.87 -50.86 56.8 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 124.661 1.124 . . . . 0.0 112.884 170.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.666 HH21 ' HA ' ' B' ' 190' ' ' SER 0.288 14.8 ptm180 -67.98 -33.81 75.35 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.405 ' HD3' ' CZ ' ' B' ' 182' ' ' TYR . 14.2 mmm-85 -56.7 -34.66 67.65 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 173.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.409 HD12 ' HA2' ' B' ' 184' ' ' GLY . 53.6 mt -65.74 -24.79 67.04 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 171.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 47.9 p -117.05 -79.98 0.6 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.7 t -147.96 107.96 4.04 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.793 1.637 . . . . 0.0 110.066 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 190' ' ' SER . . . . . 0.666 ' HA ' HH21 ' B' ' 185' ' ' ARG . 32.1 t . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 116.405 -1.76 . . . . 0.0 113.858 -169.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -47.82 -46.37 30.76 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 167.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.6 p -98.63 109.84 22.54 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 123.427 1.584 . . . . 0.0 114.55 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 46.0 m -139.96 -176.36 4.56 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.242 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.65 92.83 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 170.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -85.54 50.86 2.04 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 122.322 1.058 . . . . 0.0 110.993 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -121.99 138.01 54.59 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -166.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -92.64 -39.97 11.01 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 112.464 -2.153 . . . . 0.0 110.78 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.78 -131.23 0.03 OUTLIER Glycine 0 CA--C 1.538 1.477 0 O-C-N 124.866 1.354 . . . . 0.0 112.605 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 171.86 83.87 0.06 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 tp -72.9 143.04 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 125.42 1.306 . . . . 0.0 114.166 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -60.6 -45.03 95.53 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.1 t -152.87 109.28 3.4 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.36 95.57 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.715 167.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -54.32 -49.21 70.23 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.195 0.598 . . . . 0.0 111.468 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.91 -52.02 66.82 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.62 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.88 -36.63 72.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -49.55 -56.89 8.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.617 1.167 . . . . 0.0 112.485 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.76 -42.46 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -56.01 -42.81 77.0 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.896 1.278 . . . . 0.0 114.403 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.74 -61.82 5.63 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 116.163 -1.875 . . . . 0.0 116.017 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -63.01 -37.57 52.28 Favored 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 122.559 2.173 . . . . 0.0 114.697 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 p -64.63 -46.33 83.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.11 -49.35 78.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 9.4 mt -49.78 -55.71 13.03 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.5 -37.6 81.6 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.6 p -55.36 -47.41 75.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -66.81 -45.35 78.64 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.404 0.681 . . . . 0.0 112.787 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.616 ' HA ' HD12 ' A' ' 177' ' ' ILE . 25.4 mt -49.39 -47.1 48.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 174.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.63 -37.12 85.05 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 173.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.39 -46.79 87.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.494 0.718 . . . . 0.0 112.523 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 174' ' ' LEU . 6.2 mt -60.37 -46.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.466 0.706 . . . . 0.0 109.738 172.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.27 -62.78 2.62 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 125.569 1.557 . . . . 0.0 111.887 171.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.5 tp -50.57 -46.95 57.98 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.402 1.081 . . . . 0.0 111.882 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.76 -63.33 3.56 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.55 1.156 . . . . 0.0 113.996 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.47 -46.43 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.579 0.352 . . . . 0.0 110.595 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -49.5 -58.61 4.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.76 1.224 . . . . 0.0 113.193 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.2 tp -68.32 -33.82 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.484 1.114 . . . . 0.0 113.849 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.56 -39.56 91.07 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 125.408 1.48 . . . . 0.0 115.11 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.46 ' HD2' HD22 ' B' ' 187' ' ' LEU . 23.5 mtp180 -60.49 -23.13 64.26 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 190' ' ' SER . 68.7 mtm-85 -112.91 -13.02 13.19 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 161.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.09 -56.53 19.84 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.402 HG21 ' HB2' ' B' ' 185' ' ' ARG . 40.0 p -69.74 -66.03 0.64 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 122.845 0.458 . . . . 0.0 111.756 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 60.9 p -122.11 143.09 49.75 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.309 1.043 . . . . 0.0 109.477 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 186' ' ' ARG . 93.0 p . . . . . 0 C--O 1.258 1.528 0 CA-C-O 117.542 -1.218 . . . . 0.0 111.129 -173.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -57.6 -40.54 79.32 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.831 1.957 . . . . 0.0 111.672 167.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.5 m -99.72 89.65 4.19 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 169.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 39.5 m -56.83 109.7 0.68 Allowed 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 113.42 -1.718 . . . . 0.0 111.977 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.64 119.27 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.74 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -115.48 -26.94 7.33 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.949 170.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -119.26 116.18 25.72 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 168.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.54 -51.43 56.63 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.817 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.18 78.03 0.74 Allowed Glycine 0 CA--C 1.536 1.366 0 O-C-N 125.393 1.683 . . . . 0.0 113.014 170.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.97 -53.75 0.53 Allowed Glycine 0 N--CA 1.484 1.853 0 CA-C-N 113.686 -1.257 . . . . 0.0 115.5 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -36.84 139.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.52 -57.3 4.54 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.351 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 16.5 t -135.49 97.02 3.57 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.486 1.136 . . . . 0.0 113.195 -172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.15 -58.36 8.97 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -171.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -63.58 -36.27 83.24 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -55.66 -56.16 23.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.595 1.158 . . . . 0.0 111.573 170.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 31.5 mt -59.36 -38.79 81.34 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.508 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -59.35 -55.79 30.29 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.94 -30.52 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -66.3 -46.36 77.21 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 43.4 mt -43.49 -52.99 12.52 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.57 -54.93 2.05 Favored 'Trans proline' 0 C--N 1.356 0.941 0 CA-C-N 122.913 2.076 . . . . 0.0 113.411 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 4.2 p -63.85 -36.28 83.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.91 1.284 . . . . 0.0 112.668 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 35.6 mt -55.5 -59.18 5.19 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 50.5 mt -51.14 -46.81 62.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.578 0.751 . . . . 0.0 112.893 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.29 -57.52 10.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.533 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 84.8 p -56.39 -44.22 80.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -61.34 -51.34 69.23 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 177' ' ' ILE . 3.8 mp -61.81 -39.79 92.99 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.1 -25.69 55.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.63 98.84 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.719 0.637 . . . . 0.0 111.284 165.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' B' ' 174' ' ' LEU . 30.5 mt -58.97 -54.93 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.145 0.903 . . . . 0.0 109.114 169.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.08 -61.18 3.19 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 125.188 1.375 . . . . 0.0 113.403 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 15.9 tp -55.73 -42.1 74.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.083 1.353 . . . . 0.0 112.185 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.633 ' HA2' HD12 ' B' ' 183' ' ' ILE . . . -56.43 -48.89 72.64 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.425 1.012 . . . . 0.0 112.994 171.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mt -57.9 -41.94 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.174 0.99 . . . . 0.0 110.778 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -55.87 -46.85 78.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.633 HD12 ' HA2' ' B' ' 180' ' ' GLY . 20.6 mt -58.18 -48.27 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.643 0.777 . . . . 0.0 109.886 172.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.52 -50.53 35.72 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 125.255 1.407 . . . . 0.0 112.984 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HB2' HG21 ' A' ' 188' ' ' THR . 16.9 ttt180 -54.55 -47.84 72.74 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.383 1.073 . . . . 0.0 111.695 173.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.474 ' HA ' ' HB2' ' B' ' 190' ' ' SER . 53.1 mtt-85 -61.04 -33.02 72.64 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.46 HD22 ' HD2' ' A' ' 185' ' ' ARG . 4.6 mp -59.18 -55.91 28.91 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 167.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 41.3 p -81.08 -37.85 28.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 -170.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 19.6 p -122.88 5.39 9.38 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 118.798 2.888 . . . . 0.0 118.798 -175.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 190' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' B' ' 186' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 117.574 -1.203 . . . . 0.0 109.702 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -139.08 136.46 35.24 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -160.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.6 m -63.54 115.56 4.79 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.313 1.054 . . . . 0.0 112.667 -171.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.4 p -135.29 113.39 11.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 112.501 -2.136 . . . . 0.0 111.554 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.93 112.48 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.926 -172.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.7 ttt -139.45 147.51 41.47 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.791 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -115.28 120.02 38.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.448 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -67.31 -22.65 65.61 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 117.737 2.495 . . . . 0.0 117.737 -170.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.76 172.36 33.17 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -161.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -136.25 -69.13 0.06 OUTLIER Glycine 0 N--CA 1.471 0.98 0 CA-C-O 121.63 0.572 . . . . 0.0 113.485 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.6 mt -70.95 126.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.459 1.123 . . . . 0.0 112.311 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' B' ' 161' ' ' PHE . 65.6 m-85 -104.23 -42.27 5.56 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.267 -1.788 . . . . 0.0 114.063 171.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -122.0 94.87 4.44 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.911 0.862 . . . . 0.0 110.933 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -51.8 -46.59 64.28 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.793 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -47.18 -51.58 18.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.568 1.947 . . . . 0.0 113.32 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.9 -58.18 5.96 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.97 1.308 . . . . 0.0 112.268 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.02 -25.65 68.22 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.508 ' HA ' HD12 ' A' ' 166' ' ' LEU . 96.6 mttt -75.87 -52.61 9.96 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.749 0.819 . . . . 0.0 112.1 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.34 -47.55 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 O-C-N 124.151 0.907 . . . . 0.0 108.807 173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -34.4 51.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 117.643 2.461 . . . . 0.0 117.643 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 163' ' ' LYS 0.293 2.2 mt -36.6 -46.46 1.48 Allowed Pre-proline 0 N--CA 1.481 1.12 0 N-CA-C 119.749 3.24 . . . . 0.0 119.749 -173.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -53.44 -65.57 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.297 2.665 . . . . 0.0 111.984 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.3 m -47.4 -45.04 24.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 47.3 mt -51.97 -64.44 0.82 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.215 -0.898 . . . . 0.0 112.057 173.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.5 mt -44.63 -59.22 2.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.356 1.462 . . . . 0.0 112.605 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.61 -48.42 81.86 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -60.28 -42.3 95.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -63.64 -48.69 76.22 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.444 HD23 HD12 ' A' ' 177' ' ' ILE . 31.7 mt -61.86 -34.27 75.68 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 -41.98 87.8 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.416 1.086 . . . . 0.0 113.153 166.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -67.52 -43.26 81.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.444 HD12 HD23 ' A' ' 174' ' ' LEU . 35.8 mt -59.25 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.017 0.527 . . . . 0.0 109.663 172.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.09 -55.16 16.27 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 124.8 1.19 . . . . 0.0 112.267 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.487 ' O ' HG12 ' A' ' 183' ' ' ILE . 46.3 tp -45.33 -57.97 3.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.124 1.37 . . . . 0.0 111.879 169.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -50.76 -48.67 43.48 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.846 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.9 mt -59.86 -58.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.436 0.694 . . . . 0.0 109.387 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 186' ' ' ARG . 72.8 t80 -47.65 -61.0 2.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.457 1.503 . . . . 0.0 112.621 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 179' ' ' LEU . 38.2 pt -64.45 -44.76 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.47 95.78 Favored Glycine 0 N--CA 1.479 1.564 0 C-N-CA 124.886 1.231 . . . . 0.0 112.405 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -66.1 -54.16 29.1 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.36 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 13.7 mtp180 -48.56 -33.68 10.1 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 tp -44.22 -41.39 5.78 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.613 1.965 . . . . 0.0 115.023 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 19.3 m -113.37 -21.85 10.7 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -172.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.6 p -109.93 160.78 16.1 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.986 0.914 . . . . 0.0 112.459 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -174.838 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -98.32 101.72 13.25 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.297 1.046 . . . . 0.0 111.668 -170.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 9.9 t -152.85 146.7 25.25 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.038 -1.892 . . . . 0.0 111.9 -164.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 8.5 p -72.73 71.51 1.01 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.712 1.72 . . . . 0.0 113.754 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . 0.262 1.9 m -91.3 115.94 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 113.603 -1.635 . . . . 0.0 114.431 -174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 31.6 tpp 65.01 -64.65 0.16 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.591 2.356 . . . . 0.0 110.314 -167.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.79 117.77 4.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.061 1.744 . . . . 0.0 111.476 173.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 46.84 27.38 0.69 Allowed 'General case' 0 C--O 1.163 -3.474 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -144.73 60.05 0.5 Allowed Glycine 1 C--N 1.4 4.103 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.761 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 92.1 -170.15 32.79 Favored Glycine 0 CA--C 1.545 1.965 0 O-C-N 124.863 0.978 . . . . 0.0 111.997 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 6.3 pt -152.32 158.68 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.881 1.272 . . . . 0.0 112.664 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.74 -35.9 81.28 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -60.39 93.4 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 123.462 1.601 . . . . 0.0 114.119 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.602 ' HB1' ' HE2' ' B' ' 163' ' ' LYS . . . -64.9 -35.76 82.19 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 111.687 -2.506 . . . . 0.0 109.282 170.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -53.08 -43.34 66.68 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 172.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 7.3 t80 -74.79 -48.35 25.85 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.046 173.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 69.4 mt -56.8 -43.26 80.78 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.602 ' HE2' ' HB1' ' B' ' 159' ' ' ALA . 66.4 mttm -62.35 -29.34 70.4 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.2 t -77.93 -53.62 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 121.432 0.634 . . . . 0.0 110.54 171.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -54.52 -49.06 71.13 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.812 1.245 . . . . 0.0 113.77 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.271 96.4 mt -62.64 -52.11 67.35 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 115.614 -2.136 . . . . 0.0 116.491 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -60.03 -43.28 37.42 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.41 2.073 . . . . 0.0 112.722 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 20.2 m -53.04 -55.22 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.155 0.909 . . . . 0.0 111.732 173.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 20.5 tp -52.79 -53.07 53.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.166 1.786 . . . . 0.0 112.488 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -50.92 -55.48 16.98 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' B' ' 174' ' ' LEU . 5.7 mp -61.37 -36.9 81.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.9 p -59.73 -39.29 84.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.772 1.026 . . . . 0.0 113.772 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -68.01 -43.08 79.63 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.91 0.756 . . . . 0.0 112.802 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' B' ' 171' ' ' LEU . 34.2 mt -59.07 -43.29 91.76 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.379 0.672 . . . . 0.0 111.045 172.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.71 -42.07 99.46 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.77 82.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 31.1 mt -59.09 -41.82 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.48 0.712 . . . . 0.0 110.298 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.95 -51.23 56.8 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 125.166 1.365 . . . . 0.0 114.212 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 13.1 tp -57.08 -45.69 83.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.573 0.749 . . . . 0.0 111.042 172.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -49.52 -59.41 7.22 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.335 169.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -51.11 -48.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.982 1.313 . . . . 0.0 112.98 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.546 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 36.6 t80 -40.99 -58.55 1.69 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.629 1.172 . . . . 0.0 112.876 168.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.78 -52.38 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.559 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.06 -57.64 8.63 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 125.298 1.428 . . . . 0.0 112.677 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -56.81 -49.46 75.3 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.151 1.38 . . . . 0.0 114.235 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -63.45 -37.55 87.71 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.37 -37.18 84.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.74 1.216 . . . . 0.0 113.588 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 33.6 p -84.35 -73.0 0.44 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 30.4 p -128.53 107.87 10.07 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.03 0.919 . . . . 0.0 109.877 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.477 0.924 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.639 -172.5 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -125.23 143.38 50.98 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.955 170.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.0 p -129.57 141.26 51.0 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.736 -167.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.5 t -93.75 128.84 40.17 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.65 113.15 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 166.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -65.48 -15.65 62.87 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 117.095 2.258 . . . . 0.0 117.095 -169.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -45.07 117.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -170.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttm 44.57 85.64 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 111.424 -2.625 . . . . 0.0 115.62 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.15 -108.59 0.02 OUTLIER Glycine 0 CA--C 1.534 1.254 0 CA-C-N 112.179 -2.282 . . . . 0.0 112.98 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.72 24.79 64.76 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 113.503 -1.349 . . . . 0.0 114.38 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.78 147.74 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -64.17 -71.44 0.18 Allowed 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.075 168.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.7 t -103.89 122.69 45.69 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.49 -34.89 31.05 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 113.554 -1.657 . . . . 0.0 112.236 168.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 14.9 mp0 -50.74 -53.33 32.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.587 1.555 . . . . 0.0 110.789 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -51.51 -57.79 8.09 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.387 1.075 . . . . 0.0 109.891 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 165' ' ' PHE . 80.5 mt -52.85 -42.34 65.11 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -61.75 -50.17 73.45 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 160' ' ' GLU . 0.7 OUTLIER -70.73 -36.73 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 122.046 0.927 . . . . 0.0 110.724 177.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 162' ' ' LEU . 46.4 t80 -54.74 -37.92 66.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.251 1.82 . . . . 0.0 113.565 173.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 13.0 tp -62.11 -49.83 83.09 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.302 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.95 -43.73 34.95 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.093 1.862 . . . . 0.0 112.774 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.3 t -58.71 -51.69 68.9 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.347 1.059 . . . . 0.0 112.568 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.46 -57.21 12.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.591 1.957 . . . . 0.0 111.547 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 mp -46.28 -61.97 1.55 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.288 1.435 . . . . 0.0 113.69 175.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.42 -35.31 79.99 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.213 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.2 p -60.77 -45.4 94.49 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -59.75 -45.69 91.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.14 -45.62 79.54 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.735 0.647 . . . . 0.0 112.271 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.18 -38.03 89.21 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.23 93.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.266 0.626 . . . . 0.0 111.812 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.414 HG13 ' HB1' ' B' ' 176' ' ' ALA . 42.4 mt -57.43 -47.71 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.176 170.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.17 -54.34 26.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.899 1.238 . . . . 0.0 114.084 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.6 tp -49.88 -49.84 48.04 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.09 -49.51 71.4 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.655 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.49 -47.06 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.382 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -54.03 -53.67 49.88 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.257 0.973 . . . . 0.0 112.096 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.7 mt -51.68 -56.56 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.506 1.122 . . . . 0.0 111.151 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.51 22.11 Favored Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.829 1.331 . . . . 0.0 113.459 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.435 ' HA ' HG21 ' B' ' 188' ' ' THR . 0.0 OUTLIER -47.7 -56.66 6.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.554 1.542 . . . . 0.0 111.611 171.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' A' ' 186' ' ' ARG . 31.1 tpt85 -62.69 -36.82 84.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -174.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.8 mt -49.85 -37.13 29.43 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 170.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.9 -45.99 5.26 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 26.0 p -128.62 132.74 48.16 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.022 0.915 . . . . 0.0 112.763 -173.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.259 1.6 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.006 178.636 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.005 -0.522 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -116.04 166.09 12.39 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 124.41 1.069 . . . . 0.0 111.545 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -126.94 171.69 11.09 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.506 2.323 . . . . 0.0 113.507 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 15.5 t 63.43 116.98 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 126.67 1.988 . . . . 0.0 113.268 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 21.4 t 70.93 135.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.936 2.094 . . . . 0.0 109.959 -172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.51 110.64 0.17 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -83.29 111.47 19.01 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.933 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' B' ' 156' ' ' ILE . 56.9 mtpt -116.64 106.82 13.96 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.53 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.48 -62.59 5.87 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-N 112.855 -1.975 . . . . 0.0 113.937 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.94 -91.84 0.02 OUTLIER Glycine 0 N--CA 1.476 1.343 0 C-N-CA 124.84 1.21 . . . . 0.0 110.436 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' ILE . . . . . 0.481 ' O ' ' HE2' ' B' ' 153' ' ' LYS . 2.0 pp -118.74 131.99 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 172.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.24 -55.26 34.05 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.66 168.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 9.2 t 172.28 141.53 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.247 1.819 . . . . 0.0 110.525 170.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.24 -43.26 52.92 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -60.99 -29.63 69.8 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -75.44 -42.1 54.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.025 0.93 . . . . 0.0 111.148 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 44.4 tp -67.56 -51.69 47.63 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.533 1.533 . . . . 0.0 114.8 173.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -89.88 -63.57 1.26 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.432 ' O ' ' HD2' ' B' ' 167' ' ' PRO . 97.3 t -69.91 -59.99 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -176.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -56.53 -46.08 80.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.255 4.8 mt -49.73 -60.78 4.4 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' B' ' 164' ' ' VAL . 52.4 Cg_exo -60.48 -53.26 3.0 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.351 2.701 . . . . 0.0 110.874 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 8.2 p -54.87 -44.3 73.93 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.84 -67.32 0.3 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.396 168.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.85 -50.22 57.23 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.62 -44.66 93.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.006 1.322 . . . . 0.0 114.322 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -61.13 -42.45 98.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.07 -45.47 94.61 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.3 tp -50.49 -54.5 21.79 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 0.0 112.652 170.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' B' ' 175' ' ' LEU . 12.1 tp -67.68 -29.6 68.91 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -63.4 -46.44 86.39 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.354 0.661 . . . . 0.0 112.758 170.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 33.9 mt -57.04 -48.23 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 170.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.59 -54.71 15.9 Favored Glycine 0 N--CA 1.482 1.714 0 C-N-CA 124.426 1.012 . . . . 0.0 113.024 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 12.9 tp -52.96 -49.21 66.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 111.233 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.49 -52.36 28.9 Favored Glycine 0 N--CA 1.482 1.723 0 O-C-N 124.253 0.97 . . . . 0.0 113.428 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.21 -51.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.896 0.878 . . . . 0.0 110.1 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 76.8 t80 -46.34 -56.29 6.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.783 1.233 . . . . 0.0 112.729 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.37 -61.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.138 1.375 . . . . 0.0 111.543 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.52 -52.18 29.69 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.514 1.531 . . . . 0.0 112.68 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.562 ' O ' HG22 ' B' ' 189' ' ' THR . 48.1 mtp180 -56.25 -59.84 4.37 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 117.562 -1.209 . . . . 0.0 110.71 173.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -45.78 -53.09 10.12 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 42.9 mt -56.67 -54.73 42.71 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 185' ' ' ARG . 71.6 p -78.92 -25.33 43.7 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 189' ' ' THR . . . . . 0.562 HG22 ' O ' ' B' ' 185' ' ' ARG . 5.0 t -99.95 145.35 27.94 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 117.26 -1.352 . . . . 0.0 111.578 177.98 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -108.35 123.98 49.66 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -165.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.522 ' O ' ' HB3' ' B' ' 149' ' ' SER . 9.9 p -107.74 169.98 8.26 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.4 m -114.76 54.98 0.76 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.961 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.547 HG23 HG12 ' B' ' 150' ' ' VAL . 12.2 m -77.16 142.13 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.15 91.68 8.8 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.271 1.034 . . . . 0.0 113.562 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 155' ' ' GLY . 13.8 tppt? -142.87 128.67 19.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 111.417 -2.629 . . . . 0.0 112.058 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -100.32 -28.15 13.11 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 113.332 -1.758 . . . . 0.0 114.473 168.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.55 -107.26 0.53 Allowed Glycine 0 N--CA 1.48 1.622 0 C-N-CA 124.401 1.001 . . . . 0.0 114.852 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' B' ' 158' ' ' SER . . . -140.27 -123.95 2.05 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 124.286 0.946 . . . . 0.0 113.116 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.0 pp -49.81 147.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -79.22 -39.39 33.32 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.381 170.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.2 t -112.66 138.28 49.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.75 1.22 . . . . 0.0 111.418 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.48 9.47 3.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.612 -1.631 . . . . 0.0 113.832 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -55.63 -46.92 77.35 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.437 171.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 165' ' ' PHE . 60.3 t80 -43.87 -56.59 3.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.878 1.271 . . . . 0.0 113.172 168.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 78.3 mt -64.21 -41.23 97.13 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.041 1.337 . . . . 0.0 113.838 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -73.41 -37.67 65.86 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.1 m -76.17 -27.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 1.9 t80 -48.32 -50.62 29.51 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.784 1.633 . . . . 0.0 111.692 171.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.0 mt -58.4 -49.16 95.07 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 116.666 -1.635 . . . . 0.0 115.37 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.71 -50.51 7.78 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.313 2.009 . . . . 0.0 112.294 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.2 m -50.56 -45.5 57.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.854 0.861 . . . . 0.0 112.408 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -66.68 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.683 1.593 . . . . 0.0 111.724 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pp -62.24 -43.8 97.99 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 mt -57.72 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.45 0.7 . . . . 0.0 112.344 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.5 p -63.55 -40.12 96.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -56.48 -51.13 69.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.6 mt -54.83 -51.43 65.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 112.633 172.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.0 mt -55.76 -43.28 76.54 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.711 1.204 . . . . 0.0 114.222 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.415 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -55.26 -47.35 75.58 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.33 1.452 . . . . 0.0 113.643 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.1 mt -61.21 -41.1 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.81 . . . . 0.0 111.131 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -57.71 14.82 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 124.154 0.909 . . . . 0.0 112.3 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 182' ' ' TYR . 15.3 tp -48.67 -46.01 39.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.349 1.059 . . . . 0.0 111.827 172.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.85 -57.54 10.77 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.977 1.275 . . . . 0.0 113.548 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 33.7 mt -53.56 -43.93 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.654 1.182 . . . . 0.0 111.828 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 179' ' ' LEU . 88.6 t80 -51.83 -54.11 32.62 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.044 0.84 . . . . 0.0 112.376 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.6 mt -56.54 -54.45 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.278 1.031 . . . . 0.0 109.863 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -44.34 -60.6 3.56 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 125.773 1.654 . . . . 0.0 112.577 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -65.8 -36.26 83.01 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.4 -42.12 98.23 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 29.9 mt -59.81 -44.21 94.1 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.702 0.801 . . . . 0.0 111.672 171.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.0 m -60.8 -48.92 79.6 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.828 0.705 . . . . 0.0 112.69 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 27.4 p -109.33 53.88 0.67 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.253 1.255 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.021 174.955 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -119.95 132.6 55.56 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 11.7 t -159.14 121.77 3.58 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 148' ' ' THR . 10.3 t 175.59 140.94 0.06 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.691 1.996 . . . . 0.0 110.948 161.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' B' ' 157' ' ' PHE . 28.0 m -100.89 134.23 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -175.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 59.83 -47.79 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.31 2.244 . . . . 0.0 115.31 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -120.98 162.47 19.86 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.311 1.444 . . . . 0.0 108.706 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -78.73 -2.65 40.37 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -126.66 81.14 0.36 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.601 162.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -160.18 127.2 1.75 Allowed Glycine 0 N--CA 1.48 1.588 0 C-N-CA 124.336 0.97 . . . . 0.0 111.868 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 pt -59.49 121.78 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.585 ' HA ' HG13 ' B' ' 150' ' ' VAL . 59.2 t80 -54.81 -54.39 42.8 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.869 -1.059 . . . . 0.0 112.817 -174.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.631 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 72.8 m -79.55 62.77 3.95 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 123.1 1.429 . . . . 0.0 110.635 173.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -45.74 -52.68 10.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.911 2.084 . . . . 0.0 115.19 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.53 -25.17 16.95 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.693 172.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -95.77 48.7 1.14 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -170.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 75.7 mt -139.55 82.31 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.443 171.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -148.22 -39.97 0.17 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 162.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 t -113.42 -53.79 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -159.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -51.43 -70.18 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -170.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 21.7 tp -44.47 -51.65 19.72 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 116.163 -1.875 . . . . 0.0 115.575 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -56.2 -52.45 7.18 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.451 2.101 . . . . 0.0 112.761 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 25.6 p -61.74 -35.22 77.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 52.5 mt -54.82 -64.15 0.93 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 117.726 -1.13 . . . . 0.0 112.291 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.514 ' O ' HD12 ' B' ' 174' ' ' LEU . 19.1 mt -51.78 -50.04 61.49 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.198 0.999 . . . . 0.0 112.794 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 36.0 tp -53.31 -54.68 32.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.591 1.556 . . . . 0.0 112.737 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' SER . . . . . 0.544 ' HA ' HD12 ' B' ' 175' ' ' LEU . 76.8 p -63.66 -31.62 72.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -59.63 -49.4 77.89 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.532 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' LEU . . . . . 0.514 HD12 ' O ' ' B' ' 170' ' ' LEU . 0.5 OUTLIER -56.41 -43.61 79.52 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 172.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' B' ' 172' ' ' SER . 79.4 mt -54.99 -51.62 65.65 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.647 0.779 . . . . 0.0 112.828 170.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.45 -47.29 86.77 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.114 1.366 . . . . 0.0 114.118 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.415 HG13 ' HB1' ' A' ' 176' ' ' ALA . 26.0 mt -58.92 -49.11 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.162 0.585 . . . . 0.0 109.448 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.93 10.44 Favored Glycine 0 N--CA 1.483 1.823 0 O-C-N 124.665 1.228 . . . . 0.0 112.538 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.78 -45.94 70.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.885 1.274 . . . . 0.0 112.514 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -49.93 62.04 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 124.735 1.16 . . . . 0.0 113.123 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 177' ' ' ILE . 17.7 mt -60.61 -48.62 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.076 0.95 . . . . 0.0 109.152 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' B' ' 186' ' ' ARG . 28.1 t80 -40.89 -59.65 1.38 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.101 1.36 . . . . 0.0 112.273 169.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 70.4 mt -57.27 -54.73 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.829 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.07 -31.66 18.84 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 126.206 1.86 . . . . 0.0 116.191 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 14.6 tpt85 -99.22 -41.67 7.38 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' B' ' 182' ' ' TYR . 8.4 tpt180 -51.34 -38.99 56.08 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 -169.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.23 -44.1 71.43 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 124.565 1.166 . . . . 0.0 112.985 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 22.5 m -82.29 -41.08 20.6 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.182 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 3.0 m -106.04 70.21 0.84 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.387 1.089 . . . . 0.0 112.775 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.245 0.838 0 CA-C-N 112.186 -2.279 . . . . 0.0 106.172 165.247 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -104.06 118.85 37.65 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.379 1.049 . . . . 0.0 110.153 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 p -45.9 -27.13 0.81 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.1 m -41.3 112.88 0.34 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.194 1.397 . . . . 0.0 114.424 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . 0.351 12.6 m 36.95 50.24 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.278 2.558 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -173.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.609 ' HG3' ' HB2' ' B' ' 149' ' ' SER . 11.1 mmt -76.3 83.19 3.07 Favored 'General case' 0 C--O 1.275 2.423 0 C-N-CA 125.098 1.359 . . . . 0.0 109.077 166.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 158' ' ' SER . 29.7 mttm -37.84 -62.81 0.52 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 127.824 2.45 . . . . 0.0 114.389 -169.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -112.22 80.81 1.38 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 124.137 0.898 . . . . 0.0 109.98 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 119.49 96.82 1.68 Allowed Glycine 0 CA--C 1.542 1.721 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.545 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.89 -62.04 0.58 Allowed Glycine 0 N--CA 1.48 1.605 0 CA-C-N 114.068 -1.066 . . . . 0.0 111.725 -171.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 pt -94.86 174.2 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.814 -0.693 . . . . 0.0 110.571 170.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -73.32 100.08 3.07 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 169.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 24.2 t -16.2 125.07 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 112.499 -2.137 . . . . 0.0 116.39 -172.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.623 ' HA ' HD12 ' A' ' 162' ' ' LEU . . . -50.1 -47.36 53.89 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.559 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 164' ' ' VAL . 30.8 mt-10 -56.64 -48.26 77.93 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 171.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 158' ' ' SER . 41.9 m-85 -66.78 -34.3 77.53 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' A' ' 159' ' ' ALA . 80.0 mt -53.77 -47.13 71.02 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.875 0.87 . . . . 0.0 111.17 166.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -64.86 -42.69 94.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.225 1.01 . . . . 0.0 113.451 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 160' ' ' GLU . 59.6 t -58.68 -39.8 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.571 0.748 . . . . 0.0 110.541 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -60.24 -23.69 64.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.068 1.347 . . . . 0.0 114.232 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 39.4 mt -43.57 -47.68 18.81 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 164' ' ' VAL . 84.9 Cg_exo -65.32 -58.45 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.904 1.736 . . . . 0.0 112.598 168.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 m -43.57 -44.77 6.35 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.6 tp -44.62 -67.59 0.27 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.237 2.215 . . . . 0.0 112.31 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 mp -71.26 -37.86 71.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.409 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.7 mt -49.1 -57.44 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.132 0.895 . . . . 0.0 111.334 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.5 t -54.05 -58.94 5.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.129 1.371 . . . . 0.0 111.697 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -50.35 -68.54 0.16 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.27 -55.23 35.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.26 -48.09 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.457 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -66.68 -39.09 87.99 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.509 HG13 ' HB1' ' B' ' 176' ' ' ALA . 56.5 mt -55.86 -45.21 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.985 0.514 . . . . 0.0 110.689 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.11 -53.33 41.09 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 124.227 0.918 . . . . 0.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 16.7 tp -52.77 -47.22 67.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.563 0.745 . . . . 0.0 112.32 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.622 ' HA2' HD12 ' A' ' 183' ' ' ILE . . . -54.1 -51.79 47.94 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.868 173.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.7 mt -48.56 -46.0 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.159 0.983 . . . . 0.0 113.132 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -53.71 -56.28 18.74 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.658 0.599 . . . . 0.0 112.308 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.622 HD12 ' HA2' ' A' ' 180' ' ' GLY . 23.0 mt -50.59 -53.37 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.875 1.27 . . . . 0.0 110.326 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.81 -59.84 9.66 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 124.738 1.161 . . . . 0.0 112.278 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -49.06 -52.97 22.42 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.552 1.541 . . . . 0.0 112.69 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -53.94 -36.56 62.93 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.216 1.806 . . . . 0.0 114.266 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.3 mt -57.51 -39.71 77.11 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.57 -34.24 23.24 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 4.7 p -127.36 127.37 44.13 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 117.34 -1.314 . . . . 0.0 112.639 -173.404 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 119.425 -0.322 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 147' ' ' ASN . . . . . 0.509 ' OD1' ' HB2' ' A' ' 152' ' ' LYS . 12.7 t30 -130.52 -49.8 1.07 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 31.0 m -132.45 115.26 15.32 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' SER . . . . . 0.609 ' HB2' ' HG3' ' A' ' 151' ' ' MET . 5.1 t -109.76 -45.05 3.72 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 113.517 -1.674 . . . . 0.0 110.631 169.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.33 118.18 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.26 91.64 6.84 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.123 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.594 ' HD2' ' HG3' ' B' ' 160' ' ' GLU . 53.3 mmtt -70.68 95.92 1.16 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -103.78 152.31 22.03 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 110.963 -2.835 . . . . 0.0 110.913 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 74.61 -88.18 0.73 Allowed Glycine 0 N--CA 1.479 1.508 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.18 74.0 0.39 Allowed Glycine 0 N--CA 1.479 1.501 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 160.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.8 156.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 113.387 -1.406 . . . . 0.0 113.602 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -43.61 -56.25 3.83 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -163.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.421 ' O ' HD12 ' B' ' 162' ' ' LEU . 29.2 p -50.5 -54.28 23.55 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.57 1.148 . . . . 0.0 112.773 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.16 -54.77 35.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.512 1.525 . . . . 0.0 112.898 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.594 ' HG3' ' HD2' ' B' ' 152' ' ' LYS . 11.7 mm-40 -56.14 -41.75 75.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.277 1.031 . . . . 0.0 113.439 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 158' ' ' SER . 27.1 m-85 -78.39 -34.72 47.94 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.421 HD12 ' O ' ' B' ' 158' ' ' SER . 0.4 OUTLIER -56.86 -44.38 82.12 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.448 0.567 . . . . 0.0 111.394 161.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -83.08 13.39 4.11 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.8 t -106.58 -40.3 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 153.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -49.48 -62.55 1.49 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.359 1.464 . . . . 0.0 112.073 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.34 -41.62 61.2 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.145 -1.407 . . . . 0.0 114.345 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -51.49 -52.77 8.31 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.868 2.379 . . . . 0.0 114.32 165.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -59.66 -40.45 87.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.179 0.992 . . . . 0.0 113.432 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.16 -44.89 95.61 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.524 0.73 . . . . 0.0 112.414 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.19 -51.37 70.01 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.785 0.834 . . . . 0.0 112.087 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 25.6 tp -49.03 -53.48 19.94 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.592 1.557 . . . . 0.0 111.826 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 33.3 t -54.81 -57.29 12.17 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.909 1.284 . . . . 0.0 112.192 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -47.41 -52.39 17.01 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.358 1.063 . . . . 0.0 113.245 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.28 -50.37 73.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 47.5 mt -71.49 -32.31 68.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.509 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -66.47 -47.46 72.99 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.585 0.754 . . . . 0.0 111.615 169.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.457 HG13 ' HB1' ' A' ' 176' ' ' ALA . 23.2 mt -50.23 -53.59 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.179 1.392 . . . . 0.0 110.787 167.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.07 -60.21 4.64 Favored Glycine 0 N--CA 1.483 1.814 0 O-C-N 124.415 1.072 . . . . 0.0 113.286 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 15.4 tp -50.95 -46.34 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.606 1.162 . . . . 0.0 112.225 173.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.22 -53.33 43.56 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 124.773 1.178 . . . . 0.0 113.63 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 23.2 mt -53.31 -46.8 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.862 0.865 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 22.0 t80 -49.44 -59.63 3.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.835 1.654 . . . . 0.0 113.449 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.73 -49.9 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 121.632 0.73 . . . . 0.0 111.651 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.0 -48.27 46.31 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.719 1.628 . . . . 0.0 113.529 -178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -58.69 -33.31 70.01 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 114.249 1.204 . . . . 0.0 114.249 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.31 -50.5 10.09 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . 0.285 91.4 mt 6.47 -73.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 120.898 3.666 . . . . 0.0 120.898 -167.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.0 p -64.51 -44.41 91.0 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 39.5 p -90.52 58.4 3.95 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 123.17 1.462 . . . . 0.0 112.538 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 C--O 1.25 1.079 0 CA-C-N 112.726 -2.034 . . . . 0.0 107.987 -178.782 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 22.8 ttt-85 . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 21.4 78.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 127.245 2.218 . . . . 0.0 116.291 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.431 ' HB ' HG22 ' A' ' 150' ' ' VAL . 17.8 p -105.63 166.06 10.72 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -168.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.13 69.55 1.44 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.491 164.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.638 HG23 ' HE2' ' A' ' 152' ' ' LYS . 20.1 m -126.59 115.79 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.712 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 23.1 mmt -15.37 99.11 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.638 ' HE2' HG23 ' A' ' 150' ' ' VAL . 71.9 mmtt -118.52 93.46 4.12 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 123.179 1.466 . . . . 0.0 112.871 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -115.82 100.5 8.05 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 113.209 -1.814 . . . . 0.0 107.382 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -80.21 -113.16 0.28 Allowed Glycine 0 N--CA 1.473 1.157 0 CA-C-N 113.299 -1.773 . . . . 0.0 108.989 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -177.37 -140.99 3.88 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-N 114.221 -0.989 . . . . 0.0 112.118 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.43 ' HB ' ' H ' ' A' ' 157' ' ' PHE . 9.6 pt -134.88 -148.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 113.386 -1.407 . . . . 0.0 110.757 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' H ' ' HB ' ' A' ' 156' ' ' ILE . 38.6 t80 -96.11 -59.79 1.77 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.837 0.289 . . . . 0.0 111.268 172.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.5 t -93.47 102.67 14.9 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.894 1.33 . . . . 0.0 112.634 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.73 -30.83 70.22 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 112.831 -1.986 . . . . 0.0 113.047 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -73.22 -32.01 64.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.316 1.046 . . . . 0.0 113.171 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -66.96 -45.54 77.43 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.647 166.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.0 tp -54.57 -37.05 65.02 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -56.75 -33.05 66.18 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.747 1.619 . . . . 0.0 114.668 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.3 -40.61 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -48.42 -60.51 2.62 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 166' ' ' LEU 0.27 36.0 mt -54.12 -55.03 40.84 Favored Pre-proline 0 N--CA 1.482 1.125 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.646 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -46.96 -52.09 8.26 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.12 2.547 . . . . 0.0 114.237 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.1 p -66.12 -47.2 74.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.14 -58.4 6.24 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.102 0.961 . . . . 0.0 110.999 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.6 mt -54.29 -52.74 60.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.631 1.172 . . . . 0.0 112.704 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.4 tp -55.15 -51.84 65.2 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.174 0.99 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.8 p -57.05 -39.7 75.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -63.27 -48.09 79.62 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 177' ' ' ILE . 14.6 tp -58.76 -45.31 90.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.575 0.75 . . . . 0.0 112.394 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.46 -35.62 81.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -61.97 -42.12 98.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.333 0.653 . . . . 0.0 112.422 172.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 174' ' ' LEU . 27.2 mt -59.33 -49.57 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 169.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -47.75 -55.78 9.31 Favored Glycine 0 CA--C 1.546 2.008 0 C-N-CA 124.952 1.263 . . . . 0.0 113.091 174.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 55.9 tp -45.74 -56.76 4.9 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.296 1.439 . . . . 0.0 112.697 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.52 -48.24 55.66 Favored Glycine 0 CA--C 1.541 1.689 0 O-C-N 124.533 1.146 . . . . 0.0 113.756 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.407 HD12 ' HA2' ' A' ' 178' ' ' GLY . 27.0 mt -57.54 -50.78 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.96 0.504 . . . . 0.0 110.11 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -53.74 -54.79 33.16 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.704 1.253 . . . . 0.0 112.427 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.6 mt -53.85 -56.38 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.318 0.647 . . . . 0.0 111.356 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -46.76 -58.26 6.22 Favored Glycine 0 N--CA 1.487 2.036 0 O-C-N 124.481 1.113 . . . . 0.0 112.168 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.72 -52.02 54.62 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -55.15 -43.26 74.04 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.55 -47.48 85.38 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.932 0.77 . . . . 0.0 111.997 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 92.1 m -63.21 -39.38 94.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.947 0.499 . . . . 0.0 111.941 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.5 p -96.84 52.96 1.2 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.516 0.51 . . . . 0.0 112.237 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 126.81 2.044 . . . . 0.0 111.955 172.844 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 . . . . . 0 C--O 1.24 0.586 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -81.96 73.17 9.02 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.043 0.925 . . . . 0.0 109.383 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.3 m -88.51 131.64 34.83 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.808 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 58.8 m -50.71 -50.76 54.43 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.894 -1.503 . . . . 0.0 114.713 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.01 78.8 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 122.15 0.976 . . . . 0.0 110.663 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 30.8 mtt -137.37 134.67 36.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.821 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -54.24 -54.13 44.19 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -171.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -98.61 -43.1 6.97 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.384 0.428 . . . . 0.0 110.199 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -42.22 -67.9 0.8 Allowed Glycine 0 N--CA 1.476 1.365 0 C-N-CA 126.189 1.852 . . . . 0.0 115.226 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -111.42 -110.16 3.14 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.31 149.91 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.707 1.603 . . . . 0.0 113.985 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -74.33 -43.98 54.37 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.114 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 25.9 t -136.42 138.82 41.92 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.29 -43.86 85.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.943 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -48.03 -49.14 32.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.692 0.797 . . . . 0.0 112.812 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -63.34 -44.22 95.49 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.704 0.802 . . . . 0.0 112.416 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 40.8 tp -52.68 -45.83 66.97 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -64.25 -16.55 62.3 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' B' ' 168' ' ' SER . 7.3 t -93.47 -48.65 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 124.477 1.11 . . . . 0.0 109.291 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -36.4 -71.79 0.07 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -47.88 97.67 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.1 -52.86 6.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.75 2.3 . . . . 0.0 112.992 170.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.403 ' HB2' HG12 ' B' ' 164' ' ' VAL . 19.5 t -52.09 -48.99 64.44 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.182 0.993 . . . . 0.0 111.864 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.9 mp -55.34 -65.45 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.907 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mt -41.08 -61.5 0.99 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.363 1.465 . . . . 0.0 114.921 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' B' ' 174' ' ' LEU . 54.2 mt -62.79 -36.73 84.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -77.7 -34.37 52.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -67.3 -40.15 86.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' B' ' 171' ' ' LEU . 70.1 mt -53.81 -53.16 56.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 0.0 111.929 168.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 7.7 mt -48.48 -47.93 38.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.233 1.013 . . . . 0.0 113.237 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.416 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -57.73 -52.01 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.497 HG13 ' HB1' ' A' ' 176' ' ' ALA . 29.0 mt -61.28 -42.33 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.31 0.644 . . . . 0.0 110.636 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.99 -51.48 55.24 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.848 1.213 . . . . 0.0 112.831 173.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.35 -44.34 44.59 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.43 -57.36 19.0 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.456 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -47.76 -52.2 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.947 1.299 . . . . 0.0 110.971 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.61 -50.15 25.07 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.942 0.897 . . . . 0.0 113.227 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.467 ' HA ' ' HB3' ' B' ' 187' ' ' LEU . 19.1 mt -61.63 -63.58 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.913 0.485 . . . . 0.0 110.563 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.09 -54.66 5.2 Favored Glycine 0 N--CA 1.474 1.219 0 C-N-CA 126.297 1.903 . . . . 0.0 114.162 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -96.55 -81.29 0.42 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.818 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -50.21 -56.69 10.02 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -166.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.467 ' HB3' ' HA ' ' B' ' 183' ' ' ILE . 5.7 tt -62.48 -40.89 98.14 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.581 1.152 . . . . 0.0 111.719 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.402 HG23 ' O ' ' B' ' 183' ' ' ILE . 31.6 p -63.7 -52.37 60.89 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 117.4 -1.286 . . . . 0.0 110.687 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 69.0 p -79.01 26.71 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.483 1.219 0 C-N-CA 123.258 0.623 . . . . 0.0 110.263 175.843 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.554 HH11 ' HA ' ' B' ' 150' ' ' VAL . 79.6 mtt85 . . . . . 0 C--O 1.254 1.334 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.96 173.36 0.79 Allowed 'General case' 0 C--O 1.175 -2.854 0 CA-C-O 124.344 2.021 . . . . 0.0 110.369 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' B' ' 158' ' ' SER . 18.7 p -46.05 127.7 8.66 Favored 'General case' 0 C--N 1.376 1.725 0 CA-C-N 110.686 -2.961 . . . . 0.0 118.663 -174.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -55.68 140.47 41.36 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 129.082 2.953 . . . . 0.0 111.398 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.37 97.29 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.937 1.351 . . . . 0.0 109.785 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 43.8 mtt -115.31 48.01 1.23 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.307 -165.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 21.1 tptp -54.18 -53.08 58.31 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -174.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -86.93 -52.25 5.57 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.126 166.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -80.03 63.87 4.02 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-O 118.553 -1.137 . . . . 0.0 115.059 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.99 -75.66 1.04 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 124.778 1.18 . . . . 0.0 111.548 -173.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.53 87.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 123.444 1.592 . . . . 0.0 107.015 164.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -47.65 -36.94 11.78 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 127.258 2.223 . . . . 0.0 116.605 -164.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.2 p -160.56 145.06 14.19 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.932 1.395 . . . . 0.0 113.485 173.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.38 -29.0 70.08 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.358 -1.292 . . . . 0.0 113.365 163.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 163' ' ' LYS . 43.2 tt0 -45.67 -53.78 8.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.387 1.475 . . . . 0.0 110.83 170.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -44.44 -59.85 2.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.016 1.326 . . . . 0.0 113.269 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 mt -54.09 -55.04 31.39 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 46.2 pttt -57.7 -43.75 85.38 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 124.064 0.853 . . . . 0.0 112.863 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 p -76.72 -22.05 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -98.01 7.36 46.44 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 169' ' ' LEU 0.285 35.7 mt -49.79 -26.64 1.02 Allowed Pre-proline 0 N--CA 1.483 1.176 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 177.229 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -51.96 -71.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 121.518 1.479 . . . . 0.0 112.125 164.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 p -55.78 -42.31 75.36 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 47.1 mt -56.35 -61.36 2.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.49 -17.74 62.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.98 -41.04 82.94 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 165.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 175' ' ' LEU . 6.9 p -61.68 -34.39 75.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 169.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -72.93 -38.47 66.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 118.28 -0.867 . . . . 0.0 113.211 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.6 tp -51.81 -47.01 64.49 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.649 0.593 . . . . 0.0 111.555 168.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 172' ' ' SER . 94.5 mt -49.62 -56.69 9.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.834 0.709 . . . . 0.0 112.436 168.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.52 -52.6 63.13 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.42 HG13 ' HB1' ' B' ' 176' ' ' ALA . 30.2 mt -56.04 -47.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.369 1.067 . . . . 0.0 110.357 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.15 -57.39 10.18 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.912 1.244 . . . . 0.0 112.724 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 30.0 tp -53.11 -45.96 68.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.221 1.009 . . . . 0.0 112.499 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.66 -56.07 6.72 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 125.233 1.397 . . . . 0.0 113.822 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.8 mt -59.32 -53.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.314 -0.943 . . . . 0.0 109.565 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -51.84 -58.24 7.02 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.559 -1.2 . . . . 0.0 113.101 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 184' ' ' GLY 0.256 2.9 pp -60.79 -38.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.05 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 183' ' ' ILE . . . -59.58 -47.61 90.05 Favored Glycine 0 N--CA 1.481 1.689 0 C-N-CA 123.83 0.728 . . . . 0.0 112.943 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -59.02 -50.84 72.56 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.213 -0.994 . . . . 0.0 111.83 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -54.24 -51.05 65.72 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.405 1.082 . . . . 0.0 113.336 175.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.39 -33.87 75.61 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 26.4 p -84.02 -58.09 2.92 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.301 1.0 . . . . 0.0 111.891 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 12.1 t -110.47 125.13 52.97 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.256 1.435 0 C-N-CA 131.519 3.928 . . . . 0.0 106.248 -178.919 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -82.6 142.02 32.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.524 HG22 ' HD3' ' B' ' 153' ' ' LYS . 82.3 p -67.65 -23.41 65.33 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 112.837 -1.983 . . . . 0.0 114.18 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 27.3 m -62.97 -43.73 98.0 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.554 ' HA ' HH11 ' A' ' 146' ' ' ARG . 58.0 t -82.9 -40.95 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.565 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 68.9 mtm -58.98 160.68 5.72 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.458 1.098 . . . . 0.0 111.544 169.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -101.1 68.17 1.23 Allowed 'General case' 0 C--O 1.201 -1.495 0 CA-C-O 124.301 2.0 . . . . 0.0 112.279 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' LYS . . . . . 0.524 ' HD3' HG22 ' B' ' 148' ' ' THR . 80.0 tttt -135.61 118.3 16.04 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 110.239 -3.164 . . . . 0.0 110.391 -174.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.53 77.96 0.26 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 112.986 -1.915 . . . . 0.0 108.723 172.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.74 -57.14 5.05 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 124.332 0.968 . . . . 0.0 111.522 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' ILE . . . . . 0.404 HG12 HD11 ' B' ' 162' ' ' LEU . 1.4 pp -116.0 156.09 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 112.342 -1.929 . . . . 0.0 109.926 171.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -67.76 -45.02 76.1 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' B' ' 161' ' ' PHE . 39.6 t -151.77 139.94 20.26 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.74 -55.07 38.91 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.707 170.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -47.47 -50.3 23.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.582 1.553 . . . . 0.0 112.53 172.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' B' ' 158' ' ' SER . 32.4 t80 -52.49 -56.42 15.27 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.491 1.119 . . . . 0.0 112.628 175.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.404 HD11 HG12 ' B' ' 156' ' ' ILE . 25.4 mt -55.91 -48.97 74.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -54.19 -29.74 47.08 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.71 -38.62 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -82.34 -43.44 17.43 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -172.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' B' ' 169' ' ' LEU . 54.3 tp -54.91 -42.29 94.85 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.226 -1.369 . . . . 0.0 113.479 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -54.09 -51.84 9.72 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.132 1.888 . . . . 0.0 113.504 168.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 41.4 m -53.15 -48.67 67.76 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' B' ' 166' ' ' LEU . 80.4 mt -50.71 -59.89 3.61 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.665 170.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.0 mt -50.64 -57.91 7.1 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.99 -52.85 47.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.794 0.837 . . . . 0.0 113.164 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 60.5 p -66.77 -42.52 85.96 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -63.9 -43.38 96.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.74 -47.46 79.98 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 170.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 39.0 mt -56.68 -42.55 79.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 170.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.42 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -65.17 -43.65 91.02 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 175.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 44.0 mt -55.37 -47.48 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 168.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.38 -53.57 23.75 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.52 1.057 . . . . 0.0 113.014 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.25 -41.75 69.14 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.79 -54.11 29.84 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.153 0.882 . . . . 0.0 112.42 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 13.2 mt -53.8 -54.32 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.614 1.166 . . . . 0.0 110.531 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -49.52 -50.95 39.65 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.193 1.797 . . . . 0.0 113.97 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.6 tp -68.13 -38.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.92 -43.43 87.6 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 170.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.522 HH21 ' HA ' ' B' ' 190' ' ' SER . 35.1 mtp180 -61.54 -36.73 81.41 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -58.8 -60.84 3.19 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.845 0.716 . . . . 0.0 112.767 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.02 -61.22 2.28 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 13.1 p -126.97 -39.81 1.92 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -169.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 15.6 m -114.24 94.99 5.05 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -167.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 190' ' ' SER . . . . . 0.522 ' HA ' HH21 ' B' ' 185' ' ' ARG . 2.5 m . . . . . 0 N--CA 1.48 1.032 0 CA-C-N 112.225 -2.261 . . . . 0.0 110.392 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -91.38 141.68 28.5 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-O 121.642 0.734 . . . . 0.0 110.731 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.6 p -76.82 51.34 0.77 Allowed 'General case' 0 C--O 1.154 -3.942 0 CA-C-O 124.628 2.156 . . . . 0.0 115.748 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.9 m -51.35 115.72 1.72 Allowed 'General case' 0 C--N 1.403 2.927 0 CA-C-N 110.734 -2.939 . . . . 0.0 113.761 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.9 m -119.6 85.18 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.128 0.966 . . . . 0.0 110.921 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 16.3 mtm -58.85 116.84 4.02 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.966 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.488 ' HB3' HG21 ' B' ' 164' ' ' VAL . 49.6 mtmt -57.87 -33.19 68.42 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 112.893 -1.958 . . . . 0.0 115.253 -171.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -78.67 -17.81 55.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 134.79 164.31 10.46 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 124.318 0.961 . . . . 0.0 112.007 -172.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.22 94.3 0.18 Allowed Glycine 0 N--CA 1.478 1.474 0 CA-C-N 113.467 -1.367 . . . . 0.0 112.003 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.605 HG12 HD13 ' A' ' 162' ' ' LEU . 2.8 pp -97.8 152.72 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.631 1.205 . . . . 0.0 112.535 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -97.52 -40.2 8.77 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.399 -1.273 . . . . 0.0 114.024 164.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.0 t -63.38 101.34 0.31 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 122.202 1.001 . . . . 0.0 113.257 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.35 74.5 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.228 -1.806 . . . . 0.0 111.764 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.86 -34.6 63.1 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -65.17 -55.1 20.51 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.102 1.361 . . . . 0.0 112.667 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.605 HD13 HG12 ' A' ' 156' ' ' ILE . 1.9 tp -66.29 -32.39 73.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -53.15 -57.63 9.79 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.704 0.628 . . . . 0.0 112.08 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.2 m -66.55 -23.72 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -54.49 -49.11 70.9 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.0 tp -52.5 -55.88 27.96 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 115.907 -1.997 . . . . 0.0 113.703 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.36 -52.32 4.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.35 2.033 . . . . 0.0 112.759 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -46.45 63.08 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.28 -66.55 0.51 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.866 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -47.15 -53.21 13.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.498 1.119 . . . . 0.0 113.978 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.01 -44.79 95.02 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.9 p -70.86 -41.89 70.81 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -57.81 -42.92 85.24 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' A' ' 177' ' ' ILE . 28.0 mt -56.19 -52.9 62.71 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 169.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.0 mt -49.17 -47.5 45.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 112.221 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.3 -48.57 76.41 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 174' ' ' LEU . 16.4 mt -59.81 -49.26 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 123.55 0.74 . . . . 0.0 110.462 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.1 -51.27 36.09 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 124.25 0.928 . . . . 0.0 112.027 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.09 -46.13 79.14 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.214 1.005 . . . . 0.0 112.012 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -48.42 -53.65 15.52 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.253 0.93 . . . . 0.0 113.438 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.14 -50.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.252 0.621 . . . . 0.0 109.792 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.83 -55.63 18.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.041 0.936 . . . . 0.0 113.255 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -48.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.39 -55.59 12.69 Favored Glycine 0 N--CA 1.481 1.694 0 C-N-CA 124.196 0.903 . . . . 0.0 111.46 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -55.73 -45.42 77.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.301 1.441 . . . . 0.0 114.402 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -65.04 -27.05 68.53 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.0 mt -78.06 -52.86 8.11 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.097 0.559 . . . . 0.0 111.982 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 23.0 p -95.98 -66.15 0.93 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 10.4 p -106.23 67.46 0.74 Allowed 'General case' 0 C--O 1.196 -1.753 0 CA-C-O 124.366 2.032 . . . . 0.0 115.564 -170.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 71.8 m . . . . . 0 N--CA 1.482 1.131 0 CA-C-N 111.384 -2.644 . . . . 0.0 107.654 173.632 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -135.37 -69.22 0.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.444 1.098 . . . . 0.0 111.952 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 57.7 p -62.51 -41.86 99.11 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.809 0.844 . . . . 0.0 112.817 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 6.9 m -111.97 104.67 12.95 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.516 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.36 120.49 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.986 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -118.37 -3.99 10.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -39.96 134.62 1.45 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.947 2.099 . . . . 0.0 115.711 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' B' ' 153' ' ' LYS . 56.7 mmtt -69.53 111.72 5.56 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 125.443 1.714 . . . . 0.0 113.123 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 139.33 81.74 0.08 OUTLIER Glycine 0 N--CA 1.478 1.461 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.966 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.43 -153.84 18.83 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 114.049 -1.075 . . . . 0.0 112.246 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 37.4 pt -66.51 130.14 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -70.96 -32.69 69.63 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 44.1 t -139.14 127.79 23.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.443 0.639 . . . . 0.0 112.568 167.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.02 -56.19 5.48 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.071 -1.877 . . . . 0.0 114.054 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -51.77 -50.93 59.72 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -53.16 -56.19 18.32 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.334 1.021 . . . . 0.0 113.132 172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.452 HD23 HD11 ' B' ' 169' ' ' LEU . 4.1 mt -58.12 -39.8 79.62 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -57.26 -52.14 66.52 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.077 0.951 . . . . 0.0 112.729 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 152' ' ' LYS . 35.9 m -66.05 -26.92 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -86.5 -5.02 59.26 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' B' ' 169' ' ' LEU . 15.3 tp -53.49 -38.44 62.19 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 116.362 -1.78 . . . . 0.0 115.722 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -60.9 -64.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 CA-C-O 116.703 -1.457 . . . . 0.0 111.126 168.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -43.38 -42.78 4.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.452 HD11 HD23 ' B' ' 162' ' ' LEU . 41.6 mt -53.95 -71.08 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.089 0.956 . . . . 0.0 111.276 170.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 4.8 mt -46.43 -46.94 19.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.6 1.56 . . . . 0.0 114.73 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 67.1 mt -57.11 -53.54 56.91 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.138 1.375 . . . . 0.0 112.751 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 85.5 p -61.98 -39.69 93.04 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -58.49 -45.05 89.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' LEU . . . . . 0.52 HD12 HD12 ' B' ' 177' ' ' ILE . 6.4 tp -66.8 -38.64 86.88 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 tp -55.19 -46.24 75.85 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.048 0.939 . . . . 0.0 110.429 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.66 80.03 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.52 HD12 HD12 ' B' ' 174' ' ' LEU . 36.7 mt -57.56 -48.08 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 117.748 0.249 . . . . 0.0 110.736 173.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.51 -49.67 38.61 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.322 0.963 . . . . 0.0 112.977 174.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 14.6 tp -53.12 -45.14 68.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.117 0.967 . . . . 0.0 112.557 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -55.71 -51.6 53.94 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.589 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 9.1 mt -59.03 -45.44 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.318 0.647 . . . . 0.0 109.587 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 48.3 t80 -47.82 -49.97 27.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.637 1.175 . . . . 0.0 113.504 171.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -60.34 -52.14 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.349 0.66 . . . . 0.0 110.941 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' GLY . . . . . 0.46 ' HA2' HD12 ' B' ' 187' ' ' LEU . . . -51.31 -44.88 52.78 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 124.872 1.225 . . . . 0.0 113.441 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -65.62 -47.71 74.69 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.251 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -49.27 -50.46 38.94 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 168.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.46 HD12 ' HA2' ' B' ' 184' ' ' GLY . 46.5 mt -51.42 -48.19 62.74 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.3 p -119.42 -65.22 1.19 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 34.0 p -80.09 14.16 1.98 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -170.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.252 1.207 0 O-C-N 124.055 0.847 . . . . 0.0 112.22 173.568 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -126.75 138.06 53.32 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.186 0.929 . . . . 0.0 110.388 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.0 p -127.35 -66.05 0.9 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.07 61.32 5.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.803 1.763 . . . . 0.0 111.826 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 1.4 m -104.92 -25.4 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 111.491 -2.595 . . . . 0.0 116.485 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -66.14 118.9 10.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.65 0.262 . . . . 0.0 111.597 -164.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 58.8 tttt 64.25 97.3 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 O-C-N 126.219 2.2 . . . . 0.0 109.869 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -98.24 118.46 34.92 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.216 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -149.91 -85.45 0.05 OUTLIER Glycine 0 N--CA 1.476 1.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 169.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 107.8 -158.75 14.76 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -170.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.21 134.84 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.881 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.15 -50.38 16.49 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -177.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.484 ' HB2' HG11 ' B' ' 150' ' ' VAL . 45.3 t -136.63 111.35 8.72 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.112 0.958 . . . . 0.0 112.707 175.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.29 68.67 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 112.859 -1.973 . . . . 0.0 111.937 167.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 2.1 mp0 -58.41 -56.93 15.77 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.608 1.563 . . . . 0.0 110.498 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 165' ' ' PHE . 0.2 OUTLIER -55.78 -45.6 78.13 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.31 1.006 . . . . 0.0 112.032 174.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -55.21 37.4 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -52.07 -51.98 54.12 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 161' ' ' PHE . 7.0 p -67.65 -40.85 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -71.47 -18.79 62.29 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -176.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.254 35.3 mt -40.34 -51.47 6.28 Favored Pre-proline 0 N--CA 1.483 1.188 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.32 -59.11 0.47 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.8 p -59.42 -40.65 87.38 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.4 tp -50.7 -63.32 1.16 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.639 1.576 . . . . 0.0 110.756 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.42 -42.33 77.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.439 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.0 tp -53.6 -47.69 69.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.596 1.159 . . . . 0.0 111.654 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 175' ' ' LEU . 24.7 p -66.62 -39.59 88.4 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -69.71 -35.45 75.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.4 mt -55.49 -49.05 73.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.956 0.785 . . . . 0.0 111.645 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 172' ' ' SER . 86.6 mt -51.55 -52.18 49.31 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 170.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.17 75.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.4 mt -59.1 -48.89 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.648 1.179 . . . . 0.0 111.695 169.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.1 -47.62 88.07 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.252 0.93 . . . . 0.0 113.25 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.86 -41.99 78.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.751 1.621 . . . . 0.0 111.575 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.18 -51.24 58.66 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.266 1.412 . . . . 0.0 112.321 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 29.8 mt -55.86 -47.67 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.378 1.071 . . . . 0.0 111.311 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -50.42 -63.16 1.21 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.47 1.106 . . . . 0.0 112.798 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 183' ' ' ILE . 7.4 tp -69.59 -35.27 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.44 43.71 Favored Glycine 0 N--CA 1.479 1.515 0 C-N-CA 124.307 0.956 . . . . 0.0 111.832 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -62.96 -37.13 85.87 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 190' ' ' SER . 4.3 mmt180 -60.68 -46.26 91.03 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.354 0.662 . . . . 0.0 112.512 171.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.65 -44.68 95.67 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . 0.259 16.9 m -71.8 -56.41 5.81 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 175.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 4.5 p -104.07 -74.58 0.64 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 186' ' ' ARG . 33.4 t . . . . . 0 C--O 1.25 1.09 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -63.51 146.99 52.57 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.034 -177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -138.18 111.19 7.79 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 81.2 p -72.05 9.44 0.95 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 158' ' ' SER . 19.3 m -105.96 84.16 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 124.255 1.979 . . . . 0.0 110.404 170.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.07 166.69 31.66 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 111.227 -2.715 . . . . 0.0 111.012 -167.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -73.71 132.92 43.19 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.543 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -130.08 71.18 1.44 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.24 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 62.18 29.36 72.71 Favored Glycine 0 N--CA 1.483 1.786 0 CA-C-N 112.657 -2.065 . . . . 0.0 114.57 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.64 -78.02 0.39 Allowed Glycine 0 N--CA 1.481 1.65 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 pp -53.51 131.01 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 122.243 1.02 . . . . 0.0 112.188 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -84.81 78.47 9.87 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.175 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t 64.66 129.64 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 112.263 -2.244 . . . . 0.0 114.741 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.84 -56.13 26.14 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.754 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -45.7 -45.11 14.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.749 1.22 . . . . 0.0 114.252 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -62.41 -58.22 8.43 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.037 0.935 . . . . 0.0 112.066 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.16 -38.93 84.65 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -51.0 -30.62 15.67 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.06 -37.1 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.65 -47.21 86.51 Favored 'General case' 0 C--O 1.219 -0.553 0 C-N-CA 126.166 1.786 . . . . 0.0 113.782 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.71 -34.96 7.16 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 -62.41 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 122.085 1.857 . . . . 0.0 112.406 160.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 36.4 p -55.42 -41.93 73.45 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.98 -62.16 2.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 116.513 -1.708 . . . . 0.0 113.079 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' B' ' 174' ' ' LEU . 22.6 tp -50.98 -53.92 28.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.526 0.73 . . . . 0.0 112.018 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt -60.01 -52.21 66.34 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 95.2 p -62.51 -39.35 93.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -58.72 -48.06 82.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 0.0 111.795 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' B' ' 177' ' ' ILE . 84.2 mt -53.74 -45.7 70.64 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.241 1.017 . . . . 0.0 112.64 172.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 27.4 tp -57.66 -46.49 84.16 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.129 0.572 . . . . 0.0 112.163 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.38 96.78 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 174' ' ' LEU . 26.7 mt -57.26 -48.44 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.26 -55.09 20.78 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 124.396 0.998 . . . . 0.0 112.593 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.408 ' O ' HG12 ' B' ' 183' ' ' ILE . 23.3 mt -51.66 -46.51 63.78 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.61 -52.83 45.54 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 124.787 1.185 . . . . 0.0 112.527 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.88 -48.26 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 113.758 -1.221 . . . . 0.0 110.281 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -30.38 41.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 179' ' ' LEU . 44.4 pt -67.01 -40.46 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 119.677 1.126 . . . . 0.0 111.178 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.92 -47.46 79.4 Favored Glycine 0 N--CA 1.477 1.407 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.242 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.544 ' HG3' ' OG1' ' B' ' 189' ' ' THR . 3.7 ttt180 -61.42 -54.61 41.34 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.94 -39.25 3.88 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.978 0.911 . . . . 0.0 112.073 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.513 HD23 ' HB ' ' B' ' 188' ' ' THR . 0.8 OUTLIER -65.97 -57.22 8.3 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.17 0.919 . . . . 0.0 113.316 170.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.513 ' HB ' HD23 ' B' ' 187' ' ' LEU 0.282 2.6 t -101.47 -60.63 1.5 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 118.474 2.768 . . . . 0.0 118.474 -168.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 189' ' ' THR . . . . . 0.544 ' OG1' ' HG3' ' B' ' 185' ' ' ARG . 47.6 p -103.56 9.14 37.62 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 -168.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -96.51 -36.13 10.88 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.13 151.68 30.51 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.9 t -57.03 -51.01 70.98 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.44 117.29 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.825 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -124.34 125.54 44.51 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.445 1.091 . . . . 0.0 111.33 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -114.02 100.77 8.65 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.467 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -73.58 167.94 20.32 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.59 160.07 53.9 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.436 1.017 . . . . 0.0 114.487 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.15 129.97 0.04 OUTLIER Glycine 0 N--CA 1.487 2.051 0 CA-C-N 113.245 -1.478 . . . . 0.0 114.831 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 159' ' ' ALA . 2.4 pp -59.02 142.33 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.391 -0.904 . . . . 0.0 113.129 172.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -98.29 -72.07 0.66 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.306 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 163' ' ' LYS . 36.2 t -49.94 -59.36 3.94 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -174.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 156' ' ' ILE . . . 35.99 50.35 0.67 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.875 1.67 . . . . 0.0 114.21 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 66.75 -55.66 0.42 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.295 2.238 . . . . 0.0 114.475 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . 0.297 65.2 m-85 -75.87 -14.07 60.27 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 119.704 3.224 . . . . 0.0 119.704 -170.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.55 -32.72 28.46 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 165.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.408 ' HB2' ' OG ' ' A' ' 158' ' ' SER . 29.7 tttt -65.18 -32.08 73.58 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.706 0.802 . . . . 0.0 111.426 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.5 m -97.13 43.1 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 168.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -151.47 -68.2 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.952 1.301 . . . . 0.0 110.905 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 169' ' ' LEU . 7.3 tp -60.93 -35.74 27.7 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -54.66 -58.87 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.848 2.365 . . . . 0.0 114.182 171.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.2 p -58.67 -39.36 80.42 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 2.8 mp -54.21 -66.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 171.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 30.5 mt -50.86 -43.35 59.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.15 -49.89 70.34 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.1 p -69.62 -29.18 66.62 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.438 ' HE1' HD23 ' A' ' 169' ' ' LEU . 24.3 m170 -57.18 -44.96 84.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.074 0.549 . . . . 0.0 111.905 165.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.98 -35.22 76.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.03 -50.24 73.34 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.546 0.529 . . . . 0.0 111.994 167.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.426 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -58.49 -48.97 79.03 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.55 -47.23 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.67 1.188 . . . . 0.0 111.648 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.75 -57.75 11.78 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.411 1.481 . . . . 0.0 111.678 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.0 tp -49.7 -46.23 49.83 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.943 1.297 . . . . 0.0 112.171 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -46.81 -62.3 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.618 1.58 . . . . 0.0 113.847 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.91 -31.94 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -49.01 -67.41 0.27 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.313 1.045 . . . . 0.0 112.223 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . 0.294 2.3 pp -67.83 -30.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.27 -64.34 3.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 124.997 1.284 . . . . 0.0 112.723 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 -64.05 -22.11 66.79 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -56.42 -22.68 33.4 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 168.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.6 tp -49.86 -49.15 50.31 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.131 0.972 . . . . 0.0 111.833 167.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.2 p -93.39 -1.68 55.56 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 7.1 p -121.05 42.65 3.0 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 165.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 C--O 1.249 1.074 0 CA-C-N 113.023 -1.898 . . . . 0.0 108.785 167.999 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 74.76 -64.97 0.36 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 118.1 2.629 . . . . 0.0 118.1 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 16.6 p -121.23 147.27 45.85 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 19.6 m -70.4 171.36 10.15 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.563 1.145 . . . . 0.0 110.876 166.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.608 ' HB ' ' HA2' ' B' ' 154' ' ' GLY 0.31 19.2 m -81.45 71.05 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 123.315 1.531 . . . . 0.0 113.933 179.041 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 77.5 mtm -82.8 108.54 16.22 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 112.256 -2.247 . . . . 0.0 111.563 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt 67.14 -64.56 0.25 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.624 1.97 . . . . 0.0 111.194 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -65.97 94.37 0.23 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.053 1.341 . . . . 0.0 109.557 166.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' B' ' 150' ' ' VAL . . . -109.69 -171.79 20.46 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 112.859 -1.973 . . . . 0.0 112.34 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.9 -59.92 1.74 Allowed Glycine 0 N--CA 1.479 1.535 0 CA-C-N 113.726 -1.237 . . . . 0.0 115.628 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -43.68 144.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.383 1.473 . . . . 0.0 114.175 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -75.96 -21.89 56.52 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -167.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.99 102.31 5.98 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.231 1.015 . . . . 0.0 111.295 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.81 -12.45 10.85 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -51.66 -29.06 16.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.976 1.311 . . . . 0.0 113.013 166.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -43.26 -46.05 6.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.608 1.963 . . . . 0.0 113.052 168.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 5.9 mp -52.16 -36.08 50.59 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.988 1.315 . . . . 0.0 113.96 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -89.42 -52.07 5.23 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -71.47 -20.96 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' B' ' 168' ' ' SER . 4.4 p90 -51.34 -43.51 61.78 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -174.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.98 -46.01 30.8 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.732 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -55.4 -45.56 39.05 Favored 'Trans proline' 0 N--CA 1.48 0.681 0 C-N-CA 122.284 1.989 . . . . 0.0 111.923 164.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' B' ' 165' ' ' PHE . 55.0 m -47.55 -52.58 17.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.143 0.977 . . . . 0.0 112.003 174.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.412 HD21 HD11 ' A' ' 169' ' ' LEU . 58.7 mt -53.35 -61.62 2.18 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.882 0.873 . . . . 0.0 113.289 176.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 11.4 mt -54.97 -52.05 64.26 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.526 -1.215 . . . . 0.0 113.637 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.75 -58.79 7.06 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.245 1.418 . . . . 0.0 112.64 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 87.4 p -64.03 -37.27 86.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -66.79 -40.25 88.08 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.53 -51.07 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.569 0.7 . . . . 0.0 111.292 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.52 -38.91 72.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.393 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.28 86.15 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.426 HG13 ' HB1' ' A' ' 176' ' ' ALA . 6.9 mt -57.26 -48.46 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 171.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.53 -57.31 9.53 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.269 1.414 . . . . 0.0 112.618 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 62.4 tp -45.82 -53.12 10.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.19 -62.27 3.98 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 124.642 1.115 . . . . 0.0 112.963 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -54.25 -51.11 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.85 0.86 . . . . 0.0 110.828 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -61.18 -33.54 73.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.1 mt -51.46 -51.96 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.237 0.615 . . . . 0.0 110.086 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.47 -46.99 45.3 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 124.798 1.19 . . . . 0.0 112.62 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.07 -56.21 7.5 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -55.01 -37.05 66.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.086 0.954 . . . . 0.0 113.102 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 4.0 mp -64.72 -45.78 85.09 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 171.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 35.9 p -89.48 -15.2 33.6 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -171.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 11.9 p -61.59 154.12 25.84 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 115.005 1.484 . . . . 0.0 115.005 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 95.1 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.433 -1.27 . . . . 0.0 113.993 -173.362 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -107.37 102.85 12.11 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.834 0.826 . . . . 0.0 109.56 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.4 t -110.85 107.08 16.45 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.812 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 55.6 m -61.64 102.88 0.28 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.518 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.9 t -122.38 -46.46 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.547 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 84.7 mmm -129.34 152.45 48.88 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.322 1.049 . . . . 0.0 112.107 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -52.89 120.86 6.3 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.023 166.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -126.93 90.1 3.1 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.008 -176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -102.52 -65.14 0.73 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.383 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.08 90.64 0.7 Allowed Glycine 0 CA--C 1.538 1.498 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 159' ' ' ALA . 2.0 pp -110.93 -167.43 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.4 ' H ' ' HB ' ' A' ' 156' ' ' ILE . 17.7 t80 -96.12 -47.43 6.07 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.8 t -126.08 125.72 43.04 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.628 0.727 . . . . 0.0 111.004 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 156' ' ' ILE . . . -115.82 48.91 1.15 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 124.786 2.232 . . . . 0.0 113.026 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -66.13 -47.01 75.53 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 111.327 -2.67 . . . . 0.0 114.734 -174.371 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -74.13 -35.12 64.09 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.922 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.6 tp -52.38 -44.07 65.07 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.001 0.52 . . . . 0.0 111.284 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 160' ' ' GLU . 37.8 tptt -52.51 -27.75 17.72 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.775 1.63 . . . . 0.0 114.952 171.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.0 t -88.97 -64.69 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.808 0.843 . . . . 0.0 108.79 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 168' ' ' SER . 43.2 t80 -45.13 -56.54 4.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.836 2.454 . . . . 0.0 115.615 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 169' ' ' LEU 0.251 0.2 OUTLIER -75.81 -41.42 3.45 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 -174.704 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -55.06 -44.62 47.83 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 121.885 1.723 . . . . 0.0 112.507 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 165' ' ' PHE . 75.2 m -51.79 -53.29 41.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.869 0.868 . . . . 0.0 112.798 170.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 166' ' ' LEU . 22.4 mt -55.8 -44.84 78.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 173.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.4 mt -59.74 -50.91 71.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.008 0.923 . . . . 0.0 113.005 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.0 tp -57.12 -45.58 83.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.327 1.051 . . . . 0.0 110.998 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.8 t -51.2 -58.62 5.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.177 1.391 . . . . 0.0 113.487 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -48.01 -51.58 23.38 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.474 1.109 . . . . 0.0 113.494 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 44.2 tp -54.22 -57.07 12.56 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.767 1.227 . . . . 0.0 112.788 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.6 mt -54.35 -44.85 72.52 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.09 -54.48 7.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.617 HG13 ' HB1' ' B' ' 176' ' ' ALA . 25.5 mt -55.9 -40.94 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.123 0.569 . . . . 0.0 110.297 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -62.1 5.97 Favored Glycine 0 N--CA 1.48 1.597 0 O-C-N 124.801 1.313 . . . . 0.0 112.35 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.03 -49.75 30.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.807 0.843 . . . . 0.0 113.108 171.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.62 -64.22 3.85 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 125.268 1.413 . . . . 0.0 114.168 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.8 pp -56.62 -33.94 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.8 -58.05 6.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.906 1.282 . . . . 0.0 113.219 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 21.5 mt -56.9 -34.69 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.548 0.739 . . . . 0.0 111.166 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.24 31.35 0.96 Allowed Glycine 0 CA--C 1.54 1.622 0 N-CA-C 116.439 1.335 . . . . 0.0 116.439 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.418 ' HA ' HG21 ' B' ' 188' ' ' THR . 1.1 tmt_? -122.47 -42.83 2.32 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -116.06 -39.21 3.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.316 0.647 . . . . 0.0 112.182 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 8.0 tp -83.93 55.43 3.28 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 123.573 1.654 . . . . 0.0 111.147 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.4 p -123.5 -27.14 4.1 Favored 'General case' 0 C--O 1.199 -1.586 0 CA-C-N 111.667 -2.515 . . . . 0.0 115.148 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 2.2 p -67.11 68.76 0.08 Allowed 'General case' 0 C--N 1.384 2.094 0 CA-C-O 124.999 2.333 . . . . 0.0 112.955 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--N 1.374 1.643 0 CA-C-N 109.789 -3.369 . . . . 0.0 111.151 -165.986 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 119.265 -0.398 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -54.48 -38.87 66.94 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 124.007 0.817 . . . . 0.0 113.191 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.7 p -112.76 119.22 37.31 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.71 1.204 . . . . 0.0 110.888 162.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 3.6 m -72.42 128.98 37.27 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.654 1.216 . . . . 0.0 112.742 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.4 -31.8 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -164.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 13.1 tpt -19.77 -64.43 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.451 2.7 . . . . 0.0 118.151 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -70.74 87.52 0.69 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.841 1.256 . . . . 0.0 108.597 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -76.71 114.16 15.15 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.107 -0.952 . . . . 0.0 113.557 -164.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 59.98 50.4 68.09 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.326 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -142.94 110.21 0.6 Allowed Glycine 0 N--CA 1.472 1.066 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 1.5 pp -48.3 131.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -54.75 -28.78 50.99 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 46.3 t -164.15 126.83 2.45 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.404 1.082 . . . . 0.0 110.665 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.01 -40.78 71.61 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.142 0.901 . . . . 0.0 110.499 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -50.27 -45.28 54.21 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.985 172.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -87.39 -25.58 23.75 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.02 -36.47 72.75 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.256 0.551 . . . . 0.0 111.534 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -49.55 -47.57 49.04 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 168.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.9 -40.55 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.976 0.91 . . . . 0.0 110.062 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -42.05 -58.22 2.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.816 1.646 . . . . 0.0 114.384 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.16 -53.23 67.53 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 115.842 -2.028 . . . . 0.0 114.737 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -56.39 -50.19 12.73 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 123.161 2.574 . . . . 0.0 113.159 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.7 m -57.02 -45.97 82.68 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.74 -46.19 89.24 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.023 1.329 . . . . 0.0 114.424 174.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.7 mt -53.23 -56.92 12.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.569 0.7 . . . . 0.0 111.113 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' B' ' 171' ' ' LEU . 9.9 tp -58.71 -45.15 90.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.393 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 42.8 t -47.78 -60.39 2.61 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.791 1.237 . . . . 0.0 113.062 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.55 -47.65 72.97 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.163 0.914 . . . . 0.0 113.21 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 4.7 mp -60.93 -53.78 53.05 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.9 mt -51.29 -54.56 24.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.33 1.052 . . . . 0.0 111.094 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.617 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -60.7 -48.75 80.37 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.396 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 tt -64.19 -41.92 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.38 63.6 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 124.09 0.869 . . . . 0.0 112.008 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 9.5 tp -54.44 -50.47 67.59 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 113.611 -1.294 . . . . 0.0 111.588 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' B' ' 183' ' ' ILE . . . -49.47 -54.18 17.5 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 124.984 1.278 . . . . 0.0 113.941 176.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 10.2 mt -56.16 -48.56 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.632 0.773 . . . . 0.0 111.484 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -51.23 -52.35 45.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.901 0.881 . . . . 0.0 112.351 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.411 HD12 ' HA2' ' B' ' 180' ' ' GLY . 34.0 mt -54.77 -53.94 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.879 177.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.19 -50.74 44.95 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 125.096 1.331 . . . . 0.0 112.955 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -58.47 -51.26 70.62 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -64.56 -35.23 80.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 17.6 mt -78.97 -32.8 45.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.418 HG21 ' HA ' ' A' ' 185' ' ' ARG . 6.5 p -66.69 -47.47 72.32 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.285 0.991 . . . . 0.0 113.275 170.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 32.5 p -84.26 151.45 24.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.479 0.999 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.767 177.248 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 . . . . . 0 N--CA 1.465 0.304 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -114.78 103.55 11.08 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.108 0.956 . . . . 0.0 112.144 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 t -52.0 105.75 0.12 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.035 170.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.1 t -65.01 155.12 35.68 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 110.57 -3.013 . . . . 0.0 112.69 -170.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.88 -77.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 117.175 -1.393 . . . . 0.0 109.315 166.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.61 136.38 29.12 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -108.53 -59.18 1.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.053 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -80.6 118.33 22.08 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -166.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 130.1 69.09 0.11 Allowed Glycine 0 N--CA 1.478 1.448 0 CA-C-N 112.784 -2.007 . . . . 0.0 113.398 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -84.48 -111.4 0.63 Allowed Glycine 0 N--CA 1.476 1.309 0 C-N-CA 123.451 0.548 . . . . 0.0 112.703 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.85 153.66 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.447 1.118 . . . . 0.0 113.759 169.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.96 -77.33 0.07 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.087 -1.87 . . . . 0.0 113.335 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.404 ' HB3' ' CD2' ' B' ' 161' ' ' PHE . 32.2 t -99.76 100.6 11.57 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.513 1.149 . . . . 0.0 113.349 -170.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.69 -20.8 25.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -43.44 65.62 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 174.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -51.76 -55.21 21.09 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.895 1.678 . . . . 0.0 109.651 168.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 162' ' ' LEU . 26.1 mt -55.3 -45.91 76.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -53.49 -55.36 26.05 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 15.3 m -69.77 -16.66 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -103.43 -23.65 13.52 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 118.275 2.695 . . . . 0.0 118.275 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.276 17.9 mt -47.9 -45.15 61.44 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-O 115.639 -2.124 . . . . 0.0 116.662 176.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -57.27 -57.5 1.25 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.203 1.935 . . . . 0.0 112.536 171.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.7 m -45.4 -46.01 13.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 37.2 mt -62.48 -54.25 42.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.492 1.517 . . . . 0.0 114.606 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.47 -43.74 68.39 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.572 0.749 . . . . 0.0 112.164 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.1 mt -53.08 -63.11 1.25 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.101 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.6 p -59.1 -43.34 91.85 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -66.03 -46.98 75.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 174' ' ' LEU . 8.7 mt -56.29 -45.62 80.13 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.3 mt -60.8 -45.33 94.85 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.463 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.1 -46.54 79.06 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.439 HG13 ' HB1' ' B' ' 176' ' ' ALA . 11.0 mt -47.53 -54.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.789 0.835 . . . . 0.0 111.385 170.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.549 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -51.98 -56.81 14.76 Favored Glycine 0 CA--C 1.544 1.872 0 C-N-CA 124.548 1.07 . . . . 0.0 113.138 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.7 mt -51.83 -48.68 63.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.317 1.047 . . . . 0.0 111.702 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.68 -51.12 40.14 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.231 1.396 . . . . 0.0 112.488 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.549 HD12 ' HA2' ' A' ' 178' ' ' GLY . 21.5 mt -54.66 -54.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.023 1.329 . . . . 0.0 110.373 174.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -53.02 -51.71 60.8 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.969 1.418 . . . . 0.0 111.038 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.4 mt -56.67 -62.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 124.382 1.073 . . . . 0.0 109.796 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.76 4.48 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 124.734 1.159 . . . . 0.0 113.366 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.435 ' HG3' HG23 ' B' ' 188' ' ' THR . 21.5 ttt180 -62.37 -55.97 22.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.368 1.067 . . . . 0.0 112.741 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -69.62 -17.15 63.5 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.74 -23.41 36.71 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 171.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 49.2 p -121.31 56.8 1.03 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.219 1.008 . . . . 0.0 111.426 -171.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 73.2 p -62.2 135.05 57.32 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 113.591 -1.64 . . . . 0.0 114.839 -160.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.979 0 C-N-CA 125.261 1.424 . . . . 0.0 108.929 176.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -63.74 133.0 52.73 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.028 0.442 . . . . 0.0 110.707 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 68.0 p -111.66 152.25 27.9 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -79.73 139.5 37.29 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.77 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.471 HG23 ' HE3' ' B' ' 152' ' ' LYS . 15.3 m -123.55 134.78 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 112.809 -1.996 . . . . 0.0 110.711 163.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 151' ' ' MET . . . . . 0.455 ' SD ' ' HB2' ' B' ' 153' ' ' LYS . 7.8 tmm? -74.18 109.27 7.54 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.687 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.471 ' HE3' HG23 ' B' ' 150' ' ' VAL . 96.1 mttt -111.82 104.59 12.91 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.499 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 153' ' ' LYS . . . . . 0.455 ' HB2' ' SD ' ' B' ' 151' ' ' MET . 4.9 ttmt -138.12 102.76 4.76 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.702 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 165.65 65.43 0.03 OUTLIER Glycine 0 N--CA 1.487 2.081 0 O-C-N 125.33 1.644 . . . . 0.0 111.087 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.11 110.09 3.52 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.07 0.843 . . . . 0.0 112.826 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' ILE . . . . . 0.443 HD11 HD13 ' B' ' 162' ' ' LEU . 9.8 pt -21.24 98.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 127.149 2.179 . . . . 0.0 116.375 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 71.94 -46.28 0.64 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.848 2.059 . . . . 0.0 113.964 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 27.0 t -161.74 113.23 1.71 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.876 2.47 . . . . 0.0 110.329 171.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.75 -33.87 67.0 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.444 -1.707 . . . . 0.0 113.66 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.65 -42.98 85.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.055 1.342 . . . . 0.0 112.513 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 158' ' ' SER . 30.8 t80 -65.56 -45.45 83.28 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 173.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.443 HD13 HD11 ' B' ' 156' ' ' ILE . 46.4 tp -54.34 -44.04 71.76 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 123.729 0.643 . . . . 0.0 112.599 172.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -56.12 -47.66 77.68 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 6.1 m -74.12 -31.65 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.96 -51.1 71.49 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.485 1.116 . . . . 0.0 111.399 169.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.296 1.5 mm? -40.51 -61.56 1.17 Allowed Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.28 -56.51 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 122.966 2.444 . . . . 0.0 111.382 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 3.1 p -64.05 -27.82 69.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 38.0 tp -63.41 -52.63 60.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.997 1.319 . . . . 0.0 112.248 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -58.29 -36.34 73.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.38 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.68 -33.52 66.57 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 69.7 m -71.0 -35.04 71.93 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 172.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -56.29 -42.66 77.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.583 165.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.26 -34.69 65.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.82 -54.24 44.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.306 1.442 . . . . 0.0 110.895 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.439 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -55.09 -48.36 73.66 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.463 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.9 mt -61.3 -51.04 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.5 1.12 . . . . 0.0 111.823 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.94 -53.89 24.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.671 1.605 . . . . 0.0 112.845 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.54 -47.3 76.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.906 0.882 . . . . 0.0 112.731 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.18 -53.51 23.17 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.989 1.281 . . . . 0.0 113.131 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.66 -46.66 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.067 0.947 . . . . 0.0 112.517 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -51.4 -55.51 18.22 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.531 0.519 . . . . 0.0 112.392 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 181' ' ' ILE 0.26 6.4 tp -61.76 -42.47 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.334 175.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.58 -52.95 31.09 Favored Glycine 0 N--CA 1.483 1.785 0 C-N-CA 124.417 1.008 . . . . 0.0 113.424 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -56.15 -50.89 69.87 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.811 1.244 . . . . 0.0 111.212 175.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -65.02 -24.16 67.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.7 mt -65.2 -52.34 55.41 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.032 0.933 . . . . 0.0 112.806 166.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 185' ' ' ARG . 3.3 p -70.72 -19.96 62.7 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 174.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 49.5 m -71.53 136.59 47.58 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.276 0.631 . . . . 0.0 109.454 165.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.246 0.887 0 CA-C-O 117.717 -1.135 . . . . 0.0 111.955 179.529 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.477 HH11 ' HB3' ' A' ' 146' ' ' ARG . 5.4 mtp-105 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -51.4 121.75 6.8 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.486 HG22 HG22 ' A' ' 150' ' ' VAL . 84.1 m -117.63 134.49 54.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.648 167.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.6 t -93.42 -70.28 0.71 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.649 1.218 . . . . 0.0 111.144 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 148' ' ' THR 0.291 35.5 m 36.58 103.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 22.8 ttt -72.92 82.97 1.21 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.984 170.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -147.77 136.15 21.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.48 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -156.29 128.86 7.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 112.643 -2.071 . . . . 0.0 108.921 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.53 -97.35 1.18 Allowed Glycine 0 N--CA 1.476 1.337 0 N-CA-C 107.002 -2.439 . . . . 0.0 107.002 171.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -50.48 126.16 23.6 Favored Glycine 0 N--CA 1.477 1.379 0 O-C-N 126.27 1.806 . . . . 0.0 113.861 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -81.33 143.74 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 113.682 -1.259 . . . . 0.0 111.148 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -40.9 97.09 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.795 172.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.0 t -174.85 119.34 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.269 1.428 . . . . 0.0 110.916 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.89 -77.99 0.6 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.032 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 164' ' ' VAL . 2.5 tp10 -60.81 -40.59 93.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.512 1.125 . . . . 0.0 110.229 173.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -55.27 -46.5 76.14 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.674 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.31 -56.14 25.89 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.809 0.844 . . . . 0.0 111.659 168.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -49.94 -49.75 48.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 160' ' ' GLU . 73.6 t -49.1 -45.07 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.576 1.15 . . . . 0.0 112.29 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -94.97 14.61 21.16 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt -48.05 -42.08 46.66 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.15 -66.12 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.183 2.588 . . . . 0.0 111.17 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.0 m -48.73 -56.6 8.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.641 1.576 . . . . 0.0 112.47 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.8 mt -42.54 -51.26 5.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.804 1.642 . . . . 0.0 114.199 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.65 -26.69 20.61 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.95 -35.71 74.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 170.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -68.84 -38.0 79.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 168.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.1 mt -53.49 -50.38 65.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.579 0.752 . . . . 0.0 112.263 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.6 tp -51.02 -53.32 34.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.17 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.08 -51.82 39.56 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 181' ' ' ILE . 19.4 mt -59.61 -56.58 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.412 0.685 . . . . 0.0 110.625 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.09 -50.52 45.17 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 124.281 0.943 . . . . 0.0 112.816 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.453 HD23 HD11 ' B' ' 177' ' ' ILE . 5.5 tp -56.11 -44.13 78.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.171 1.388 . . . . 0.0 112.139 176.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -58.11 -46.37 92.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.99 0.805 . . . . 0.0 113.2 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 177' ' ' ILE . 2.4 mp -53.08 -45.81 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 124.139 0.552 . . . . 0.0 111.425 172.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -56.57 -55.36 34.82 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.6 mt -53.32 -57.82 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.179 0.991 . . . . 0.0 111.243 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.82 -50.26 32.54 Favored Glycine 0 CA--C 1.548 2.124 0 C-N-CA 124.783 1.183 . . . . 0.0 112.403 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -62.32 -47.13 85.6 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 186' ' ' ARG . 11.5 mmt180 -68.45 -24.97 64.78 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.4 mt -73.09 -51.33 18.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.635 165.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.518 HG23 ' HD3' ' B' ' 185' ' ' ARG . 72.4 p -64.13 -37.11 86.26 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . 0.315 9.5 t 20.4 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 128.24 2.616 . . . . 0.0 117.84 174.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 C--O 1.251 1.165 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.594 177.332 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 8.6 p30 7.91 75.73 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.269 2.228 . . . . 0.0 116.807 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 36.9 p -119.98 98.73 6.22 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.121 0.962 . . . . 0.0 110.498 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 70.9 m -79.72 163.27 24.64 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -168.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.49 127.44 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.777 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 12.2 tpt -61.37 -66.49 0.53 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.184 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 85.6 mttt 34.6 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -115.06 147.54 40.04 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.891 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 134.3 104.75 0.84 Allowed Glycine 0 N--CA 1.485 1.901 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.636 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.55 -101.06 0.25 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.014 1.293 . . . . 0.0 111.366 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 156' ' ' ILE . . . . . 0.724 HG12 ' HB2' ' B' ' 162' ' ' LEU . 9.8 tp -47.09 125.74 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 175.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -52.35 -43.12 64.46 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 113.892 -1.504 . . . . 0.0 114.284 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' B' ' 161' ' ' PHE . 31.1 t -138.64 115.13 10.5 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.283 1.033 . . . . 0.0 113.023 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.15 -45.13 71.93 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.043 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -54.17 -51.08 65.49 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.583 1.153 . . . . 0.0 112.698 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' B' ' 158' ' ' SER . 0.3 OUTLIER -59.61 -47.58 85.01 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.724 ' HB2' HG12 ' B' ' 156' ' ' ILE . 20.8 tp -52.42 -52.47 53.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.296 1.038 . . . . 0.0 111.555 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -49.25 -60.38 2.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.676 1.19 . . . . 0.0 111.6 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 18.5 m -66.0 -25.64 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -176.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.21 -42.73 30.48 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.507 HD23 HD23 ' B' ' 169' ' ' LEU 0.256 23.8 mt -43.35 -43.62 11.39 Favored Pre-proline 0 N--CA 1.481 1.1 0 N-CA-C 118.714 2.857 . . . . 0.0 118.714 -177.004 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -51.7 -66.62 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.498 2.799 . . . . 0.0 113.199 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 19.5 p -54.26 -42.55 70.07 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.507 HD23 HD23 ' B' ' 166' ' ' LEU . 41.6 tp -55.96 -58.0 9.73 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.492 1.12 . . . . 0.0 112.218 175.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -47.2 85.96 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 173.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 51.9 tp -54.5 -45.58 73.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -62.1 -44.77 95.94 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.559 0.537 . . . . 0.0 112.173 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -67.72 -37.2 81.89 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.715 1.206 . . . . 0.0 112.488 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 20.3 mt -60.32 -51.14 70.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.697 1.199 . . . . 0.0 112.326 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.5 mt -58.77 -45.48 89.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.67 86.98 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.453 HD11 HD23 ' A' ' 179' ' ' LEU . 2.3 tt -70.9 -36.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.86 -50.4 54.66 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.244 0.926 . . . . 0.0 111.191 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.41 -42.74 82.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.721 -0.739 . . . . 0.0 112.651 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -51.64 -56.81 14.03 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.087 0.851 . . . . 0.0 112.674 170.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 6.2 mt -60.6 -41.01 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.727 0.811 . . . . 0.0 109.881 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -51.81 -61.75 2.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.286 1.034 . . . . 0.0 111.156 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 28.0 mt -60.25 -41.34 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.865 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.35 -47.39 89.96 Favored Glycine 0 N--CA 1.48 1.626 0 C-N-CA 125.134 1.35 . . . . 0.0 115.922 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.518 ' HD3' HG23 ' A' ' 188' ' ' THR . 27.5 mmt180 -74.11 -37.03 64.26 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 172.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.735 HH11 ' HA ' ' B' ' 190' ' ' SER . 22.9 mmt180 -59.28 -32.54 70.12 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 172.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 1.4 mp -44.67 -34.75 2.33 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.942 1.297 . . . . 0.0 113.41 169.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.1 p -97.22 -75.17 0.55 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.751 0.82 . . . . 0.0 111.012 167.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 189' ' ' THR . . . . . 0.49 ' O ' ' HD3' ' B' ' 186' ' ' ARG . 8.9 t -75.83 89.35 2.88 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.918 1.342 . . . . 0.0 114.023 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 190' ' ' SER . . . . . 0.735 ' HA ' HH11 ' B' ' 186' ' ' ARG . 29.6 t . . . . . 0 N--CA 1.48 1.03 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.112 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -140.5 116.59 10.5 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.108 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.9 p -70.16 144.17 52.07 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 76.7 p -68.37 174.9 3.66 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.084 -1.416 . . . . 0.0 114.648 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 87.8 t -93.64 130.81 42.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 155.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -107.07 137.22 45.55 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.19 0.995 . . . . 0.0 112.449 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.5 90.85 5.69 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.549 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' HE2' ' CE2' ' A' ' 157' ' ' PHE . 3.1 tmmt? -166.36 122.21 1.24 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 112.381 -2.191 . . . . 0.0 107.102 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.02 -100.73 0.01 OUTLIER Glycine 0 N--CA 1.484 1.837 0 O-C-N 124.144 0.903 . . . . 0.0 112.044 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -110.51 -81.9 1.26 Allowed Glycine 0 N--CA 1.475 1.286 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -175.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 tt -106.73 134.13 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' CE2' ' HE2' ' A' ' 153' ' ' LYS . 73.5 m-85 -51.63 -47.79 63.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 172.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.8 t -149.8 106.96 3.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.398 1.094 . . . . 0.0 112.885 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.65 -31.35 72.49 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.495 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.521 ' O ' HG23 ' A' ' 164' ' ' VAL . 16.8 mp0 -59.08 -60.03 4.51 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.295 1.438 . . . . 0.0 110.527 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -45.32 -57.88 3.7 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.443 1.897 . . . . 0.0 111.413 172.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.0 tp -39.25 -64.49 0.46 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.899 2.08 . . . . 0.0 113.19 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -55.95 -51.24 68.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.2 1.4 . . . . 0.0 112.556 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 160' ' ' GLU . 6.9 t -59.62 -37.13 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 123.965 0.791 . . . . 0.0 111.836 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.472 ' HB3' HD12 ' A' ' 169' ' ' LEU . 13.3 m-85 -80.09 -33.93 38.42 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 117.535 2.42 . . . . 0.0 117.535 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -33.37 -57.33 0.57 Allowed Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -67.11 -43.84 5.87 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 121.774 1.649 . . . . 0.0 114.705 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.3 p -68.11 -38.38 82.21 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 165' ' ' PHE . 46.6 mt -66.98 -39.91 87.31 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 17.0 mt -51.85 -47.2 64.54 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 167.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.37 -53.89 53.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 59.2 p -59.61 -39.7 85.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -68.75 -43.47 75.78 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 tp -57.43 -44.89 85.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.179 0.992 . . . . 0.0 111.918 170.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -48.78 79.52 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.378 1.071 . . . . 0.0 112.123 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.43 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -58.08 -46.54 85.29 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.521 1.129 . . . . 0.0 113.609 176.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.507 HG22 HD11 ' A' ' 181' ' ' ILE . 58.9 mt -53.68 -53.32 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.307 0.643 . . . . 0.0 110.118 170.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.495 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -48.52 -51.2 22.77 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.155 1.359 . . . . 0.0 113.88 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -52.38 -48.66 65.48 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.01 -48.38 83.03 Favored Glycine 0 N--CA 1.488 2.103 0 O-C-N 124.181 0.926 . . . . 0.0 112.43 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 177' ' ' ILE . 27.0 mt -56.89 -49.22 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 124.944 1.297 . . . . 0.0 110.471 175.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.84 -49.14 59.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.563 1.145 . . . . 0.0 112.922 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.5 mm -52.91 -50.78 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.325 0.65 . . . . 0.0 111.231 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.14 -56.59 22.48 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 124.55 1.071 . . . . 0.0 113.075 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.663 ' HG3' HD13 ' B' ' 187' ' ' LEU . 22.8 mtt180 -54.2 -48.01 71.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 186' ' ' ARG . 41.9 mmt-85 -60.44 -38.1 83.04 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.62 -57.92 10.65 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 124.457 1.098 . . . . 0.0 110.439 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 28.6 p -87.77 40.45 0.94 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.7 t -47.18 128.22 11.42 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.774 1.629 . . . . 0.0 114.846 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.245 0.858 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.27 179.122 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 41.83 87.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 O-C-N 125.421 1.7 . . . . 0.0 113.775 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 23.2 p -89.04 -50.98 5.84 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.974 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 19.7 m -105.11 -52.28 2.87 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.115 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.82 119.36 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 122.335 1.064 . . . . 0.0 109.143 -171.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.46 84.91 3.27 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 113.272 -1.786 . . . . 0.0 111.776 -169.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.64 76.78 7.51 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 112.266 -2.243 . . . . 0.0 113.669 -172.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -163.14 134.92 5.08 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.143 -1.844 . . . . 0.0 111.626 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.37 66.43 1.9 Allowed Glycine 0 N--CA 1.476 1.312 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -176.25 -66.0 0.06 OUTLIER Glycine 0 N--CA 1.475 1.278 0 CA-C-N 113.387 -1.406 . . . . 0.0 111.705 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 156' ' ' ILE . . . . . 0.43 HG21 HD22 ' B' ' 162' ' ' LEU . 3.8 mp -87.78 77.35 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.984 0 CA-C-O 124.16 1.934 . . . . 0.0 108.738 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -81.97 19.23 1.16 Allowed 'General case' 0 C--O 1.191 -1.987 0 CA-C-N 111.557 -2.565 . . . . 0.0 116.162 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 47.9 t -173.53 119.95 0.31 Allowed 'General case' 0 C--N 1.369 1.439 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.959 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.55 -36.94 65.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.177 -1.829 . . . . 0.0 109.668 174.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -58.69 -45.57 89.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.313 1.045 . . . . 0.0 112.624 172.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.6 -46.09 84.15 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.669 172.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.43 HD22 HG21 ' B' ' 156' ' ' ILE . 16.3 tp -52.91 -37.14 60.36 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 175.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -50.17 -59.9 3.48 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.684 0.794 . . . . 0.0 112.677 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.49 -34.71 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.177 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -53.69 -62.64 1.52 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.106 1.363 . . . . 0.0 113.554 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.268 16.5 mt -46.88 -56.03 13.1 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 116.288 -1.815 . . . . 0.0 115.728 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.46 -45.32 11.93 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.453 2.102 . . . . 0.0 114.716 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 39.0 m -63.08 -38.62 91.91 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.26 -48.37 80.64 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.947 1.299 . . . . 0.0 111.698 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.56 -49.43 74.86 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.62 0.368 . . . . 0.0 111.306 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 39.3 p -61.64 -38.93 89.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -62.27 -45.67 92.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.33 -45.31 72.64 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 22.3 mt -62.29 -38.97 91.4 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.47 82.93 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.43 HG13 ' HB1' ' A' ' 176' ' ' ALA . 18.7 mt -60.08 -41.39 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.13 -52.18 23.25 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 124.919 1.247 . . . . 0.0 113.243 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.64 -44.51 85.68 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.919 0.888 . . . . 0.0 111.782 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.42 -55.35 30.57 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 115.313 -0.858 . . . . 0.0 114.269 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 4.8 tp -62.45 -28.73 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 112.824 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.75 -53.72 55.24 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.358 0.663 . . . . 0.0 110.66 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 34.0 mt -54.71 -46.66 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 124.149 0.98 . . . . 0.0 109.302 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.39 -48.07 42.23 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.797 1.665 . . . . 0.0 114.338 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' B' ' 185' ' ' ARG . 10.6 mmm180 -61.42 -28.84 69.55 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 174.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -81.48 -32.97 32.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.663 HD13 ' HG3' ' A' ' 185' ' ' ARG . 57.6 mt -63.23 -21.44 66.23 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 169.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 71.5 p -88.91 -33.66 17.21 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 171.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 71.9 p -71.38 166.83 20.84 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.953 176.782 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -126.19 120.49 30.21 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.377 0.608 . . . . 0.0 111.392 176.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.7 t -103.83 128.65 51.25 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.546 168.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.9 m -142.64 124.07 14.79 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.18 125.38 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 164.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -89.85 77.9 6.92 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.511 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -88.97 130.04 35.53 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -83.92 -44.4 14.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 112.018 -2.356 . . . . 0.0 113.188 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.97 129.66 15.86 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.725 1.155 . . . . 0.0 114.892 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.25 93.79 0.13 Allowed Glycine 0 CA--C 1.541 1.674 0 CA-C-N 112.719 -1.74 . . . . 0.0 109.754 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 6.0 tp -125.83 133.51 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 124.087 0.522 . . . . 0.0 111.405 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -113.92 128.92 56.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.869 169.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.4 t 18.77 109.59 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.98 -27.51 68.34 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.661 168.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.581 ' HA ' ' HE3' ' A' ' 163' ' ' LYS . 5.5 mp0 -63.02 -51.27 67.43 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.048 0.939 . . . . 0.0 112.188 169.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -54.32 -49.16 70.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.355 1.462 . . . . 0.0 110.884 171.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.55 -43.9 80.37 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.627 ' HA ' HD12 ' A' ' 166' ' ' LEU . 32.6 mtmt -59.58 -47.2 86.47 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 172.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.0 t -56.94 -45.69 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -64.5 -29.77 70.81 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 172.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.627 HD12 ' HA ' ' A' ' 163' ' ' LYS 0.294 2.5 mt -44.98 -47.64 30.44 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 118.318 2.71 . . . . 0.0 118.318 -173.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.2 -52.19 9.29 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.142 1.895 . . . . 0.0 112.657 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.8 p -64.88 -38.64 91.63 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.86 -48.79 74.9 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.63 0.729 . . . . 0.0 111.509 171.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.98 -42.51 99.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.977 1.311 . . . . 0.0 113.614 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.6 tp -57.59 -46.32 84.16 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.521 0.728 . . . . 0.0 112.333 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.3 t -58.07 -45.08 87.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.566 0.746 . . . . 0.0 112.073 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.437 ' O ' HG13 ' A' ' 177' ' ' ILE . 29.3 m80 -54.98 -43.41 73.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 169.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.1 tp -64.89 -44.09 90.75 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.005 0.522 . . . . 0.0 111.723 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.19 -35.83 76.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.96 83.38 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 168.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 173' ' ' HIS . 10.5 mt -60.77 -45.29 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 173.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.66 -54.23 18.11 Favored Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.196 0.935 . . . . 0.0 113.266 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 183' ' ' ILE . 7.4 tt -50.73 -47.47 59.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 111.626 174.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -57.06 -56.16 26.51 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 124.3 1.0 . . . . 0.0 113.485 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.5 mt -53.58 -50.45 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.062 0.945 . . . . 0.0 110.178 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.419 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 2.6 t80 -50.13 -64.3 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.981 1.426 . . . . 0.0 112.268 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 179' ' ' LEU . 27.2 pt -59.73 -43.77 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.32 -53.68 23.02 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 125.654 1.597 . . . . 0.0 113.622 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.462 ' HG3' HG23 ' B' ' 188' ' ' THR . 54.5 ttt-85 -83.87 -53.3 5.69 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.417 0.716 . . . . 0.0 112.695 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.419 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 17.6 mtp180 -70.86 -29.98 66.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 -161.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.8 tt -55.02 -34.11 63.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.546 1.138 . . . . 0.0 112.595 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.9 t -105.26 -44.65 4.69 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 16.3 m -125.65 104.67 8.5 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 116.745 -1.598 . . . . 0.0 113.299 167.099 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -76.26 133.14 40.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.702 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.1 m -96.91 88.75 4.64 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.942 0.877 . . . . 0.0 110.481 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 12.2 t 65.25 117.38 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 112.27 -2.241 . . . . 0.0 114.367 171.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.41 129.76 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.502 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 12.6 ttt -144.81 72.55 1.34 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.744 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -90.81 120.62 32.0 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.462 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -126.92 121.11 30.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.119 -1.855 . . . . 0.0 112.771 -169.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.6 -82.46 0.17 Allowed Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.774 -1.103 . . . . 0.0 114.015 -171.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.52 -48.3 3.94 Favored Glycine 0 N--CA 1.474 1.221 0 O-C-N 125.01 1.065 . . . . 0.0 112.524 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mt -55.49 115.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.365 1.866 . . . . 0.0 107.622 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.22 -41.81 94.08 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.037 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 33.8 t -116.79 103.28 10.17 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.9 -36.64 79.78 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.087 167.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' B' ' 160' ' ' GLU . 7.8 mp0 -56.15 -46.5 79.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.285 1.834 . . . . 0.0 112.318 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -57.28 -58.53 7.83 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.44 1.087 . . . . 0.0 112.411 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 33.7 tp -52.93 -41.19 64.23 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -49.66 -56.29 10.64 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 16.0 m -76.31 -26.63 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.0 -49.89 75.88 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.919 1.288 . . . . 0.0 112.603 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 25.3 mt -47.09 -45.56 52.93 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -52.19 -63.65 0.24 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.468 2.779 . . . . 0.0 114.753 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 96.3 p -55.89 -43.98 77.74 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.19 0.596 . . . . 0.0 111.951 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.0 tp -52.2 -57.42 9.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.839 1.656 . . . . 0.0 111.852 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tp -53.01 -59.06 5.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.878 1.271 . . . . 0.0 111.125 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 39.1 mt -51.65 -52.62 46.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.85 1.26 . . . . 0.0 113.548 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 24.4 t -59.62 -52.98 63.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.946 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -60.84 -41.47 95.89 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -38.39 86.71 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.27 -29.24 68.79 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 167.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.73 -44.56 85.63 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.863 0.727 . . . . 0.0 112.748 167.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.39 -43.25 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.884 0.873 . . . . 0.0 109.796 166.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -48.93 -61.92 4.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.491 1.52 . . . . 0.0 113.622 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.519 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 7.0 tp -53.17 -40.93 64.72 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.438 1.095 . . . . 0.0 112.07 172.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -52.0 -60.62 7.36 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.644 171.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.5 -31.84 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.482 0.713 . . . . 0.0 111.605 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.519 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 83.2 t80 -50.96 -52.41 42.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.407 0.683 . . . . 0.0 111.917 168.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt -66.96 -52.52 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.275 1.03 . . . . 0.0 109.765 174.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 184' ' ' GLY . . . . . 0.586 ' HA2' HD12 ' B' ' 187' ' ' LEU . . . -45.53 -50.35 10.73 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 125.877 1.703 . . . . 0.0 113.628 177.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.432 ' HD2' ' OG1' ' B' ' 189' ' ' THR . 18.3 mmt180 -67.53 -45.77 74.76 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.8 1.24 . . . . 0.0 113.777 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -61.92 -18.96 62.08 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.586 HD12 ' HA2' ' B' ' 184' ' ' GLY . 68.9 mt -68.74 -44.09 74.52 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.299 1.04 . . . . 0.0 112.275 166.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.462 HG23 ' HG3' ' A' ' 185' ' ' ARG . 22.8 p -96.54 -75.22 0.54 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.673 1.189 . . . . 0.0 114.117 -174.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 189' ' ' THR . . . . . 0.432 ' OG1' ' HD2' ' B' ' 185' ' ' ARG . 38.7 p -97.04 162.7 13.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.299 1.44 . . . . 0.0 114.557 -174.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 C--O 1.254 1.308 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.97 178.574 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -57.09 -56.96 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.483 2.122 . . . . 0.0 112.739 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.4 p -65.19 -35.6 81.59 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.92 -61.84 2.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.725 0.81 . . . . 0.0 111.922 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -45.43 73.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.837 0.855 . . . . 0.0 113.288 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.54 -53.82 53.8 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.662 0.601 . . . . 0.0 112.025 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.535 ' HA ' HD12 ' A' ' 175' ' ' LEU . 91.6 p -63.59 -42.13 98.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -64.69 -43.04 94.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.33 -41.66 97.39 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 172' ' ' SER . 85.0 mt -54.4 -50.52 67.37 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.579 0.752 . . . . 0.0 111.923 170.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.42 93.63 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.73 -50.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.483 0.713 . . . . 0.0 111.402 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.65 91.8 Favored Glycine 0 CA--C 1.545 1.943 0 O-C-N 123.687 0.617 . . . . 0.0 112.114 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 183' ' ' ILE . 38.1 tp -57.86 -44.1 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.522 -0.839 . . . . 0.0 111.897 173.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.02 92.85 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.84 0.733 . . . . 0.0 113.868 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.32 -47.0 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.954 0.901 . . . . 0.0 110.494 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.67 -46.13 89.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 113.027 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 179' ' ' LEU . 41.5 mm -59.49 -42.25 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.42 1.088 . . . . 0.0 111.577 173.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.19 55.36 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 124.092 0.853 . . . . 0.0 111.821 170.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.403 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 20.4 t80 . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 26.6 tp -55.49 -44.03 99.44 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.117 -1.42 . . . . 0.0 114.822 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.79 -47.92 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.649 2.232 . . . . 0.0 113.488 172.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . 0.456 ' HA ' HD12 ' B' ' 171' ' ' LEU . 68.4 m -57.12 -35.86 69.98 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.65 -56.26 23.63 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.021 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.39 -40.01 85.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 113.503 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' B' ' 168' ' ' SER . 85.6 mt -57.08 -43.85 82.55 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' B' ' 175' ' ' LEU . 57.7 p -68.76 -28.37 66.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -61.99 -45.03 95.42 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 67.2 mt -58.0 -45.27 87.12 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.405 0.682 . . . . 0.0 111.997 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' B' ' 172' ' ' SER . 1.0 OUTLIER -53.13 -50.98 63.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.079 1.352 . . . . 0.0 112.633 170.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.78 83.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.477 1.111 . . . . 0.0 113.753 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.59 -45.17 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 0.0 111.587 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.88 -49.05 73.83 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.611 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.89 -41.42 78.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 112.995 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.35 -47.01 78.0 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.99 1.281 . . . . 0.0 112.738 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.33 -42.34 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.394 0.677 . . . . 0.0 111.501 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -63.99 -50.3 69.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.485 1.288 0 CA-C-N 117.972 0.351 . . . . 0.0 111.894 173.538 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.553 1.085 0 CA-C-O 116.163 -1.875 . . . . 0.0 116.017 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -63.01 -37.57 52.28 Favored 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 122.559 2.173 . . . . 0.0 114.697 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 p -64.63 -46.33 83.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.11 -49.35 78.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 9.4 mt -49.78 -55.71 13.03 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.5 -37.6 81.6 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.6 p -55.36 -47.41 75.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -66.81 -45.35 78.64 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.404 0.681 . . . . 0.0 112.787 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.616 ' HA ' HD12 ' A' ' 177' ' ' ILE . 25.4 mt -49.39 -47.1 48.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 174.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.63 -37.12 85.05 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 173.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.39 -46.79 87.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.494 0.718 . . . . 0.0 112.523 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 174' ' ' LEU . 6.2 mt -60.37 -46.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.466 0.706 . . . . 0.0 109.738 172.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.27 -62.78 2.62 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 125.569 1.557 . . . . 0.0 111.887 171.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.5 tp -50.57 -46.95 57.98 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.402 1.081 . . . . 0.0 111.882 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.76 -63.33 3.56 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.55 1.156 . . . . 0.0 113.996 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.47 -46.43 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.579 0.352 . . . . 0.0 110.595 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -49.5 -58.61 4.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.76 1.224 . . . . 0.0 113.193 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.2 tp -68.32 -33.82 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.484 1.114 . . . . 0.0 113.849 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.56 -39.56 91.07 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 125.408 1.48 . . . . 0.0 115.11 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -178.409 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 43.4 mt -43.49 -52.99 12.52 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.57 -54.93 2.05 Favored 'Trans proline' 0 C--N 1.356 0.941 0 CA-C-N 122.913 2.076 . . . . 0.0 113.411 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 4.2 p -63.85 -36.28 83.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.91 1.284 . . . . 0.0 112.668 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 35.6 mt -55.5 -59.18 5.19 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 50.5 mt -51.14 -46.81 62.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.578 0.751 . . . . 0.0 112.893 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.29 -57.52 10.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.533 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 84.8 p -56.39 -44.22 80.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -61.34 -51.34 69.23 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 177' ' ' ILE . 3.8 mp -61.81 -39.79 92.99 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.1 -25.69 55.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.63 98.84 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.719 0.637 . . . . 0.0 111.284 165.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' B' ' 174' ' ' LEU . 30.5 mt -58.97 -54.93 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.145 0.903 . . . . 0.0 109.114 169.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.08 -61.18 3.19 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 125.188 1.375 . . . . 0.0 113.403 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 15.9 tp -55.73 -42.1 74.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.083 1.353 . . . . 0.0 112.185 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.633 ' HA2' HD12 ' B' ' 183' ' ' ILE . . . -56.43 -48.89 72.64 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.425 1.012 . . . . 0.0 112.994 171.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mt -57.9 -41.94 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.174 0.99 . . . . 0.0 110.778 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -55.87 -46.85 78.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.633 HD12 ' HA2' ' B' ' 180' ' ' GLY . 20.6 mt . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.643 0.777 . . . . 0.0 109.886 172.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.293 2.2 mt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 119.749 3.24 . . . . 0.0 119.749 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -53.44 -65.57 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.297 2.665 . . . . 0.0 111.984 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.3 m -47.4 -45.04 24.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 47.3 mt -51.97 -64.44 0.82 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.215 -0.898 . . . . 0.0 112.057 173.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.5 mt -44.63 -59.22 2.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.356 1.462 . . . . 0.0 112.605 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.61 -48.42 81.86 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -60.28 -42.3 95.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -63.64 -48.69 76.22 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.444 HD23 HD12 ' A' ' 177' ' ' ILE . 31.7 mt -61.86 -34.27 75.68 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 -41.98 87.8 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.416 1.086 . . . . 0.0 113.153 166.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -67.52 -43.26 81.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.444 HD12 HD23 ' A' ' 174' ' ' LEU . 35.8 mt -59.25 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.017 0.527 . . . . 0.0 109.663 172.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.09 -55.16 16.27 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 124.8 1.19 . . . . 0.0 112.267 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.487 ' O ' HG12 ' A' ' 183' ' ' ILE . 46.3 tp -45.33 -57.97 3.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.124 1.37 . . . . 0.0 111.879 169.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -50.76 -48.67 43.48 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.846 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.9 mt -59.86 -58.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.436 0.694 . . . . 0.0 109.387 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -47.65 -61.0 2.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.457 1.503 . . . . 0.0 112.621 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 179' ' ' LEU . 38.2 pt -64.45 -44.76 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.47 95.78 Favored Glycine 0 N--CA 1.479 1.564 0 C-N-CA 124.886 1.231 . . . . 0.0 112.405 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 . . . . . 0 N--CA 1.47 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.36 172.578 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 55.1 t80 . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 117.699 -1.143 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.271 96.4 mt -62.64 -52.11 67.35 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 115.614 -2.136 . . . . 0.0 116.491 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -60.03 -43.28 37.42 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.41 2.073 . . . . 0.0 112.722 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 20.2 m -53.04 -55.22 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.155 0.909 . . . . 0.0 111.732 173.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 20.5 tp -52.79 -53.07 53.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.166 1.786 . . . . 0.0 112.488 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -50.92 -55.48 16.98 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' B' ' 174' ' ' LEU . 5.7 mp -61.37 -36.9 81.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.9 p -59.73 -39.29 84.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.772 1.026 . . . . 0.0 113.772 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -68.01 -43.08 79.63 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.91 0.756 . . . . 0.0 112.802 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' B' ' 171' ' ' LEU . 34.2 mt -59.07 -43.29 91.76 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.379 0.672 . . . . 0.0 111.045 172.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.71 -42.07 99.46 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.77 82.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 31.1 mt -59.09 -41.82 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.48 0.712 . . . . 0.0 110.298 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.95 -51.23 56.8 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 125.166 1.365 . . . . 0.0 114.212 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 13.1 tp -57.08 -45.69 83.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.573 0.749 . . . . 0.0 111.042 172.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -49.52 -59.41 7.22 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.335 169.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -51.11 -48.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.982 1.313 . . . . 0.0 112.98 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.546 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 36.6 t80 -40.99 -58.55 1.69 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.629 1.172 . . . . 0.0 112.876 168.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 36.1 mt . . . . . 0 N--CA 1.479 1.008 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.559 175.6 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.302 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.95 -43.73 34.95 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.093 1.862 . . . . 0.0 112.774 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.3 t -58.71 -51.69 68.9 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.347 1.059 . . . . 0.0 112.568 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.46 -57.21 12.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.591 1.957 . . . . 0.0 111.547 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 mp -46.28 -61.97 1.55 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.288 1.435 . . . . 0.0 113.69 175.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.42 -35.31 79.99 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.213 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.2 p -60.77 -45.4 94.49 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -59.75 -45.69 91.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.14 -45.62 79.54 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.735 0.647 . . . . 0.0 112.271 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.18 -38.03 89.21 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.23 93.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.266 0.626 . . . . 0.0 111.812 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.414 HG13 ' HB1' ' B' ' 176' ' ' ALA . 42.4 mt -57.43 -47.71 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.176 170.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.17 -54.34 26.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.899 1.238 . . . . 0.0 114.084 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.6 tp -49.88 -49.84 48.04 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.09 -49.51 71.4 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.655 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.49 -47.06 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.382 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -54.03 -53.67 49.88 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.257 0.973 . . . . 0.0 112.096 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.7 mt -51.68 -56.56 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.506 1.122 . . . . 0.0 111.151 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.51 22.11 Favored Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.829 1.331 . . . . 0.0 113.459 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 125.554 1.542 . . . . 0.0 111.611 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.255 4.8 mt -49.73 -60.78 4.4 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.48 -53.26 3.0 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.351 2.701 . . . . 0.0 110.874 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 8.2 p -54.87 -44.3 73.93 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.84 -67.32 0.3 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.396 168.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.85 -50.22 57.23 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.62 -44.66 93.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.006 1.322 . . . . 0.0 114.322 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -61.13 -42.45 98.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.07 -45.47 94.61 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.3 tp -50.49 -54.5 21.79 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 0.0 112.652 170.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' B' ' 175' ' ' LEU . 12.1 tp -67.68 -29.6 68.91 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -63.4 -46.44 86.39 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.354 0.661 . . . . 0.0 112.758 170.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 33.9 mt -57.04 -48.23 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 170.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.59 -54.71 15.9 Favored Glycine 0 N--CA 1.482 1.714 0 C-N-CA 124.426 1.012 . . . . 0.0 113.024 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 12.9 tp -52.96 -49.21 66.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 111.233 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.49 -52.36 28.9 Favored Glycine 0 N--CA 1.482 1.723 0 O-C-N 124.253 0.97 . . . . 0.0 113.428 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.21 -51.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.896 0.878 . . . . 0.0 110.1 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 76.8 t80 -46.34 -56.29 6.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.783 1.233 . . . . 0.0 112.729 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 125.138 1.375 . . . . 0.0 111.543 175.563 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 116.666 -1.635 . . . . 0.0 115.37 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.71 -50.51 7.78 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.313 2.009 . . . . 0.0 112.294 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.2 m -50.56 -45.5 57.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.854 0.861 . . . . 0.0 112.408 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -66.68 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.683 1.593 . . . . 0.0 111.724 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pp -62.24 -43.8 97.99 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 mt -57.72 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.45 0.7 . . . . 0.0 112.344 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.5 p -63.55 -40.12 96.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -56.48 -51.13 69.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.6 mt -54.83 -51.43 65.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 112.633 172.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.0 mt -55.76 -43.28 76.54 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.711 1.204 . . . . 0.0 114.222 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.415 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -55.26 -47.35 75.58 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.33 1.452 . . . . 0.0 113.643 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.1 mt -61.21 -41.1 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.81 . . . . 0.0 111.131 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -57.71 14.82 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 124.154 0.909 . . . . 0.0 112.3 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 182' ' ' TYR . 15.3 tp -48.67 -46.01 39.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.349 1.059 . . . . 0.0 111.827 172.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.85 -57.54 10.77 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.977 1.275 . . . . 0.0 113.548 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 33.7 mt -53.56 -43.93 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.654 1.182 . . . . 0.0 111.828 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 179' ' ' LEU . 88.6 t80 -51.83 -54.11 32.62 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.044 0.84 . . . . 0.0 112.376 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.6 mt -56.54 -54.45 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.278 1.031 . . . . 0.0 109.863 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -44.34 -60.6 3.56 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 125.773 1.654 . . . . 0.0 112.577 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.8 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 . . . . . 0 N--CA 1.486 1.346 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 21.7 tp -44.47 -51.65 19.72 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 116.163 -1.875 . . . . 0.0 115.575 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -56.2 -52.45 7.18 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.451 2.101 . . . . 0.0 112.761 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 25.6 p -61.74 -35.22 77.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 52.5 mt -54.82 -64.15 0.93 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 117.726 -1.13 . . . . 0.0 112.291 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.514 ' O ' HD12 ' B' ' 174' ' ' LEU . 19.1 mt -51.78 -50.04 61.49 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.198 0.999 . . . . 0.0 112.794 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 36.0 tp -53.31 -54.68 32.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.591 1.556 . . . . 0.0 112.737 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . 0.544 ' HA ' HD12 ' B' ' 175' ' ' LEU . 76.8 p -63.66 -31.62 72.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -59.63 -49.4 77.89 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.532 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . 0.514 HD12 ' O ' ' B' ' 170' ' ' LEU . 0.5 OUTLIER -56.41 -43.61 79.52 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 172.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' B' ' 172' ' ' SER . 79.4 mt -54.99 -51.62 65.65 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.647 0.779 . . . . 0.0 112.828 170.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.45 -47.29 86.77 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.114 1.366 . . . . 0.0 114.118 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.415 HG13 ' HB1' ' A' ' 176' ' ' ALA . 26.0 mt -58.92 -49.11 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.162 0.585 . . . . 0.0 109.448 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.93 10.44 Favored Glycine 0 N--CA 1.483 1.823 0 O-C-N 124.665 1.228 . . . . 0.0 112.538 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.78 -45.94 70.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.885 1.274 . . . . 0.0 112.514 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -49.93 62.04 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 124.735 1.16 . . . . 0.0 113.123 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 177' ' ' ILE . 17.7 mt -60.61 -48.62 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.076 0.95 . . . . 0.0 109.152 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -40.89 -59.65 1.38 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.101 1.36 . . . . 0.0 112.273 169.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.483 1.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.829 174.651 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -65.32 -58.45 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.904 1.736 . . . . 0.0 112.598 168.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 m -43.57 -44.77 6.35 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.6 tp -44.62 -67.59 0.27 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.237 2.215 . . . . 0.0 112.31 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 mp -71.26 -37.86 71.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.409 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.7 mt -49.1 -57.44 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.132 0.895 . . . . 0.0 111.334 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.5 t -54.05 -58.94 5.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.129 1.371 . . . . 0.0 111.697 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -50.35 -68.54 0.16 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.27 -55.23 35.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.26 -48.09 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.457 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -66.68 -39.09 87.99 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.509 HG13 ' HB1' ' B' ' 176' ' ' ALA . 56.5 mt -55.86 -45.21 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.985 0.514 . . . . 0.0 110.689 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.11 -53.33 41.09 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 124.227 0.918 . . . . 0.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 16.7 tp -52.77 -47.22 67.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.563 0.745 . . . . 0.0 112.32 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.622 ' HA2' HD12 ' A' ' 183' ' ' ILE . . . -54.1 -51.79 47.94 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.868 173.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.7 mt -48.56 -46.0 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.159 0.983 . . . . 0.0 113.132 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -53.71 -56.28 18.74 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.658 0.599 . . . . 0.0 112.308 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.622 HD12 ' HA2' ' A' ' 180' ' ' GLY . 23.0 mt -50.59 -53.37 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.875 1.27 . . . . 0.0 110.326 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.81 -59.84 9.66 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 124.738 1.161 . . . . 0.0 112.278 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 125.552 1.541 . . . . 0.0 112.69 174.934 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.34 -41.62 61.2 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.145 -1.407 . . . . 0.0 114.345 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -51.49 -52.77 8.31 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.868 2.379 . . . . 0.0 114.32 165.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -59.66 -40.45 87.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.179 0.992 . . . . 0.0 113.432 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.16 -44.89 95.61 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.524 0.73 . . . . 0.0 112.414 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.19 -51.37 70.01 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.785 0.834 . . . . 0.0 112.087 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 25.6 tp -49.03 -53.48 19.94 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.592 1.557 . . . . 0.0 111.826 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 33.3 t -54.81 -57.29 12.17 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.909 1.284 . . . . 0.0 112.192 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -47.41 -52.39 17.01 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.358 1.063 . . . . 0.0 113.245 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.28 -50.37 73.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 47.5 mt -71.49 -32.31 68.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.509 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -66.47 -47.46 72.99 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.585 0.754 . . . . 0.0 111.615 169.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.457 HG13 ' HB1' ' A' ' 176' ' ' ALA . 23.2 mt -50.23 -53.59 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.179 1.392 . . . . 0.0 110.787 167.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.07 -60.21 4.64 Favored Glycine 0 N--CA 1.483 1.814 0 O-C-N 124.415 1.072 . . . . 0.0 113.286 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 15.4 tp -50.95 -46.34 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.606 1.162 . . . . 0.0 112.225 173.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.22 -53.33 43.56 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 124.773 1.178 . . . . 0.0 113.63 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 23.2 mt -53.31 -46.8 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.862 0.865 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 22.0 t80 -49.44 -59.63 3.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.835 1.654 . . . . 0.0 113.449 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.632 0.73 . . . . 0.0 111.651 177.539 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 166' ' ' LEU 0.27 36.0 mt . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.646 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -46.96 -52.09 8.26 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.12 2.547 . . . . 0.0 114.237 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.1 p -66.12 -47.2 74.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.14 -58.4 6.24 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.102 0.961 . . . . 0.0 110.999 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.6 mt -54.29 -52.74 60.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.631 1.172 . . . . 0.0 112.704 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.4 tp -55.15 -51.84 65.2 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.174 0.99 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.8 p -57.05 -39.7 75.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -63.27 -48.09 79.62 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 177' ' ' ILE . 14.6 tp -58.76 -45.31 90.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.575 0.75 . . . . 0.0 112.394 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.46 -35.62 81.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -61.97 -42.12 98.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.333 0.653 . . . . 0.0 112.422 172.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 174' ' ' LEU . 27.2 mt -59.33 -49.57 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 169.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -47.75 -55.78 9.31 Favored Glycine 0 CA--C 1.546 2.008 0 C-N-CA 124.952 1.263 . . . . 0.0 113.091 174.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 55.9 tp -45.74 -56.76 4.9 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.296 1.439 . . . . 0.0 112.697 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.52 -48.24 55.66 Favored Glycine 0 CA--C 1.541 1.689 0 O-C-N 124.533 1.146 . . . . 0.0 113.756 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.407 HD12 ' HA2' ' A' ' 178' ' ' GLY . 27.0 mt -57.54 -50.78 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.96 0.504 . . . . 0.0 110.11 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -53.74 -54.79 33.16 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.704 1.253 . . . . 0.0 112.427 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.6 mt -53.85 -56.38 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.318 0.647 . . . . 0.0 111.356 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -46.76 -58.26 6.22 Favored Glycine 0 N--CA 1.487 2.036 0 O-C-N 124.481 1.113 . . . . 0.0 112.168 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 53.8 t80 . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -47.88 97.67 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.1 -52.86 6.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.75 2.3 . . . . 0.0 112.992 170.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 19.5 t -52.09 -48.99 64.44 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.182 0.993 . . . . 0.0 111.864 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.9 mp -55.34 -65.45 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.907 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mt -41.08 -61.5 0.99 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.363 1.465 . . . . 0.0 114.921 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' B' ' 174' ' ' LEU . 54.2 mt -62.79 -36.73 84.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -77.7 -34.37 52.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -67.3 -40.15 86.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' B' ' 171' ' ' LEU . 70.1 mt -53.81 -53.16 56.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 0.0 111.929 168.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 7.7 mt -48.48 -47.93 38.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.233 1.013 . . . . 0.0 113.237 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.416 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -57.73 -52.01 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.497 HG13 ' HB1' ' A' ' 176' ' ' ALA . 29.0 mt -61.28 -42.33 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.31 0.644 . . . . 0.0 110.636 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.99 -51.48 55.24 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.848 1.213 . . . . 0.0 112.831 173.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.35 -44.34 44.59 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.43 -57.36 19.0 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.456 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -47.76 -52.2 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.947 1.299 . . . . 0.0 110.971 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.61 -50.15 25.07 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.942 0.897 . . . . 0.0 113.227 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 122.913 0.485 . . . . 0.0 110.563 173.842 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 169' ' ' LEU 0.285 35.7 mt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -51.96 -71.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 121.518 1.479 . . . . 0.0 112.125 164.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 p -55.78 -42.31 75.36 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 47.1 mt -56.35 -61.36 2.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.49 -17.74 62.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.98 -41.04 82.94 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 165.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 175' ' ' LEU . 6.9 p -61.68 -34.39 75.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 169.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -72.93 -38.47 66.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 118.28 -0.867 . . . . 0.0 113.211 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.6 tp -51.81 -47.01 64.49 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.649 0.593 . . . . 0.0 111.555 168.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 172' ' ' SER . 94.5 mt -49.62 -56.69 9.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.834 0.709 . . . . 0.0 112.436 168.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.52 -52.6 63.13 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.42 HG13 ' HB1' ' B' ' 176' ' ' ALA . 30.2 mt -56.04 -47.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.369 1.067 . . . . 0.0 110.357 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.15 -57.39 10.18 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.912 1.244 . . . . 0.0 112.724 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 30.0 tp -53.11 -45.96 68.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.221 1.009 . . . . 0.0 112.499 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.66 -56.07 6.72 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 125.233 1.397 . . . . 0.0 113.822 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.8 mt -59.32 -53.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.314 -0.943 . . . . 0.0 109.565 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -51.84 -58.24 7.02 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.559 -1.2 . . . . 0.0 113.101 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 184' ' ' GLY 0.256 2.9 pp -60.79 -38.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 183' ' ' ILE . . . -59.58 -47.61 90.05 Favored Glycine 0 N--CA 1.481 1.689 0 C-N-CA 123.83 0.728 . . . . 0.0 112.943 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 . . . . . 0 N--CA 1.478 0.974 0 CA-C-N 114.213 -0.994 . . . . 0.0 111.83 174.236 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' B' ' 169' ' ' LEU . 54.3 tp -54.91 -42.29 94.85 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.226 -1.369 . . . . 0.0 113.479 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -54.09 -51.84 9.72 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.132 1.888 . . . . 0.0 113.504 168.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 41.4 m -53.15 -48.67 67.76 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' B' ' 166' ' ' LEU . 80.4 mt -50.71 -59.89 3.61 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.665 170.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.0 mt -50.64 -57.91 7.1 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.99 -52.85 47.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.794 0.837 . . . . 0.0 113.164 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 60.5 p -66.77 -42.52 85.96 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -63.9 -43.38 96.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.74 -47.46 79.98 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 170.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 39.0 mt -56.68 -42.55 79.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 170.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.42 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -65.17 -43.65 91.02 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 175.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 44.0 mt -55.37 -47.48 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 168.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.38 -53.57 23.75 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.52 1.057 . . . . 0.0 113.014 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.25 -41.75 69.14 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.79 -54.11 29.84 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.153 0.882 . . . . 0.0 112.42 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 13.2 mt -53.8 -54.32 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.614 1.166 . . . . 0.0 110.531 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -49.52 -50.95 39.65 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.193 1.797 . . . . 0.0 113.97 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.613 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.0 tp . . . . . 0 CA--C 1.553 1.059 0 CA-C-O 115.907 -1.997 . . . . 0.0 113.703 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.36 -52.32 4.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.35 2.033 . . . . 0.0 112.759 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -46.45 63.08 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.28 -66.55 0.51 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.866 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -47.15 -53.21 13.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.498 1.119 . . . . 0.0 113.978 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.01 -44.79 95.02 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.9 p -70.86 -41.89 70.81 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -57.81 -42.92 85.24 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' A' ' 177' ' ' ILE . 28.0 mt -56.19 -52.9 62.71 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 169.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.0 mt -49.17 -47.5 45.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 112.221 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.3 -48.57 76.41 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 174' ' ' LEU . 16.4 mt -59.81 -49.26 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 123.55 0.74 . . . . 0.0 110.462 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.1 -51.27 36.09 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 124.25 0.928 . . . . 0.0 112.027 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.09 -46.13 79.14 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.214 1.005 . . . . 0.0 112.012 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -48.42 -53.65 15.52 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.253 0.93 . . . . 0.0 113.438 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.14 -50.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.252 0.621 . . . . 0.0 109.792 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.83 -55.63 18.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.041 0.936 . . . . 0.0 113.255 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -48.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.39 -55.59 12.69 Favored Glycine 0 N--CA 1.481 1.694 0 C-N-CA 124.196 0.903 . . . . 0.0 111.46 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 . . . . . 0 N--CA 1.476 0.872 0 C-N-CA 125.301 1.441 . . . . 0.0 114.402 174.845 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' B' ' 169' ' ' LEU . 15.3 tp -53.49 -38.44 62.19 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 116.362 -1.78 . . . . 0.0 115.722 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -60.9 -64.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 CA-C-O 116.703 -1.457 . . . . 0.0 111.126 168.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -43.38 -42.78 4.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' B' ' 166' ' ' LEU . 41.6 mt -53.95 -71.08 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.089 0.956 . . . . 0.0 111.276 170.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 4.8 mt -46.43 -46.94 19.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.6 1.56 . . . . 0.0 114.73 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 67.1 mt -57.11 -53.54 56.91 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.138 1.375 . . . . 0.0 112.751 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 85.5 p -61.98 -39.69 93.04 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -58.49 -45.05 89.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . 0.52 HD12 HD12 ' B' ' 177' ' ' ILE . 6.4 tp -66.8 -38.64 86.88 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 tp -55.19 -46.24 75.85 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.048 0.939 . . . . 0.0 110.429 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.66 80.03 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.52 HD12 HD12 ' B' ' 174' ' ' LEU . 36.7 mt -57.56 -48.08 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 117.748 0.249 . . . . 0.0 110.736 173.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.51 -49.67 38.61 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.322 0.963 . . . . 0.0 112.977 174.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 14.6 tp -53.12 -45.14 68.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.117 0.967 . . . . 0.0 112.557 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -55.71 -51.6 53.94 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.589 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 9.1 mt -59.03 -45.44 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.318 0.647 . . . . 0.0 109.587 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 48.3 t80 -47.82 -49.97 27.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.637 1.175 . . . . 0.0 113.504 171.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt . . . . . 0 N--CA 1.481 1.088 0 C-N-CA 123.349 0.66 . . . . 0.0 110.941 174.451 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.254 35.3 mt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.32 -59.11 0.47 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.8 p -59.42 -40.65 87.38 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.4 tp -50.7 -63.32 1.16 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.639 1.576 . . . . 0.0 110.756 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.42 -42.33 77.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.439 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.0 tp -53.6 -47.69 69.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.596 1.159 . . . . 0.0 111.654 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 175' ' ' LEU . 24.7 p -66.62 -39.59 88.4 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -69.71 -35.45 75.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.4 mt -55.49 -49.05 73.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.956 0.785 . . . . 0.0 111.645 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 172' ' ' SER . 86.6 mt -51.55 -52.18 49.31 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 170.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.17 75.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.4 mt -59.1 -48.89 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.648 1.179 . . . . 0.0 111.695 169.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.1 -47.62 88.07 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.252 0.93 . . . . 0.0 113.25 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.86 -41.99 78.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.751 1.621 . . . . 0.0 111.575 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.18 -51.24 58.66 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.266 1.412 . . . . 0.0 112.321 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 29.8 mt -55.86 -47.67 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.378 1.071 . . . . 0.0 111.311 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -50.42 -63.16 1.21 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.47 1.106 . . . . 0.0 112.798 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 183' ' ' ILE . 7.4 tp -69.59 -35.27 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.44 43.71 Favored Glycine 0 N--CA 1.479 1.515 0 C-N-CA 124.307 0.956 . . . . 0.0 111.832 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.528 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 C--O 1.219 -0.553 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.71 -34.96 7.16 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 -62.41 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 122.085 1.857 . . . . 0.0 112.406 160.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 36.4 p -55.42 -41.93 73.45 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.98 -62.16 2.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 116.513 -1.708 . . . . 0.0 113.079 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' B' ' 174' ' ' LEU . 22.6 tp -50.98 -53.92 28.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.526 0.73 . . . . 0.0 112.018 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt -60.01 -52.21 66.34 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 95.2 p -62.51 -39.35 93.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -58.72 -48.06 82.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 0.0 111.795 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' B' ' 177' ' ' ILE . 84.2 mt -53.74 -45.7 70.64 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.241 1.017 . . . . 0.0 112.64 172.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 27.4 tp -57.66 -46.49 84.16 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.129 0.572 . . . . 0.0 112.163 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.38 96.78 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 174' ' ' LEU . 26.7 mt -57.26 -48.44 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.26 -55.09 20.78 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 124.396 0.998 . . . . 0.0 112.593 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.408 ' O ' HG12 ' B' ' 183' ' ' ILE . 23.3 mt -51.66 -46.51 63.78 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.61 -52.83 45.54 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 124.787 1.185 . . . . 0.0 112.527 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.88 -48.26 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 113.758 -1.221 . . . . 0.0 110.281 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -30.38 41.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 179' ' ' LEU . 44.4 pt . . . . . 0 N--CA 1.486 1.339 0 CA-C-N 119.677 1.126 . . . . 0.0 111.178 170.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 169' ' ' LEU . 7.3 tp . . . . . 0 CA--C 1.549 0.931 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -54.66 -58.87 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.848 2.365 . . . . 0.0 114.182 171.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.2 p -58.67 -39.36 80.42 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 2.8 mp -54.21 -66.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 171.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 30.5 mt -50.86 -43.35 59.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.15 -49.89 70.34 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.1 p -69.62 -29.18 66.62 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.438 ' HE1' HD23 ' A' ' 169' ' ' LEU . 24.3 m170 -57.18 -44.96 84.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.074 0.549 . . . . 0.0 111.905 165.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.98 -35.22 76.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.03 -50.24 73.34 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.546 0.529 . . . . 0.0 111.994 167.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.426 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -58.49 -48.97 79.03 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.55 -47.23 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.67 1.188 . . . . 0.0 111.648 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.75 -57.75 11.78 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.411 1.481 . . . . 0.0 111.678 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.0 tp -49.7 -46.23 49.83 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.943 1.297 . . . . 0.0 112.171 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -46.81 -62.3 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.618 1.58 . . . . 0.0 113.847 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.91 -31.94 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -49.01 -67.41 0.27 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.313 1.045 . . . . 0.0 112.223 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . 0.294 2.3 pp -67.83 -30.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.27 -64.34 3.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 124.997 1.284 . . . . 0.0 112.723 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 176.335 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' B' ' 168' ' ' SER . 4.4 p90 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.98 -46.01 30.8 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.732 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -55.4 -45.56 39.05 Favored 'Trans proline' 0 N--CA 1.48 0.681 0 C-N-CA 122.284 1.989 . . . . 0.0 111.923 164.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' B' ' 165' ' ' PHE . 55.0 m -47.55 -52.58 17.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.143 0.977 . . . . 0.0 112.003 174.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.412 HD21 HD11 ' A' ' 169' ' ' LEU . 58.7 mt -53.35 -61.62 2.18 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.882 0.873 . . . . 0.0 113.289 176.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 11.4 mt -54.97 -52.05 64.26 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.526 -1.215 . . . . 0.0 113.637 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.75 -58.79 7.06 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.245 1.418 . . . . 0.0 112.64 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 87.4 p -64.03 -37.27 86.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -66.79 -40.25 88.08 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.53 -51.07 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.569 0.7 . . . . 0.0 111.292 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.52 -38.91 72.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.393 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.28 86.15 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.426 HG13 ' HB1' ' A' ' 176' ' ' ALA . 6.9 mt -57.26 -48.46 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 171.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.53 -57.31 9.53 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.269 1.414 . . . . 0.0 112.618 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 62.4 tp -45.82 -53.12 10.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.19 -62.27 3.98 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 124.642 1.115 . . . . 0.0 112.963 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -54.25 -51.11 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.85 0.86 . . . . 0.0 110.828 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -61.18 -33.54 73.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.1 mt . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 123.237 0.615 . . . . 0.0 110.086 171.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 169' ' ' LEU 0.251 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -55.06 -44.62 47.83 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 121.885 1.723 . . . . 0.0 112.507 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.2 m -51.79 -53.29 41.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.869 0.868 . . . . 0.0 112.798 170.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 166' ' ' LEU . 22.4 mt -55.8 -44.84 78.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 173.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.4 mt -59.74 -50.91 71.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.008 0.923 . . . . 0.0 113.005 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.0 tp -57.12 -45.58 83.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.327 1.051 . . . . 0.0 110.998 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.8 t -51.2 -58.62 5.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.177 1.391 . . . . 0.0 113.487 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -48.01 -51.58 23.38 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.474 1.109 . . . . 0.0 113.494 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 44.2 tp -54.22 -57.07 12.56 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.767 1.227 . . . . 0.0 112.788 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.6 mt -54.35 -44.85 72.52 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.09 -54.48 7.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.617 HG13 ' HB1' ' B' ' 176' ' ' ALA . 25.5 mt -55.9 -40.94 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.123 0.569 . . . . 0.0 110.297 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -62.1 5.97 Favored Glycine 0 N--CA 1.48 1.597 0 O-C-N 124.801 1.313 . . . . 0.0 112.35 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.03 -49.75 30.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.807 0.843 . . . . 0.0 113.108 171.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.62 -64.22 3.85 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 125.268 1.413 . . . . 0.0 114.168 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.8 pp -56.62 -33.94 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.8 -58.05 6.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.906 1.282 . . . . 0.0 113.219 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 21.5 mt -56.9 -34.69 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.548 0.739 . . . . 0.0 111.166 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.24 31.35 0.96 Allowed Glycine 0 CA--C 1.54 1.622 0 N-CA-C 116.439 1.335 . . . . 0.0 116.439 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.614 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 26.7 t80 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.16 -53.23 67.53 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 115.842 -2.028 . . . . 0.0 114.737 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -56.39 -50.19 12.73 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 123.161 2.574 . . . . 0.0 113.159 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.7 m -57.02 -45.97 82.68 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.74 -46.19 89.24 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.023 1.329 . . . . 0.0 114.424 174.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.7 mt -53.23 -56.92 12.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.569 0.7 . . . . 0.0 111.113 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' B' ' 171' ' ' LEU . 9.9 tp -58.71 -45.15 90.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.393 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 42.8 t -47.78 -60.39 2.61 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.791 1.237 . . . . 0.0 113.062 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.55 -47.65 72.97 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.163 0.914 . . . . 0.0 113.21 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 4.7 mp -60.93 -53.78 53.05 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.9 mt -51.29 -54.56 24.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.33 1.052 . . . . 0.0 111.094 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.617 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -60.7 -48.75 80.37 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.396 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 tt -64.19 -41.92 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.38 63.6 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 124.09 0.869 . . . . 0.0 112.008 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 9.5 tp -54.44 -50.47 67.59 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 113.611 -1.294 . . . . 0.0 111.588 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' B' ' 183' ' ' ILE . . . -49.47 -54.18 17.5 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 124.984 1.278 . . . . 0.0 113.941 176.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 10.2 mt -56.16 -48.56 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.632 0.773 . . . . 0.0 111.484 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -51.23 -52.35 45.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.901 0.881 . . . . 0.0 112.351 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.411 HD12 ' HA2' ' B' ' 180' ' ' GLY . 34.0 mt . . . . . 0 N--CA 1.483 1.218 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.879 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.276 17.9 mt . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 115.639 -2.124 . . . . 0.0 116.662 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -57.27 -57.5 1.25 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.203 1.935 . . . . 0.0 112.536 171.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.7 m -45.4 -46.01 13.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 37.2 mt -62.48 -54.25 42.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.492 1.517 . . . . 0.0 114.606 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.47 -43.74 68.39 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.572 0.749 . . . . 0.0 112.164 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.1 mt -53.08 -63.11 1.25 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.101 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.6 p -59.1 -43.34 91.85 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -66.03 -46.98 75.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 174' ' ' LEU . 8.7 mt -56.29 -45.62 80.13 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.3 mt -60.8 -45.33 94.85 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.463 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.1 -46.54 79.06 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.439 HG13 ' HB1' ' B' ' 176' ' ' ALA . 11.0 mt -47.53 -54.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.789 0.835 . . . . 0.0 111.385 170.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.549 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -51.98 -56.81 14.76 Favored Glycine 0 CA--C 1.544 1.872 0 C-N-CA 124.548 1.07 . . . . 0.0 113.138 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.7 mt -51.83 -48.68 63.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.317 1.047 . . . . 0.0 111.702 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.68 -51.12 40.14 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.231 1.396 . . . . 0.0 112.488 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.549 HD12 ' HA2' ' A' ' 178' ' ' GLY . 21.5 mt -54.66 -54.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.023 1.329 . . . . 0.0 110.373 174.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -53.02 -51.71 60.8 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.969 1.418 . . . . 0.0 111.038 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.4 mt -56.67 -62.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 124.382 1.073 . . . . 0.0 109.796 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.76 4.48 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 124.734 1.159 . . . . 0.0 113.366 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.368 1.067 . . . . 0.0 112.741 -179.678 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.296 1.5 mm? -40.51 -61.56 1.17 Allowed Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.28 -56.51 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 122.966 2.444 . . . . 0.0 111.382 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 3.1 p -64.05 -27.82 69.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 38.0 tp -63.41 -52.63 60.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.997 1.319 . . . . 0.0 112.248 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -58.29 -36.34 73.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.38 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.68 -33.52 66.57 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 69.7 m -71.0 -35.04 71.93 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 172.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -56.29 -42.66 77.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.583 165.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.26 -34.69 65.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.82 -54.24 44.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.306 1.442 . . . . 0.0 110.895 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.439 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -55.09 -48.36 73.66 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.463 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.9 mt -61.3 -51.04 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.5 1.12 . . . . 0.0 111.823 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.94 -53.89 24.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.671 1.605 . . . . 0.0 112.845 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.54 -47.3 76.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.906 0.882 . . . . 0.0 112.731 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.18 -53.51 23.17 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.989 1.281 . . . . 0.0 113.131 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.66 -46.66 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.067 0.947 . . . . 0.0 112.517 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -51.4 -55.51 18.22 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.531 0.519 . . . . 0.0 112.392 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 181' ' ' ILE 0.26 6.4 tp . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.334 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.15 -66.12 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.183 2.588 . . . . 0.0 111.17 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.0 m -48.73 -56.6 8.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.641 1.576 . . . . 0.0 112.47 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.8 mt -42.54 -51.26 5.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.804 1.642 . . . . 0.0 114.199 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.65 -26.69 20.61 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.95 -35.71 74.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 170.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -68.84 -38.0 79.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 168.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.1 mt -53.49 -50.38 65.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.579 0.752 . . . . 0.0 112.263 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.6 tp -51.02 -53.32 34.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.17 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.08 -51.82 39.56 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 181' ' ' ILE . 19.4 mt -59.61 -56.58 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.412 0.685 . . . . 0.0 110.625 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.09 -50.52 45.17 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 124.281 0.943 . . . . 0.0 112.816 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.453 HD23 HD11 ' B' ' 177' ' ' ILE . 5.5 tp -56.11 -44.13 78.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.171 1.388 . . . . 0.0 112.139 176.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -58.11 -46.37 92.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.99 0.805 . . . . 0.0 113.2 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 177' ' ' ILE . 2.4 mp -53.08 -45.81 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 124.139 0.552 . . . . 0.0 111.425 172.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -56.57 -55.36 34.82 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.6 mt -53.32 -57.82 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.179 0.991 . . . . 0.0 111.243 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.82 -50.26 32.54 Favored Glycine 0 CA--C 1.548 2.124 0 C-N-CA 124.783 1.183 . . . . 0.0 112.403 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 177.065 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.507 HD23 HD23 ' B' ' 169' ' ' LEU 0.256 23.8 mt -43.35 -43.62 11.39 Favored Pre-proline 0 N--CA 1.481 1.1 0 N-CA-C 118.714 2.857 . . . . 0.0 118.714 -177.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -51.7 -66.62 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.498 2.799 . . . . 0.0 113.199 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 19.5 p -54.26 -42.55 70.07 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.507 HD23 HD23 ' B' ' 166' ' ' LEU . 41.6 tp -55.96 -58.0 9.73 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.492 1.12 . . . . 0.0 112.218 175.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -47.2 85.96 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 173.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 51.9 tp -54.5 -45.58 73.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -62.1 -44.77 95.94 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.559 0.537 . . . . 0.0 112.173 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -67.72 -37.2 81.89 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.715 1.206 . . . . 0.0 112.488 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 20.3 mt -60.32 -51.14 70.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.697 1.199 . . . . 0.0 112.326 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.5 mt -58.77 -45.48 89.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.67 86.98 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.453 HD11 HD23 ' A' ' 179' ' ' LEU . 2.3 tt -70.9 -36.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.86 -50.4 54.66 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.244 0.926 . . . . 0.0 111.191 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.41 -42.74 82.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.721 -0.739 . . . . 0.0 112.651 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -51.64 -56.81 14.03 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.087 0.851 . . . . 0.0 112.674 170.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 6.2 mt -60.6 -41.01 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.727 0.811 . . . . 0.0 109.881 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -51.81 -61.75 2.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.286 1.034 . . . . 0.0 111.156 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 28.0 mt . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.865 177.434 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.113 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -67.11 -43.84 5.87 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 121.774 1.649 . . . . 0.0 114.705 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.3 p -68.11 -38.38 82.21 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 169' ' ' LEU . 46.6 mt -66.98 -39.91 87.31 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 17.0 mt -51.85 -47.2 64.54 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 167.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.37 -53.89 53.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 59.2 p -59.61 -39.7 85.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -68.75 -43.47 75.78 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 tp -57.43 -44.89 85.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.179 0.992 . . . . 0.0 111.918 170.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -48.78 79.52 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.378 1.071 . . . . 0.0 112.123 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.43 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -58.08 -46.54 85.29 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.521 1.129 . . . . 0.0 113.609 176.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.507 HG22 HD11 ' A' ' 181' ' ' ILE . 58.9 mt -53.68 -53.32 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.307 0.643 . . . . 0.0 110.118 170.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.495 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -48.52 -51.2 22.77 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.155 1.359 . . . . 0.0 113.88 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -52.38 -48.66 65.48 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.01 -48.38 83.03 Favored Glycine 0 N--CA 1.488 2.103 0 O-C-N 124.181 0.926 . . . . 0.0 112.43 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 177' ' ' ILE . 27.0 mt -56.89 -49.22 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 124.944 1.297 . . . . 0.0 110.471 175.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.84 -49.14 59.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.563 1.145 . . . . 0.0 112.922 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.5 mm -52.91 -50.78 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.325 0.65 . . . . 0.0 111.231 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.14 -56.59 22.48 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 124.55 1.071 . . . . 0.0 113.075 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 22.8 mtt180 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.147 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.268 16.5 mt -46.88 -56.03 13.1 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 116.288 -1.815 . . . . 0.0 115.728 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.46 -45.32 11.93 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.453 2.102 . . . . 0.0 114.716 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 39.0 m -63.08 -38.62 91.91 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.26 -48.37 80.64 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.947 1.299 . . . . 0.0 111.698 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.56 -49.43 74.86 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.62 0.368 . . . . 0.0 111.306 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 39.3 p -61.64 -38.93 89.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -62.27 -45.67 92.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.33 -45.31 72.64 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 22.3 mt -62.29 -38.97 91.4 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.47 82.93 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.43 HG13 ' HB1' ' A' ' 176' ' ' ALA . 18.7 mt -60.08 -41.39 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.13 -52.18 23.25 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 124.919 1.247 . . . . 0.0 113.243 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.64 -44.51 85.68 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.919 0.888 . . . . 0.0 111.782 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.42 -55.35 30.57 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 115.313 -0.858 . . . . 0.0 114.269 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 4.8 tp -62.45 -28.73 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 112.824 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.75 -53.72 55.24 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.358 0.663 . . . . 0.0 110.66 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 34.0 mt . . . . . 0 N--CA 1.488 1.431 0 C-N-CA 124.149 0.98 . . . . 0.0 109.302 171.185 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.294 2.5 mt . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 118.318 2.71 . . . . 0.0 118.318 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.2 -52.19 9.29 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.142 1.895 . . . . 0.0 112.657 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.8 p -64.88 -38.64 91.63 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.86 -48.79 74.9 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.63 0.729 . . . . 0.0 111.509 171.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.98 -42.51 99.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.977 1.311 . . . . 0.0 113.614 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.6 tp -57.59 -46.32 84.16 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.521 0.728 . . . . 0.0 112.333 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.3 t -58.07 -45.08 87.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.566 0.746 . . . . 0.0 112.073 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.437 ' O ' HG13 ' A' ' 177' ' ' ILE . 29.3 m80 -54.98 -43.41 73.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 169.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.1 tp -64.89 -44.09 90.75 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.005 0.522 . . . . 0.0 111.723 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.19 -35.83 76.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.96 83.38 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 168.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 173' ' ' HIS . 10.5 mt -60.77 -45.29 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 173.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.66 -54.23 18.11 Favored Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.196 0.935 . . . . 0.0 113.266 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 183' ' ' ILE . 7.4 tt -50.73 -47.47 59.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 111.626 174.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -57.06 -56.16 26.51 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 124.3 1.0 . . . . 0.0 113.485 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.5 mt -53.58 -50.45 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.062 0.945 . . . . 0.0 110.178 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -50.13 -64.3 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.981 1.426 . . . . 0.0 112.268 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 179' ' ' LEU . 27.2 pt -59.73 -43.77 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.32 -53.68 23.02 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 125.654 1.597 . . . . 0.0 113.622 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 54.5 ttt-85 . . . . . 0 N--CA 1.476 0.834 0 O-C-N 124.417 0.716 . . . . 0.0 112.695 178.431 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 79.3 t80 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 25.3 mt -47.09 -45.56 52.93 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -52.19 -63.65 0.24 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.468 2.779 . . . . 0.0 114.753 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 96.3 p -55.89 -43.98 77.74 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.19 0.596 . . . . 0.0 111.951 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.0 tp -52.2 -57.42 9.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.839 1.656 . . . . 0.0 111.852 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tp -53.01 -59.06 5.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.878 1.271 . . . . 0.0 111.125 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 39.1 mt -51.65 -52.62 46.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.85 1.26 . . . . 0.0 113.548 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 24.4 t -59.62 -52.98 63.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.946 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -60.84 -41.47 95.89 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -38.39 86.71 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.27 -29.24 68.79 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 167.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.73 -44.56 85.63 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.863 0.727 . . . . 0.0 112.748 167.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.39 -43.25 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.884 0.873 . . . . 0.0 109.796 166.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -48.93 -61.92 4.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.491 1.52 . . . . 0.0 113.622 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.519 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 7.0 tp -53.17 -40.93 64.72 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.438 1.095 . . . . 0.0 112.07 172.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -52.0 -60.62 7.36 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.644 171.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.5 -31.84 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.482 0.713 . . . . 0.0 111.605 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.519 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 83.2 t80 -50.96 -52.41 42.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.407 0.683 . . . . 0.0 111.917 168.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt . . . . . 0 N--CA 1.484 1.251 0 C-N-CA 124.275 1.03 . . . . 0.0 109.765 174.372 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 117.59 -1.195 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.65 128.42 36.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.845 0.858 . . . . 0.0 110.619 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.0 t -136.83 43.28 2.41 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.821 1.296 . . . . 0.0 113.263 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.6 t -114.84 101.24 8.86 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.027 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.94 91.8 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 113.346 -1.752 . . . . 0.0 106.898 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 67.0 mtt -64.08 96.23 0.14 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 113.281 -1.781 . . . . 0.0 115.254 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -81.87 117.44 22.13 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.333 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -104.17 -69.63 0.8 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -169.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -162.05 -96.85 0.11 Allowed Glycine 0 N--CA 1.478 1.463 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' B' ' 165' ' ' PHE . . . 59.25 -117.42 11.0 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 162' ' ' LEU . 9.6 tp -106.24 108.7 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 113.814 -1.193 . . . . 0.0 110.069 175.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -63.67 -39.8 95.22 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 42.4 t -119.75 132.16 55.55 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 122.081 0.943 . . . . 0.0 113.159 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.39 -28.35 69.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 113.045 -1.889 . . . . 0.0 114.337 171.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 163' ' ' LYS . 23.2 mm-40 -64.79 -46.2 83.09 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.957 0.503 . . . . 0.0 112.144 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -60.06 -40.02 88.02 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.536 HD13 HG21 ' A' ' 156' ' ' ILE . 25.7 tp -58.36 -41.56 84.98 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.933 172.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 166' ' ' LEU . 64.4 mttp -55.69 -51.76 66.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.327 0.651 . . . . 0.0 112.169 171.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 92.9 t -52.6 -46.53 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 124.652 1.181 . . . . 0.0 111.798 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -77.12 -21.31 54.43 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 163' ' ' LYS . 24.9 mt -49.05 -40.48 45.49 Favored Pre-proline 0 N--CA 1.475 0.781 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -57.09 -56.96 1.51 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.483 2.122 . . . . 0.0 112.739 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 42.4 p -65.19 -35.6 81.59 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.92 -61.84 2.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.725 0.81 . . . . 0.0 111.922 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -45.43 73.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.837 0.855 . . . . 0.0 113.288 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.54 -53.82 53.8 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.662 0.601 . . . . 0.0 112.025 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.535 ' HA ' HD12 ' A' ' 175' ' ' LEU . 91.6 p -63.59 -42.13 98.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -64.69 -43.04 94.8 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.33 -41.66 97.39 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 172' ' ' SER . 85.0 mt -54.4 -50.52 67.37 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.579 0.752 . . . . 0.0 111.923 170.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.42 93.63 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.73 -50.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.483 0.713 . . . . 0.0 111.402 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.54 -46.65 91.8 Favored Glycine 0 CA--C 1.545 1.943 0 O-C-N 123.687 0.617 . . . . 0.0 112.114 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 183' ' ' ILE . 38.1 tp -57.86 -44.1 86.38 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.522 -0.839 . . . . 0.0 111.897 173.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.02 92.85 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.84 0.733 . . . . 0.0 113.868 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.32 -47.0 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.954 0.901 . . . . 0.0 110.494 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -59.67 -46.13 89.98 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.315 1.046 . . . . 0.0 113.027 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 179' ' ' LEU . 41.5 mm -59.49 -42.25 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.42 1.088 . . . . 0.0 111.577 173.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.19 55.36 Favored Glycine 0 N--CA 1.486 1.969 0 C-N-CA 124.092 0.853 . . . . 0.0 111.821 170.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -60.06 -45.52 92.6 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.437 ' HD3' ' HA ' ' A' ' 186' ' ' ARG . 29.5 mmt180 -64.53 -25.25 67.9 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.35 -23.86 63.82 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 170.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.4 t -111.59 -41.66 4.03 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 19.0 p -128.05 98.64 5.19 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.547 1.539 . . . . 0.0 110.07 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.432 ' HA ' HH11 ' A' ' 186' ' ' ARG . 26.0 t . . . . . 0 C--O 1.247 0.922 0 CA-C-O 116.865 -1.541 . . . . 0.0 109.38 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 116.846 -1.549 . . . . 0.0 107.704 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -94.59 -29.94 14.62 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 25.6 p -71.82 78.24 0.87 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 122.488 0.315 . . . . 0.0 110.195 164.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 47.7 t 177.08 149.18 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 110.315 -3.129 . . . . 0.0 106.9 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.57 103.09 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-O 121.838 0.828 . . . . 0.0 109.573 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 92.4 mtp -111.4 139.92 46.42 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.137 -1.392 . . . . 0.0 113.404 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -88.48 79.34 7.68 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -113.02 132.24 55.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.348 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -117.36 -94.45 1.76 Allowed Glycine 0 CA--C 1.535 1.328 0 O-C-N 125.939 2.024 . . . . 0.0 109.737 174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.23 42.39 83.5 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 113.468 -1.366 . . . . 0.0 113.78 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 43.1 pt -71.21 159.09 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.031 1.332 . . . . 0.0 112.206 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -54.27 -61.51 2.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 24.6 t -113.98 101.34 9.16 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.366 1.079 . . . . 0.0 109.886 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.92 95.28 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 113.15 -1.841 . . . . 0.0 113.577 -174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.525 ' O ' HG22 ' B' ' 164' ' ' VAL . 4.9 pm0 -66.53 -49.0 67.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.556 1.942 . . . . 0.0 114.265 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.94 -57.06 13.18 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.7 31.73 0.3 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -127.09 -72.58 0.64 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.269 163.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.525 HG22 ' O ' ' B' ' 160' ' ' GLU . 34.9 m -60.94 -30.8 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -173.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.619 ' HB2' ' HA2' ' A' ' 155' ' ' GLY . 20.4 t80 -111.41 -4.31 14.92 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 26.6 tp -55.49 -44.03 99.44 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.117 -1.42 . . . . 0.0 114.822 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -64.79 -47.92 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.649 2.232 . . . . 0.0 113.488 172.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.456 ' HA ' HD12 ' B' ' 171' ' ' LEU . 68.4 m -57.12 -35.86 69.98 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.65 -56.26 23.63 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.021 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.39 -40.01 85.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 113.503 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' B' ' 168' ' ' SER . 85.6 mt -57.08 -43.85 82.55 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 172.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' B' ' 175' ' ' LEU . 57.7 p -68.76 -28.37 66.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -61.99 -45.03 95.42 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 67.2 mt -58.0 -45.27 87.12 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.405 0.682 . . . . 0.0 111.997 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' B' ' 172' ' ' SER . 1.0 OUTLIER -53.13 -50.98 63.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.079 1.352 . . . . 0.0 112.633 170.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.78 83.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.477 1.111 . . . . 0.0 113.753 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.59 -45.17 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 0.0 111.587 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.88 -49.05 73.83 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.611 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.89 -41.42 78.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.266 1.026 . . . . 0.0 112.995 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.35 -47.01 78.0 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 124.99 1.281 . . . . 0.0 112.738 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.33 -42.34 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.394 0.677 . . . . 0.0 111.501 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.405 ' CZ ' ' HD3' ' B' ' 186' ' ' ARG . 40.1 t80 -63.99 -50.3 69.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.86 -33.53 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 117.972 0.351 . . . . 0.0 111.894 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . 0.409 ' HA2' HD12 ' B' ' 187' ' ' LEU . . . -54.87 -50.86 56.8 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 124.661 1.124 . . . . 0.0 112.884 170.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.666 HH21 ' HA ' ' B' ' 190' ' ' SER 0.288 14.8 ptm180 -67.98 -33.81 75.35 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.405 ' HD3' ' CZ ' ' B' ' 182' ' ' TYR . 14.2 mmm-85 -56.7 -34.66 67.65 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 173.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.409 HD12 ' HA2' ' B' ' 184' ' ' GLY . 53.6 mt -65.74 -24.79 67.04 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 171.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 47.9 p -117.05 -79.98 0.6 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.7 t -147.96 107.96 4.04 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.793 1.637 . . . . 0.0 110.066 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . 0.666 ' HA ' HH21 ' B' ' 185' ' ' ARG . 32.1 t . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 116.405 -1.76 . . . . 0.0 113.858 -169.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -47.82 -46.37 30.76 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 167.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.6 p -98.63 109.84 22.54 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 123.427 1.584 . . . . 0.0 114.55 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 46.0 m -139.96 -176.36 4.56 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.242 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.65 92.83 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 170.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -85.54 50.86 2.04 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 122.322 1.058 . . . . 0.0 110.993 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -121.99 138.01 54.59 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -166.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -92.64 -39.97 11.01 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 112.464 -2.153 . . . . 0.0 110.78 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.78 -131.23 0.03 OUTLIER Glycine 0 CA--C 1.538 1.477 0 O-C-N 124.866 1.354 . . . . 0.0 112.605 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 171.86 83.87 0.06 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 tp -72.9 143.04 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 125.42 1.306 . . . . 0.0 114.166 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -60.6 -45.03 95.53 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.1 t -152.87 109.28 3.4 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.36 95.57 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.715 167.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -54.32 -49.21 70.23 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.195 0.598 . . . . 0.0 111.468 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -56.91 -52.02 66.82 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.62 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.88 -36.63 72.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -49.55 -56.89 8.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.617 1.167 . . . . 0.0 112.485 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.76 -42.46 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -56.01 -42.81 77.0 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.896 1.278 . . . . 0.0 114.403 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.74 -61.82 5.63 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 116.163 -1.875 . . . . 0.0 116.017 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -63.01 -37.57 52.28 Favored 'Trans proline' 0 N--CA 1.481 0.744 0 C-N-CA 122.559 2.173 . . . . 0.0 114.697 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 p -64.63 -46.33 83.01 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.11 -49.35 78.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 9.4 mt -49.78 -55.71 13.03 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.5 -37.6 81.6 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.6 p -55.36 -47.41 75.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -66.81 -45.35 78.64 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.404 0.681 . . . . 0.0 112.787 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.616 ' HA ' HD12 ' A' ' 177' ' ' ILE . 25.4 mt -49.39 -47.1 48.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 174.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.63 -37.12 85.05 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 173.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.39 -46.79 87.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.494 0.718 . . . . 0.0 112.523 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 174' ' ' LEU . 6.2 mt -60.37 -46.22 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.466 0.706 . . . . 0.0 109.738 172.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.27 -62.78 2.62 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 125.569 1.557 . . . . 0.0 111.887 171.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.5 tp -50.57 -46.95 57.98 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.402 1.081 . . . . 0.0 111.882 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.76 -63.33 3.56 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.55 1.156 . . . . 0.0 113.996 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.47 -46.43 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.579 0.352 . . . . 0.0 110.595 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -49.5 -58.61 4.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.76 1.224 . . . . 0.0 113.193 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 4.2 tp -68.32 -33.82 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.484 1.114 . . . . 0.0 113.849 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.56 -39.56 91.07 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 125.408 1.48 . . . . 0.0 115.11 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.46 ' HD2' HD22 ' B' ' 187' ' ' LEU . 23.5 mtp180 -60.49 -23.13 64.26 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 190' ' ' SER . 68.7 mtm-85 -112.91 -13.02 13.19 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 161.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.09 -56.53 19.84 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.402 HG21 ' HB2' ' B' ' 185' ' ' ARG . 40.0 p -69.74 -66.03 0.64 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 122.845 0.458 . . . . 0.0 111.756 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 60.9 p -122.11 143.09 49.75 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.309 1.043 . . . . 0.0 109.477 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 186' ' ' ARG . 93.0 p . . . . . 0 C--O 1.258 1.528 0 CA-C-O 117.542 -1.218 . . . . 0.0 111.129 -173.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -57.6 -40.54 79.32 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 125.831 1.957 . . . . 0.0 111.672 167.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.5 m -99.72 89.65 4.19 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 169.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 39.5 m -56.83 109.7 0.68 Allowed 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 113.42 -1.718 . . . . 0.0 111.977 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.64 119.27 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.74 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -115.48 -26.94 7.33 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.949 170.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -119.26 116.18 25.72 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 168.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -66.54 -51.43 56.63 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.817 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.18 78.03 0.74 Allowed Glycine 0 CA--C 1.536 1.366 0 O-C-N 125.393 1.683 . . . . 0.0 113.014 170.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.97 -53.75 0.53 Allowed Glycine 0 N--CA 1.484 1.853 0 CA-C-N 113.686 -1.257 . . . . 0.0 115.5 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -36.84 139.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.52 -57.3 4.54 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.351 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 16.5 t -135.49 97.02 3.57 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.486 1.136 . . . . 0.0 113.195 -172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.15 -58.36 8.97 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -171.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -63.58 -36.27 83.24 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -55.66 -56.16 23.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.595 1.158 . . . . 0.0 111.573 170.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 31.5 mt -59.36 -38.79 81.34 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.508 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -59.35 -55.79 30.29 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.94 -30.52 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -66.3 -46.36 77.21 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 43.4 mt -43.49 -52.99 12.52 Favored Pre-proline 0 N--CA 1.482 1.127 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -59.57 -54.93 2.05 Favored 'Trans proline' 0 C--N 1.356 0.941 0 CA-C-N 122.913 2.076 . . . . 0.0 113.411 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 4.2 p -63.85 -36.28 83.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.91 1.284 . . . . 0.0 112.668 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 35.6 mt -55.5 -59.18 5.19 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 167.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 50.5 mt -51.14 -46.81 62.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.578 0.751 . . . . 0.0 112.893 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.29 -57.52 10.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.533 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 84.8 p -56.39 -44.22 80.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -61.34 -51.34 69.23 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 177' ' ' ILE . 3.8 mp -61.81 -39.79 92.99 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.1 -25.69 55.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.63 98.84 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.719 0.637 . . . . 0.0 111.284 165.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' B' ' 174' ' ' LEU . 30.5 mt -58.97 -54.93 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.145 0.903 . . . . 0.0 109.114 169.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.08 -61.18 3.19 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 125.188 1.375 . . . . 0.0 113.403 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 15.9 tp -55.73 -42.1 74.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.083 1.353 . . . . 0.0 112.185 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.633 ' HA2' HD12 ' B' ' 183' ' ' ILE . . . -56.43 -48.89 72.64 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.425 1.012 . . . . 0.0 112.994 171.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.9 mt -57.9 -41.94 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 124.174 0.99 . . . . 0.0 110.778 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -55.87 -46.85 78.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.633 HD12 ' HA2' ' B' ' 180' ' ' GLY . 20.6 mt -58.18 -48.27 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.643 0.777 . . . . 0.0 109.886 172.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.52 -50.53 35.72 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 125.255 1.407 . . . . 0.0 112.984 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HB2' HG21 ' A' ' 188' ' ' THR . 16.9 ttt180 -54.55 -47.84 72.74 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.383 1.073 . . . . 0.0 111.695 173.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.474 ' HA ' ' HB2' ' B' ' 190' ' ' SER . 53.1 mtt-85 -61.04 -33.02 72.64 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.46 HD22 ' HD2' ' A' ' 185' ' ' ARG . 4.6 mp -59.18 -55.91 28.91 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 167.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 41.3 p -81.08 -37.85 28.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 -170.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 19.6 p -122.88 5.39 9.38 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 118.798 2.888 . . . . 0.0 118.798 -175.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' B' ' 186' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 117.574 -1.203 . . . . 0.0 109.702 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -139.08 136.46 35.24 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -160.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.6 m -63.54 115.56 4.79 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.313 1.054 . . . . 0.0 112.667 -171.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.4 p -135.29 113.39 11.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 112.501 -2.136 . . . . 0.0 111.554 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.93 112.48 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.926 -172.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.7 ttt -139.45 147.51 41.47 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.791 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -115.28 120.02 38.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.448 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -67.31 -22.65 65.61 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 117.737 2.495 . . . . 0.0 117.737 -170.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.76 172.36 33.17 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -161.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -136.25 -69.13 0.06 OUTLIER Glycine 0 N--CA 1.471 0.98 0 CA-C-O 121.63 0.572 . . . . 0.0 113.485 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 23.6 mt -70.95 126.75 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.459 1.123 . . . . 0.0 112.311 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' B' ' 161' ' ' PHE . 65.6 m-85 -104.23 -42.27 5.56 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.267 -1.788 . . . . 0.0 114.063 171.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -122.0 94.87 4.44 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.911 0.862 . . . . 0.0 110.933 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -51.8 -46.59 64.28 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.793 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -47.18 -51.58 18.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.568 1.947 . . . . 0.0 113.32 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.9 -58.18 5.96 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.97 1.308 . . . . 0.0 112.268 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.02 -25.65 68.22 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.508 ' HA ' HD12 ' A' ' 166' ' ' LEU . 96.6 mttt -75.87 -52.61 9.96 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.749 0.819 . . . . 0.0 112.1 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.34 -47.55 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 O-C-N 124.151 0.907 . . . . 0.0 108.807 173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -34.4 51.6 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 117.643 2.461 . . . . 0.0 117.643 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 163' ' ' LYS 0.293 2.2 mt -36.6 -46.46 1.48 Allowed Pre-proline 0 N--CA 1.481 1.12 0 N-CA-C 119.749 3.24 . . . . 0.0 119.749 -173.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -53.44 -65.57 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.297 2.665 . . . . 0.0 111.984 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.3 m -47.4 -45.04 24.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 47.3 mt -51.97 -64.44 0.82 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.215 -0.898 . . . . 0.0 112.057 173.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.5 mt -44.63 -59.22 2.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.356 1.462 . . . . 0.0 112.605 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.61 -48.42 81.86 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -60.28 -42.3 95.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -63.64 -48.69 76.22 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.444 HD23 HD12 ' A' ' 177' ' ' ILE . 31.7 mt -61.86 -34.27 75.68 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 -41.98 87.8 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.416 1.086 . . . . 0.0 113.153 166.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -67.52 -43.26 81.26 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.444 HD12 HD23 ' A' ' 174' ' ' LEU . 35.8 mt -59.25 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.017 0.527 . . . . 0.0 109.663 172.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.09 -55.16 16.27 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 124.8 1.19 . . . . 0.0 112.267 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.487 ' O ' HG12 ' A' ' 183' ' ' ILE . 46.3 tp -45.33 -57.97 3.64 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.124 1.37 . . . . 0.0 111.879 169.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -50.76 -48.67 43.48 Favored Glycine 0 N--CA 1.479 1.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.846 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 13.9 mt -59.86 -58.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.436 0.694 . . . . 0.0 109.387 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 186' ' ' ARG . 72.8 t80 -47.65 -61.0 2.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.457 1.503 . . . . 0.0 112.621 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 179' ' ' LEU . 38.2 pt -64.45 -44.76 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.38 -38.47 95.78 Favored Glycine 0 N--CA 1.479 1.564 0 C-N-CA 124.886 1.231 . . . . 0.0 112.405 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -66.1 -54.16 29.1 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.36 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 13.7 mtp180 -48.56 -33.68 10.1 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 tp -44.22 -41.39 5.78 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.613 1.965 . . . . 0.0 115.023 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 19.3 m -113.37 -21.85 10.7 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -172.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.6 p -109.93 160.78 16.1 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.986 0.914 . . . . 0.0 112.459 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -174.838 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 54.2 ttt-85 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -98.32 101.72 13.25 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.297 1.046 . . . . 0.0 111.668 -170.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 9.9 t -152.85 146.7 25.25 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.038 -1.892 . . . . 0.0 111.9 -164.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 8.5 p -72.73 71.51 1.01 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 123.712 1.72 . . . . 0.0 113.754 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . 0.262 1.9 m -91.3 115.94 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 113.603 -1.635 . . . . 0.0 114.431 -174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 31.6 tpp 65.01 -64.65 0.16 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.591 2.356 . . . . 0.0 110.314 -167.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.79 117.77 4.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.061 1.744 . . . . 0.0 111.476 173.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 46.84 27.38 0.69 Allowed 'General case' 0 C--O 1.163 -3.474 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -144.73 60.05 0.5 Allowed Glycine 1 C--N 1.4 4.103 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.761 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 92.1 -170.15 32.79 Favored Glycine 0 CA--C 1.545 1.965 0 O-C-N 124.863 0.978 . . . . 0.0 111.997 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 6.3 pt -152.32 158.68 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.881 1.272 . . . . 0.0 112.664 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.74 -35.9 81.28 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 47.2 t -60.39 93.4 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 123.462 1.601 . . . . 0.0 114.119 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.602 ' HB1' ' HE2' ' B' ' 163' ' ' LYS . . . -64.9 -35.76 82.19 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 111.687 -2.506 . . . . 0.0 109.282 170.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -53.08 -43.34 66.68 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 172.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 7.3 t80 -74.79 -48.35 25.85 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.046 173.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 69.4 mt -56.8 -43.26 80.78 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.602 ' HE2' ' HB1' ' B' ' 159' ' ' ALA . 66.4 mttm -62.35 -29.34 70.4 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.2 t -77.93 -53.62 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 121.432 0.634 . . . . 0.0 110.54 171.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -54.52 -49.06 71.13 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.812 1.245 . . . . 0.0 113.77 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.271 96.4 mt -62.64 -52.11 67.35 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 115.614 -2.136 . . . . 0.0 116.491 -174.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -60.03 -43.28 37.42 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.41 2.073 . . . . 0.0 112.722 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 20.2 m -53.04 -55.22 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.155 0.909 . . . . 0.0 111.732 173.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 20.5 tp -52.79 -53.07 53.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.166 1.786 . . . . 0.0 112.488 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 25.5 mt -50.92 -55.48 16.98 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' B' ' 174' ' ' LEU . 5.7 mp -61.37 -36.9 81.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.9 p -59.73 -39.29 84.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.772 1.026 . . . . 0.0 113.772 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -68.01 -43.08 79.63 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.91 0.756 . . . . 0.0 112.802 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' B' ' 171' ' ' LEU . 34.2 mt -59.07 -43.29 91.76 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.379 0.672 . . . . 0.0 111.045 172.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.71 -42.07 99.46 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.77 82.01 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 31.1 mt -59.09 -41.82 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.48 0.712 . . . . 0.0 110.298 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.95 -51.23 56.8 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 125.166 1.365 . . . . 0.0 114.212 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 13.1 tp -57.08 -45.69 83.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.573 0.749 . . . . 0.0 111.042 172.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -49.52 -59.41 7.22 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.335 169.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -51.11 -48.81 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.982 1.313 . . . . 0.0 112.98 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.546 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 36.6 t80 -40.99 -58.55 1.69 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.629 1.172 . . . . 0.0 112.876 168.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.78 -52.38 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.559 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.06 -57.64 8.63 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 125.298 1.428 . . . . 0.0 112.677 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -56.81 -49.46 75.3 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.151 1.38 . . . . 0.0 114.235 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -63.45 -37.55 87.71 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.37 -37.18 84.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.74 1.216 . . . . 0.0 113.588 172.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 33.6 p -84.35 -73.0 0.44 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 30.4 p -128.53 107.87 10.07 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.03 0.919 . . . . 0.0 109.877 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.477 0.924 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.639 -172.5 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.7 ttt-85 . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -125.23 143.38 50.98 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.955 170.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.0 p -129.57 141.26 51.0 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.736 -167.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.5 t -93.75 128.84 40.17 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.65 113.15 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 166.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -65.48 -15.65 62.87 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 117.095 2.258 . . . . 0.0 117.095 -169.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -45.07 117.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -170.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.2 tttm 44.57 85.64 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 111.424 -2.625 . . . . 0.0 115.62 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.15 -108.59 0.02 OUTLIER Glycine 0 CA--C 1.534 1.254 0 CA-C-N 112.179 -2.282 . . . . 0.0 112.98 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.72 24.79 64.76 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 113.503 -1.349 . . . . 0.0 114.38 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.78 147.74 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -64.17 -71.44 0.18 Allowed 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.075 168.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.7 t -103.89 122.69 45.69 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.49 -34.89 31.05 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 113.554 -1.657 . . . . 0.0 112.236 168.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 14.9 mp0 -50.74 -53.33 32.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.587 1.555 . . . . 0.0 110.789 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -51.51 -57.79 8.09 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.387 1.075 . . . . 0.0 109.891 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 165' ' ' PHE . 80.5 mt -52.85 -42.34 65.11 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -61.75 -50.17 73.45 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 160' ' ' GLU . 0.7 OUTLIER -70.73 -36.73 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 122.046 0.927 . . . . 0.0 110.724 177.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 162' ' ' LEU . 46.4 t80 -54.74 -37.92 66.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.251 1.82 . . . . 0.0 113.565 173.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 13.0 tp -62.11 -49.83 83.09 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-O 116.58 -1.676 . . . . 0.0 115.302 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.95 -43.73 34.95 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.093 1.862 . . . . 0.0 112.774 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.3 t -58.71 -51.69 68.9 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.347 1.059 . . . . 0.0 112.568 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 14.4 tp -54.46 -57.21 12.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.591 1.957 . . . . 0.0 111.547 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 mp -46.28 -61.97 1.55 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.288 1.435 . . . . 0.0 113.69 175.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.3 tp -66.42 -35.31 79.99 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.213 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.2 p -60.77 -45.4 94.49 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -59.75 -45.69 91.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.14 -45.62 79.54 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.735 0.647 . . . . 0.0 112.271 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.18 -38.03 89.21 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.23 93.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.266 0.626 . . . . 0.0 111.812 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.414 HG13 ' HB1' ' B' ' 176' ' ' ALA . 42.4 mt -57.43 -47.71 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.176 170.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.17 -54.34 26.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.899 1.238 . . . . 0.0 114.084 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.6 tp -49.88 -49.84 48.04 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.818 1.247 . . . . 0.0 112.004 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.09 -49.51 71.4 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.655 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.49 -47.06 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.382 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -54.03 -53.67 49.88 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 124.257 0.973 . . . . 0.0 112.096 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.7 mt -51.68 -56.56 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.506 1.122 . . . . 0.0 111.151 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.51 22.11 Favored Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.829 1.331 . . . . 0.0 113.459 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.435 ' HA ' HG21 ' B' ' 188' ' ' THR . 0.0 OUTLIER -47.7 -56.66 6.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.554 1.542 . . . . 0.0 111.611 171.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' A' ' 186' ' ' ARG . 31.1 tpt85 -62.69 -36.82 84.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -174.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 40.8 mt -49.85 -37.13 29.43 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 170.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.9 -45.99 5.26 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 26.0 p -128.62 132.74 48.16 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.022 0.915 . . . . 0.0 112.763 -173.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.259 1.6 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.006 178.636 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 119.005 -0.522 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -116.04 166.09 12.39 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 124.41 1.069 . . . . 0.0 111.545 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -126.94 171.69 11.09 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.506 2.323 . . . . 0.0 113.507 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 15.5 t 63.43 116.98 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 126.67 1.988 . . . . 0.0 113.268 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 21.4 t 70.93 135.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.936 2.094 . . . . 0.0 109.959 -172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.51 110.64 0.17 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -83.29 111.47 19.01 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.933 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' B' ' 156' ' ' ILE . 56.9 mtpt -116.64 106.82 13.96 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.53 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -53.48 -62.59 5.87 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-N 112.855 -1.975 . . . . 0.0 113.937 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.94 -91.84 0.02 OUTLIER Glycine 0 N--CA 1.476 1.343 0 C-N-CA 124.84 1.21 . . . . 0.0 110.436 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . 0.481 ' O ' ' HE2' ' B' ' 153' ' ' LYS . 2.0 pp -118.74 131.99 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 172.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.24 -55.26 34.05 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.66 168.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 9.2 t 172.28 141.53 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.247 1.819 . . . . 0.0 110.525 170.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.24 -43.26 52.92 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -60.99 -29.63 69.8 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -75.44 -42.1 54.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.025 0.93 . . . . 0.0 111.148 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 44.4 tp -67.56 -51.69 47.63 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.533 1.533 . . . . 0.0 114.8 173.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -89.88 -63.57 1.26 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.432 ' O ' ' HD2' ' B' ' 167' ' ' PRO . 97.3 t -69.91 -59.99 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -176.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -56.53 -46.08 80.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.255 4.8 mt -49.73 -60.78 4.4 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' B' ' 164' ' ' VAL . 52.4 Cg_exo -60.48 -53.26 3.0 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.351 2.701 . . . . 0.0 110.874 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 8.2 p -54.87 -44.3 73.93 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.84 -67.32 0.3 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.396 168.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.85 -50.22 57.23 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.62 -44.66 93.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.006 1.322 . . . . 0.0 114.322 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -61.13 -42.45 98.55 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.07 -45.47 94.61 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.3 tp -50.49 -54.5 21.79 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 0.0 112.652 170.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' B' ' 175' ' ' LEU . 12.1 tp -67.68 -29.6 68.91 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -63.4 -46.44 86.39 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.354 0.661 . . . . 0.0 112.758 170.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 33.9 mt -57.04 -48.23 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 170.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.59 -54.71 15.9 Favored Glycine 0 N--CA 1.482 1.714 0 C-N-CA 124.426 1.012 . . . . 0.0 113.024 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 12.9 tp -52.96 -49.21 66.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.956 1.702 . . . . 0.0 111.233 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.49 -52.36 28.9 Favored Glycine 0 N--CA 1.482 1.723 0 O-C-N 124.253 0.97 . . . . 0.0 113.428 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.21 -51.24 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.896 0.878 . . . . 0.0 110.1 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 76.8 t80 -46.34 -56.29 6.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.783 1.233 . . . . 0.0 112.729 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.37 -61.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.138 1.375 . . . . 0.0 111.543 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.52 -52.18 29.69 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.514 1.531 . . . . 0.0 112.68 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.562 ' O ' HG22 ' B' ' 189' ' ' THR . 48.1 mtp180 -56.25 -59.84 4.37 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 117.562 -1.209 . . . . 0.0 110.71 173.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -45.78 -53.09 10.12 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 42.9 mt -56.67 -54.73 42.71 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 185' ' ' ARG . 71.6 p -78.92 -25.33 43.7 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . 0.562 HG22 ' O ' ' B' ' 185' ' ' ARG . 5.0 t -99.95 145.35 27.94 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 117.26 -1.352 . . . . 0.0 111.578 177.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -108.35 123.98 49.66 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -165.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.522 ' O ' ' HB3' ' B' ' 149' ' ' SER . 9.9 p -107.74 169.98 8.26 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.4 m -114.76 54.98 0.76 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.046 -1.434 . . . . 0.0 110.961 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.547 HG23 HG12 ' B' ' 150' ' ' VAL . 12.2 m -77.16 142.13 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.15 91.68 8.8 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.271 1.034 . . . . 0.0 113.562 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 155' ' ' GLY . 13.8 tppt? -142.87 128.67 19.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 111.417 -2.629 . . . . 0.0 112.058 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -100.32 -28.15 13.11 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 113.332 -1.758 . . . . 0.0 114.473 168.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.55 -107.26 0.53 Allowed Glycine 0 N--CA 1.48 1.622 0 C-N-CA 124.401 1.001 . . . . 0.0 114.852 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' B' ' 158' ' ' SER . . . -140.27 -123.95 2.05 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 124.286 0.946 . . . . 0.0 113.116 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.0 pp -49.81 147.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -79.22 -39.39 33.32 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.381 170.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.2 t -112.66 138.28 49.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.75 1.22 . . . . 0.0 111.418 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.48 9.47 3.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.612 -1.631 . . . . 0.0 113.832 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -55.63 -46.92 77.35 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.437 171.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 165' ' ' PHE . 60.3 t80 -43.87 -56.59 3.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.878 1.271 . . . . 0.0 113.172 168.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 78.3 mt -64.21 -41.23 97.13 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.041 1.337 . . . . 0.0 113.838 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -73.41 -37.67 65.86 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.1 m -76.17 -27.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 1.9 t80 -48.32 -50.62 29.51 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.784 1.633 . . . . 0.0 111.692 171.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.0 mt -58.4 -49.16 95.07 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 116.666 -1.635 . . . . 0.0 115.37 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.71 -50.51 7.78 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.313 2.009 . . . . 0.0 112.294 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 24.2 m -50.56 -45.5 57.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.854 0.861 . . . . 0.0 112.408 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.14 -66.68 0.34 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.683 1.593 . . . . 0.0 111.724 173.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pp -62.24 -43.8 97.99 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.6 mt -57.72 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.45 0.7 . . . . 0.0 112.344 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.5 p -63.55 -40.12 96.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -56.48 -51.13 69.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.6 mt -54.83 -51.43 65.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 112.633 172.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.0 mt -55.76 -43.28 76.54 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.711 1.204 . . . . 0.0 114.222 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.415 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -55.26 -47.35 75.58 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.33 1.452 . . . . 0.0 113.643 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.1 mt -61.21 -41.1 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.81 . . . . 0.0 111.131 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -57.71 14.82 Favored Glycine 0 N--CA 1.491 2.33 0 O-C-N 124.154 0.909 . . . . 0.0 112.3 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 182' ' ' TYR . 15.3 tp -48.67 -46.01 39.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.349 1.059 . . . . 0.0 111.827 172.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.85 -57.54 10.77 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.977 1.275 . . . . 0.0 113.548 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 33.7 mt -53.56 -43.93 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.654 1.182 . . . . 0.0 111.828 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 179' ' ' LEU . 88.6 t80 -51.83 -54.11 32.62 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 124.044 0.84 . . . . 0.0 112.376 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.6 mt -56.54 -54.45 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.278 1.031 . . . . 0.0 109.863 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -44.34 -60.6 3.56 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 125.773 1.654 . . . . 0.0 112.577 176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -65.8 -36.26 83.01 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.4 -42.12 98.23 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 29.9 mt -59.81 -44.21 94.1 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.702 0.801 . . . . 0.0 111.672 171.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.0 m -60.8 -48.92 79.6 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.828 0.705 . . . . 0.0 112.69 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 27.4 p -109.33 53.88 0.67 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.253 1.255 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.021 174.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -119.95 132.6 55.56 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 11.7 t -159.14 121.77 3.58 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 148' ' ' THR . 10.3 t 175.59 140.94 0.06 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.691 1.996 . . . . 0.0 110.948 161.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' B' ' 157' ' ' PHE . 28.0 m -100.89 134.23 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -175.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 59.83 -47.79 0.08 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.31 2.244 . . . . 0.0 115.31 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -120.98 162.47 19.86 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.311 1.444 . . . . 0.0 108.706 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -78.73 -2.65 40.37 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -126.66 81.14 0.36 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.601 162.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -160.18 127.2 1.75 Allowed Glycine 0 N--CA 1.48 1.588 0 C-N-CA 124.336 0.97 . . . . 0.0 111.868 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 pt -59.49 121.78 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.585 ' HA ' HG13 ' B' ' 150' ' ' VAL . 59.2 t80 -54.81 -54.39 42.8 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.869 -1.059 . . . . 0.0 112.817 -174.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.631 ' HA ' ' HA2' ' A' ' 155' ' ' GLY . 72.8 m -79.55 62.77 3.95 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 123.1 1.429 . . . . 0.0 110.635 173.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -45.74 -52.68 10.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.911 2.084 . . . . 0.0 115.19 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.53 -25.17 16.95 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.693 172.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -95.77 48.7 1.14 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -170.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 75.7 mt -139.55 82.31 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.443 171.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -148.22 -39.97 0.17 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 162.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 10.0 t -113.42 -53.79 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -159.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -51.43 -70.18 0.09 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -170.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 21.7 tp -44.47 -51.65 19.72 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 116.163 -1.875 . . . . 0.0 115.575 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -56.2 -52.45 7.18 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.451 2.101 . . . . 0.0 112.761 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 25.6 p -61.74 -35.22 77.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 52.5 mt -54.82 -64.15 0.93 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 117.726 -1.13 . . . . 0.0 112.291 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.514 ' O ' HD12 ' B' ' 174' ' ' LEU . 19.1 mt -51.78 -50.04 61.49 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.198 0.999 . . . . 0.0 112.794 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 36.0 tp -53.31 -54.68 32.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.591 1.556 . . . . 0.0 112.737 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . 0.544 ' HA ' HD12 ' B' ' 175' ' ' LEU . 76.8 p -63.66 -31.62 72.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -59.63 -49.4 77.89 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.532 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . 0.514 HD12 ' O ' ' B' ' 170' ' ' LEU . 0.5 OUTLIER -56.41 -43.61 79.52 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 172.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' B' ' 172' ' ' SER . 79.4 mt -54.99 -51.62 65.65 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.647 0.779 . . . . 0.0 112.828 170.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.45 -47.29 86.77 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.114 1.366 . . . . 0.0 114.118 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.415 HG13 ' HB1' ' A' ' 176' ' ' ALA . 26.0 mt -58.92 -49.11 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.162 0.585 . . . . 0.0 109.448 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -47.83 -54.93 10.44 Favored Glycine 0 N--CA 1.483 1.823 0 O-C-N 124.665 1.228 . . . . 0.0 112.538 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.78 -45.94 70.84 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.885 1.274 . . . . 0.0 112.514 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -49.93 62.04 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 124.735 1.16 . . . . 0.0 113.123 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 177' ' ' ILE . 17.7 mt -60.61 -48.62 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.076 0.95 . . . . 0.0 109.152 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' B' ' 186' ' ' ARG . 28.1 t80 -40.89 -59.65 1.38 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.101 1.36 . . . . 0.0 112.273 169.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 70.4 mt -57.27 -54.73 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.829 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.07 -31.66 18.84 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 126.206 1.86 . . . . 0.0 116.191 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 14.6 tpt85 -99.22 -41.67 7.38 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' B' ' 182' ' ' TYR . 8.4 tpt180 -51.34 -38.99 56.08 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 -169.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.23 -44.1 71.43 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 124.565 1.166 . . . . 0.0 112.985 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 22.5 m -82.29 -41.08 20.6 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.182 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 3.0 m -106.04 70.21 0.84 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.387 1.089 . . . . 0.0 112.775 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.245 0.838 0 CA-C-N 112.186 -2.279 . . . . 0.0 106.172 165.247 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -104.06 118.85 37.65 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.379 1.049 . . . . 0.0 110.153 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 p -45.9 -27.13 0.81 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.1 m -41.3 112.88 0.34 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.194 1.397 . . . . 0.0 114.424 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . 0.351 12.6 m 36.95 50.24 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.278 2.558 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -173.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.609 ' HG3' ' HB2' ' B' ' 149' ' ' SER . 11.1 mmt -76.3 83.19 3.07 Favored 'General case' 0 C--O 1.275 2.423 0 C-N-CA 125.098 1.359 . . . . 0.0 109.077 166.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 158' ' ' SER . 29.7 mttm -37.84 -62.81 0.52 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 127.824 2.45 . . . . 0.0 114.389 -169.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -112.22 80.81 1.38 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 124.137 0.898 . . . . 0.0 109.98 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 119.49 96.82 1.68 Allowed Glycine 0 CA--C 1.542 1.721 0 CA-C-N 113.683 -1.599 . . . . 0.0 112.545 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.89 -62.04 0.58 Allowed Glycine 0 N--CA 1.48 1.605 0 CA-C-N 114.068 -1.066 . . . . 0.0 111.725 -171.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 pt -94.86 174.2 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.814 -0.693 . . . . 0.0 110.571 170.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -73.32 100.08 3.07 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 169.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 24.2 t -16.2 125.07 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 112.499 -2.137 . . . . 0.0 116.39 -172.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.623 ' HA ' HD12 ' A' ' 162' ' ' LEU . . . -50.1 -47.36 53.89 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.559 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 164' ' ' VAL . 30.8 mt-10 -56.64 -48.26 77.93 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 171.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 158' ' ' SER . 41.9 m-85 -66.78 -34.3 77.53 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' A' ' 159' ' ' ALA . 80.0 mt -53.77 -47.13 71.02 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.875 0.87 . . . . 0.0 111.17 166.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -64.86 -42.69 94.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.225 1.01 . . . . 0.0 113.451 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 160' ' ' GLU . 59.6 t -58.68 -39.8 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.571 0.748 . . . . 0.0 110.541 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -60.24 -23.69 64.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.068 1.347 . . . . 0.0 114.232 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 39.4 mt -43.57 -47.68 18.81 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 164' ' ' VAL . 84.9 Cg_exo -65.32 -58.45 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.904 1.736 . . . . 0.0 112.598 168.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 m -43.57 -44.77 6.35 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.6 tp -44.62 -67.59 0.27 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.237 2.215 . . . . 0.0 112.31 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 mp -71.26 -37.86 71.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.409 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.7 mt -49.1 -57.44 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.132 0.895 . . . . 0.0 111.334 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.5 t -54.05 -58.94 5.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.129 1.371 . . . . 0.0 111.697 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -50.35 -68.54 0.16 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.27 -55.23 35.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.26 -48.09 81.53 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.457 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -66.68 -39.09 87.99 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.509 HG13 ' HB1' ' B' ' 176' ' ' ALA . 56.5 mt -55.86 -45.21 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.985 0.514 . . . . 0.0 110.689 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.11 -53.33 41.09 Favored Glycine 0 N--CA 1.487 2.049 0 C-N-CA 124.227 0.918 . . . . 0.0 112.899 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 16.7 tp -52.77 -47.22 67.66 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.563 0.745 . . . . 0.0 112.32 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.622 ' HA2' HD12 ' A' ' 183' ' ' ILE . . . -54.1 -51.79 47.94 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.868 173.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.7 mt -48.56 -46.0 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.159 0.983 . . . . 0.0 113.132 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -53.71 -56.28 18.74 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.658 0.599 . . . . 0.0 112.308 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.622 HD12 ' HA2' ' A' ' 180' ' ' GLY . 23.0 mt -50.59 -53.37 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.875 1.27 . . . . 0.0 110.326 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.81 -59.84 9.66 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 124.738 1.161 . . . . 0.0 112.278 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -49.06 -52.97 22.42 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.552 1.541 . . . . 0.0 112.69 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -53.94 -36.56 62.93 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.216 1.806 . . . . 0.0 114.266 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.3 mt -57.51 -39.71 77.11 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.57 -34.24 23.24 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 4.7 p -127.36 127.37 44.13 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 117.34 -1.314 . . . . 0.0 112.639 -173.404 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 119.425 -0.322 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.509 ' OD1' ' HB2' ' A' ' 152' ' ' LYS . 12.7 t30 -130.52 -49.8 1.07 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 31.0 m -132.45 115.26 15.32 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . 0.609 ' HB2' ' HG3' ' A' ' 151' ' ' MET . 5.1 t -109.76 -45.05 3.72 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 113.517 -1.674 . . . . 0.0 110.631 169.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.33 118.18 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.26 91.64 6.84 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.123 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.594 ' HD2' ' HG3' ' B' ' 160' ' ' GLU . 53.3 mmtt -70.68 95.92 1.16 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -103.78 152.31 22.03 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 110.963 -2.835 . . . . 0.0 110.913 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 74.61 -88.18 0.73 Allowed Glycine 0 N--CA 1.479 1.508 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.18 74.0 0.39 Allowed Glycine 0 N--CA 1.479 1.501 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 160.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.8 156.61 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 113.387 -1.406 . . . . 0.0 113.602 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -43.61 -56.25 3.83 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -163.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.421 ' O ' HD12 ' B' ' 162' ' ' LEU . 29.2 p -50.5 -54.28 23.55 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.57 1.148 . . . . 0.0 112.773 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.16 -54.77 35.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.512 1.525 . . . . 0.0 112.898 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.594 ' HG3' ' HD2' ' B' ' 152' ' ' LYS . 11.7 mm-40 -56.14 -41.75 75.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.277 1.031 . . . . 0.0 113.439 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 158' ' ' SER . 27.1 m-85 -78.39 -34.72 47.94 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.421 HD12 ' O ' ' B' ' 158' ' ' SER . 0.4 OUTLIER -56.86 -44.38 82.12 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.448 0.567 . . . . 0.0 111.394 161.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -83.08 13.39 4.11 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.8 t -106.58 -40.3 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 153.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -49.48 -62.55 1.49 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.359 1.464 . . . . 0.0 112.073 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.34 -41.62 61.2 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.145 -1.407 . . . . 0.0 114.345 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -51.49 -52.77 8.31 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.868 2.379 . . . . 0.0 114.32 165.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -59.66 -40.45 87.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.179 0.992 . . . . 0.0 113.432 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.16 -44.89 95.61 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.524 0.73 . . . . 0.0 112.414 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.19 -51.37 70.01 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.785 0.834 . . . . 0.0 112.087 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 25.6 tp -49.03 -53.48 19.94 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.592 1.557 . . . . 0.0 111.826 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 33.3 t -54.81 -57.29 12.17 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.909 1.284 . . . . 0.0 112.192 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -47.41 -52.39 17.01 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.358 1.063 . . . . 0.0 113.245 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -58.28 -50.37 73.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 47.5 mt -71.49 -32.31 68.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.509 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -66.47 -47.46 72.99 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.585 0.754 . . . . 0.0 111.615 169.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.457 HG13 ' HB1' ' A' ' 176' ' ' ALA . 23.2 mt -50.23 -53.59 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.179 1.392 . . . . 0.0 110.787 167.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.07 -60.21 4.64 Favored Glycine 0 N--CA 1.483 1.814 0 O-C-N 124.415 1.072 . . . . 0.0 113.286 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 15.4 tp -50.95 -46.34 61.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.606 1.162 . . . . 0.0 112.225 173.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.22 -53.33 43.56 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 124.773 1.178 . . . . 0.0 113.63 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 23.2 mt -53.31 -46.8 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.862 0.865 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 22.0 t80 -49.44 -59.63 3.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.835 1.654 . . . . 0.0 113.449 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.73 -49.9 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 121.632 0.73 . . . . 0.0 111.651 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.0 -48.27 46.31 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.719 1.628 . . . . 0.0 113.529 -178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -58.69 -33.31 70.01 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 114.249 1.204 . . . . 0.0 114.249 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.31 -50.5 10.09 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . 0.285 91.4 mt 6.47 -73.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 120.898 3.666 . . . . 0.0 120.898 -167.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.0 p -64.51 -44.41 91.0 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 39.5 p -90.52 58.4 3.95 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 123.17 1.462 . . . . 0.0 112.538 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 C--O 1.25 1.079 0 CA-C-N 112.726 -2.034 . . . . 0.0 107.987 -178.782 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 22.8 ttt-85 . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 21.4 78.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 127.245 2.218 . . . . 0.0 116.291 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.431 ' HB ' HG22 ' A' ' 150' ' ' VAL . 17.8 p -105.63 166.06 10.72 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -168.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.13 69.55 1.44 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.491 164.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.638 HG23 ' HE2' ' A' ' 152' ' ' LYS . 20.1 m -126.59 115.79 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.712 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 23.1 mmt -15.37 99.11 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.638 ' HE2' HG23 ' A' ' 150' ' ' VAL . 71.9 mmtt -118.52 93.46 4.12 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 123.179 1.466 . . . . 0.0 112.871 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -115.82 100.5 8.05 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 113.209 -1.814 . . . . 0.0 107.382 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -80.21 -113.16 0.28 Allowed Glycine 0 N--CA 1.473 1.157 0 CA-C-N 113.299 -1.773 . . . . 0.0 108.989 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -177.37 -140.99 3.88 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-N 114.221 -0.989 . . . . 0.0 112.118 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.43 ' HB ' ' H ' ' A' ' 157' ' ' PHE . 9.6 pt -134.88 -148.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 113.386 -1.407 . . . . 0.0 110.757 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' H ' ' HB ' ' A' ' 156' ' ' ILE . 38.6 t80 -96.11 -59.79 1.77 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.837 0.289 . . . . 0.0 111.268 172.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.5 t -93.47 102.67 14.9 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.894 1.33 . . . . 0.0 112.634 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.73 -30.83 70.22 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 112.831 -1.986 . . . . 0.0 113.047 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -73.22 -32.01 64.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.316 1.046 . . . . 0.0 113.171 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -66.96 -45.54 77.43 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.647 166.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.0 tp -54.57 -37.05 65.02 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -56.75 -33.05 66.18 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.747 1.619 . . . . 0.0 114.668 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.9 m -85.3 -40.61 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -48.42 -60.51 2.62 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 166' ' ' LEU 0.27 36.0 mt -54.12 -55.03 40.84 Favored Pre-proline 0 N--CA 1.482 1.125 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.646 178.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -46.96 -52.09 8.26 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.12 2.547 . . . . 0.0 114.237 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.1 p -66.12 -47.2 74.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.14 -58.4 6.24 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.102 0.961 . . . . 0.0 110.999 172.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 93.6 mt -54.29 -52.74 60.49 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.631 1.172 . . . . 0.0 112.704 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.4 tp -55.15 -51.84 65.2 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.174 0.99 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.8 p -57.05 -39.7 75.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -63.27 -48.09 79.62 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 171.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 177' ' ' ILE . 14.6 tp -58.76 -45.31 90.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.575 0.75 . . . . 0.0 112.394 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.4 mt -65.46 -35.62 81.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -61.97 -42.12 98.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.333 0.653 . . . . 0.0 112.422 172.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 174' ' ' LEU . 27.2 mt -59.33 -49.57 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 169.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -47.75 -55.78 9.31 Favored Glycine 0 CA--C 1.546 2.008 0 C-N-CA 124.952 1.263 . . . . 0.0 113.091 174.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 55.9 tp -45.74 -56.76 4.9 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.296 1.439 . . . . 0.0 112.697 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.52 -48.24 55.66 Favored Glycine 0 CA--C 1.541 1.689 0 O-C-N 124.533 1.146 . . . . 0.0 113.756 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.407 HD12 ' HA2' ' A' ' 178' ' ' GLY . 27.0 mt -57.54 -50.78 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.96 0.504 . . . . 0.0 110.11 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -53.74 -54.79 33.16 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.704 1.253 . . . . 0.0 112.427 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.6 mt -53.85 -56.38 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.318 0.647 . . . . 0.0 111.356 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -46.76 -58.26 6.22 Favored Glycine 0 N--CA 1.487 2.036 0 O-C-N 124.481 1.113 . . . . 0.0 112.168 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.72 -52.02 54.62 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -55.15 -43.26 74.04 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.55 -47.48 85.38 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.932 0.77 . . . . 0.0 111.997 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 92.1 m -63.21 -39.38 94.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.947 0.499 . . . . 0.0 111.941 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 25.5 p -96.84 52.96 1.2 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.516 0.51 . . . . 0.0 112.237 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 126.81 2.044 . . . . 0.0 111.955 172.844 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 . . . . . 0 C--O 1.24 0.586 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -81.96 73.17 9.02 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.043 0.925 . . . . 0.0 109.383 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.3 m -88.51 131.64 34.83 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.808 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 58.8 m -50.71 -50.76 54.43 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 113.894 -1.503 . . . . 0.0 114.713 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.01 78.8 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 122.15 0.976 . . . . 0.0 110.663 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 30.8 mtt -137.37 134.67 36.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.821 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -54.24 -54.13 44.19 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -171.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -98.61 -43.1 6.97 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.384 0.428 . . . . 0.0 110.199 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -42.22 -67.9 0.8 Allowed Glycine 0 N--CA 1.476 1.365 0 C-N-CA 126.189 1.852 . . . . 0.0 115.226 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -111.42 -110.16 3.14 Favored Glycine 0 N--CA 1.482 1.757 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.31 149.91 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.707 1.603 . . . . 0.0 113.985 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -74.33 -43.98 54.37 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.114 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 25.9 t -136.42 138.82 41.92 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.29 -43.86 85.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.943 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -48.03 -49.14 32.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.692 0.797 . . . . 0.0 112.812 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -63.34 -44.22 95.49 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.704 0.802 . . . . 0.0 112.416 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 40.8 tp -52.68 -45.83 66.97 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -64.25 -16.55 62.3 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' B' ' 168' ' ' SER . 7.3 t -93.47 -48.65 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 124.477 1.11 . . . . 0.0 109.291 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -36.4 -71.79 0.07 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -47.88 97.67 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -56.1 -52.86 6.33 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.75 2.3 . . . . 0.0 112.992 170.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.403 ' HB2' HG12 ' B' ' 164' ' ' VAL . 19.5 t -52.09 -48.99 64.44 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.182 0.993 . . . . 0.0 111.864 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.9 mp -55.34 -65.45 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.907 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mt -41.08 -61.5 0.99 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.363 1.465 . . . . 0.0 114.921 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' B' ' 174' ' ' LEU . 54.2 mt -62.79 -36.73 84.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 88.1 p -77.7 -34.37 52.8 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -67.3 -40.15 86.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' B' ' 171' ' ' LEU . 70.1 mt -53.81 -53.16 56.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.47 0.708 . . . . 0.0 111.929 168.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 7.7 mt -48.48 -47.93 38.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.233 1.013 . . . . 0.0 113.237 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.416 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -57.73 -52.01 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.497 HG13 ' HB1' ' A' ' 176' ' ' ALA . 29.0 mt -61.28 -42.33 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.31 0.644 . . . . 0.0 110.636 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.99 -51.48 55.24 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.848 1.213 . . . . 0.0 112.831 173.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.35 -44.34 44.59 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.43 -57.36 19.0 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.456 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 48.0 mm -47.76 -52.2 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.947 1.299 . . . . 0.0 110.971 172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -47.61 -50.15 25.07 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.942 0.897 . . . . 0.0 113.227 174.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.467 ' HA ' ' HB3' ' B' ' 187' ' ' LEU . 19.1 mt -61.63 -63.58 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.913 0.485 . . . . 0.0 110.563 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.09 -54.66 5.2 Favored Glycine 0 N--CA 1.474 1.219 0 C-N-CA 126.297 1.903 . . . . 0.0 114.162 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -96.55 -81.29 0.42 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.818 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -50.21 -56.69 10.02 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -166.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.467 ' HB3' ' HA ' ' B' ' 183' ' ' ILE . 5.7 tt -62.48 -40.89 98.14 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.581 1.152 . . . . 0.0 111.719 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.402 HG23 ' O ' ' B' ' 183' ' ' ILE . 31.6 p -63.7 -52.37 60.89 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 117.4 -1.286 . . . . 0.0 110.687 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 69.0 p -79.01 26.71 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.483 1.219 0 C-N-CA 123.258 0.623 . . . . 0.0 110.263 175.843 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.554 HH11 ' HA ' ' B' ' 150' ' ' VAL . 79.6 mtt85 . . . . . 0 C--O 1.254 1.334 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.96 173.36 0.79 Allowed 'General case' 0 C--O 1.175 -2.854 0 CA-C-O 124.344 2.021 . . . . 0.0 110.369 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' B' ' 158' ' ' SER . 18.7 p -46.05 127.7 8.66 Favored 'General case' 0 C--N 1.376 1.725 0 CA-C-N 110.686 -2.961 . . . . 0.0 118.663 -174.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -55.68 140.47 41.36 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 129.082 2.953 . . . . 0.0 111.398 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.37 97.29 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.937 1.351 . . . . 0.0 109.785 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 43.8 mtt -115.31 48.01 1.23 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.307 -165.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 21.1 tptp -54.18 -53.08 58.31 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -174.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -86.93 -52.25 5.57 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 119.207 -0.425 . . . . 0.0 111.126 166.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -80.03 63.87 4.02 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-O 118.553 -1.137 . . . . 0.0 115.059 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -79.99 -75.66 1.04 Allowed Glycine 0 N--CA 1.478 1.493 0 C-N-CA 124.778 1.18 . . . . 0.0 111.548 -173.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.53 87.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 123.444 1.592 . . . . 0.0 107.015 164.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -47.65 -36.94 11.78 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 127.258 2.223 . . . . 0.0 116.605 -164.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.2 p -160.56 145.06 14.19 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.932 1.395 . . . . 0.0 113.485 173.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.38 -29.0 70.08 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.358 -1.292 . . . . 0.0 113.365 163.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 163' ' ' LYS . 43.2 tt0 -45.67 -53.78 8.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.387 1.475 . . . . 0.0 110.83 170.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -44.44 -59.85 2.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.016 1.326 . . . . 0.0 113.269 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 mt -54.09 -55.04 31.39 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 46.2 pttt -57.7 -43.75 85.38 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 124.064 0.853 . . . . 0.0 112.863 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.5 p -76.72 -22.05 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -98.01 7.36 46.44 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 169' ' ' LEU 0.285 35.7 mt -49.79 -26.64 1.02 Allowed Pre-proline 0 N--CA 1.483 1.176 0 N-CA-C 119.214 3.042 . . . . 0.0 119.214 177.229 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -51.96 -71.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 121.518 1.479 . . . . 0.0 112.125 164.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.1 p -55.78 -42.31 75.36 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 47.1 mt -56.35 -61.36 2.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.49 -17.74 62.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.98 -41.04 82.94 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 165.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 175' ' ' LEU . 6.9 p -61.68 -34.39 75.66 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 169.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -72.93 -38.47 66.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 118.28 -0.867 . . . . 0.0 113.211 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.6 tp -51.81 -47.01 64.49 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.649 0.593 . . . . 0.0 111.555 168.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 172' ' ' SER . 94.5 mt -49.62 -56.69 9.11 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.834 0.709 . . . . 0.0 112.436 168.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.52 -52.6 63.13 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.42 HG13 ' HB1' ' B' ' 176' ' ' ALA . 30.2 mt -56.04 -47.24 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.369 1.067 . . . . 0.0 110.357 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.15 -57.39 10.18 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.912 1.244 . . . . 0.0 112.724 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 30.0 tp -53.11 -45.96 68.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.221 1.009 . . . . 0.0 112.499 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.66 -56.07 6.72 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 125.233 1.397 . . . . 0.0 113.822 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.8 mt -59.32 -53.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.314 -0.943 . . . . 0.0 109.565 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -51.84 -58.24 7.02 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.559 -1.2 . . . . 0.0 113.101 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 184' ' ' GLY 0.256 2.9 pp -60.79 -38.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 183' ' ' ILE . . . -59.58 -47.61 90.05 Favored Glycine 0 N--CA 1.481 1.689 0 C-N-CA 123.83 0.728 . . . . 0.0 112.943 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -59.02 -50.84 72.56 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.213 -0.994 . . . . 0.0 111.83 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -54.24 -51.05 65.72 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.405 1.082 . . . . 0.0 113.336 175.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.39 -33.87 75.61 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 26.4 p -84.02 -58.09 2.92 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.301 1.0 . . . . 0.0 111.891 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 12.1 t -110.47 125.13 52.97 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.256 1.435 0 C-N-CA 131.519 3.928 . . . . 0.0 106.248 -178.919 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -82.6 142.02 32.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.524 HG22 ' HD3' ' B' ' 153' ' ' LYS . 82.3 p -67.65 -23.41 65.33 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 112.837 -1.983 . . . . 0.0 114.18 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 27.3 m -62.97 -43.73 98.0 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.554 ' HA ' HH11 ' A' ' 146' ' ' ARG . 58.0 t -82.9 -40.95 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.565 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 68.9 mtm -58.98 160.68 5.72 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.458 1.098 . . . . 0.0 111.544 169.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -101.1 68.17 1.23 Allowed 'General case' 0 C--O 1.201 -1.495 0 CA-C-O 124.301 2.0 . . . . 0.0 112.279 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . 0.524 ' HD3' HG22 ' B' ' 148' ' ' THR . 80.0 tttt -135.61 118.3 16.04 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 110.239 -3.164 . . . . 0.0 110.391 -174.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -114.53 77.96 0.26 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 112.986 -1.915 . . . . 0.0 108.723 172.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.74 -57.14 5.05 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 124.332 0.968 . . . . 0.0 111.522 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . 0.404 HG12 HD11 ' B' ' 162' ' ' LEU . 1.4 pp -116.0 156.09 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 112.342 -1.929 . . . . 0.0 109.926 171.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -67.76 -45.02 76.1 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' B' ' 161' ' ' PHE . 39.6 t -151.77 139.94 20.26 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.74 -55.07 38.91 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.707 170.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -47.47 -50.3 23.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.582 1.553 . . . . 0.0 112.53 172.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' B' ' 158' ' ' SER . 32.4 t80 -52.49 -56.42 15.27 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.491 1.119 . . . . 0.0 112.628 175.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.404 HD11 HG12 ' B' ' 156' ' ' ILE . 25.4 mt -55.91 -48.97 74.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -54.19 -29.74 47.08 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.71 -38.62 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -82.34 -43.44 17.43 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -172.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' B' ' 169' ' ' LEU . 54.3 tp -54.91 -42.29 94.85 Favored Pre-proline 0 CA--C 1.549 0.928 0 CA-C-O 117.226 -1.369 . . . . 0.0 113.479 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -54.09 -51.84 9.72 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.132 1.888 . . . . 0.0 113.504 168.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 41.4 m -53.15 -48.67 67.76 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 173.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' B' ' 166' ' ' LEU . 80.4 mt -50.71 -59.89 3.61 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.665 170.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.0 mt -50.64 -57.91 7.1 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.99 -52.85 47.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.794 0.837 . . . . 0.0 113.164 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 60.5 p -66.77 -42.52 85.96 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -63.9 -43.38 96.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.74 -47.46 79.98 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 170.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 39.0 mt -56.68 -42.55 79.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 170.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.42 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -65.17 -43.65 91.02 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 175.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 44.0 mt -55.37 -47.48 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 168.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.38 -53.57 23.75 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.52 1.057 . . . . 0.0 113.014 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.25 -41.75 69.14 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.79 -54.11 29.84 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.153 0.882 . . . . 0.0 112.42 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 13.2 mt -53.8 -54.32 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.614 1.166 . . . . 0.0 110.531 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -49.52 -50.95 39.65 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.193 1.797 . . . . 0.0 113.97 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.6 tp -68.13 -38.58 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.92 -43.43 87.6 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 170.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.522 HH21 ' HA ' ' B' ' 190' ' ' SER . 35.1 mtp180 -61.54 -36.73 81.41 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -58.8 -60.84 3.19 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.845 0.716 . . . . 0.0 112.767 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.02 -61.22 2.28 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 13.1 p -126.97 -39.81 1.92 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -169.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 15.6 m -114.24 94.99 5.05 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -167.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . 0.522 ' HA ' HH21 ' B' ' 185' ' ' ARG . 2.5 m . . . . . 0 N--CA 1.48 1.032 0 CA-C-N 112.225 -2.261 . . . . 0.0 110.392 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -91.38 141.68 28.5 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-O 121.642 0.734 . . . . 0.0 110.731 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.6 p -76.82 51.34 0.77 Allowed 'General case' 0 C--O 1.154 -3.942 0 CA-C-O 124.628 2.156 . . . . 0.0 115.748 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.9 m -51.35 115.72 1.72 Allowed 'General case' 0 C--N 1.403 2.927 0 CA-C-N 110.734 -2.939 . . . . 0.0 113.761 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.9 m -119.6 85.18 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 122.128 0.966 . . . . 0.0 110.921 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 16.3 mtm -58.85 116.84 4.02 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.966 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.488 ' HB3' HG21 ' B' ' 164' ' ' VAL . 49.6 mtmt -57.87 -33.19 68.42 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 112.893 -1.958 . . . . 0.0 115.253 -171.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -78.67 -17.81 55.37 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 134.79 164.31 10.46 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 124.318 0.961 . . . . 0.0 112.007 -172.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.22 94.3 0.18 Allowed Glycine 0 N--CA 1.478 1.474 0 CA-C-N 113.467 -1.367 . . . . 0.0 112.003 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.605 HG12 HD13 ' A' ' 162' ' ' LEU . 2.8 pp -97.8 152.72 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.631 1.205 . . . . 0.0 112.535 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -97.52 -40.2 8.77 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.399 -1.273 . . . . 0.0 114.024 164.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.0 t -63.38 101.34 0.31 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 122.202 1.001 . . . . 0.0 113.257 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.35 74.5 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.228 -1.806 . . . . 0.0 111.764 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.86 -34.6 63.1 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -65.17 -55.1 20.51 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.102 1.361 . . . . 0.0 112.667 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.605 HD13 HG12 ' A' ' 156' ' ' ILE . 1.9 tp -66.29 -32.39 73.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -53.15 -57.63 9.79 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.704 0.628 . . . . 0.0 112.08 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.2 m -66.55 -23.72 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -54.49 -49.11 70.9 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.0 tp -52.5 -55.88 27.96 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 115.907 -1.997 . . . . 0.0 113.703 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -60.36 -52.32 4.17 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.35 2.033 . . . . 0.0 112.759 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -46.45 63.08 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.28 -66.55 0.51 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.866 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -47.15 -53.21 13.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.498 1.119 . . . . 0.0 113.978 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.01 -44.79 95.02 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.9 p -70.86 -41.89 70.81 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -57.81 -42.92 85.24 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' A' ' 177' ' ' ILE . 28.0 mt -56.19 -52.9 62.71 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 169.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 93.0 mt -49.17 -47.5 45.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 112.221 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.3 -48.57 76.41 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 174' ' ' LEU . 16.4 mt -59.81 -49.26 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 123.55 0.74 . . . . 0.0 110.462 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.1 -51.27 36.09 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 124.25 0.928 . . . . 0.0 112.027 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.09 -46.13 79.14 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.214 1.005 . . . . 0.0 112.012 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -48.42 -53.65 15.52 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.253 0.93 . . . . 0.0 113.438 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.14 -50.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.252 0.621 . . . . 0.0 109.792 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -51.83 -55.63 18.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.041 0.936 . . . . 0.0 113.255 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -48.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.39 -55.59 12.69 Favored Glycine 0 N--CA 1.481 1.694 0 C-N-CA 124.196 0.903 . . . . 0.0 111.46 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -55.73 -45.42 77.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.301 1.441 . . . . 0.0 114.402 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -65.04 -27.05 68.53 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.0 mt -78.06 -52.86 8.11 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.097 0.559 . . . . 0.0 111.982 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 23.0 p -95.98 -66.15 0.93 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 10.4 p -106.23 67.46 0.74 Allowed 'General case' 0 C--O 1.196 -1.753 0 CA-C-O 124.366 2.032 . . . . 0.0 115.564 -170.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 71.8 m . . . . . 0 N--CA 1.482 1.131 0 CA-C-N 111.384 -2.644 . . . . 0.0 107.654 173.632 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -135.37 -69.22 0.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.444 1.098 . . . . 0.0 111.952 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 57.7 p -62.51 -41.86 99.11 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.809 0.844 . . . . 0.0 112.817 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 6.9 m -111.97 104.67 12.95 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.516 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.36 120.49 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.986 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -118.37 -3.99 10.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -39.96 134.62 1.45 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.947 2.099 . . . . 0.0 115.711 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' B' ' 153' ' ' LYS . 56.7 mmtt -69.53 111.72 5.56 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 125.443 1.714 . . . . 0.0 113.123 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 139.33 81.74 0.08 OUTLIER Glycine 0 N--CA 1.478 1.461 0 CA-C-N 113.11 -1.859 . . . . 0.0 108.966 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.43 -153.84 18.83 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 114.049 -1.075 . . . . 0.0 112.246 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 37.4 pt -66.51 130.14 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -70.96 -32.69 69.63 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 44.1 t -139.14 127.79 23.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.443 0.639 . . . . 0.0 112.568 167.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.02 -56.19 5.48 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.071 -1.877 . . . . 0.0 114.054 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -51.77 -50.93 59.72 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -53.16 -56.19 18.32 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.334 1.021 . . . . 0.0 113.132 172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.452 HD23 HD11 ' B' ' 169' ' ' LEU . 4.1 mt -58.12 -39.8 79.62 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -57.26 -52.14 66.52 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.077 0.951 . . . . 0.0 112.729 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 152' ' ' LYS . 35.9 m -66.05 -26.92 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -86.5 -5.02 59.26 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' B' ' 169' ' ' LEU . 15.3 tp -53.49 -38.44 62.19 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 116.362 -1.78 . . . . 0.0 115.722 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -60.9 -64.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 CA-C-O 116.703 -1.457 . . . . 0.0 111.126 168.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -43.38 -42.78 4.8 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.452 HD11 HD23 ' B' ' 162' ' ' LEU . 41.6 mt -53.95 -71.08 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.089 0.956 . . . . 0.0 111.276 170.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 4.8 mt -46.43 -46.94 19.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.6 1.56 . . . . 0.0 114.73 175.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 67.1 mt -57.11 -53.54 56.91 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.138 1.375 . . . . 0.0 112.751 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 85.5 p -61.98 -39.69 93.04 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -58.49 -45.05 89.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . 0.52 HD12 HD12 ' B' ' 177' ' ' ILE . 6.4 tp -66.8 -38.64 86.88 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 tp -55.19 -46.24 75.85 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.048 0.939 . . . . 0.0 110.429 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.66 80.03 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.52 HD12 HD12 ' B' ' 174' ' ' LEU . 36.7 mt -57.56 -48.08 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 117.748 0.249 . . . . 0.0 110.736 173.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.51 -49.67 38.61 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.322 0.963 . . . . 0.0 112.977 174.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 14.6 tp -53.12 -45.14 68.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.117 0.967 . . . . 0.0 112.557 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.434 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -55.71 -51.6 53.94 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.589 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 9.1 mt -59.03 -45.44 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.318 0.647 . . . . 0.0 109.587 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 48.3 t80 -47.82 -49.97 27.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.637 1.175 . . . . 0.0 113.504 171.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -60.34 -52.14 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.349 0.66 . . . . 0.0 110.941 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . 0.46 ' HA2' HD12 ' B' ' 187' ' ' LEU . . . -51.31 -44.88 52.78 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 124.872 1.225 . . . . 0.0 113.441 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -65.62 -47.71 74.69 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.251 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -49.27 -50.46 38.94 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 168.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.46 HD12 ' HA2' ' B' ' 184' ' ' GLY . 46.5 mt -51.42 -48.19 62.74 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.3 p -119.42 -65.22 1.19 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 34.0 p -80.09 14.16 1.98 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -170.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.252 1.207 0 O-C-N 124.055 0.847 . . . . 0.0 112.22 173.568 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -126.75 138.06 53.32 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.186 0.929 . . . . 0.0 110.388 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.0 p -127.35 -66.05 0.9 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.07 61.32 5.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.803 1.763 . . . . 0.0 111.826 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 1.4 m -104.92 -25.4 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 111.491 -2.595 . . . . 0.0 116.485 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -66.14 118.9 10.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.65 0.262 . . . . 0.0 111.597 -164.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 58.8 tttt 64.25 97.3 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 O-C-N 126.219 2.2 . . . . 0.0 109.869 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -98.24 118.46 34.92 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.216 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -149.91 -85.45 0.05 OUTLIER Glycine 0 N--CA 1.476 1.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 169.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 107.8 -158.75 14.76 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -170.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.21 134.84 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.881 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.15 -50.38 16.49 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -177.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.484 ' HB2' HG11 ' B' ' 150' ' ' VAL . 45.3 t -136.63 111.35 8.72 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.112 0.958 . . . . 0.0 112.707 175.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.29 68.67 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 112.859 -1.973 . . . . 0.0 111.937 167.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 2.1 mp0 -58.41 -56.93 15.77 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.608 1.563 . . . . 0.0 110.498 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 165' ' ' PHE . 0.2 OUTLIER -55.78 -45.6 78.13 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.31 1.006 . . . . 0.0 112.032 174.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -55.21 37.4 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -52.07 -51.98 54.12 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 161' ' ' PHE . 7.0 p -67.65 -40.85 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -71.47 -18.79 62.29 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -176.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.254 35.3 mt -40.34 -51.47 6.28 Favored Pre-proline 0 N--CA 1.483 1.188 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -59.32 -59.11 0.47 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.8 p -59.42 -40.65 87.38 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.4 tp -50.7 -63.32 1.16 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.639 1.576 . . . . 0.0 110.756 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.42 -42.33 77.85 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.439 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.0 tp -53.6 -47.69 69.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.596 1.159 . . . . 0.0 111.654 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 175' ' ' LEU . 24.7 p -66.62 -39.59 88.4 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -69.71 -35.45 75.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.4 mt -55.49 -49.05 73.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.956 0.785 . . . . 0.0 111.645 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 172' ' ' SER . 86.6 mt -51.55 -52.18 49.31 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 170.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.17 75.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.4 mt -59.1 -48.89 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.648 1.179 . . . . 0.0 111.695 169.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.1 -47.62 88.07 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.252 0.93 . . . . 0.0 113.25 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.86 -41.99 78.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.751 1.621 . . . . 0.0 111.575 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.18 -51.24 58.66 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.266 1.412 . . . . 0.0 112.321 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 29.8 mt -55.86 -47.67 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.378 1.071 . . . . 0.0 111.311 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -50.42 -63.16 1.21 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.47 1.106 . . . . 0.0 112.798 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 183' ' ' ILE . 7.4 tp -69.59 -35.27 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.44 43.71 Favored Glycine 0 N--CA 1.479 1.515 0 C-N-CA 124.307 0.956 . . . . 0.0 111.832 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -62.96 -37.13 85.87 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 190' ' ' SER . 4.3 mmt180 -60.68 -46.26 91.03 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.354 0.662 . . . . 0.0 112.512 171.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.65 -44.68 95.67 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . 0.259 16.9 m -71.8 -56.41 5.81 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 175.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 4.5 p -104.07 -74.58 0.64 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 186' ' ' ARG . 33.4 t . . . . . 0 C--O 1.25 1.09 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -63.51 146.99 52.57 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.034 -177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -138.18 111.19 7.79 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 81.2 p -72.05 9.44 0.95 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 158' ' ' SER . 19.3 m -105.96 84.16 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 124.255 1.979 . . . . 0.0 110.404 170.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.07 166.69 31.66 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 111.227 -2.715 . . . . 0.0 111.012 -167.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -73.71 132.92 43.19 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.543 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -130.08 71.18 1.44 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.24 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 62.18 29.36 72.71 Favored Glycine 0 N--CA 1.483 1.786 0 CA-C-N 112.657 -2.065 . . . . 0.0 114.57 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 129.64 -78.02 0.39 Allowed Glycine 0 N--CA 1.481 1.65 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 pp -53.51 131.01 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 122.243 1.02 . . . . 0.0 112.188 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -84.81 78.47 9.87 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.175 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t 64.66 129.64 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 112.263 -2.244 . . . . 0.0 114.741 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.84 -56.13 26.14 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.754 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -45.7 -45.11 14.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.749 1.22 . . . . 0.0 114.252 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -62.41 -58.22 8.43 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.037 0.935 . . . . 0.0 112.066 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.16 -38.93 84.65 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -51.0 -30.62 15.67 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.06 -37.1 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.65 -47.21 86.51 Favored 'General case' 0 C--O 1.219 -0.553 0 C-N-CA 126.166 1.786 . . . . 0.0 113.782 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.71 -34.96 7.16 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 -62.41 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.903 0 C-N-CA 122.085 1.857 . . . . 0.0 112.406 160.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 36.4 p -55.42 -41.93 73.45 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.98 -62.16 2.1 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 116.513 -1.708 . . . . 0.0 113.079 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' B' ' 174' ' ' LEU . 22.6 tp -50.98 -53.92 28.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.526 0.73 . . . . 0.0 112.018 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 48.0 mt -60.01 -52.21 66.34 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 95.2 p -62.51 -39.35 93.25 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -58.72 -48.06 82.45 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 0.0 111.795 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' B' ' 177' ' ' ILE . 84.2 mt -53.74 -45.7 70.64 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.241 1.017 . . . . 0.0 112.64 172.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 27.4 tp -57.66 -46.49 84.16 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.129 0.572 . . . . 0.0 112.163 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.38 96.78 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 174' ' ' LEU . 26.7 mt -57.26 -48.44 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.26 -55.09 20.78 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 124.396 0.998 . . . . 0.0 112.593 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.408 ' O ' HG12 ' B' ' 183' ' ' ILE . 23.3 mt -51.66 -46.51 63.78 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.61 -52.83 45.54 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 124.787 1.185 . . . . 0.0 112.527 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.88 -48.26 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 113.758 -1.221 . . . . 0.0 110.281 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -30.38 41.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 179' ' ' LEU . 44.4 pt -67.01 -40.46 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 119.677 1.126 . . . . 0.0 111.178 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.92 -47.46 79.4 Favored Glycine 0 N--CA 1.477 1.407 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.242 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.544 ' HG3' ' OG1' ' B' ' 189' ' ' THR . 3.7 ttt180 -61.42 -54.61 41.34 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.94 -39.25 3.88 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.978 0.911 . . . . 0.0 112.073 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.513 HD23 ' HB ' ' B' ' 188' ' ' THR . 0.8 OUTLIER -65.97 -57.22 8.3 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.17 0.919 . . . . 0.0 113.316 170.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.513 ' HB ' HD23 ' B' ' 187' ' ' LEU 0.282 2.6 t -101.47 -60.63 1.5 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 118.474 2.768 . . . . 0.0 118.474 -168.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . 0.544 ' OG1' ' HG3' ' B' ' 185' ' ' ARG . 47.6 p -103.56 9.14 37.62 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 -168.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -96.51 -36.13 10.88 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.13 151.68 30.51 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.9 t -57.03 -51.01 70.98 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.44 117.29 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.825 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -124.34 125.54 44.51 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.445 1.091 . . . . 0.0 111.33 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -114.02 100.77 8.65 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.467 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -73.58 167.94 20.32 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.59 160.07 53.9 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.436 1.017 . . . . 0.0 114.487 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.15 129.97 0.04 OUTLIER Glycine 0 N--CA 1.487 2.051 0 CA-C-N 113.245 -1.478 . . . . 0.0 114.831 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' A' ' 159' ' ' ALA . 2.4 pp -59.02 142.33 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 114.391 -0.904 . . . . 0.0 113.129 172.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -98.29 -72.07 0.66 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.306 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 163' ' ' LYS . 36.2 t -49.94 -59.36 3.94 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -174.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 156' ' ' ILE . . . 35.99 50.35 0.67 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.875 1.67 . . . . 0.0 114.21 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 66.75 -55.66 0.42 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.295 2.238 . . . . 0.0 114.475 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . 0.297 65.2 m-85 -75.87 -14.07 60.27 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 119.704 3.224 . . . . 0.0 119.704 -170.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.2 mt -82.55 -32.72 28.46 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 165.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.408 ' HB2' ' OG ' ' A' ' 158' ' ' SER . 29.7 tttt -65.18 -32.08 73.58 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.706 0.802 . . . . 0.0 111.426 172.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.5 m -97.13 43.1 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 168.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -151.47 -68.2 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.952 1.301 . . . . 0.0 110.905 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 169' ' ' LEU . 7.3 tp -60.93 -35.74 27.7 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -54.66 -58.87 1.02 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.848 2.365 . . . . 0.0 114.182 171.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.2 p -58.67 -39.36 80.42 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 166' ' ' LEU . 2.8 mp -54.21 -66.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 171.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 30.5 mt -50.86 -43.35 59.39 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.15 -49.89 70.34 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.1 p -69.62 -29.18 66.62 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.438 ' HE1' HD23 ' A' ' 169' ' ' LEU . 24.3 m170 -57.18 -44.96 84.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.074 0.549 . . . . 0.0 111.905 165.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.98 -35.22 76.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.03 -50.24 73.34 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 123.546 0.529 . . . . 0.0 111.994 167.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.426 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -58.49 -48.97 79.03 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.55 -47.23 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.67 1.188 . . . . 0.0 111.648 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.75 -57.75 11.78 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.411 1.481 . . . . 0.0 111.678 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.0 tp -49.7 -46.23 49.83 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.943 1.297 . . . . 0.0 112.171 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -46.81 -62.3 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.618 1.58 . . . . 0.0 113.847 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 10.1 mt -69.91 -31.94 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -49.01 -67.41 0.27 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.313 1.045 . . . . 0.0 112.223 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . 0.294 2.3 pp -67.83 -30.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.27 -64.34 3.42 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 124.997 1.284 . . . . 0.0 112.723 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.0 mtp85 -64.05 -22.11 66.79 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -56.42 -22.68 33.4 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 168.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.6 tp -49.86 -49.15 50.31 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.131 0.972 . . . . 0.0 111.833 167.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.2 p -93.39 -1.68 55.56 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 7.1 p -121.05 42.65 3.0 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 165.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 C--O 1.249 1.074 0 CA-C-N 113.023 -1.898 . . . . 0.0 108.785 167.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 74.76 -64.97 0.36 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 118.1 2.629 . . . . 0.0 118.1 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 16.6 p -121.23 147.27 45.85 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 19.6 m -70.4 171.36 10.15 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.563 1.145 . . . . 0.0 110.876 166.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.608 ' HB ' ' HA2' ' B' ' 154' ' ' GLY 0.31 19.2 m -81.45 71.05 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 123.315 1.531 . . . . 0.0 113.933 179.041 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 77.5 mtm -82.8 108.54 16.22 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 112.256 -2.247 . . . . 0.0 111.563 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt 67.14 -64.56 0.25 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.624 1.97 . . . . 0.0 111.194 -177.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -65.97 94.37 0.23 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.053 1.341 . . . . 0.0 109.557 166.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' B' ' 150' ' ' VAL . . . -109.69 -171.79 20.46 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 112.859 -1.973 . . . . 0.0 112.34 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.9 -59.92 1.74 Allowed Glycine 0 N--CA 1.479 1.535 0 CA-C-N 113.726 -1.237 . . . . 0.0 115.628 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -43.68 144.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.383 1.473 . . . . 0.0 114.175 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -75.96 -21.89 56.52 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -167.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.99 102.31 5.98 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.231 1.015 . . . . 0.0 111.295 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.81 -12.45 10.85 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -51.66 -29.06 16.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.976 1.311 . . . . 0.0 113.013 166.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -43.26 -46.05 6.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.608 1.963 . . . . 0.0 113.052 168.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 5.9 mp -52.16 -36.08 50.59 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.988 1.315 . . . . 0.0 113.96 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -89.42 -52.07 5.23 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -71.47 -20.96 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' B' ' 168' ' ' SER . 4.4 p90 -51.34 -43.51 61.78 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -174.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.98 -46.01 30.8 Favored Pre-proline 0 N--CA 1.485 1.277 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.732 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -55.4 -45.56 39.05 Favored 'Trans proline' 0 N--CA 1.48 0.681 0 C-N-CA 122.284 1.989 . . . . 0.0 111.923 164.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' B' ' 165' ' ' PHE . 55.0 m -47.55 -52.58 17.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.143 0.977 . . . . 0.0 112.003 174.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.412 HD21 HD11 ' A' ' 169' ' ' LEU . 58.7 mt -53.35 -61.62 2.18 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.882 0.873 . . . . 0.0 113.289 176.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 11.4 mt -54.97 -52.05 64.26 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.526 -1.215 . . . . 0.0 113.637 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.75 -58.79 7.06 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.245 1.418 . . . . 0.0 112.64 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 87.4 p -64.03 -37.27 86.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -66.79 -40.25 88.08 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.53 -51.07 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.569 0.7 . . . . 0.0 111.292 170.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.52 -38.91 72.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.393 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.6 -47.28 86.15 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.426 HG13 ' HB1' ' A' ' 176' ' ' ALA . 6.9 mt -57.26 -48.46 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 171.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.53 -57.31 9.53 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.269 1.414 . . . . 0.0 112.618 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 62.4 tp -45.82 -53.12 10.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.392 1.477 . . . . 0.0 111.602 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.19 -62.27 3.98 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 124.642 1.115 . . . . 0.0 112.963 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -54.25 -51.11 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.85 0.86 . . . . 0.0 110.828 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -61.18 -33.54 73.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 57.1 mt -51.46 -51.96 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.237 0.615 . . . . 0.0 110.086 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.47 -46.99 45.3 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 124.798 1.19 . . . . 0.0 112.62 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.07 -56.21 7.5 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -55.01 -37.05 66.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.086 0.954 . . . . 0.0 113.102 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 4.0 mp -64.72 -45.78 85.09 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 171.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 35.9 p -89.48 -15.2 33.6 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -171.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 11.9 p -61.59 154.12 25.84 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 115.005 1.484 . . . . 0.0 115.005 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 95.1 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.433 -1.27 . . . . 0.0 113.993 -173.362 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -107.37 102.85 12.11 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.834 0.826 . . . . 0.0 109.56 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.4 t -110.85 107.08 16.45 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.812 -173.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 55.6 m -61.64 102.88 0.28 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.518 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 19.9 t -122.38 -46.46 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.547 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 84.7 mmm -129.34 152.45 48.88 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.322 1.049 . . . . 0.0 112.107 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -52.89 120.86 6.3 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.023 166.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -126.93 90.1 3.1 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.008 -176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -102.52 -65.14 0.73 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.383 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.08 90.64 0.7 Allowed Glycine 0 CA--C 1.538 1.498 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 159' ' ' ALA . 2.0 pp -110.93 -167.43 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.4 ' H ' ' HB ' ' A' ' 156' ' ' ILE . 17.7 t80 -96.12 -47.43 6.07 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.8 t -126.08 125.72 43.04 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.628 0.727 . . . . 0.0 111.004 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 156' ' ' ILE . . . -115.82 48.91 1.15 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 124.786 2.232 . . . . 0.0 113.026 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -66.13 -47.01 75.53 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 111.327 -2.67 . . . . 0.0 114.734 -174.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -74.13 -35.12 64.09 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.922 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 12.6 tp -52.38 -44.07 65.07 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.001 0.52 . . . . 0.0 111.284 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 160' ' ' GLU . 37.8 tptt -52.51 -27.75 17.72 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.775 1.63 . . . . 0.0 114.952 171.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.0 t -88.97 -64.69 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.808 0.843 . . . . 0.0 108.79 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 168' ' ' SER . 43.2 t80 -45.13 -56.54 4.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.836 2.454 . . . . 0.0 115.615 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 169' ' ' LEU 0.251 0.2 OUTLIER -75.81 -41.42 3.45 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 -174.704 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -55.06 -44.62 47.83 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 121.885 1.723 . . . . 0.0 112.507 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 165' ' ' PHE . 75.2 m -51.79 -53.29 41.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.869 0.868 . . . . 0.0 112.798 170.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 166' ' ' LEU . 22.4 mt -55.8 -44.84 78.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 173.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.4 mt -59.74 -50.91 71.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.008 0.923 . . . . 0.0 113.005 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.0 tp -57.12 -45.58 83.34 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.327 1.051 . . . . 0.0 110.998 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.8 t -51.2 -58.62 5.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.177 1.391 . . . . 0.0 113.487 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -48.01 -51.58 23.38 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.474 1.109 . . . . 0.0 113.494 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 44.2 tp -54.22 -57.07 12.56 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.767 1.227 . . . . 0.0 112.788 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.6 mt -54.35 -44.85 72.52 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.09 -54.48 7.73 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.617 HG13 ' HB1' ' B' ' 176' ' ' ALA . 25.5 mt -55.9 -40.94 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.123 0.569 . . . . 0.0 110.297 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.08 -62.1 5.97 Favored Glycine 0 N--CA 1.48 1.597 0 O-C-N 124.801 1.313 . . . . 0.0 112.35 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.03 -49.75 30.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.807 0.843 . . . . 0.0 113.108 171.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.62 -64.22 3.85 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 125.268 1.413 . . . . 0.0 114.168 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.8 pp -56.62 -33.94 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.8 -58.05 6.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.906 1.282 . . . . 0.0 113.219 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 21.5 mt -56.9 -34.69 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.548 0.739 . . . . 0.0 111.166 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.24 31.35 0.96 Allowed Glycine 0 CA--C 1.54 1.622 0 N-CA-C 116.439 1.335 . . . . 0.0 116.439 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.418 ' HA ' HG21 ' B' ' 188' ' ' THR . 1.1 tmt_? -122.47 -42.83 2.32 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -116.06 -39.21 3.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.316 0.647 . . . . 0.0 112.182 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 8.0 tp -83.93 55.43 3.28 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 123.573 1.654 . . . . 0.0 111.147 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.4 p -123.5 -27.14 4.1 Favored 'General case' 0 C--O 1.199 -1.586 0 CA-C-N 111.667 -2.515 . . . . 0.0 115.148 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 2.2 p -67.11 68.76 0.08 Allowed 'General case' 0 C--N 1.384 2.094 0 CA-C-O 124.999 2.333 . . . . 0.0 112.955 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--N 1.374 1.643 0 CA-C-N 109.789 -3.369 . . . . 0.0 111.151 -165.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 119.265 -0.398 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -54.48 -38.87 66.94 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 124.007 0.817 . . . . 0.0 113.191 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 2.7 p -112.76 119.22 37.31 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.71 1.204 . . . . 0.0 110.888 162.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 3.6 m -72.42 128.98 37.27 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.654 1.216 . . . . 0.0 112.742 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.4 -31.8 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -164.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 13.1 tpt -19.77 -64.43 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.451 2.7 . . . . 0.0 118.151 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -70.74 87.52 0.69 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.841 1.256 . . . . 0.0 108.597 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -76.71 114.16 15.15 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.107 -0.952 . . . . 0.0 113.557 -164.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 59.98 50.4 68.09 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.326 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -142.94 110.21 0.6 Allowed Glycine 0 N--CA 1.472 1.066 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 1.5 pp -48.3 131.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -54.75 -28.78 50.99 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 46.3 t -164.15 126.83 2.45 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.404 1.082 . . . . 0.0 110.665 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.01 -40.78 71.61 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.142 0.901 . . . . 0.0 110.499 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -50.27 -45.28 54.21 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.985 172.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -87.39 -25.58 23.75 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.02 -36.47 72.75 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.256 0.551 . . . . 0.0 111.534 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -49.55 -47.57 49.04 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 168.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.9 -40.55 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.976 0.91 . . . . 0.0 110.062 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -42.05 -58.22 2.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.816 1.646 . . . . 0.0 114.384 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.16 -53.23 67.53 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 115.842 -2.028 . . . . 0.0 114.737 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -56.39 -50.19 12.73 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 123.161 2.574 . . . . 0.0 113.159 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.7 m -57.02 -45.97 82.68 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.74 -46.19 89.24 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.023 1.329 . . . . 0.0 114.424 174.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 33.7 mt -53.23 -56.92 12.67 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.569 0.7 . . . . 0.0 111.113 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' B' ' 171' ' ' LEU . 9.9 tp -58.71 -45.15 90.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.393 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 42.8 t -47.78 -60.39 2.61 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.791 1.237 . . . . 0.0 113.062 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.55 -47.65 72.97 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.163 0.914 . . . . 0.0 113.21 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 4.7 mp -60.93 -53.78 53.05 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.9 mt -51.29 -54.56 24.86 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.33 1.052 . . . . 0.0 111.094 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.617 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -60.7 -48.75 80.37 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.473 -1.694 . . . . 0.0 113.396 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 tt -64.19 -41.92 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.38 63.6 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 124.09 0.869 . . . . 0.0 112.008 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 9.5 tp -54.44 -50.47 67.59 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 113.611 -1.294 . . . . 0.0 111.588 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' B' ' 183' ' ' ILE . . . -49.47 -54.18 17.5 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 124.984 1.278 . . . . 0.0 113.941 176.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 10.2 mt -56.16 -48.56 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.632 0.773 . . . . 0.0 111.484 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -51.23 -52.35 45.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.901 0.881 . . . . 0.0 112.351 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.411 HD12 ' HA2' ' B' ' 180' ' ' GLY . 34.0 mt -54.77 -53.94 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.879 177.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.19 -50.74 44.95 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 125.096 1.331 . . . . 0.0 112.955 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -58.47 -51.26 70.62 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -64.56 -35.23 80.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 17.6 mt -78.97 -32.8 45.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.418 HG21 ' HA ' ' A' ' 185' ' ' ARG . 6.5 p -66.69 -47.47 72.32 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.285 0.991 . . . . 0.0 113.275 170.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 32.5 p -84.26 151.45 24.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.479 0.999 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.767 177.248 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 . . . . . 0 N--CA 1.465 0.304 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -114.78 103.55 11.08 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.108 0.956 . . . . 0.0 112.144 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 t -52.0 105.75 0.12 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.035 170.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.1 t -65.01 155.12 35.68 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 110.57 -3.013 . . . . 0.0 112.69 -170.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.88 -77.8 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 117.175 -1.393 . . . . 0.0 109.315 166.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.61 136.38 29.12 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -108.53 -59.18 1.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.053 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -80.6 118.33 22.08 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -166.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 130.1 69.09 0.11 Allowed Glycine 0 N--CA 1.478 1.448 0 CA-C-N 112.784 -2.007 . . . . 0.0 113.398 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -84.48 -111.4 0.63 Allowed Glycine 0 N--CA 1.476 1.309 0 C-N-CA 123.451 0.548 . . . . 0.0 112.703 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.85 153.66 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.447 1.118 . . . . 0.0 113.759 169.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.96 -77.33 0.07 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.087 -1.87 . . . . 0.0 113.335 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.404 ' HB3' ' CD2' ' B' ' 161' ' ' PHE . 32.2 t -99.76 100.6 11.57 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.513 1.149 . . . . 0.0 113.349 -170.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.69 -20.8 25.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -43.44 65.62 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 174.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -51.76 -55.21 21.09 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.895 1.678 . . . . 0.0 109.651 168.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 162' ' ' LEU . 26.1 mt -55.3 -45.91 76.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -53.49 -55.36 26.05 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 15.3 m -69.77 -16.66 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -103.43 -23.65 13.52 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 118.275 2.695 . . . . 0.0 118.275 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . 0.276 17.9 mt -47.9 -45.15 61.44 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-O 115.639 -2.124 . . . . 0.0 116.662 176.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -57.27 -57.5 1.25 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.203 1.935 . . . . 0.0 112.536 171.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 70.7 m -45.4 -46.01 13.05 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 37.2 mt -62.48 -54.25 42.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.492 1.517 . . . . 0.0 114.606 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.47 -43.74 68.39 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.572 0.749 . . . . 0.0 112.164 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.1 mt -53.08 -63.11 1.25 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.101 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.6 p -59.1 -43.34 91.85 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -66.03 -46.98 75.95 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 174' ' ' LEU . 8.7 mt -56.29 -45.62 80.13 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.3 mt -60.8 -45.33 94.85 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.463 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -56.1 -46.54 79.06 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.439 HG13 ' HB1' ' B' ' 176' ' ' ALA . 11.0 mt -47.53 -54.5 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 123.789 0.835 . . . . 0.0 111.385 170.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.549 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -51.98 -56.81 14.76 Favored Glycine 0 CA--C 1.544 1.872 0 C-N-CA 124.548 1.07 . . . . 0.0 113.138 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.7 mt -51.83 -48.68 63.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.317 1.047 . . . . 0.0 111.702 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.68 -51.12 40.14 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.231 1.396 . . . . 0.0 112.488 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.549 HD12 ' HA2' ' A' ' 178' ' ' GLY . 21.5 mt -54.66 -54.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.023 1.329 . . . . 0.0 110.373 174.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -53.02 -51.71 60.8 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.969 1.418 . . . . 0.0 111.038 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.4 mt -56.67 -62.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 124.382 1.073 . . . . 0.0 109.796 176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -43.15 -56.76 4.48 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 124.734 1.159 . . . . 0.0 113.366 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.435 ' HG3' HG23 ' B' ' 188' ' ' THR . 21.5 ttt180 -62.37 -55.97 22.88 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.368 1.067 . . . . 0.0 112.741 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -69.62 -17.15 63.5 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.74 -23.41 36.71 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 171.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 49.2 p -121.31 56.8 1.03 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.219 1.008 . . . . 0.0 111.426 -171.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 73.2 p -62.2 135.05 57.32 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 113.591 -1.64 . . . . 0.0 114.839 -160.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.979 0 C-N-CA 125.261 1.424 . . . . 0.0 108.929 176.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -63.74 133.0 52.73 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.028 0.442 . . . . 0.0 110.707 175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 68.0 p -111.66 152.25 27.9 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -79.73 139.5 37.29 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.77 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.471 HG23 ' HE3' ' B' ' 152' ' ' LYS . 15.3 m -123.55 134.78 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 112.809 -1.996 . . . . 0.0 110.711 163.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . 0.455 ' SD ' ' HB2' ' B' ' 153' ' ' LYS . 7.8 tmm? -74.18 109.27 7.54 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.687 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.471 ' HE3' HG23 ' B' ' 150' ' ' VAL . 96.1 mttt -111.82 104.59 12.91 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.499 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . 0.455 ' HB2' ' SD ' ' B' ' 151' ' ' MET . 4.9 ttmt -138.12 102.76 4.76 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.702 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 165.65 65.43 0.03 OUTLIER Glycine 0 N--CA 1.487 2.081 0 O-C-N 125.33 1.644 . . . . 0.0 111.087 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.11 110.09 3.52 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.07 0.843 . . . . 0.0 112.826 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . 0.443 HD11 HD13 ' B' ' 162' ' ' LEU . 9.8 pt -21.24 98.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 127.149 2.179 . . . . 0.0 116.375 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 71.94 -46.28 0.64 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.848 2.059 . . . . 0.0 113.964 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 27.0 t -161.74 113.23 1.71 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.876 2.47 . . . . 0.0 110.329 171.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.75 -33.87 67.0 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.444 -1.707 . . . . 0.0 113.66 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.65 -42.98 85.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.055 1.342 . . . . 0.0 112.513 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 158' ' ' SER . 30.8 t80 -65.56 -45.45 83.28 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 173.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.443 HD13 HD11 ' B' ' 156' ' ' ILE . 46.4 tp -54.34 -44.04 71.76 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 123.729 0.643 . . . . 0.0 112.599 172.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -56.12 -47.66 77.68 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 6.1 m -74.12 -31.65 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.96 -51.1 71.49 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.485 1.116 . . . . 0.0 111.399 169.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.296 1.5 mm? -40.51 -61.56 1.17 Allowed Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.28 -56.51 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 122.966 2.444 . . . . 0.0 111.382 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 3.1 p -64.05 -27.82 69.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 38.0 tp -63.41 -52.63 60.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.997 1.319 . . . . 0.0 112.248 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 66.5 mt -58.29 -36.34 73.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.38 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.68 -33.52 66.57 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 69.7 m -71.0 -35.04 71.93 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 172.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -56.29 -42.66 77.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.583 165.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.26 -34.69 65.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.82 -54.24 44.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.306 1.442 . . . . 0.0 110.895 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.439 ' HB1' HG13 ' A' ' 177' ' ' ILE . . . -55.09 -48.36 73.66 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.463 HG13 ' HB1' ' A' ' 176' ' ' ALA . 53.9 mt -61.3 -51.04 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.5 1.12 . . . . 0.0 111.823 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -50.94 -53.89 24.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.671 1.605 . . . . 0.0 112.845 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.54 -47.3 76.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.906 0.882 . . . . 0.0 112.731 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.18 -53.51 23.17 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.989 1.281 . . . . 0.0 113.131 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.66 -46.66 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.067 0.947 . . . . 0.0 112.517 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -51.4 -55.51 18.22 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.531 0.519 . . . . 0.0 112.392 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 181' ' ' ILE 0.26 6.4 tp -61.76 -42.47 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 118.353 -0.832 . . . . 0.0 112.334 175.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -51.58 -52.95 31.09 Favored Glycine 0 N--CA 1.483 1.785 0 C-N-CA 124.417 1.008 . . . . 0.0 113.424 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -56.15 -50.89 69.87 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.811 1.244 . . . . 0.0 111.212 175.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -65.02 -24.16 67.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.7 mt -65.2 -52.34 55.41 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.032 0.933 . . . . 0.0 112.806 166.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 185' ' ' ARG . 3.3 p -70.72 -19.96 62.7 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 174.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 49.5 m -71.53 136.59 47.58 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.276 0.631 . . . . 0.0 109.454 165.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.246 0.887 0 CA-C-O 117.717 -1.135 . . . . 0.0 111.955 179.529 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.477 HH11 ' HB3' ' A' ' 146' ' ' ARG . 5.4 mtp-105 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -51.4 121.75 6.8 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.486 HG22 HG22 ' A' ' 150' ' ' VAL . 84.1 m -117.63 134.49 54.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.648 167.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.6 t -93.42 -70.28 0.71 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.649 1.218 . . . . 0.0 111.144 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 148' ' ' THR 0.291 35.5 m 36.58 103.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 22.8 ttt -72.92 82.97 1.21 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.984 170.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -147.77 136.15 21.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.48 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -156.29 128.86 7.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 112.643 -2.071 . . . . 0.0 108.921 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.53 -97.35 1.18 Allowed Glycine 0 N--CA 1.476 1.337 0 N-CA-C 107.002 -2.439 . . . . 0.0 107.002 171.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -50.48 126.16 23.6 Favored Glycine 0 N--CA 1.477 1.379 0 O-C-N 126.27 1.806 . . . . 0.0 113.861 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -81.33 143.74 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 113.682 -1.259 . . . . 0.0 111.148 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -40.9 97.09 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.795 172.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.0 t -174.85 119.34 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.269 1.428 . . . . 0.0 110.916 175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.89 -77.99 0.6 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.032 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 164' ' ' VAL . 2.5 tp10 -60.81 -40.59 93.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.512 1.125 . . . . 0.0 110.229 173.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -55.27 -46.5 76.14 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.674 175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.31 -56.14 25.89 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.809 0.844 . . . . 0.0 111.659 168.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -49.94 -49.75 48.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 160' ' ' GLU . 73.6 t -49.1 -45.07 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.576 1.15 . . . . 0.0 112.29 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -94.97 14.61 21.16 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.6 mt -48.05 -42.08 46.66 Favored Pre-proline 0 N--CA 1.484 1.253 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.15 -66.12 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.183 2.588 . . . . 0.0 111.17 169.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.0 m -48.73 -56.6 8.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.641 1.576 . . . . 0.0 112.47 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.8 mt -42.54 -51.26 5.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.804 1.642 . . . . 0.0 114.199 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 52.7 mt -89.65 -26.69 20.61 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.95 -35.71 74.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 170.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 74.1 p -68.84 -38.0 79.52 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 168.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -57.58 -47.08 83.09 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.1 mt -53.49 -50.38 65.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.579 0.752 . . . . 0.0 112.263 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.6 tp -51.02 -53.32 34.44 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.17 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.08 -51.82 39.56 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 181' ' ' ILE . 19.4 mt -59.61 -56.58 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.412 0.685 . . . . 0.0 110.625 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.09 -50.52 45.17 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 124.281 0.943 . . . . 0.0 112.816 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.453 HD23 HD11 ' B' ' 177' ' ' ILE . 5.5 tp -56.11 -44.13 78.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.171 1.388 . . . . 0.0 112.139 176.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -58.11 -46.37 92.77 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.99 0.805 . . . . 0.0 113.2 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 177' ' ' ILE . 2.4 mp -53.08 -45.81 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 124.139 0.552 . . . . 0.0 111.425 172.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -56.57 -55.36 34.82 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.6 mt -53.32 -57.82 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.179 0.991 . . . . 0.0 111.243 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -49.82 -50.26 32.54 Favored Glycine 0 CA--C 1.548 2.124 0 C-N-CA 124.783 1.183 . . . . 0.0 112.403 176.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -62.32 -47.13 85.6 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 186' ' ' ARG . 11.5 mmt180 -68.45 -24.97 64.78 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.4 mt -73.09 -51.33 18.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.635 165.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.518 HG23 ' HD3' ' B' ' 185' ' ' ARG . 72.4 p -64.13 -37.11 86.26 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . 0.315 9.5 t 20.4 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 128.24 2.616 . . . . 0.0 117.84 174.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 C--O 1.251 1.165 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.594 177.332 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 8.6 p30 7.91 75.73 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.269 2.228 . . . . 0.0 116.807 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 36.9 p -119.98 98.73 6.22 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.121 0.962 . . . . 0.0 110.498 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 70.9 m -79.72 163.27 24.64 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -168.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.49 127.44 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.777 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 12.2 tpt -61.37 -66.49 0.53 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.184 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 85.6 mttt 34.6 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -115.06 147.54 40.04 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.891 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 134.3 104.75 0.84 Allowed Glycine 0 N--CA 1.485 1.901 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.636 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.55 -101.06 0.25 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.014 1.293 . . . . 0.0 111.366 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . 0.724 HG12 ' HB2' ' B' ' 162' ' ' LEU . 9.8 tp -47.09 125.74 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 175.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -52.35 -43.12 64.46 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 113.892 -1.504 . . . . 0.0 114.284 172.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' B' ' 161' ' ' PHE . 31.1 t -138.64 115.13 10.5 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.283 1.033 . . . . 0.0 113.023 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.15 -45.13 71.93 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.043 171.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -54.17 -51.08 65.49 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.583 1.153 . . . . 0.0 112.698 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' B' ' 158' ' ' SER . 0.3 OUTLIER -59.61 -47.58 85.01 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.724 ' HB2' HG12 ' B' ' 156' ' ' ILE . 20.8 tp -52.42 -52.47 53.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.296 1.038 . . . . 0.0 111.555 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -49.25 -60.38 2.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.676 1.19 . . . . 0.0 111.6 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 18.5 m -66.0 -25.64 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -176.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.21 -42.73 30.48 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.507 HD23 HD23 ' B' ' 169' ' ' LEU 0.256 23.8 mt -43.35 -43.62 11.39 Favored Pre-proline 0 N--CA 1.481 1.1 0 N-CA-C 118.714 2.857 . . . . 0.0 118.714 -177.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -51.7 -66.62 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.498 2.799 . . . . 0.0 113.199 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 19.5 p -54.26 -42.55 70.07 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.507 HD23 HD23 ' B' ' 166' ' ' LEU . 41.6 tp -55.96 -58.0 9.73 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.492 1.12 . . . . 0.0 112.218 175.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -47.2 85.96 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 173.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 51.9 tp -54.5 -45.58 73.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.7 p -62.1 -44.77 95.94 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 123.559 0.537 . . . . 0.0 112.173 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -67.72 -37.2 81.89 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.715 1.206 . . . . 0.0 112.488 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 20.3 mt -60.32 -51.14 70.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.697 1.199 . . . . 0.0 112.326 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 73.5 mt -58.77 -45.48 89.69 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.67 86.98 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.453 HD11 HD23 ' A' ' 179' ' ' LEU . 2.3 tt -70.9 -36.6 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.86 -50.4 54.66 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.244 0.926 . . . . 0.0 111.191 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.41 -42.74 82.89 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.721 -0.739 . . . . 0.0 112.651 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -51.64 -56.81 14.03 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.087 0.851 . . . . 0.0 112.674 170.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 6.2 mt -60.6 -41.01 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.727 0.811 . . . . 0.0 109.881 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -51.81 -61.75 2.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.286 1.034 . . . . 0.0 111.156 174.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 28.0 mt -60.25 -41.34 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.865 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -58.35 -47.39 89.96 Favored Glycine 0 N--CA 1.48 1.626 0 C-N-CA 125.134 1.35 . . . . 0.0 115.922 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.518 ' HD3' HG23 ' A' ' 188' ' ' THR . 27.5 mmt180 -74.11 -37.03 64.26 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 172.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.735 HH11 ' HA ' ' B' ' 190' ' ' SER . 22.9 mmt180 -59.28 -32.54 70.12 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 172.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 1.4 mp -44.67 -34.75 2.33 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.942 1.297 . . . . 0.0 113.41 169.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.1 p -97.22 -75.17 0.55 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.751 0.82 . . . . 0.0 111.012 167.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . 0.49 ' O ' ' HD3' ' B' ' 186' ' ' ARG . 8.9 t -75.83 89.35 2.88 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.918 1.342 . . . . 0.0 114.023 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . 0.735 ' HA ' HH11 ' B' ' 186' ' ' ARG . 29.6 t . . . . . 0 N--CA 1.48 1.03 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.112 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -140.5 116.59 10.5 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.108 175.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.9 p -70.16 144.17 52.07 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 76.7 p -68.37 174.9 3.66 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.084 -1.416 . . . . 0.0 114.648 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 87.8 t -93.64 130.81 42.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 155.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -107.07 137.22 45.55 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.19 0.995 . . . . 0.0 112.449 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.5 90.85 5.69 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.549 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' HE2' ' CE2' ' A' ' 157' ' ' PHE . 3.1 tmmt? -166.36 122.21 1.24 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 112.381 -2.191 . . . . 0.0 107.102 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.02 -100.73 0.01 OUTLIER Glycine 0 N--CA 1.484 1.837 0 O-C-N 124.144 0.903 . . . . 0.0 112.044 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -110.51 -81.9 1.26 Allowed Glycine 0 N--CA 1.475 1.286 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -175.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 tt -106.73 134.13 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' CE2' ' HE2' ' A' ' 153' ' ' LYS . 73.5 m-85 -51.63 -47.79 63.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 172.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.8 t -149.8 106.96 3.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.398 1.094 . . . . 0.0 112.885 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.65 -31.35 72.49 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.495 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.521 ' O ' HG23 ' A' ' 164' ' ' VAL . 16.8 mp0 -59.08 -60.03 4.51 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.295 1.438 . . . . 0.0 110.527 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -45.32 -57.88 3.7 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.443 1.897 . . . . 0.0 111.413 172.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.0 tp -39.25 -64.49 0.46 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.899 2.08 . . . . 0.0 113.19 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -55.95 -51.24 68.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.2 1.4 . . . . 0.0 112.556 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 160' ' ' GLU . 6.9 t -59.62 -37.13 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 123.965 0.791 . . . . 0.0 111.836 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.472 ' HB3' HD12 ' A' ' 169' ' ' LEU . 13.3 m-85 -80.09 -33.93 38.42 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 117.535 2.42 . . . . 0.0 117.535 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -33.37 -57.33 0.57 Allowed Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -67.11 -43.84 5.87 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 121.774 1.649 . . . . 0.0 114.705 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 83.3 p -68.11 -38.38 82.21 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 165' ' ' PHE . 46.6 mt -66.98 -39.91 87.31 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 17.0 mt -51.85 -47.2 64.54 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 167.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.37 -53.89 53.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 59.2 p -59.61 -39.7 85.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -68.75 -43.47 75.78 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 tp -57.43 -44.89 85.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.179 0.992 . . . . 0.0 111.918 170.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -48.78 79.52 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.378 1.071 . . . . 0.0 112.123 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.43 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -58.08 -46.54 85.29 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.521 1.129 . . . . 0.0 113.609 176.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.507 HG22 HD11 ' A' ' 181' ' ' ILE . 58.9 mt -53.68 -53.32 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.307 0.643 . . . . 0.0 110.118 170.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.495 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -48.52 -51.2 22.77 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.155 1.359 . . . . 0.0 113.88 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.2 mt -52.38 -48.66 65.48 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.01 -48.38 83.03 Favored Glycine 0 N--CA 1.488 2.103 0 O-C-N 124.181 0.926 . . . . 0.0 112.43 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 177' ' ' ILE . 27.0 mt -56.89 -49.22 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 124.944 1.297 . . . . 0.0 110.471 175.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.84 -49.14 59.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.563 1.145 . . . . 0.0 112.922 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 49.5 mm -52.91 -50.78 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.325 0.65 . . . . 0.0 111.231 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.14 -56.59 22.48 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 124.55 1.071 . . . . 0.0 113.075 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.663 ' HG3' HD13 ' B' ' 187' ' ' LEU . 22.8 mtt180 -54.2 -48.01 71.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 186' ' ' ARG . 41.9 mmt-85 -60.44 -38.1 83.04 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.62 -57.92 10.65 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 124.457 1.098 . . . . 0.0 110.439 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 28.6 p -87.77 40.45 0.94 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 9.7 t -47.18 128.22 11.42 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.774 1.629 . . . . 0.0 114.846 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.245 0.858 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.27 179.122 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 41.83 87.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 O-C-N 125.421 1.7 . . . . 0.0 113.775 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 23.2 p -89.04 -50.98 5.84 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.974 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 19.7 m -105.11 -52.28 2.87 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.115 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.82 119.36 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 122.335 1.064 . . . . 0.0 109.143 -171.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.46 84.91 3.27 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 113.272 -1.786 . . . . 0.0 111.776 -169.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.64 76.78 7.51 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 112.266 -2.243 . . . . 0.0 113.669 -172.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -163.14 134.92 5.08 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.143 -1.844 . . . . 0.0 111.626 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.37 66.43 1.9 Allowed Glycine 0 N--CA 1.476 1.312 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -176.25 -66.0 0.06 OUTLIER Glycine 0 N--CA 1.475 1.278 0 CA-C-N 113.387 -1.406 . . . . 0.0 111.705 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . 0.43 HG21 HD22 ' B' ' 162' ' ' LEU . 3.8 mp -87.78 77.35 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.984 0 CA-C-O 124.16 1.934 . . . . 0.0 108.738 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -81.97 19.23 1.16 Allowed 'General case' 0 C--O 1.191 -1.987 0 CA-C-N 111.557 -2.565 . . . . 0.0 116.162 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 47.9 t -173.53 119.95 0.31 Allowed 'General case' 0 C--N 1.369 1.439 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.959 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.55 -36.94 65.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.177 -1.829 . . . . 0.0 109.668 174.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -58.69 -45.57 89.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.313 1.045 . . . . 0.0 112.624 172.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.6 -46.09 84.15 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.669 172.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.43 HD22 HG21 ' B' ' 156' ' ' ILE . 16.3 tp -52.91 -37.14 60.36 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 175.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -50.17 -59.9 3.48 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.684 0.794 . . . . 0.0 112.677 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.49 -34.71 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.177 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -53.69 -62.64 1.52 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.106 1.363 . . . . 0.0 113.554 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . 0.268 16.5 mt -46.88 -56.03 13.1 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 116.288 -1.815 . . . . 0.0 115.728 -170.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.46 -45.32 11.93 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.453 2.102 . . . . 0.0 114.716 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 39.0 m -63.08 -38.62 91.91 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.26 -48.37 80.64 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.947 1.299 . . . . 0.0 111.698 169.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.56 -49.43 74.86 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.62 0.368 . . . . 0.0 111.306 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 39.3 p -61.64 -38.93 89.51 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -62.27 -45.67 92.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.33 -45.31 72.64 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 22.3 mt -62.29 -38.97 91.4 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.02 -47.47 82.93 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.43 HG13 ' HB1' ' A' ' 176' ' ' ALA . 18.7 mt -60.08 -41.39 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.13 -52.18 23.25 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 124.919 1.247 . . . . 0.0 113.243 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.64 -44.51 85.68 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.919 0.888 . . . . 0.0 111.782 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.42 -55.35 30.57 Favored Glycine 0 CA--C 1.541 1.658 0 CA-C-N 115.313 -0.858 . . . . 0.0 114.269 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 4.8 tp -62.45 -28.73 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.4 1.08 . . . . 0.0 112.824 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.75 -53.72 55.24 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.358 0.663 . . . . 0.0 110.66 168.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 34.0 mt -54.71 -46.66 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 124.149 0.98 . . . . 0.0 109.302 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.39 -48.07 42.23 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.797 1.665 . . . . 0.0 114.338 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' B' ' 185' ' ' ARG . 10.6 mmm180 -61.42 -28.84 69.55 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 174.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -81.48 -32.97 32.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.663 HD13 ' HG3' ' A' ' 185' ' ' ARG . 57.6 mt -63.23 -21.44 66.23 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 169.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 71.5 p -88.91 -33.66 17.21 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 171.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 71.9 p -71.38 166.83 20.84 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.953 176.782 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -126.19 120.49 30.21 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.377 0.608 . . . . 0.0 111.392 176.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.7 t -103.83 128.65 51.25 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.546 168.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.9 m -142.64 124.07 14.79 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.18 125.38 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 164.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -89.85 77.9 6.92 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.511 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -88.97 130.04 35.53 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -83.92 -44.4 14.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 112.018 -2.356 . . . . 0.0 113.188 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.97 129.66 15.86 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.725 1.155 . . . . 0.0 114.892 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.25 93.79 0.13 Allowed Glycine 0 CA--C 1.541 1.674 0 CA-C-N 112.719 -1.74 . . . . 0.0 109.754 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 6.0 tp -125.83 133.51 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 124.087 0.522 . . . . 0.0 111.405 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -113.92 128.92 56.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.869 169.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.4 t 18.77 109.59 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.98 -27.51 68.34 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.661 168.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.581 ' HA ' ' HE3' ' A' ' 163' ' ' LYS . 5.5 mp0 -63.02 -51.27 67.43 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.048 0.939 . . . . 0.0 112.188 169.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -54.32 -49.16 70.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.355 1.462 . . . . 0.0 110.884 171.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.55 -43.9 80.37 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.627 ' HA ' HD12 ' A' ' 166' ' ' LEU . 32.6 mtmt -59.58 -47.2 86.47 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 172.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.0 t -56.94 -45.69 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -64.5 -29.77 70.81 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 172.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.627 HD12 ' HA ' ' A' ' 163' ' ' LYS 0.294 2.5 mt -44.98 -47.64 30.44 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 118.318 2.71 . . . . 0.0 118.318 -173.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.2 -52.19 9.29 Favored 'Trans proline' 0 N--CA 1.48 0.709 0 C-N-CA 122.142 1.895 . . . . 0.0 112.657 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.8 p -64.88 -38.64 91.63 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.86 -48.79 74.9 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.63 0.729 . . . . 0.0 111.509 171.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.98 -42.51 99.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.977 1.311 . . . . 0.0 113.614 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.6 tp -57.59 -46.32 84.16 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.521 0.728 . . . . 0.0 112.333 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.3 t -58.07 -45.08 87.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.566 0.746 . . . . 0.0 112.073 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.437 ' O ' HG13 ' A' ' 177' ' ' ILE . 29.3 m80 -54.98 -43.41 73.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 169.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.1 tp -64.89 -44.09 90.75 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.005 0.522 . . . . 0.0 111.723 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.19 -35.83 76.27 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.96 83.38 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 168.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 173' ' ' HIS . 10.5 mt -60.77 -45.29 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 173.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -49.66 -54.23 18.11 Favored Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.196 0.935 . . . . 0.0 113.266 172.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 183' ' ' ILE . 7.4 tt -50.73 -47.47 59.29 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 111.626 174.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' B' ' 180' ' ' GLY . . . -57.06 -56.16 26.51 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 124.3 1.0 . . . . 0.0 113.485 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.5 mt -53.58 -50.45 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.062 0.945 . . . . 0.0 110.178 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.419 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 2.6 t80 -50.13 -64.3 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.981 1.426 . . . . 0.0 112.268 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 179' ' ' LEU . 27.2 pt -59.73 -43.77 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -50.32 -53.68 23.02 Favored Glycine 0 N--CA 1.483 1.77 0 C-N-CA 125.654 1.597 . . . . 0.0 113.622 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.462 ' HG3' HG23 ' B' ' 188' ' ' THR . 54.5 ttt-85 -83.87 -53.3 5.69 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.417 0.716 . . . . 0.0 112.695 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.419 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 17.6 mtp180 -70.86 -29.98 66.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 -161.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.8 tt -55.02 -34.11 63.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.546 1.138 . . . . 0.0 112.595 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.9 t -105.26 -44.65 4.69 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . . . . . . . . . 16.3 m -125.65 104.67 8.5 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 116.745 -1.598 . . . . 0.0 113.299 167.099 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -76.26 133.14 40.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.702 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 19.1 m -96.91 88.75 4.64 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.942 0.877 . . . . 0.0 110.481 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 12.2 t 65.25 117.38 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 112.27 -2.241 . . . . 0.0 114.367 171.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.41 129.76 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.502 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' MET . . . . . . . . . . . . . 12.6 ttt -144.81 72.55 1.34 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.744 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -90.81 120.62 32.0 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 113.386 -1.734 . . . . 0.0 110.462 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -126.92 121.11 30.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.119 -1.855 . . . . 0.0 112.771 -169.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -68.6 -82.46 0.17 Allowed Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.774 -1.103 . . . . 0.0 114.015 -171.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 82.52 -48.3 3.94 Favored Glycine 0 N--CA 1.474 1.221 0 O-C-N 125.01 1.065 . . . . 0.0 112.524 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mt -55.49 115.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.365 1.866 . . . . 0.0 107.622 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -65.22 -41.81 94.08 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.037 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 33.8 t -116.79 103.28 10.17 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 172.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.9 -36.64 79.78 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.087 167.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' B' ' 160' ' ' GLU . 7.8 mp0 -56.15 -46.5 79.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.285 1.834 . . . . 0.0 112.318 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -57.28 -58.53 7.83 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.44 1.087 . . . . 0.0 112.411 172.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 33.7 tp -52.93 -41.19 64.23 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -49.66 -56.29 10.64 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 16.0 m -76.31 -26.63 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.0 -49.89 75.88 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.919 1.288 . . . . 0.0 112.603 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . . . . . . . . . 25.3 mt -47.09 -45.56 52.93 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -52.19 -63.65 0.24 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.468 2.779 . . . . 0.0 114.753 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 96.3 p -55.89 -43.98 77.74 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.19 0.596 . . . . 0.0 111.951 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.0 tp -52.2 -57.42 9.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.839 1.656 . . . . 0.0 111.852 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 8.4 tp -53.01 -59.06 5.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.878 1.271 . . . . 0.0 111.125 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 39.1 mt -51.65 -52.62 46.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.85 1.26 . . . . 0.0 113.548 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 24.4 t -59.62 -52.98 63.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.946 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -60.84 -41.47 95.89 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -38.39 86.71 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.27 -29.24 68.79 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 167.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.73 -44.56 85.63 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.863 0.727 . . . . 0.0 112.748 167.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.39 -43.25 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.884 0.873 . . . . 0.0 109.796 166.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -48.93 -61.92 4.95 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.491 1.52 . . . . 0.0 113.622 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.519 ' O ' ' HB3' ' B' ' 182' ' ' TYR . 7.0 tp -53.17 -40.93 64.72 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.438 1.095 . . . . 0.0 112.07 172.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 180' ' ' GLY . . . -52.0 -60.62 7.36 Favored Glycine 0 N--CA 1.474 1.204 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.644 171.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.5 -31.84 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.482 0.713 . . . . 0.0 111.605 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.519 ' HB3' ' O ' ' B' ' 179' ' ' LEU . 83.2 t80 -50.96 -52.41 42.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.407 0.683 . . . . 0.0 111.917 168.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt -66.96 -52.52 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.275 1.03 . . . . 0.0 109.765 174.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . 0.586 ' HA2' HD12 ' B' ' 187' ' ' LEU . . . -45.53 -50.35 10.73 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 125.877 1.703 . . . . 0.0 113.628 177.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.432 ' HD2' ' OG1' ' B' ' 189' ' ' THR . 18.3 mmt180 -67.53 -45.77 74.76 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.8 1.24 . . . . 0.0 113.777 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -61.92 -18.96 62.08 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.586 HD12 ' HA2' ' B' ' 184' ' ' GLY . 68.9 mt -68.74 -44.09 74.52 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.299 1.04 . . . . 0.0 112.275 166.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.462 HG23 ' HG3' ' A' ' 185' ' ' ARG . 22.8 p -96.54 -75.22 0.54 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.673 1.189 . . . . 0.0 114.117 -174.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . 0.432 ' OG1' ' HD2' ' B' ' 185' ' ' ARG . 38.7 p -97.04 162.7 13.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.299 1.44 . . . . 0.0 114.557 -174.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 C--O 1.254 1.308 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.97 178.574 . . . . . . . . 0 0 . 1 stop_ save_